1	ARTICLES	NNS	O	article	_	0	SENT_1	[p1l92t81r246b102],

1	Chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	_	0	SENT_2	[p1l90t181r804b240],
2	versus	CC	O	versus	prep	1	SENT_2	[p1l829t193r1025b229],
3	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	dep	2	SENT_2	[p1l1050t181r1866b240],
4	for	IN	O	for	_	0	SENT_2	[p1l1890t181r1970b229],
5	sequential	JJ	O	sequential	amod	6	SENT_2	[p1l89t271r403b329],
6	episodes	NNS	O	episode	prep_for	3	SENT_2	[p1l430t271r698b329],
7	of	IN	O	of	_	0	SENT_2	[p1l723t271r780b318],
8	uncomplicated	JJ	O	uncomplicated	amod	10	SENT_2	[p1l804t271r1248b329],
9	falciparum	NN	O	falciparum	nn	10	SENT_2	[p1l1273t271r1592b329],
10	malaria	NN	O	malaria	prep_of	1	SENT_2	[p1l1620t271r1841b318],
11	in	IN	O	in	_	0	SENT_2	[p1l1868t271r1916b318],
12	Kenya	NNP	LOCATION	Kenya	prep_in	10	SENT_2	[p1l92t362r269b420],
13	and	CC	O	and	_	0	SENT_2	[p1l295t362r400b409],
14	Malawi	NNP	LOCATION	Malawi	conj_and	12	SENT_2	[p1l429t361r659b409],
15	:	:	O	:	_	0	SENT_2	[p1l429t361r659b409],
16	a	DT	O	a	det	19	SENT_2	[p1l687t373r719b409],
17	randomised	JJ	O	randomised	amod	19	SENT_2	[p1l747t361r1093b409],
18	clinical	JJ	O	clinical	amod	19	SENT_2	[p1l1120t361r1335b409],
19	trial	NN	O	trial	dep	1	SENT_2	[p1l1361t361r1480b409],

1	J	NNP	O	J	nn	2	SENT_3	[p1l87t496r102b522],
2	Sulo	NNP	O	Sulo	_	0	SENT_3	[p1l114t495r192b527],
3	,	,	O	,	_	0	SENT_3	[p1l114t495r192b527],
4	P	NN	O	p	nn	5	SENT_3	[p1l209t496r229b522],
5	Chimpeni	NNP	O	Chimpeni	appos	2	SENT_3	[p1l242t495r401b528],
6	,	,	O	,	_	0	SENT_3	[p1l242t495r401b528],
7	J	NNP	PERSON	J	nn	8	SENT_3	[p1l415t496r430b522],
8	Hatcher	NNP	PERSON	Hatcher	appos	2	SENT_3	[p1l444t496r579b527],
9	,	,	O	,	_	0	SENT_3	[p1l444t496r579b527],
10	J	NNP	O	J	nn	12	SENT_3	[p1l592t496r608b522],
11	G	NNP	O	G	nn	12	SENT_3	[p1l621t495r643b522],
12	Kublin	NNP	O	Kublin	appos	2	SENT_3	[p1l657t496r767b527],
13	,	,	O	,	_	0	SENT_3	[p1l657t496r767b527],
14	C	NNP	O	C	nn	16	SENT_3	[p1l784t495r805b522],
15	V	NNP	O	V	nn	16	SENT_3	[p1l818t496r838b522],
16	Plowe	NNP	O	Plowe	appos	2	SENT_3	[p1l849t496r950b527],
17	,	,	O	,	_	0	SENT_3	[p1l849t496r950b527],
18	M	NN	O	m	nn	20	SENT_3	[p1l967t496r996b522],
19	E	NN	O	e	nn	20	SENT_3	[p1l1009t496r1030b522],
20	Molyneux	NNP	PERSON	Molyneux	appos	2	SENT_3	[p1l1042t496r1203b528],
21	,	,	O	,	_	0	SENT_3	[p1l1042t496r1203b528],
22	K	NNP	O	K	nn	23	SENT_3	[p1l1219t496r1242b522],
23	Marsh	NNP	PERSON	Marsh	appos	2	SENT_3	[p1l1255t496r1363b527],
24	,	,	O	,	_	0	SENT_3	[p1l1255t496r1363b527],
25	T	NN	O	t	nn	27	SENT_3	[p1l1381t496r1399b522],
26	E	NN	O	e	nn	27	SENT_3	[p1l1410t496r1430b522],
27	Taylor	NNP	PERSON	Taylor	appos	2	SENT_3	[p1l1444t496r1546b528],
28	,	,	O	,	_	0	SENT_3	[p1l1444t496r1546b528],
29	W	NNP	O	W	nn	31	SENT_3	[p1l1564t496r1594b522],
30	M	NNP	O	M	nn	31	SENT_3	[p1l1605t496r1634b522],
31	Watkins	NNP	PERSON	Watkins	appos	2	SENT_3	[p1l1649t496r1783b527],
32	,	,	O	,	_	0	SENT_3	[p1l1649t496r1783b527],
33	P	NN	O	p	nn	35	SENT_3	[p1l1800t496r1820b522],
34	A	NN	O	a	nn	35	SENT_3	[p1l1830t496r1850b522],
35	Winstanley	NN	LOCATION	winstanley	appos	2	SENT_3	[p1l1867t496r2043b528],

1	Summary	NN	O	summary	_	0	SENT_4	[p1l7t675r437b758],

1	Background	NN	MISC	background	nn	2	SENT_5	[p1l10t874r444b943],
2	Chlorproguanil-dapsone	NN	MISC	chlorproguanil-dapsone	nsubj	3	SENT_5	[p1l598t873r1440b944],
3	exerts	VBZ	O	exert	_	0	SENT_5	[p1l1594t877r1809b930],
4	lower	JJR	O	lower	amod	6	SENT_5	[p1l1967t874r2151b930],
5	resistance	NN	O	resistance	nn	6	SENT_5	[p1l11t967r380b1024],
6	pressure	NN	O	pressure	dobj	3	SENT_5	[p1l426t980r734b1036],
7	on	IN	O	on	_	0	SENT_5	[p1l776t980r856b1024],
8	Plasmodium	NN	O	plasmodium	nn	9	SENT_5	[p1l901t969r1326b1024],
9	falciparum	NN	O	falciparum	prep_on	3	SENT_5	[p1l1369t968r1737b1036],
10	than	IN	O	than	mark	11	SENT_5	[p1l1778t967r1933b1024],
11	does	VBZ	O	do	advcl	3	SENT_5	[p1l1978t967r2147b1024],
12	sulfadoxine	NN	O	sulfadoxine	nn	14	SENT_5	[p1l9t1060r987b1130],
13	—	NN	O	—	nn	14	SENT_5	[p1l9t1060r987b1130],
14	pyrimethamine	NN	O	pyrimethamine	dobj	11	SENT_5	[p1l9t1060r987b1130],
15	,	,	O	,	_	0	SENT_5	[p1l9t1060r987b1130],
16	but	CC	O	but	_	0	SENT_5	[p1l1044t1060r1155b1117],
17	is	VBZ	O	be	auxpass	19	SENT_5	[p1l1207t1060r1260b1117],
18	rapidly	RB	O	rapidly	advmod	19	SENT_5	[p1l1315t1060r1545b1130],
19	eliminated	VBN	O	eliminate	conj_but	11	SENT_5	[p1l1593t1060r1986b1117],
20	.	.	O	.	_	0	SENT_5	[p1l1593t1060r1986b1117],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l2040t1060r2146b1117],
2	aimed	VBD	O	aim	_	0	SENT_6	[p1l8t1153r221b1209],
3	to	TO	O	to	aux	4	SENT_6	[p1l250t1156r318b1209],
4	find	VB	O	find	xcomp	2	SENT_6	[p1l345t1152r474b1209],
5	out	RP	O	out	prt	4	SENT_6	[p1l506t1156r618b1209],
6	whether	IN	O	whether	complm	10	SENT_6	[p1l643t1153r929b1209],
7	chlorproguanil	NN	O	chlorproguanil	nn	9	SENT_6	[p1l955t1153r1786b1223],
8	—	NN	O	—	nn	9	SENT_6	[p1l955t1153r1786b1223],
9	dapsone	NN	O	dapsone	nsubj	10	SENT_6	[p1l955t1153r1786b1223],
10	results	VBZ	O	result	ccomp	4	SENT_6	[p1l1819t1153r2059b1209],
11	in	IN	O	in	_	0	SENT_6	[p1l2092t1153r2145b1208],
12	a	DT	O	a	det	15	SENT_6	[p1l8t1260r45b1303],
13	higher	JJR	O	higher	amod	15	SENT_6	[p1l106t1246r323b1318],
14	retreatment	NN	O	retreatment	nn	15	SENT_6	[p1l379t1249r797b1303],
15	rate	NN	O	rate	prep_in	10	SENT_6	[p1l854t1249r987b1303],
16	for	IN	O	for	_	0	SENT_6	[p1l1042t1245r1138b1303],
17	malaria	NN	O	malaria	prep_for	15	SENT_6	[p1l1194t1246r1452b1303],
18	than	IN	O	than	_	0	SENT_6	[p1l1508t1246r1663b1303],
19	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_than	10	SENT_6	[p1l1723t1245r2150b1303, p1l12t1340r554b1410],
20	.	.	O	.	_	0	SENT_6	[p1l1723t1245r2150b1303, p1l12t1340r554b1410],

1	Methods	NNS	O	method	npadvmod	15	SENT_7	[p1l10t1529r326b1586],
2	In	IN	O	in	_	0	SENT_7	[p1l380t1529r434b1585],
3	a	DT	O	a	det	5	SENT_7	[p1l487t1542r523b1586],
4	randomised	JJ	O	randomised	amod	5	SENT_7	[p1l578t1529r991b1586],
5	trial	NN	O	trial	prep_in	15	SENT_7	[p1l1041t1529r1173b1586],
6	of	IN	O	of	_	0	SENT_7	[p1l1228t1528r1295b1586],
7	paediatric	JJ	O	paediatric	amod	8	SENT_7	[p1l1344t1529r1692b1598],
8	outpatients	NNS	O	outpatient	prep_of	5	SENT_7	[p1l1743t1529r2147b1598],
9	with	IN	O	with	_	0	SENT_7	[p1l6t1622r146b1679],
10	uncomplicated	JJ	O	uncomplicated	amod	12	SENT_7	[p1l198t1622r713b1691],
11	falciparum	NN	O	falciparum	nn	12	SENT_7	[p1l760t1622r1132b1691],
12	malaria	NN	O	malaria	prep_with	8	SENT_7	[p1l1184t1622r1465b1689],
13	,	,	O	,	_	0	SENT_7	[p1l1184t1622r1465b1689],
14	patients	NNS	O	patient	nsubjpass	26	SENT_7	[p1l1519t1622r1805b1691],
15	received	VBD	O	receive	_	0	SENT_7	[p1l1855t1622r2145b1679],
16	either	CC	O	either	preconj	21	SENT_7	[p1l8t1715r214b1771],
17	ch	NN	O	ch	nn	21	SENT_7	[p1l329t1715r1160b1785],
18	|	NN	O	|	nn	21	SENT_7	[p1l329t1715r1160b1785],
19	orproguanil	NN	O	orproguanil	nn	21	SENT_7	[p1l329t1715r1160b1785],
20	—	NN	O	—	nn	21	SENT_7	[p1l329t1715r1160b1785],
21	dapsone	NN	O	dapsone	dobj	15	SENT_7	[p1l329t1715r1160b1785],
22	or	CC	O	or	_	0	SENT_7	[p1l1280t1728r1348b1771],
23	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	conj_or	21	SENT_7	[p1l1465t1714r2150b1785, p1l6t1808r294b1865],
24	and	CC	O	and	_	0	SENT_7	[p1l330t1808r456b1865],
25	were	VBD	O	be	auxpass	26	SENT_7	[p1l491t1821r656b1865],
26	followed	VBN	O	follow	conj_and	15	SENT_7	[p1l691t1807r983b1865],
27	up	RP	O	up	prt	26	SENT_7	[p1l1024t1821r1104b1877],
28	for	IN	O	for	_	0	SENT_7	[p1l1137t1807r1233b1865],
29	up	RB	DURATION	up	quantmod	31	SENT_7	[p1l1268t1821r1349b1877],
30	to	TO	DURATION	to	dep	31	SENT_7	[p1l1381t1811r1448b1865],
31	1	CD	DURATION	1	prep_for	26	SENT_7	[p1l1488t1808r1527b1864],
32	year	NN	NUMBER	year	tmod	26	SENT_7	[p1l1560t1821r1729b1878],
33	.	.	O	.	_	0	SENT_7	[p1l1560t1821r1729b1878],

1	Sites	NNS	O	site	nsubj	9	SENT_8	[p1l1769t1808r1948b1865],
2	were	VBD	O	be	cop	9	SENT_8	[p1l1982t1821r2147b1865],
3	in	IN	O	in	_	0	SENT_8	[p1l12t1901r65b1957],
4	Kenya	NNP	LOCATION	Kenya	nn	6	SENT_8	[p1l133t1901r340b1971],
5	(	CD	NUMBER	(	num	6	SENT_8	[p1l404t1901r689b1971],
6	n	NN	O	n	prep_in	9	SENT_8	[p1l404t1901r689b1971],
7	=	JJ	O	=	amod	9	SENT_8	[p1l404t1901r689b1971],
8	410	CD	NUMBER	410	tmod	7	SENT_8	[p1l404t1901r689b1971],
9	)	NN	O	)	_	0	SENT_8	[p1l404t1901r689b1971],
10	and	CC	O	and	_	0	SENT_8	[p1l751t1901r877b1958],
11	Malawi	NNP	LOCATION	Malawi	nn	13	SENT_8	[p1l944t1901r1182b1958],
12	(	CD	NUMBER	(	num	13	SENT_8	[p1l1248t1901r1554b1971],
13	n	NN	O	n	conj_and	9	SENT_8	[p1l1248t1901r1554b1971],
14	=	JJ	O	=	amod	16	SENT_8	[p1l1248t1901r1554b1971],
15	500	CD	NUMBER	500	tmod	14	SENT_8	[p1l1248t1901r1554b1971],
16	)	NN	O	)	dep	13	SENT_8	[p1l1248t1901r1554b1971],
17	.	.	O	.	_	0	SENT_8	[p1l1248t1901r1554b1971],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l1618t1901r1725b1958],
2	used	VBD	O	use	_	0	SENT_9	[p1l1790t1901r1955b1958],
3	perprotocol	NN	O	perprotocol	nn	4	SENT_9	[p1l2022t1914r2150b1970, p1l12t1994r291b2063],
4	analysis	NN	O	analysis	dobj	2	SENT_9	[p1l328t1994r617b2064],
5	to	TO	O	to	aux	6	SENT_9	[p1l648t1997r715b2050],
6	assess	VB	O	assess	xcomp	2	SENT_9	[p1l750t2007r1004b2050],
7	the	DT	O	the	det	9	SENT_9	[p1l1035t1994r1147b2050],
8	primary	JJ	O	primary	amod	9	SENT_9	[p1l1185t1994r1444b2064],
9	outcome	NN	O	outcome	dobj	6	SENT_9	[p1l1474t1997r1779b2050],
10	of	IN	O	of	_	0	SENT_9	[p1l1814t1993r1882b2050],
11	annual	JJ	SET	annual	amod	13	SENT_9	[p1l1911t1994r2144b2050],
12	malaria	NN	O	malaria	nn	13	SENT_9	[p1l11t2087r269b2144],
13	incidence	NN	O	incidence	prep_of	9	SENT_9	[p1l306t2087r661b2144],
14	.	.	O	.	_	0	SENT_9	[p1l306t2087r661b2144],

1	Findings	NNS	O	finding	nsubj	2	SENT_10	[p1l10t2275r312b2345],
2	Drop	VBP	O	drop	dep	6	SENT_10	[p1l347t2276r685b2345],
3	—	CD	NUMBER	—	num	4	SENT_10	[p1l347t2276r685b2345],
4	outs	NNS	O	out	dobj	2	SENT_10	[p1l347t2276r685b2345],
5	were	VBD	O	be	cop	6	SENT_10	[p1l715t2289r880b2332],
6	117	CD	NUMBER	117	_	0	SENT_10	[p1l915t2276r1051b2331],
7	of	IN	O	of	_	0	SENT_10	[p1l1086t2275r1154b2332],
8	410	CD	PERCENT	410	number	9	SENT_10	[p1l1180t2275r1322b2332],
9	(	CD	PERCENT	(	prep_of	6	SENT_10	[p1l1355t2275r1628b2345],
10	28-5	CD	PERCENT	28-5	num	11	SENT_10	[p1l1355t2275r1628b2345],
11	%	NN	PERCENT	%	dep	9	SENT_10	[p1l1355t2275r1628b2345],
12	)	CD	NUMBER	)	dep	9	SENT_10	[p1l1355t2275r1628b2345],
13	in	IN	O	in	_	0	SENT_10	[p1l1664t2276r1716b2331],
14	Kenya	NNP	LOCATION	Kenya	prep_in	12	SENT_10	[p1l1754t2276r1985b2346],
15	,	,	O	,	_	0	SENT_10	[p1l1754t2276r1985b2346],
16	and	CC	O	and	_	0	SENT_10	[p1l2020t2276r2145b2332],
17	342	CD	NUMBER	342	number	19	SENT_10	[p1l8t2369r148b2426],
18	of	IN	O	of	quantmod	19	SENT_10	[p1l184t2368r253b2426],
19	500	CD	PERCENT	500	prep_of	6	SENT_10	[p1l283t2368r423b2426],
20	(	CD	PERCENT	(	num	22	SENT_10	[p1l458t2369r731b2438],
21	68-4	CD	PERCENT	68-4	num	22	SENT_10	[p1l458t2369r731b2438],
22	%	NN	PERCENT	%	dep	19	SENT_10	[p1l458t2369r731b2438],
23	)	CD	NUMBER	)	nsubj	6	SENT_10	[p1l458t2369r731b2438],
24	in	IN	O	in	_	0	SENT_10	[p1l769t2369r822b2425],
25	Malawi	NNP	LOCATION	Malawi	prep_in	23	SENT_10	[p1l862t2369r1125b2426],
26	.	.	O	.	_	0	SENT_10	[p1l862t2369r1125b2426],

1	Follow-up	JJ	O	follow-up	nsubj	2	SENT_11	[p1l1167t2369r1489b2438],
2	was	VBD	O	be	_	0	SENT_11	[p1l1520t2382r1657b2426],
3	for	IN	O	for	mark	9	SENT_11	[p1l1690t2368r1785b2426],
4	a	DT	O	a	det	5	SENT_11	[p1l1816t2382r1852b2426],
5	median	NN	O	median	nsubj	9	SENT_11	[p1l1891t2369r2145b2426],
6	of	IN	O	of	_	0	SENT_11	[p1l9t2462r77b2519],
7	338	CD	DURATION	338	num	8	SENT_11	[p1l128t2462r271b2519],
8	days	NNS	NUMBER	day	prep_of	5	SENT_11	[p1l328t2462r488b2532],
9	(	VBP	O	(	advcl	2	SENT_11	[p1l547t2462r692b2532],
10	IQR	NN	O	iqr	nn	12	SENT_11	[p1l547t2462r692b2532],
11	128-360	CD	NUMBER	128-360	num	12	SENT_11	[p1l753t2462r1106b2532],
12	)	NN	O	)	nsubj	16	SENT_11	[p1l753t2462r1106b2532],
13	and	CC	O	and	_	0	SENT_11	[p1l1164t2462r1289b2519],
14	342	CD	DURATION	342	num	15	SENT_11	[p1l1348t2462r1488b2519],
15	days	NNS	NUMBER	day	conj_and	12	SENT_11	[p1l1548t2462r1708b2532],
16	(	VBP	O	(	ccomp	9	SENT_11	[p1l1767t2462r2146b2532],
17	152-359	CD	NUMBER	152-359	num	18	SENT_11	[p1l1767t2462r2146b2532],
18	)	CD	NUMBER	)	dobj	16	SENT_11	[p1l1767t2462r2146b2532],
19	in	IN	O	in	_	0	SENT_11	[p1l12t2555r65b2610],
20	Kilifi	NNP	LOCATION	Kilifi	nn	23	SENT_11	[p1l201t2554r345b2610],
21	(	NN	O	(	nn	23	SENT_11	[p1l479t2555r1334b2625],
22	chlorproguanil	NN	O	chlorproguanil	nn	23	SENT_11	[p1l479t2555r1334b2625],
23	—	NN	O	—	prep_in	16	SENT_11	[p1l479t2555r1334b2625],
24	dapsone	NN	O	dapsone	dep	23	SENT_11	[p1l479t2555r1334b2625],
25	and	CC	O	and	_	0	SENT_11	[p1l1465t2555r1590b2611],
26	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	conj_and	24	SENT_11	[p1l1723t2554r2150b2611, p1l12t2648r555b2718],
27	,	,	O	,	_	0	SENT_11	[p1l1723t2554r2150b2611, p1l12t2648r555b2718],
28	respectively	RB	O	respectively	advmod	23	SENT_11	[p1l605t2648r1071b2718],
29	)	CD	NUMBER	)	dep	23	SENT_11	[p1l605t2648r1071b2718],
30	,	,	O	,	_	0	SENT_11	[p1l605t2648r1071b2718],
31	and	CC	O	and	_	0	SENT_11	[p1l1119t2648r1243b2705],
32	for	IN	O	for	_	0	SENT_11	[p1l1288t2647r1384b2705],
33	120	CD	DURATION	120	num	34	SENT_11	[p1l1428t2648r1566b2705],
34	days	NNS	NUMBER	day	prep_for	41	SENT_11	[p1l1610t2648r1771b2718],
35	(	CD	NUMBER	(	num	37	SENT_11	[p1l1816t2648r2146b2717],
36	33-281	CD	NUMBER	33-281	num	37	SENT_11	[p1l1816t2648r2146b2717],
37	)	NN	O	)	nsubj	41	SENT_11	[p1l1816t2648r2146b2717],
38	and	CC	O	and	_	0	SENT_11	[p1l8t2741r133b2798],
39	84	CD	DURATION	84	num	40	SENT_11	[p1l181t2741r274b2798],
40	days	NNS	NUMBER	day	conj_and	37	SENT_11	[p1l319t2741r478b2811],
41	(	VBP	O	(	conj_and	2	SENT_11	[p1l525t2741r856b2811],
42	26-224	CD	NUMBER	26-224	num	43	SENT_11	[p1l525t2741r856b2811],
43	)	CD	NUMBER	)	dobj	41	SENT_11	[p1l525t2741r856b2811],
44	in	IN	O	in	_	0	SENT_11	[p1l905t2741r958b2797],
45	Blantyre	NNP	LOCATION	Blantyre	prep_in	41	SENT_11	[p1l1009t2741r1314b2811],
46	.	.	O	.	_	0	SENT_11	[p1l1009t2741r1314b2811],

1	Mean	NN	O	mean	nsubj	6	SENT_12	[p1l1367t2741r1555b2798],
2	annual	JJ	SET	annual	amod	4	SENT_12	[p1l1603t2741r1837b2798],
3	malaria	NN	O	malaria	nn	4	SENT_12	[p1l1888t2741r2145b2798],
4	incidence	NN	O	incidence	dep	1	SENT_12	[p1l12t2834r345b2890],
5	was	VBD	O	be	cop	6	SENT_12	[p1l380t2847r517b2890],
6	2-5	CD	NUMBER	2-5	_	0	SENT_12	[p1l554t2833r670b2890],
7	versus	CC	O	versus	prep	6	SENT_12	[p1l705t2847r939b2890],
8	2-1	CD	NUMBER	2-1	dep	7	SENT_12	[p1l976t2833r1092b2889],
9	in	IN	O	in	_	0	SENT_12	[p1l1133t2834r1185b2889],
10	Kenya	NNP	LOCATION	Kenya	nn	13	SENT_12	[p1l1228t2834r1435b2904],
11	(	NN	O	(	nn	13	SENT_12	[p1l1475t2834r1757b2903],
12	relative	JJ	O	relative	amod	13	SENT_12	[p1l1475t2834r1757b2903],
13	risk	NN	O	risk	prep_in	6	SENT_12	[p1l1796t2834r1921b2890],
14	1-16	CD	NUMBER	1-16	dep	13	SENT_12	[p1l1959t2833r2143b2900],
15	,	,	O	,	_	0	SENT_12	[p1l1959t2833r2143b2900],
16	95	CD	PERCENT	95	num	17	SENT_12	[p1l9t2927r159b2984],
17	%	NN	PERCENT	%	prep_in	6	SENT_12	[p1l9t2927r159b2984],
18	Cl	NN	O	cl	nn	20	SENT_12	[p1l200t2927r263b2984],
19	O-98-1-37	NN	O	o-98-1-37	nn	20	SENT_12	[p1l308t2927r737b2996],
20	)	NN	O	)	dep	17	SENT_12	[p1l308t2927r737b2996],
21	,	,	O	,	_	0	SENT_12	[p1l308t2927r737b2996],
22	and	CC	O	and	_	0	SENT_12	[p1l782t2927r907b2984],
23	2-2	CD	NUMBER	2-2	prep_in	6	SENT_12	[p1l952t2927r1067b2983],
24	versus	CC	O	versus	prep	23	SENT_12	[p1l1108t2940r1342b2984],
25	2-8	CD	NUMBER	2-8	dep	24	SENT_12	[p1l1385t2927r1502b2984],
26	in	IN	O	in	_	0	SENT_12	[p1l1546t2927r1599b2983],
27	Malawi	NNP	LOCATION	Malawi	nn	29	SENT_12	[p1l1647t2927r1885b2984],
28	(	CD	NUMBER	(	num	29	SENT_12	[p1l1931t2927r2143b2996],
29	O-77	NN	O	o-77	prep_in	25	SENT_12	[p1l1931t2927r2143b2996],
30	,	,	O	,	_	0	SENT_12	[p1l1931t2927r2143b2996],
31	O-63-0-94	NN	O	o-63-0-94	nn	32	SENT_12	[p1l9t3020r437b3090],
32	)	NN	O	)	appos	29	SENT_12	[p1l9t3020r437b3090],
33	.	.	O	.	_	0	SENT_12	[p1l9t3020r437b3090],

1	4-3	CD	PERCENT	4-3	num	2	SENT_13	[p1l479t3020r655b3077],
2	%	NN	PERCENT	%	nsubjpass	17	SENT_13	[p1l479t3020r655b3077],
3	versus	CC	O	versus	prep	2	SENT_13	[p1l689t3033r924b3077],
4	12-8	CD	PERCENT	12-8	num	5	SENT_13	[p1l965t3020r1208b3086],
5	%	NN	PERCENT	%	dep	3	SENT_13	[p1l965t3020r1208b3086],
6	,	,	O	,	_	0	SENT_13	[p1l965t3020r1208b3086],
7	and	CC	O	and	_	0	SENT_13	[p1l1250t3020r1375b3077],
8	5-4	JJ	PERCENT	5-4	quantmod	9	SENT_13	[p1l1416t3020r1591b3077],
9	%	NN	PERCENT	%	dep	3	SENT_13	[p1l1416t3020r1591b3077],
10	versus	CC	O	versus	prep	9	SENT_13	[p1l1625t3033r1859b3077],
11	20-1	CD	PERCENT	20-1	num	12	SENT_13	[p1l1899t3020r2144b3086],
12	%	NN	PERCENT	%	dep	10	SENT_13	[p1l1899t3020r2144b3086],
13	,	,	O	,	_	0	SENT_13	[p1l1899t3020r2144b3086],
14	of	IN	O	of	_	0	SENT_13	[p1l9t3112r77b3169],
15	patients	NNS	O	patient	prep_of	2	SENT_13	[p1l117t3113r403b3182],
16	were	VBD	O	be	auxpass	17	SENT_13	[p1l444t3126r609b3169],
17	withdrawn	VBN	O	withdraw	_	0	SENT_13	[p1l650t3113r1004b3169],
18	for	IN	O	for	_	0	SENT_13	[p1l1047t3112r1142b3169],
19	treatment	NN	O	treatment	nn	20	SENT_13	[p1l1179t3116r1530b3169],
20	failure	NN	O	failure	prep_for	17	SENT_13	[p1l1568t3112r1790b3169],
21	in	IN	O	in	_	0	SENT_13	[p1l1836t3113r1890b3168],
22	Kenya	NNP	LOCATION	Kenya	prep_in	20	SENT_13	[p1l1938t3113r2145b3183],
23	and	CC	O	and	_	0	SENT_13	[p1l8t3206r133b3262],
24	Malawi	NNP	LOCATION	Malawi	prep_in	20	SENT_13	[p1l252t3206r516b3272],
25	,	,	O	,	_	0	SENT_13	[p1l252t3206r516b3272],
26	respectively	RB	O	respectively	advmod	17	SENT_13	[p1l636t3206r1075b3276],
27	.	.	O	.	_	0	SENT_13	[p1l636t3206r1075b3276],

1	In	IN	O	in	_	0	SENT_14	[p1l1196t3206r1250b3261],
2	Kenya	NNP	LOCATION	Kenya	prep_in	10	SENT_14	[p1l1370t3206r1577b3276],
3	haemoglobin	NN	O	haemoglobin	nn	4	SENT_14	[p1l1695t3206r2145b3277],
4	concentration	NN	O	concentration	nsubj	10	SENT_14	[p1l8t3299r493b3355],
5	of	IN	O	of	_	0	SENT_14	[p1l545t3298r613b3355],
6	50	CD	NUMBER	50	num	7	SENT_14	[p1l658t3298r749b3355],
7	g/L	NN	O	g/l	prep_of	4	SENT_14	[p1l797t3299r921b3369],
8	or	CC	O	or	_	0	SENT_14	[p1l968t3312r1036b3355],
9	less	JJR	O	less	prep_of	4	SENT_14	[p1l1086t3299r1226b3355],
10	caused	VBD	O	cause	_	0	SENT_14	[p1l1276t3299r1528b3355],
11	exit	NN	O	exit	dobj	10	SENT_14	[p1l1580t3299r1705b3355],
12	in	IN	O	in	_	0	SENT_14	[p1l1755t3299r1808b3354],
13	6-9	CD	PERCENT	6-9	num	14	SENT_14	[p1l1860t3298r2035b3355],
14	%	NN	PERCENT	%	prep_in	10	SENT_14	[p1l1860t3298r2035b3355],
15	of	IN	O	of	_	0	SENT_14	[p1l2085t3298r2152b3355],
16	chIorproguanil	NN	O	chiorproguanil	nn	19	SENT_14	[p1l8t3392r839b3462],
17	—	NN	O	—	nn	19	SENT_14	[p1l8t3392r839b3462],
18	dapsone	NN	O	dapsone	nn	19	SENT_14	[p1l8t3392r839b3462],
19	patients	NNS	O	patient	prep_of	14	SENT_14	[p1l889t3392r1174b3461],
20	and	CC	O	and	_	0	SENT_14	[p1l1220t3392r1345b3448],
21	1-5	CD	PERCENT	1-5	num	22	SENT_14	[p1l1396t3391r1569b3448],
22	%	NN	PERCENT	%	prep_in	10	SENT_14	[p1l1396t3391r1569b3448],
23	of	IN	O	of	_	0	SENT_14	[p1l1614t3391r1681b3448],
24	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	nn	25	SENT_14	[p1l1723t3391r2150b3448, p1l12t3485r533b3555],
25	patients	NNS	O	patient	prep_of	22	SENT_14	[p1l567t3485r874b3554],
26	,	,	O	,	_	0	SENT_14	[p1l567t3485r874b3554],
27	but	CC	O	but	_	0	SENT_14	[p1l910t3485r1021b3542],
28	most	JJS	O	most	amod	29	SENT_14	[p1l1051t3488r1226b3542],
29	anaemia	NN	O	anaemia	nsubj	30	SENT_14	[p1l1254t3485r1556b3542],
30	occurred	VBD	O	occur	conj_but	10	SENT_14	[p1l1589t3485r1891b3542],
31	before	IN	O	before	_	0	SENT_14	[p1l1926t3484r2147b3542],
32	re-treatment	NN	O	re-treatment	prep_before	30	SENT_14	[p1l11t3581r467b3634],
33	.	.	O	.	_	0	SENT_14	[p1l11t3581r467b3634],

1	In	IN	O	in	_	0	SENT_15	[p1l511t3578r564b3633],
2	Malawi	NNP	LOCATION	Malawi	prep_in	6	SENT_15	[p1l606t3578r845b3634],
3	only	RB	O	only	advmod	5	SENT_15	[p1l884t3578r1024b3647],
4	one	CD	NUMBER	one	num	5	SENT_15	[p1l1058t3591r1184b3634],
5	patient	NN	O	patient	nsubj	6	SENT_15	[p1l1223t3578r1469b3646],
6	exited	VBD	O	exit	_	0	SENT_15	[p1l1502t3578r1711b3634],
7	because	IN	O	because	_	0	SENT_15	[p1l1751t3578r2048b3634],
8	of	IN	O	of	prepc_because_of	6	SENT_15	[p1l2085t3577r2153b3634],
9	anaemia	NN	O	anaemia	pobj	6	SENT_15	[p1l8t3671r334b3727],
10	.	.	O	.	_	0	SENT_15	[p1l8t3671r334b3727],

1	Interpretation	NNP	O	Interpretation	dep	18	SENT_16	[p2l10t85r513b155],
2	Despite	IN	O	despite	_	0	SENT_16	[p2l642t86r909b154],
3	the	DT	O	the	det	5	SENT_16	[p2l1032t86r1143b142],
4	rapid	JJ	O	rapid	amod	5	SENT_16	[p2l1271t86r1441b154],
5	elimination	NN	O	elimination	prep_despite	18	SENT_16	[p2l1567t86r1957b142],
6	of	IN	O	of	_	0	SENT_16	[p2l2085t85r2153b142],
7	chIorproguanil	NN	O	chiorproguanil	nn	9	SENT_16	[p2l8t179r862b249],
8	—	NN	O	—	nn	9	SENT_16	[p2l8t179r862b249],
9	dapsone	NN	O	dapsone	prep_of	5	SENT_16	[p2l8t179r862b249],
10	,	,	O	,	_	0	SENT_16	[p2l8t179r862b249],
11	children	NNS	O	child	nsubj	18	SENT_16	[p2l903t179r1180b235],
12	treated	VBN	O	treat	partmod	11	SENT_16	[p2l1218t179r1471b235],
13	with	IN	O	with	_	0	SENT_16	[p2l1509t179r1648b235],
14	this	DT	O	this	det	15	SENT_16	[p2l1686t179r1817b235],
15	drug	NN	O	drug	prep_with	12	SENT_16	[p2l1856t179r2009b249],
16	did	VBD	O	do	aux	18	SENT_16	[p2l2045t179r2145b235],
17	not	RB	O	not	neg	18	SENT_16	[p2l11t275r121b329],
18	have	VB	O	have	_	0	SENT_16	[p2l151t272r312b329],
19	a	DT	O	a	det	21	SENT_16	[p2l343t286r379b329],
20	higher	JJR	O	higher	amod	21	SENT_16	[p2l414t272r631b344],
21	incidence	NN	O	incidence	dobj	18	SENT_16	[p2l661t272r994b329],
22	of	IN	O	of	_	0	SENT_16	[p2l1026t271r1094b329],
23	malaria	NN	O	malaria	nn	24	SENT_16	[p2l1122t272r1380b329],
24	episodes	NNS	O	episode	prep_of	21	SENT_16	[p2l1412t272r1734b342],
25	than	IN	O	than	_	0	SENT_16	[p2l1763t272r1917b329],
26	those	DT	O	those	prep_than	18	SENT_16	[p2l1947t272r2146b329],

1	Centre	NNP	O	Centre	dep	192	SENT_17	[p2l8t554r217b605],
2	for	IN	O	for	dep	192	SENT_17	[p2l241t553r324b605],
3	Geographical	NNP	O	Geographical	dep	192	SENT_17	[p2l346t553r757b617],
4	Medicine	NNP	O	Medicine	dep	192	SENT_17	[p2l786t553r1089b615],
5	,	,	O	,	_	0	SENT_17	[p2l786t553r1089b615],
6	Kenya	NNP	ORGANIZATION	Kenya	dep	192	SENT_17	[p2l1119t554r1307b616],
7	Medical	NNP	ORGANIZATION	Medical	dep	192	SENT_17	[p2l1335t553r1579b605],
8	Research	NNP	ORGANIZATION	Research	dep	192	SENT_17	[p2l1609t554r1899b605],
9	Institute	NNP	ORGANIZATION	Institute	dep	192	SENT_17	[p2l10t642r275b693],
10	(	CD	NUMBER	(	dep	192	SENT_17	[p2l301t643r586b704],
11	KEMRI	NNP	O	KEMRI	dep	192	SENT_17	[p2l301t643r586b704],
12	)	CD	NUMBER	)	dep	192	SENT_17	[p2l301t643r586b704],
13	,	,	O	,	_	0	SENT_17	[p2l301t643r586b704],
14	Kilifi	NNP	LOCATION	Kilifi	dep	192	SENT_17	[p2l616t642r769b703],
15	,	,	O	,	_	0	SENT_17	[p2l616t642r769b703],
16	Kenya	NNP	LOCATION	Kenya	dep	192	SENT_17	[p2l799t643r987b704],
17	(	CD	NUMBER	(	dep	192	SENT_17	[p2l1013t643r1054b704],
18	J	NNP	O	J	dep	192	SENT_17	[p2l1013t643r1054b704],
19	Sulo	NNP	O	Sulo	dep	192	SENT_17	[p2l1084t643r1216b693],
20	MBChB	NNP	O	MBChB	dep	192	SENT_17	[p2l1243t655r1422b701],
21	,	,	O	,	_	0	SENT_17	[p2l1243t655r1422b701],
22	Prof	NNP	O	Prof	dep	192	SENT_17	[p2l1454t642r1573b693],
23	K	NNP	O	K	dep	192	SENT_17	[p2l1598t643r1637b692],
24	Marsh	NNP	PERSON	Marsh	dep	192	SENT_17	[p2l1663t643r1890b704],
25	)	NN	O	)	dep	192	SENT_17	[p2l1663t643r1890b704],
26	;	:	O	;	_	0	SENT_17	[p2l1663t643r1890b704],
27	The	DT	O	the	dep	192	SENT_17	[p2l1917t643r2029b693],
28	Malawi-Liverpool-Wellcome	NNP	ORGANIZATION	Malawi-Liverpool-Wellcome	dep	192	SENT_17	[p2l10t730r862b791],
29	Trust	NNP	ORGANIZATION	Trust	dep	192	SENT_17	[p2l886t730r1047b780],
30	Programme	NNP	ORGANIZATION	Programme	dep	192	SENT_17	[p2l1074t730r1431b792],
31	for	IN	ORGANIZATION	for	dep	192	SENT_17	[p2l1455t730r1538b780],
32	Tropical	JJ	ORGANIZATION	tropical	dep	192	SENT_17	[p2l1559t730r1808b791],
33	Medicine	NNP	ORGANIZATION	Medicine	dep	192	SENT_17	[p2l1837t730r2122b780],
34	Research	NNP	ORGANIZATION	Research	dep	192	SENT_17	[p2l10t818r320b879],
35	,	,	O	,	_	0	SENT_17	[p2l10t818r320b879],
36	Blantyre	NNP	LOCATION	Blantyre	dep	192	SENT_17	[p2l351t818r628b880],
37	,	,	O	,	_	0	SENT_17	[p2l351t818r628b880],
38	Malawi	NNP	LOCATION	Malawi	dep	192	SENT_17	[p2l658t818r879b868],
39	(	CD	NUMBER	(	dep	192	SENT_17	[p2l907t819r963b880],
40	P	NN	O	p	dep	192	SENT_17	[p2l907t819r963b880],
41	Chimpeni	NNP	O	Chimpeni	dep	192	SENT_17	[p2l989t818r1270b879],
42	MAC	NNP	O	MAC	dep	192	SENT_17	[p2l1300t831r1416b877],
43	,	,	O	,	_	0	SENT_17	[p2l1300t831r1416b877],
44	Prof	NNP	PERSON	Prof	dep	192	SENT_17	[p2l1447t818r1567b868],
45	M	NNP	PERSON	M	dep	192	SENT_17	[p2l1591t819r1639b868],
46	Molyneux	NNP	PERSON	Molyneux	dep	192	SENT_17	[p2l1671t819r1954b880],
47	FRCP	NNP	O	FRCP	dep	192	SENT_17	[p2l1980t818r2132b880],
48	)	NN	O	)	dep	192	SENT_17	[p2l1980t818r2132b880],
49	;	:	O	;	_	0	SENT_17	[p2l1980t818r2132b880],
50	Division	NN	O	division	dep	192	SENT_17	[p2l9t906r251b957],
51	of	IN	O	of	dep	192	SENT_17	[p2l277t906r337b956],
52	Epidemiology	NNP	O	Epidemiology	dep	192	SENT_17	[p2l360t906r793b968],
53	,	,	O	,	_	0	SENT_17	[p2l360t906r793b968],
54	Prevention	NNP	O	Prevention	dep	192	SENT_17	[p2l823t906r1155b957],
55	and	CC	O	and	dep	192	SENT_17	[p2l1181t907r1291b956],
56	Screening	NNP	O	Screening	dep	192	SENT_17	[p2l1315t906r1648b968],
57	,	,	O	,	_	0	SENT_17	[p2l1315t906r1648b968],
58	Alberta	NNP	ORGANIZATION	Alberta	dep	192	SENT_17	[p2l1674t907r1901b957],
59	Cancer	NNP	ORGANIZATION	Cancer	dep	192	SENT_17	[p2l1927t906r2149b957],
60	Board	NNP	ORGANIZATION	Board	dep	192	SENT_17	[p2l10t995r208b1055],
61	,	,	O	,	_	0	SENT_17	[p2l10t995r208b1055],
62	Canada	NNP	LOCATION	Canada	dep	192	SENT_17	[p2l236t994r470b1045],
63	(	CD	NUMBER	(	dep	192	SENT_17	[p2l497t995r538b1056],
64	J	NNP	PERSON	J	dep	192	SENT_17	[p2l497t995r538b1056],
65	Hatcher	NNP	PERSON	Hatcher	dep	192	SENT_17	[p2l570t995r806b1045],
66	PhD	NNP	O	PhD	dep	192	SENT_17	[p2l830t995r956b1056],
67	)	NN	O	)	dep	192	SENT_17	[p2l830t995r956b1056],
68	;	:	O	;	_	0	SENT_17	[p2l830t995r956b1056],
69	Malaria	NNP	O	Malaria	dep	192	SENT_17	[p2l986t994r1218b1045],
70	Section	NNP	O	Section	dep	192	SENT_17	[p2l1242t994r1499b1055],
71	,	,	O	,	_	0	SENT_17	[p2l1242t994r1499b1055],
72	Center	NNP	O	Center	dep	192	SENT_17	[p2l1528t994r1738b1045],
73	for	IN	O	for	dep	192	SENT_17	[p2l1760t994r1843b1045],
74	Vaccine	NNP	O	Vaccine	dep	192	SENT_17	[p2l1865t994r2115b1045],
75	Development	NNP	O	Development	dep	192	SENT_17	[p2l9t1083r436b1144],
76	,	,	O	,	_	0	SENT_17	[p2l9t1083r436b1144],
77	University	NNP	ORGANIZATION	University	dep	192	SENT_17	[p2l466t1082r777b1144],
78	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l800t1082r860b1133],
79	Maryland	NNP	ORGANIZATION	Maryland	dep	192	SENT_17	[p2l884t1083r1168b1144],
80	School	NNP	ORGANIZATION	School	dep	192	SENT_17	[p2l1193t1083r1403b1133],
81	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l1430t1082r1490b1133],
82	Medicine	NNP	ORGANIZATION	Medicine	dep	192	SENT_17	[p2l1514t1082r1817b1143],
83	,	,	O	,	_	0	SENT_17	[p2l1514t1082r1817b1143],
84	MD	NNP	O	MD	dep	192	SENT_17	[p2l1841t1083r1963b1143],
85	,	,	O	,	_	0	SENT_17	[p2l1841t1083r1963b1143],
86	USA	NNP	LOCATION	USA	dep	192	SENT_17	[p2l1992t1083r2123b1133],
87	(	CD	NUMBER	(	dep	192	SENT_17	[p2l9t1171r50b1232],
88	J	NNP	PERSON	J	dep	192	SENT_17	[p2l9t1171r50b1232],
89	G	NNP	PERSON	G	dep	192	SENT_17	[p2l80t1171r120b1221],
90	Kublin	NNP	PERSON	Kublin	dep	192	SENT_17	[p2l151t1171r333b1221],
91	MD	NNP	O	MD	dep	192	SENT_17	[p2l362t1184r451b1229],
92	,	,	O	,	_	0	SENT_17	[p2l362t1184r451b1229],
93	Prof	NNP	O	Prof	dep	192	SENT_17	[p2l483t1170r603b1221],
94	C	NNP	O	C	dep	192	SENT_17	[p2l624t1171r663b1221],
95	V	NNP	O	V	dep	192	SENT_17	[p2l687t1171r726b1220],
96	Plowe	NNP	O	Plowe	dep	192	SENT_17	[p2l752t1171r925b1221],
97	MD	NN	O	md	dep	192	SENT_17	[p2l953t1171r1064b1232],
98	)	NN	O	)	dep	192	SENT_17	[p2l953t1171r1064b1232],
99	;	:	O	;	_	0	SENT_17	[p2l953t1171r1064b1232],
100	Division	NN	O	division	dep	192	SENT_17	[p2l1094t1170r1335b1221],
101	of	IN	O	of	dep	192	SENT_17	[p2l1361t1170r1421b1221],
102	Tropical	JJ	ORGANIZATION	tropical	dep	192	SENT_17	[p2l1441t1170r1689b1232],
103	Medicine	NN	ORGANIZATION	medicine	dep	192	SENT_17	[p2l1718t1170r2021b1231],
104	,	,	O	,	_	0	SENT_17	[p2l1718t1170r2021b1231],
105	Liverpool	NNP	ORGANIZATION	Liverpool	dep	192	SENT_17	[p2l9t1258r286b1319],
106	School	NNP	ORGANIZATION	School	dep	192	SENT_17	[p2l311t1258r521b1308],
107	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l548t1258r608b1308],
108	Tropical	JJ	ORGANIZATION	tropical	dep	192	SENT_17	[p2l628t1258r876b1319],
109	Medicine	NN	ORGANIZATION	medicine	dep	192	SENT_17	[p2l905t1258r1208b1319],
110	,	,	O	,	_	0	SENT_17	[p2l905t1258r1208b1319],
111	UK	NNP	LOCATION	UK	dep	192	SENT_17	[p2l1237t1258r1326b1308],
112	(	NNP	O	(	dep	192	SENT_17	[p2l1350t1258r1493b1319],
113	Prof	NNP	PERSON	Prof	dep	192	SENT_17	[p2l1350t1258r1493b1319],
114	M	NN	PERSON	m	dep	192	SENT_17	[p2l1517t1258r1564b1307],
115	E	NN	PERSON	e	dep	192	SENT_17	[p2l1597t1258r1629b1307],
116	Molyneux	NNP	PERSON	Molyneux	dep	192	SENT_17	[p2l1657t1258r1979b1320],
117	)	CD	NUMBER	)	dep	192	SENT_17	[p2l1657t1258r1979b1320],
118	;	:	O	;	_	0	SENT_17	[p2l1657t1258r1979b1320],
119	Nuffield	NNP	ORGANIZATION	Nuffield	dep	192	SENT_17	[p2l10t1346r244b1396],
120	Department	NNP	ORGANIZATION	Department	dep	192	SENT_17	[p2l272t1346r641b1408],
121	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l665t1346r725b1396],
122	Clinical	JJ	ORGANIZATION	clinical	dep	192	SENT_17	[p2l747t1346r976b1396],
123	Medicine	NN	ORGANIZATION	medicine	dep	192	SENT_17	[p2l1006t1346r1309b1407],
124	,	,	O	,	_	0	SENT_17	[p2l1006t1346r1309b1407],
125	University	NNP	ORGANIZATION	University	dep	192	SENT_17	[p2l1338t1346r1649b1408],
126	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l1673t1346r1732b1396],
127	Oxford	NNP	ORGANIZATION	Oxford	dep	192	SENT_17	[p2l1754t1346r1976b1407],
128	,	,	O	,	_	0	SENT_17	[p2l1754t1346r1976b1407],
129	John	NNP	ORGANIZATION	John	dep	192	SENT_17	[p2l2002t1346r2142b1396],
130	Radcliffe	NNP	ORGANIZATION	Radcliffe	dep	192	SENT_17	[p2l10t1434r283b1485],
131	Hospital	NNP	ORGANIZATION	Hospital	dep	192	SENT_17	[p2l310t1434r584b1496],
132	,	,	O	,	_	0	SENT_17	[p2l310t1434r584b1496],
133	Oxford	NNP	LOCATION	Oxford	dep	192	SENT_17	[p2l612t1434r834b1495],
134	,	,	O	,	_	0	SENT_17	[p2l612t1434r834b1495],
135	UK	NNP	LOCATION	UK	dep	192	SENT_17	[p2l863t1435r951b1485],
136	(	NNP	O	(	dep	192	SENT_17	[p2l976t1434r1118b1496],
137	Prof	NNP	O	Prof	dep	192	SENT_17	[p2l976t1434r1118b1496],
138	K	NNP	O	K	dep	192	SENT_17	[p2l1143t1435r1182b1484],
139	Marsh	NNP	O	Marsh	dep	192	SENT_17	[p2l1208t1435r1435b1496],
140	)	NN	O	)	dep	192	SENT_17	[p2l1208t1435r1435b1496],
141	;	:	O	;	_	0	SENT_17	[p2l1208t1435r1435b1496],
142	Department	NNP	ORGANIZATION	Department	dep	192	SENT_17	[p2l1464t1435r1833b1496],
143	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l1858t1434r1918b1485],
144	Medicine	NNP	ORGANIZATION	Medicine	dep	192	SENT_17	[p2l10t1522r313b1583],
145	,	,	ORGANIZATION	,	_	0	SENT_17	[p2l10t1522r313b1583],
146	College	NNP	ORGANIZATION	College	dep	192	SENT_17	[p2l341t1522r576b1584],
147	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l600t1522r660b1573],
148	Osteopathic	NNP	ORGANIZATION	Osteopathic	dep	192	SENT_17	[p2l682t1522r1062b1584],
149	Medicine	NNP	ORGANIZATION	Medicine	dep	192	SENT_17	[p2l1090t1522r1393b1583],
150	,	,	O	,	_	0	SENT_17	[p2l1090t1522r1393b1583],
151	Michigan	NNP	ORGANIZATION	Michigan	dep	192	SENT_17	[p2l1423t1522r1707b1584],
152	State	NNP	ORGANIZATION	State	dep	192	SENT_17	[p2l1732t1522r1903b1573],
153	University	NNP	ORGANIZATION	University	dep	192	SENT_17	[p2l9t1610r337b1673],
154	,	,	O	,	_	0	SENT_17	[p2l9t1610r337b1673],
155	MI	NNP	O	MI	dep	192	SENT_17	[p2l368t1611r464b1672],
156	,	,	O	,	_	0	SENT_17	[p2l368t1611r464b1672],
157	USA	NNP	LOCATION	USA	dep	192	SENT_17	[p2l493t1611r623b1662],
158	(	CD	NUMBER	(	dep	192	SENT_17	[p2l648t1610r791b1673],
159	Prof	NNP	PERSON	Prof	dep	192	SENT_17	[p2l648t1610r791b1673],
160	T	NN	PERSON	t	dep	192	SENT_17	[p2l810t1611r845b1661],
161	E	NN	PERSON	e	dep	192	SENT_17	[p2l872t1611r905b1661],
162	Taylor	NNP	PERSON	Taylor	dep	192	SENT_17	[p2l928t1611r1110b1674],
163	Do	VBP	O	do	dep	192	SENT_17	[p2l1134t1611r1237b1673],
164	)	NN	O	)	dep	192	SENT_17	[p2l1134t1611r1237b1673],
165	;	:	O	;	_	0	SENT_17	[p2l1134t1611r1237b1673],
166	Department	NNP	ORGANIZATION	Department	dep	192	SENT_17	[p2l1267t1611r1636b1673],
167	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l1660t1610r1720b1661],
168	Pharmacology	NNP	ORGANIZATION	Pharmacology	dep	192	SENT_17	[p2l10t1700r453b1763],
169	and	CC	ORGANIZATION	and	dep	192	SENT_17	[p2l477t1700r587b1751],
170	Therapeutics	NNP	ORGANIZATION	Therapeutics	dep	192	SENT_17	[p2l612t1699r1040b1762],
171	,	,	O	,	_	0	SENT_17	[p2l612t1699r1040b1762],
172	University	NNP	ORGANIZATION	University	dep	192	SENT_17	[p2l1069t1699r1380b1762],
173	of	IN	ORGANIZATION	of	dep	192	SENT_17	[p2l1403t1699r1463b1751],
174	Liverpool	NNP	ORGANIZATION	Liverpool	dep	192	SENT_17	[p2l1486t1699r1783b1762],
175	,	,	O	,	_	0	SENT_17	[p2l1486t1699r1783b1762],
176	Liverpool	NNP	ORGANIZATION	Liverpool	dep	192	SENT_17	[p2l1812t1699r2089b1762],
177	L69	NNP	O	L69	dep	192	SENT_17	[p2l9t1788r124b1838],
178	3GE	NNP	O	3GE	dep	192	SENT_17	[p2l149t1788r294b1849],
179	,	,	O	,	_	0	SENT_17	[p2l149t1788r294b1849],
180	UK	NNP	LOCATION	UK	dep	192	SENT_17	[p2l324t1788r412b1838],
181	(	NNP	O	(	dep	192	SENT_17	[p2l437t1788r513b1849],
182	W	NNP	O	W	dep	192	SENT_17	[p2l437t1788r513b1849],
183	M	NN	O	m	dep	192	SENT_17	[p2l540t1788r588b1837],
184	Watkins	NNP	PERSON	Watkins	dep	192	SENT_17	[p2l615t1788r858b1838],
185	PhD	NNP	O	PhD	dep	192	SENT_17	[p2l885t1801r989b1847],
186	,	,	O	,	_	0	SENT_17	[p2l885t1801r989b1847],
187	Prof	NNP	PERSON	Prof	dep	192	SENT_17	[p2l1020t1788r1141b1838],
188	P	NN	PERSON	p	dep	192	SENT_17	[p2l1163t1788r1197b1837],
189	A	NN	PERSON	a	dep	192	SENT_17	[p2l1221t1788r1260b1837],
190	Winstanley	NN	PERSON	winstanley	dep	192	SENT_17	[p2l1282t1788r1616b1850],
191	FRCP	NN	O	frcp	dep	192	SENT_17	[p2l1641t1788r1792b1849],
192	)	NN	O	)	_	0	SENT_17	[p2l1641t1788r1792b1849],
193	.	.	O	.	_	0	SENT_17	[p2l1641t1788r1792b1849],

1	Correspondence	NN	O	correspondence	_	0	SENT_18	[p2l8t1883r536b1945],
2	:	:	O	:	_	0	SENT_18	[p2l8t1883r536b1945],
3	Prof	NNP	O	Prof	nn	4	SENT_18	[p2l566t1883r686b1933],
4	P	NN	O	p	dep	1	SENT_18	[p2l709t1883r743b1933],
5	A	DT	O	a	det	7	SENT_18	[p2l766t1883r805b1933],
6	Winstanley	NN	PERSON	winstanley	nn	7	SENT_18	[p2l827t1883r1162b1945],
7	(	NN	O	(	nsubj	14	SENT_18	[p2l9t1972r227b2033],
8	e	SYM	O	e	dep	10	SENT_18	[p2l9t1972r227b2033],
9	—	CD	NUMBER	—	num	10	SENT_18	[p2l9t1972r227b2033],
10	mail	NN	O	mail	dep	14	SENT_18	[p2l9t1972r227b2033],
11	:	:	O	:	_	0	SENT_18	[p2l9t1972r227b2033],
12	peterwin@liv.ac.uk	NN	O	peterwin@liv.ac.uk	nn	13	SENT_18	[p2l259t1971r845b2033],
13	)	NN	O	)	dobj	14	SENT_18	[p2l259t1971r845b2033],
14	treated	VBN	O	treat	rcmod	4	SENT_18	[p2l18t2058r268b2115],
15	with	IN	O	with	_	0	SENT_18	[p2l314t2058r452b2115],
16	su	FW	O	su	nn	19	SENT_18	[p2l501t2057r1469b2128],
17	|	FW	O	|	nn	19	SENT_18	[p2l501t2057r1469b2128],
18	fadoxine	FW	O	fadoxine	nn	19	SENT_18	[p2l501t2057r1469b2128],
19	—	FW	O	—	prep_with	14	SENT_18	[p2l501t2057r1469b2128],
20	pyrimethamine	NN	O	pyrimethamine	dep	19	SENT_18	[p2l501t2057r1469b2128],
21	.	.	O	.	_	0	SENT_18	[p2l501t2057r1469b2128],

1	Treatment	NN	O	treatment	nn	2	SENT_19	[p2l1517t2058r1879b2115],
2	failure	NN	O	failure	nsubj	5	SENT_19	[p2l1920t2057r2140b2115],
3	was	VBD	O	be	cop	5	SENT_19	[p2l18t2164r154b2208],
4	more	RBR	O	more	advmod	5	SENT_19	[p2l193t2164r365b2208],
5	common	JJ	O	common	_	0	SENT_19	[p2l402t2164r698b2208],
6	with	IN	O	with	_	0	SENT_19	[p2l735t2151r873b2208],
7	sulfadoxine	NN	O	sulfadoxine	nn	9	SENT_19	[p2l912t2151r1881b2221],
8	—	NN	O	—	nn	9	SENT_19	[p2l912t2151r1881b2221],
9	pyrimethamine	NN	O	pyrimethamine	prep_with	5	SENT_19	[p2l912t2151r1881b2221],
10	.	.	O	.	_	0	SENT_19	[p2l912t2151r1881b2221],

1	Cause	NN	O	cause	nsubj	6	SENT_20	[p2l1922t2151r2140b2208],
2	of	IN	O	of	_	0	SENT_20	[p2l21t2243r88b2300],
3	anaemia	NN	O	anaemia	prep_of	1	SENT_20	[p2l119t2244r419b2300],
4	in	IN	O	in	_	0	SENT_20	[p2l460t2244r512b2299],
5	Kenya	NNP	LOCATION	Kenya	prep_in	3	SENT_20	[p2l555t2244r760b2314],
6	was	VBD	O	be	_	0	SENT_20	[p2l796t2257r932b2300],
7	probably	RB	O	probably	advmod	6	SENT_20	[p2l971t2244r1267b2314],
8	not	RB	O	not	prep	6	SENT_20	[p2l1303t2247r1411b2300],
9	adverse	JJ	O	adverse	amod	10	SENT_20	[p2l1445t2244r1720b2300],
10	reaction	NN	O	reaction	pobj	8	SENT_20	[p2l1759t2244r2038b2300],
11	to	TO	O	to	aux	12	SENT_20	[p2l2073t2247r2140b2300],
12	ch	VB	O	ch	xcomp	6	SENT_20	[p2l20t2337r866b2408],
13	|	JJ	O	|	amod	16	SENT_20	[p2l20t2337r866b2408],
14	orproguanil	NN	O	orproguanil	nn	16	SENT_20	[p2l20t2337r866b2408],
15	—	NN	O	—	nn	16	SENT_20	[p2l20t2337r866b2408],
16	dapsone	NN	O	dapsone	dobj	12	SENT_20	[p2l20t2337r866b2408],
17	,	,	O	,	_	0	SENT_20	[p2l20t2337r866b2408],
18	but	CC	O	but	_	0	SENT_20	[p2l956t2337r1065b2393],
19	this	DT	O	this	det	20	SENT_20	[p2l1144t2337r1274b2393],
20	observation	NN	O	observation	nsubj	21	SENT_20	[p2l1359t2337r1767b2393],
21	requires	VBZ	O	require	conj_but	6	SENT_20	[p2l1857t2337r2140b2406],
22	further	JJ	O	further	amod	23	SENT_20	[p2l18t2430r255b2487],
23	study	NN	O	study	dobj	21	SENT_20	[p2l284t2430r490b2500],
24	.	.	O	.	_	0	SENT_20	[p2l284t2430r490b2500],

1	Lancet	NNP	O	Lancet	_	0	SENT_21	[p2l21t2620r255b2674],
2	2002	CD	DATE	2002	num	1	SENT_21	[p2l283t2618r493b2683],
3	;	:	O	;	_	0	SENT_21	[p2l283t2618r493b2683],
4	360	CD	NUMBER	360	num	6	SENT_21	[p2l527t2618r691b2674],
5	:	:	O	:	_	0	SENT_21	[p2l527t2618r691b2674],
6	1136	CD	DATE	1136	dep	1	SENT_21	[p2l728t2618r1053b2674],
7	—	CD	NUMBER	—	number	8	SENT_21	[p2l728t2618r1053b2674],
8	43	CD	NUMBER	43	dep	6	SENT_21	[p2l728t2618r1053b2674],

1	Introduction	NN	O	introduction	nsubj	41	SENT_22	[p2l23t2794r581b2861],
2	Almost	RB	O	almost	advmod	3	SENT_22	[p2l18t2894r286b2953],
3	everyone	NN	O	everyone	nsubj	21	SENT_22	[p2l317t2913r645b2969],
4	in	IN	O	in	_	0	SENT_22	[p2l676t2894r745b2952],
5	tropical	JJ	O	tropical	amod	7	SENT_22	[p2l775t2894r1058b2969],
6	Africa	NNP	LOCATION	Africa	nn	7	SENT_22	[p2l1087t2893r1312b2954],
7	contracts	NNS	O	contract	prep_in	3	SENT_22	[p2l1344t2907r1682b2954],
8	Plasmodium	NN	O	plasmodium	nn	10	SENT_22	[p2l1712t2894r2142b2953],
9	falciparum	NN	O	falciparum	nn	10	SENT_22	[p2l7t2986r393b3061],
10	infection	NN	O	infection	dep	7	SENT_22	[p2l422t2986r750b3046],
11	during	IN	O	during	_	0	SENT_22	[p2l780t2986r1024b3061],
12	childhood	NN	O	childhood	prep_during	10	SENT_22	[p2l1053t2986r1448b3058],
13	,	,	O	,	_	0	SENT_22	[p2l1053t2986r1448b3058],
14	and	CC	O	and	_	0	SENT_22	[p2l1482t2986r1617b3046],
15	the	DT	O	the	det	17	SENT_22	[p2l1645t2986r1758b3046],
16	death	NN	O	death	nn	17	SENT_22	[p2l1790t2986r1994b3046],
17	toll	NN	O	toll	conj_and	7	SENT_22	[p2l2022t2986r2141b3046],
18	is	VBZ	O	be	cop	21	SENT_22	[p2l19t3077r72b3138],
19	substantial	JJ	O	substantial	amod	21	SENT_22	[p2l159t3077r861b3138],
20	—	NN	O	—	nn	21	SENT_22	[p2l159t3077r861b3138],
21	abcut	NN	O	abcut	rcmod	1	SENT_22	[p2l159t3077r861b3138],
22	765	CD	NUMBER	765	num	24	SENT_22	[p2l946t3080r1078b3138],
23	ooo	NN	O	ooo	nn	24	SENT_22	[p2l1113t3080r1248b3138],
24	children	NNS	O	child	nsubj	25	SENT_22	[p2l1335t3077r1639b3138],
25	died	VBD	O	die	rcmod	21	SENT_22	[p2l1723t3077r1882b3138],
26	from	IN	O	from	_	0	SENT_22	[p2l1965t3077r2142b3138],
27	malaria	NN	O	malaria	prep_from	25	SENT_22	[p2l19t3170r294b3231],
28	in	IN	O	in	_	0	SENT_22	[p2l357t3171r427b3230],
29	endemic	JJ	O	endemic	amod	30	SENT_22	[p2l490t3170r802b3231],
30	areas	NNS	O	area	prep_in	27	SENT_22	[p2l867t3190r1051b3231],
31	of	IN	O	of	_	0	SENT_22	[p2l1116t3170r1194b3231],
32	Africa	NNP	LOCATION	Africa	prep_of	30	SENT_22	[p2l1245t3170r1470b3231],
33	in	IN	O	in	_	0	SENT_22	[p2l1533t3171r1602b3230],
34	1995.1	CD	NUMBER	1995.1	num	36	SENT_22	[p2l1673t3172r1897b3231],
35	Case	NN	O	case	nn	36	SENT_22	[p2l1966t3171r2141b3231],
36	management	NN	O	management	prep_in	25	SENT_22	[p2l19t3277r500b3339],
37	remains	VBZ	O	remain	cop	41	SENT_22	[p2l536t3264r827b3324],
38	the	DT	O	the	det	41	SENT_22	[p2l866t3264r979b3324],
39	main	JJ	O	main	amod	41	SENT_22	[p2l1017t3264r1203b3324],
40	control	NN	O	control	nn	41	SENT_22	[p2l1241t3264r1504b3324],
41	measure	NN	O	measure	_	0	SENT_22	[p2l1541t3283r1874b3336],
42	,	,	O	,	_	0	SENT_22	[p2l1541t3283r1874b3336],
43	and	CC	O	and	_	0	SENT_22	[p2l1916t3264r2050b3324],
44	is	VBZ	O	be	cop	45	SENT_22	[p2l2087t3264r2140b3324],
45	dependent	JJ	O	dependent	conj_and	41	SENT_22	[p2l21t3355r413b3430],
46	on	IN	O	on	_	0	SENT_22	[p2l456t3375r546b3415],
47	widespread	JJ	O	widespread	amod	48	SENT_22	[p2l585t3355r1007b3430],
48	availability	NN	O	availability	prep_on	45	SENT_22	[p2l1050t3355r1451b3430],
49	of	IN	O	of	_	0	SENT_22	[p2l1492t3355r1570b3415],
50	effective	JJ	O	effective	amod	56	SENT_22	[p2l1603t3355r1932b3427],
51	,	,	O	,	_	0	SENT_22	[p2l1603t3355r1932b3427],
52	safe	JJ	O	safe	amod	56	SENT_22	[p2l1977t3355r2138b3427],
53	,	,	O	,	_	0	SENT_22	[p2l1977t3355r2138b3427],
54	and	CC	O	and	_	0	SENT_22	[p2l21t3447r156b3507],
55	affordable	JJ	O	affordable	amod	56	SENT_22	[p2l261t3447r634b3508],
56	drugs	NNS	O	drug	prep_of	48	SENT_22	[p2l740t3447r1030b3522],
57	.	.	O	.	_	0	SENT_22	[p2l740t3447r1030b3522],

1	“	NN	O	“	nn	3	SENT_23	[p2l740t3447r1030b3522],
2	Treatment	NN	O	treatment	nn	3	SENT_23	[p2l1133t3449r1533b3508],
3	failure	NN	O	failure	nsubj	8	SENT_23	[p2l1635t3447r1870b3508],
4	after	IN	O	after	_	0	SENT_23	[p2l1976t3447r2143b3508],
5	chloroquine	NN	O	chloroquine	prep_after	3	SENT_23	[p2l21t3540r466b3615],
6	is	VBZ	O	be	cop	8	SENT_23	[p2l514t3540r566b3600],
7	now	RB	DATE	now	advmod	8	SENT_23	[p2l614t3559r771b3600],
8	ubiquitous	JJ	O	ubiquitous	_	0	SENT_23	[p2l816t3540r1214b3615],
9	in	IN	O	in	_	0	SENT_23	[p2l1262t3540r1332b3599],
10	sub	NN	O	sub	prep_in	8	SENT_23	[p2l1380t3540r1845b3600],
11	.	.	O	.	_	0	SENT_23	[p2l1380t3540r1845b3600],

1	—	NN	O	—	_	0	SENT_24	[p2l1380t3540r1845b3600],
2	.	.	O	.	_	0	SENT_24	[p2l1380t3540r1845b3600],

1	Saharan	NNP	LOCATION	Saharan	nn	2	SENT_25	[p2l1380t3540r1845b3600],
2	Africa	NNP	LOCATION	Africa	nsubj	5	SENT_25	[p2l1890t3540r2138b3612],
3	,	,	O	,	_	0	SENT_25	[p2l1890t3540r2138b3612],
4	and	CC	O	and	advmod	5	SENT_25	[p2l21t3631r156b3692],
5	occurs	VBZ	O	occur	_	0	SENT_25	[p2l237t3651r474b3692],
6	in	IN	O	in	_	0	SENT_25	[p2l556t3631r625b3691],
7	more	JJR	O	more	mwe	8	SENT_25	[p2l704t3651r893b3692],
8	than	IN	O	than	quantmod	9	SENT_25	[p2l973t3631r1138b3692],
9	25	CD	PERCENT	25	num	10	SENT_25	[p2l1219t3631r1382b3693],
10	%	NN	PERCENT	%	prep_in	5	SENT_25	[p2l1219t3631r1382b3693],
11	of	IN	O	of	_	0	SENT_25	[p2l1467t3631r1545b3692],
12	treated	JJ	O	treated	amod	13	SENT_25	[p2l1614t3631r1874b3692],
13	cases	NNS	O	case	prep_of	10	SENT_25	[p2l1955t3651r2140b3692],
14	throughout	IN	O	throughout	_	0	SENT_25	[p3l19t22r440b97],
15	east	JJ	O	east	amod	16	SENT_25	[p3l593t36r734b83],
16	Africa	NNP	LOCATION	Africa	prep_throughout	5	SENT_25	[p3l884t22r1160b82],
17	.	.	O	.	_	0	SENT_25	[p3l884t22r1160b82],

1	‘’	NN	O	‘’	nsubj	7	SENT_26	[p3l884t22r1160b82],
2	Thus	RB	O	thus	advmod	7	SENT_26	[p3l1311t23r1528b95],
3	,	,	O	,	_	0	SENT_26	[p3l1311t23r1528b95],
4	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	nsubj	7	SENT_26	[p3l1685t22r2141b83, p3l18t115r583b190],
5	is	VBZ	O	be	cop	7	SENT_26	[p3l628t115r680b175],
6	now	RB	DATE	now	advmod	7	SENT_26	[p3l724t134r880b175],
7	first-line	JJ	O	first-line	_	0	SENT_26	[p3l922t115r1235b175],
8	in	IN	O	in	_	0	SENT_26	[p3l1279t115r1348b174],
9	nine	CD	NUMBER	nine	num	10	SENT_26	[p3l1390t115r1549b175],
10	countries	NNS	O	country	prep_in	7	SENT_26	[p3l1595t115r1960b187],
11	,	,	O	,	_	0	SENT_26	[p3l1595t115r1960b187],
12	and	CC	O	and	_	0	SENT_26	[p3l2008t115r2142b175],
13	others	NNS	O	other	nsubj	15	SENT_26	[p3l21t206r246b266],
14	will	MD	O	will	aux	15	SENT_26	[p3l350t206r482b266],
15	follow	VB	O	follow	conj_and	7	SENT_26	[p3l586t206r834b266],
16	.	.	O	.	_	0	SENT_26	[p3l586t206r834b266],

1	Unfortunately	RB	O	unfortunately	advmod	8	SENT_27	[p3l943t206r1495b281],
2	,	,	O	,	_	0	SENT_27	[p3l943t206r1495b281],
3	resistance	NN	O	resistance	nsubj	8	SENT_27	[p3l1602t206r1965b266],
4	to	TO	O	to	_	0	SENT_27	[p3l2070t220r2140b266],
5	sulfadoxine	NN	O	sulfadoxine	nn	7	SENT_27	[p3l21t298r1047b373],
6	—	NN	O	—	nn	7	SENT_27	[p3l21t298r1047b373],
7	pyrimethamine	NN	O	pyrimethamine	prep_to	3	SENT_27	[p3l21t298r1047b373],
8	develops	VBZ	O	develop	_	0	SENT_27	[p3l1112t298r1431b373],
9	readily	RB	O	readily	advmod	8	SENT_27	[p3l1496t298r1748b373],
10	and	CC	O	and	_	0	SENT_27	[p3l1812t298r1946b359],
11	this	DT	O	this	det	12	SENT_27	[p3l2010t298r2140b358],
12	process	NN	O	process	nsubjpass	14	SENT_27	[p3l18t410r292b466],
13	is	VBZ	O	be	auxpass	14	SENT_27	[p3l349t391r401b451],
14	facilitated	VBN	O	facilitate	conj_and	8	SENT_27	[p3l457t391r825b451],
15	by	IN	O	by	_	0	SENT_27	[p3l878t391r967b466],
16	the	DT	O	the	det	18	SENT_27	[p3l1020t391r1133b451],
17	slow	JJ	O	slow	amod	18	SENT_27	[p3l1190t391r1354b451],
18	elimination	NN	O	elimination	agent	14	SENT_27	[p3l1409t391r1831b451],
19	of	IN	O	of	_	0	SENT_27	[p3l1887t391r1965b451],
20	this	DT	O	this	det	21	SENT_27	[p3l2009t391r2140b451],
21	drug	NN	O	drug	prep_of	18	SENT_27	[p3l21t482r285b557],
22	.	.	O	.	_	0	SENT_27	[p3l21t482r285b557],

1	“	NN	O	“	nn	3	SENT_28	[p3l21t482r285b557],
2	Point	NN	O	point	nn	3	SENT_28	[p3l372t482r572b542],
3	mutations	NNS	O	mutation	dep	14	SENT_28	[p3l657t482r1030b542],
4	of	IN	O	of	_	0	SENT_28	[p3l1119t482r1198b542],
5	both	DT	O	both	det	7	SENT_28	[p3l1272t482r1443b542],
6	enzyme	NN	O	enzyme	nn	7	SENT_28	[p3l1530t501r1808b557],
7	targets	NNS	O	target	prep_of	3	SENT_28	[p3l1894t496r2141b557],
8	of	IN	O	of	_	0	SENT_28	[p3l21t574r99b634],
9	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	10	SENT_28	[p3l137t574r1162b649],
10	(	NN	O	(	prep_of	7	SENT_28	[p3l1215t574r1740b649],
11	dihydrofolate	JJ	O	dihydrofolate	amod	12	SENT_28	[p3l1215t574r1740b649],
12	reductase	NN	O	reductase	dep	14	SENT_28	[p3l1786t574r2141b635],
13	[	CD	NUMBER	[	num	14	SENT_28	[p3l29t667r315b741],
14	DHFR	NN	O	dhfr	dep	22	SENT_28	[p3l29t667r315b741],
15	8	CD	NUMBER	8	dep	14	SENT_28	[p3l349t668r435b697],
16	"	``	O	"	punct	15	SENT_28	[p3l349t668r435b697],
17	“	NN	O	“	nn	20	SENT_28	[p3l349t668r435b697],
18	and	CC	O	and	_	0	SENT_28	[p3l487t667r621b727],
19	dihydropteroate	NN	O	dihydropteroate	nn	20	SENT_28	[p3l670t667r1266b742],
20	synthetase	NN	O	synthetase	dep	15	SENT_28	[p3l1316t667r1699b742],
21	[	CD	NUMBER	[	num	22	SENT_28	[p3l1758t667r2135b741],
22	DHPS	NN	O	dhp	dep	28	SENT_28	[p3l1758t667r2135b741],
23	]	CD	NUMBER	]	number	24	SENT_28	[p3l1758t667r2135b741],
24	”	CD	NUMBER	”	num	25	SENT_28	[p3l1758t667r2135b741],
25	)	NN	O	)	nsubjpass	28	SENT_28	[p3l1758t667r2135b741],
26	have	VBP	O	have	aux	28	SENT_28	[p3l18t758r186b818],
27	been	VBN	O	be	auxpass	28	SENT_28	[p3l248t758r424b818],
28	reported	VBN	O	report	_	0	SENT_28	[p3l485t758r823b833],
29	.	.	O	.	_	0	SENT_28	[p3l485t758r823b833],

1	Triple	JJ	O	triple	amod	3	SENT_29	[p3l889t758r1119b833],
2	point	NN	O	point	nn	3	SENT_29	[p3l1180t758r1376b833],
3	mutations	NNS	O	mutation	nsubj	20	SENT_29	[p3l1436t758r1809b818],
4	in	IN	O	in	_	0	SENT_29	[p3l1873t758r1942b817],
5	dhfr	NN	O	dhfr	nn	7	SENT_29	[p3l2004t758r2148b833],
6	(	CD	NUMBER	(	num	7	SENT_29	[p3l26t851r338b924],
7	S108N	NN	O	s108n	prep_in	3	SENT_29	[p3l26t851r338b924],
8	,	,	O	,	_	0	SENT_29	[p3l26t851r338b924],
9	N511	NN	O	n511	prep_in	3	SENT_29	[p3l392t851r612b922],
10	,	,	O	,	_	0	SENT_29	[p3l392t851r612b922],
11	and	CC	O	and	_	0	SENT_29	[p3l669t850r803b911],
12	C59R	NN	O	c59r	nn	13	SENT_29	[p3l858t851r1131b925],
13	)	NN	O	)	prep_in	3	SENT_29	[p3l858t851r1131b925],
14	,	,	O	,	_	0	SENT_29	[p3l858t851r1131b925],
15	and	CC	O	and	_	0	SENT_29	[p3l1188t850r1322b911],
16	double	JJ	O	double	amod	17	SENT_29	[p3l1376t850r1628b911],
17	mutation	NN	O	mutation	conj_and	7	SENT_29	[p3l1680t851r2021b911],
18	of	IN	O	of	_	0	SENT_29	[p3l2074t850r2152b910],
19	dhps	NNS	O	dhp	prep_of	17	SENT_29	[p3l20t943r176b1018],
20	(	VBP	O	(	_	0	SENT_29	[p3l250t943r474b1017],
21	A437	NN	O	a437	nn	22	SENT_29	[p3l250t943r474b1017],
22	G	NN	O	g	nsubj	31	SENT_29	[p3l484t943r551b1003],
23	and	CC	O	and	_	0	SENT_29	[p3l620t943r755b1003],
24	K54OE	NN	O	k54oe	nn	25	SENT_29	[p3l824t943r1117b1017],
25	)	NN	O	)	nsubj	28	SENT_29	[p3l824t943r1117b1017],
26	are	VBP	O	be	cop	28	SENT_29	[p3l1194t962r1302b1003],
27	both	DT	O	both	dep	28	SENT_29	[p3l1370t943r1541b1003],
28	common	JJ	O	common	ccomp	20	SENT_29	[p3l1611t962r1937b1003],
29	and	CC	O	and	_	0	SENT_29	[p3l2008t943r2142b1003],
30	frequently	RB	O	frequently	advmod	31	SENT_29	[p3l19t1034r401b1109],
31	associated	VBN	O	associate	conj_and	28	SENT_29	[p3l459t1034r837b1094],
32	with	IN	O	with	_	0	SENT_29	[p3l894t1034r1056b1094],
33	sulfadoxine	NN	O	sulfadoxine	nn	36	SENT_29	[p3l1115t1034r2141b1109],
34	—	NN	O	—	nn	36	SENT_29	[p3l1115t1034r2141b1109],
35	pyrimethamine	NN	O	pyrimethamine	nn	36	SENT_29	[p3l1115t1034r2141b1109],
36	failure	NN	O	failure	prep_with	31	SENT_29	[p3l19t1126r254b1186],
37	in	IN	O	in	_	0	SENT_29	[p3l286t1126r355b1186],
38	Africa	NNP	LOCATION	Africa	prep_in	36	SENT_29	[p3l382t1126r628b1186],
39	.	.	O	.	_	0	SENT_29	[p3l382t1126r628b1186],

1	In	IN	O	in	_	0	SENT_30	[p3l664t1127r743b1185],
2	southeast	NN	O	southeast	nn	3	SENT_30	[p3l773t1126r1123b1187],
3	Asia	NNP	LOCATION	Asia	prep_in	16	SENT_30	[p3l1151t1127r1332b1198],
4	,	,	O	,	_	0	SENT_30	[p3l1151t1127r1332b1198],
5	widespread	JJ	O	widespread	amod	6	SENT_30	[p3l1364t1126r1786b1201],
6	selection	NN	O	selection	appos	3	SENT_30	[p3l1817t1126r2142b1186],
7	of	IN	O	of	_	0	SENT_30	[p3l21t1219r99b1279],
8	a	DT	O	a	det	11	SENT_30	[p3l122t1238r157b1279],
9	fourth	JJ	ORDINAL	fourth	amod	11	SENT_30	[p3l187t1219r418b1279],
10	dhfr	NN	O	dhfr	nn	11	SENT_30	[p3l448t1219r592b1294],
11	mutation	NN	O	mutation	prep_of	6	SENT_30	[p3l616t1219r957b1279],
12	(	CD	NUMBER	(	num	14	SENT_30	[p3l992t1219r1278b1293],
13	I164L	NN	O	i164l	nn	14	SENT_30	[p3l992t1219r1278b1293],
14	)	NN	O	)	nsubj	16	SENT_30	[p3l992t1219r1278b1293],
15	has	VBZ	O	have	aux	16	SENT_30	[p3l1313t1219r1432b1279],
16	rendered	VBN	O	render	_	0	SENT_30	[p3l1465t1219r1797b1279],
17	the	DT	O	the	det	18	SENT_30	[p3l1827t1219r1940b1279],
18	drug	NN	O	drug	dobj	16	SENT_30	[p3l1973t1219r2143b1294],
19	clinically	RB	O	clinically	advmod	20	SENT_30	[p3l21t1310r351b1385],
20	useless	JJ	O	useless	amod	18	SENT_30	[p3l386t1310r638b1370],
21	in	IN	O	in	_	0	SENT_30	[p3l677t1310r746b1369],
22	many	JJ	O	many	amod	23	SENT_30	[p3l783t1330r987b1385],
23	areas	NNS	O	area	prep_in	16	SENT_30	[p3l1024t1330r1231b1382],
24	;	:	O	;	_	0	SENT_30	[p3l1024t1330r1231b1382],
25	the	DT	O	the	det	27	SENT_30	[p3l1271t1310r1384b1370],
26	same	JJ	O	same	amod	27	SENT_30	[p3l1423t1330r1608b1370],
27	mutation	NN	O	mutation	nsubjpass	30	SENT_30	[p3l1645t1310r1985b1370],
28	has	VBZ	O	have	aux	30	SENT_30	[p3l2020t1310r2140b1370],
29	been	VBN	O	be	auxpass	30	SENT_30	[p3l18t1402r195b1463],
30	found	VBN	O	find	parataxis	16	SENT_30	[p3l253t1402r472b1463],
31	at	IN	O	at	_	0	SENT_30	[p3l532t1416r598b1462],
32	very	RB	O	very	advmod	33	SENT_30	[p3l654t1422r809b1477],
33	low	JJ	O	low	amod	34	SENT_30	[p3l866t1402r997b1463],
34	frequency	NN	O	frequency	prep_at	30	SENT_30	[p3l1054t1402r1423b1477],
35	in	IN	O	in	_	0	SENT_30	[p3l1480t1403r1549b1462],
36	Tanzania	NNP	LOCATION	Tanzania	prep_in	34	SENT_30	[p3l1607t1403r2027b1462],
37	.	.	O	.	_	0	SENT_30	[p3l1607t1403r2027b1462],

1	”	NN	O	”	nsubj	10	SENT_31	[p3l1607t1403r2027b1462],
2	If	IN	O	if	mark	5	SENT_31	[p3l2086t1402r2152b1462],
3	I164L	NN	O	i164l	nsubj	5	SENT_31	[p3l20t1496r253b1555],
4	becomes	VBZ	O	become	cop	5	SENT_31	[p3l292t1495r614b1555],
5	widespread	JJ	O	widespread	dep	10	SENT_31	[p3l658t1495r1080b1570],
6	in	IN	O	in	_	0	SENT_31	[p3l1125t1495r1194b1554],
7	Africa	NNP	LOCATION	Africa	prep_in	5	SENT_31	[p3l1236t1495r1462b1555],
8	we	PRP	O	we	nsubj	10	SENT_31	[p3l1505t1514r1604b1555],
9	can	MD	O	can	aux	10	SENT_31	[p3l1651t1514r1778b1555],
10	expect	VB	O	expect	_	0	SENT_31	[p3l1823t1508r2061b1570],
11	a	DT	O	a	det	13	SENT_31	[p3l2107t1514r2141b1555],
12	striking	JJ	O	striking	amod	13	SENT_31	[p3l21t1586r298b1661],
13	rise	NN	O	rise	dobj	10	SENT_31	[p3l346t1586r473b1646],
14	in	IN	O	in	_	0	SENT_31	[p3l523t1586r593b1645],
15	the	DT	O	the	det	17	SENT_31	[p3l642t1586r755b1646],
16	malaria	NN	O	malaria	nn	17	SENT_31	[p3l805t1586r1080b1646],
17	burden	NN	O	burden	prep_in	10	SENT_31	[p3l1129t1586r1397b1646],
18	since	IN	O	since	mark	34	SENT_31	[p3l1448t1586r1654b1658],
19	,	,	O	,	_	0	SENT_31	[p3l1448t1586r1654b1658],
20	by	IN	O	by	_	0	SENT_31	[p3l1705t1586r1794b1661],
21	contrast	NN	O	contrast	prep_by	34	SENT_31	[p3l1844t1600r2143b1646],
22	with	IN	O	with	_	0	SENT_31	[p3l18t1678r180b1739],
23	the	DT	O	the	det	24	SENT_31	[p3l224t1678r337b1739],
24	governments	NNS	O	government	prep_with	21	SENT_31	[p3l383t1692r860b1753],
25	of	IN	O	of	_	0	SENT_31	[p3l908t1678r986b1738],
26	southeast	NN	O	southeast	nn	27	SENT_31	[p3l1022t1678r1372b1738],
27	Asia	NNP	LOCATION	Asia	prep_of	24	SENT_31	[p3l1414t1679r1595b1750],
28	,	,	O	,	_	0	SENT_31	[p3l1414t1679r1595b1750],
29	most	JJS	O	most	amod	31	SENT_31	[p3l1643t1692r1825b1738],
30	African	JJ	MISC	african	amod	31	SENT_31	[p3l1866t1678r2142b1738],
31	governments	NNS	O	government	nsubj	34	SENT_31	[p3l19t1784r496b1846],
32	would	MD	O	would	aux	34	SENT_31	[p3l532t1771r762b1831],
33	be	VB	O	be	cop	34	SENT_31	[p3l795t1771r881b1831],
34	unable	JJ	O	unable	advcl	10	SENT_31	[p3l917t1771r1166b1831],
35	to	TO	O	to	aux	36	SENT_31	[p3l1202t1784r1272b1831],
36	afford	VB	O	afford	xcomp	34	SENT_31	[p3l1311t1771r1530b1831],
37	widespread	JJ	O	widespread	amod	38	SENT_31	[p3l1565t1771r1986b1846],
38	use	NN	O	use	dobj	36	SENT_31	[p3l2021t1790r2141b1831],
39	of	IN	O	of	_	0	SENT_31	[p3l21t1862r99b1922],
40	expensive	JJ	O	expensive	amod	41	SENT_31	[p3l120t1862r477b1937],
41	drugs	NNS	O	drug	prep_of	38	SENT_31	[p3l508t1862r732b1937],
42	.	.	O	.	_	0	SENT_31	[p3l508t1862r732b1937],

1	Thus	RB	O	thus	advmod	4	SENT_32	[p3l103t1954r320b2026],
2	,	,	O	,	_	0	SENT_32	[p3l103t1954r320b2026],
3	there	EX	O	there	expl	4	SENT_32	[p3l380t1954r567b2014],
4	is	VBZ	O	be	_	0	SENT_32	[p3l625t1955r678b2014],
5	a	DT	O	a	det	7	SENT_32	[p3l738t1974r773b2014],
6	pressing	VBG	O	press	amod	7	SENT_32	[p3l830t1955r1136b2029],
7	need	NN	O	need	nsubj	4	SENT_32	[p3l1191t1954r1368b2015],
8	for	IN	O	for	_	0	SENT_32	[p3l1425t1954r1530b2014],
9	effective	JJ	O	effective	prep_for	4	SENT_32	[p3l1587t1954r1916b2026],
10	,	,	O	,	_	0	SENT_32	[p3l1587t1954r1916b2026],
11	safe	JJ	O	safe	conj_and	9	SENT_32	[p3l1978t1954r2139b2026],
12	,	,	O	,	_	0	SENT_32	[p3l1978t1954r2139b2026],
13	practicable	JJ	O	practicable	prep_for	4	SENT_32	[p3l18t2047r450b2122],
14	,	,	O	,	_	0	SENT_32	[p3l18t2047r450b2122],
15	and	CC	O	and	_	0	SENT_32	[p3l531t2047r665b2107],
16	affordable	JJ	O	affordable	prep_for	4	SENT_32	[p3l744t2047r1116b2107],
17	drugs	NNS	O	drug	tmod	4	SENT_32	[p3l1195t2047r1397b2122],
18	that	WDT	O	that	nsubj	19	SENT_32	[p3l1475t2047r1620b2107],
19	have	VBP	O	have	rcmod	17	SENT_32	[p3l1694t2047r1862b2107],
20	lower	JJR	O	lower	amod	22	SENT_32	[p3l1939t2047r2144b2107],
21	selection	NN	O	selection	nn	22	SENT_32	[p3l21t2138r346b2198],
22	pressure	NN	O	pressure	dobj	19	SENT_32	[p3l424t2158r734b2213],
23	for	IN	O	for	_	0	SENT_32	[p3l814t2138r919b2198],
24	resistance	NN	O	resistance	prep_for	19	SENT_32	[p3l996t2138r1359b2198],
25	than	IN	O	than	_	0	SENT_32	[p3l1439t2138r1604b2198],
26	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_than	24	SENT_32	[p3l1685t2138r2141b2198, p3l18t2230r607b2305],
27	,	,	O	,	_	0	SENT_32	[p3l1685t2138r2141b2198, p3l18t2230r607b2305],
28	and	CC	O	and	_	0	SENT_32	[p3l673t2230r807b2291],
29	that	DT	O	that	nsubjpass	32	SENT_32	[p3l867t2230r1013b2290],
30	could	MD	O	could	aux	32	SENT_32	[p3l1074t2230r1279b2291],
31	be	VB	O	be	auxpass	32	SENT_32	[p3l1338t2230r1423b2290],
32	used	VBN	O	use	conj_and	4	SENT_32	[p3l1485t2230r1655b2291],
33	for	IN	O	for	_	0	SENT_32	[p3l1715t2230r1820b2290],
34	salvage	NN	O	salvage	nn	35	SENT_32	[p3l1881t2230r2141b2305],
35	therapy	NN	O	therapy	prep_for	32	SENT_32	[p3l19t2323r300b2398],
36	in	IN	O	in	_	0	SENT_32	[p3l343t2323r413b2382],
37	cases	NNS	O	case	prep_in	32	SENT_32	[p3l460t2342r645b2383],
38	of	IN	O	of	_	0	SENT_32	[p3l693t2323r771b2383],
39	sulfadoxine	NN	O	sulfadoxine	nn	42	SENT_32	[p3l809t2323r1834b2398],
40	—	NN	O	—	nn	42	SENT_32	[p3l809t2323r1834b2398],
41	pyrimethamine	NN	O	pyrimethamine	nn	42	SENT_32	[p3l809t2323r1834b2398],
42	failure	NN	O	failure	prep_of	37	SENT_32	[p3l1880t2323r2136b2383],
43	.	.	O	.	_	0	SENT_32	[p3l1880t2323r2136b2383],

1	Chlorproguanil	NNP	O	Chlorproguanil	nn	3	SENT_33	[p3l23t2414r936b2489],
2	—	NN	O	—	nn	3	SENT_33	[p3l23t2414r936b2489],
3	dapsone	NN	O	dapsone	nsubj	15	SENT_33	[p3l23t2414r936b2489],
4	is	VBZ	O	be	cop	15	SENT_33	[p3l1084t2414r1136b2474],
5	an	DT	O	a	det	15	SENT_33	[p3l1286t2434r1372b2474],
6	antifolate	JJ	O	antifolate	amod	15	SENT_33	[p3l1519t2414r1866b2474],
7	like	IN	O	like	_	0	SENT_33	[p3l2013t2414r2141b2474],
8	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_like	6	SENT_33	[p3l21t2506r1070b2581],
9	,	,	O	,	_	0	SENT_33	[p3l21t2506r1070b2581],
10	but	CC	O	but	dep	13	SENT_33	[p3l1114t2506r1239b2567],
11	is	VBZ	O	be	auxpass	13	SENT_33	[p3l1280t2507r1332b2566],
12	rapidly	RB	O	rapidly	advmod	13	SENT_33	[p3l1375t2506r1635b2581],
13	eliminated	VBN	O	eliminate	dep	6	SENT_33	[p3l1676t2506r2142b2578],
14	,	,	O	,	_	0	SENT_33	[p3l1676t2506r2142b2578],
15	”	NN	O	”	_	0	SENT_33	[p3l1676t2506r2142b2578],
16	and	CC	O	and	_	0	SENT_33	[p3l21t2599r156b2659],
17	thus	RB	O	thus	advmod	18	SENT_33	[p3l192t2599r348b2659],
18	exerts	VBZ	O	exert	conj_and	15	SENT_33	[p3l388t2612r602b2659],
19	lower	JJR	O	lower	amod	21	SENT_33	[p3l640t2599r845b2659],
20	selection	NN	O	selection	nn	21	SENT_33	[p3l881t2599r1205b2659],
21	pressure	NN	O	pressure	dobj	18	SENT_33	[p3l1241t2618r1550b2674],
22	for	IN	O	for	_	0	SENT_33	[p3l1588t2599r1693b2659],
23	resistance	NN	O	resistance	prep_for	18	SENT_33	[p3l1728t2599r2141b2659],
24	?	.	O	?	_	0	SENT_33	[p3l1728t2599r2141b2659],

1	It	PRP	O	it	nsubj	2	SENT_34	[p3l20t2691r78b2750],
2	requires	VBZ	O	require	_	0	SENT_34	[p3l105t2690r403b2765],
3	a	DT	O	a	det	6	SENT_34	[p3l433t2710r468b2750],
4	3-day	JJ	DURATION	3-day	amod	6	SENT_34	[p3l499t2690r707b2765],
5	treatment	NN	O	treatment	nn	6	SENT_34	[p3l732t2704r1096b2750],
6	regimen	NN	O	regimen	dobj	2	SENT_34	[p3l1123t2690r1471b2765],
7	”	CD	NUMBER	”	number	8	SENT_34	[p3l1123t2690r1471b2765],
8	(	CD	NUMBER	(	nn	13	SENT_34	[p3l1505t2690r1646b2764],
9	the	DT	O	the	det	11	SENT_34	[p3l1505t2690r1646b2764],
10	approximate	JJ	O	approximate	amod	11	SENT_34	[p3l1677t2690r2141b2765],
11	half	NN	O	half	dep	8	SENT_34	[p3l18t2782r352b2843],
12	—	JJ	O	—	amod	13	SENT_34	[p3l18t2782r352b2843],
13	lives	NNS	O	life	tmod	2	SENT_34	[p3l18t2782r352b2843],
14	of	IN	O	of	_	0	SENT_34	[p3l396t2782r475b2842],
15	sulfadoxine	NN	O	sulfadoxine	prep_of	13	SENT_34	[p3l507t2782r955b2854],
16	,	,	O	,	_	0	SENT_34	[p3l507t2782r955b2854],
17	pyrimethamine	NN	O	pyrimethamine	prep_of	13	SENT_34	[p3l998t2782r1587b2857],
18	,	,	O	,	_	0	SENT_34	[p3l998t2782r1587b2857],
19	dapsone	NN	O	dapsone	prep_of	13	SENT_34	[p3l1633t2782r1961b2857],
20	,	,	O	,	_	0	SENT_34	[p3l1633t2782r1961b2857],
21	and	CC	O	and	_	0	SENT_34	[p3l2007t2782r2142b2843],
22	chlorproguanil	NN	O	chlorproguanil	prep_of	13	SENT_34	[p3l21t2875r567b2950],
23	are	VBP	O	be	cop	25	SENT_34	[p3l614t2894r722b2935],
24	200	CD	NUMBER	200	num	25	SENT_34	[p3l769t2877r904b2935],
25	h	NN	O	h	rcmod	15	SENT_34	[p3l949t2875r1044b2947],
26	,3	CD	NUMBER	,3	number	27	SENT_34	[p3l949t2875r1044b2947],
27	100	CD	NUMBER	100	num	28	SENT_34	[p3l1098t2877r1225b2935],
28	h	NN	O	h	dep	25	SENT_34	[p3l1271t2875r1366b2947],
29	,3	CD	NUMBER	,3	number	30	SENT_34	[p3l1271t2875r1366b2947],
30	24	CD	NUMBER	24	num	31	SENT_34	[p3l1412t2877r1499b2934],
31	h	NN	O	h	dep	25	SENT_34	[p3l1544t2875r1664b2947],
32	,	,	O	,	_	0	SENT_34	[p3l1544t2875r1664b2947],
33	”	NN	O	”	conj_and	25	SENT_34	[p3l1544t2875r1664b2947],
34	and	CC	O	and	_	0	SENT_34	[p3l1710t2875r1844b2935],
35	12	CD	NUMBER	12	num	36	SENT_34	[p3l1898t2877r1977b2934],
36	h	NN	O	h	conj_and	25	SENT_34	[p3l2022t2875r2142b2947],
37	,	,	O	,	_	0	SENT_34	[p3l2022t2875r2142b2947],
38	”	CD	NUMBER	”	appos	36	SENT_34	[p3l2022t2875r2142b2947],
39	respectively	RB	O	respectively	advmod	25	SENT_34	[p3l19t2966r508b3041],
40	)	CD	NUMBER	)	dep	13	SENT_34	[p3l19t2966r508b3041],
41	.	.	O	.	_	0	SENT_34	[p3l19t2966r508b3041],

1	Additionally	RB	O	additionally	advmod	10	SENT_35	[p3l547t2966r1033b3041],
2	,	,	O	,	_	0	SENT_35	[p3l547t2966r1033b3041],
3	in-vitro6	JJ	O	in-vitro6	nsubj	10	SENT_35	[p3l1071t2966r1431b3026],
4	"	``	O	"	punct	3	SENT_35	[p3l1071t2966r1431b3026],
5	6	CD	NUMBER	6	dep	3	SENT_35	[p3l1071t2966r1431b3026],
6	and	CC	O	and	_	0	SENT_35	[p3l1468t2966r1602b3026],
7	clinical	JJ	O	clinical	amod	9	SENT_35	[p3l1639t2966r1949b3026],
8	”	NN	O	”	nn	9	SENT_35	[p3l1639t2966r1949b3026],
9	data	NNS	O	datum	conj_and	3	SENT_35	[p3l1986t2966r2142b3026],
10	suggest	VBP	O	suggest	_	0	SENT_35	[p3l21t3072r291b3133],
11	that	IN	O	that	complm	15	SENT_35	[p3l319t3058r465b3118],
12	chlorproguani1	NN	O	chlorproguani1	nn	14	SENT_35	[p3l494t3058r1384b3133],
13	—	NN	O	—	nn	14	SENT_35	[p3l494t3058r1384b3133],
14	dapsone	NN	O	dapsone	nsubj	15	SENT_35	[p3l494t3058r1384b3133],
15	has	VBZ	O	have	ccomp	10	SENT_35	[p3l1413t3058r1532b3118],
16	greater	JJR	O	greater	amod	17	SENT_35	[p3l1563t3072r1822b3133],
17	potency	NN	O	potency	dobj	15	SENT_35	[p3l1848t3072r2143b3133],
18	than	IN	O	than	_	0	SENT_35	[p3l19t3151r184b3211],
19	sulfadoxine	JJ	O	sulfadoxine	amod	21	SENT_35	[p3l232t3151r1258b3226],
20	—	NN	O	—	nn	21	SENT_35	[p3l232t3151r1258b3226],
21	pyrimethamine	NN	O	pyrimethamine	prep_than	15	SENT_35	[p3l232t3151r1258b3226],
22	against	IN	O	against	_	0	SENT_35	[p3l1307t3151r1566b3226],
23	parasites	NNS	O	parasite	prep_against	21	SENT_35	[p3l1611t3151r1934b3226],
24	with	IN	O	with	_	0	SENT_35	[p3l1981t3151r2142b3211],
25	dhfr/dhps	JJ	O	dhfr/dhps	amod	26	SENT_35	[p3l20t3242r344b3317],
26	mutations	NNS	O	mutation	prep_with	23	SENT_35	[p3l371t3242r765b3302],
27	.	.	O	.	_	0	SENT_35	[p3l371t3242r765b3302],

1	In	IN	O	in	_	0	SENT_36	[p3l800t3243r878b3301],
2	particular	JJ	O	particular	prep_in	15	SENT_36	[p3l904t3242r1288b3317],
3	,	,	O	,	_	0	SENT_36	[p3l904t3242r1288b3317],
4	mutants	NNS	O	mutant	nsubj	15	SENT_36	[p3l1319t3256r1621b3302],
5	with	IN	O	with	_	0	SENT_36	[p3l1649t3242r1811b3302],
6	dhfr	NN	O	dhfr	nn	7	SENT_36	[p3l1840t3242r1984b3317],
7	ser108-asn	NN	O	ser108-asn	prep_with	4	SENT_36	[p3l2008t3262r2141b3302, p3l29t3337r339b3406],
8	,	,	O	,	_	0	SENT_36	[p3l2008t3262r2141b3302, p3l29t3337r339b3406],
9	asn-51	NN	O	asn-51	nn	11	SENT_36	[p3l383t3334r773b3406],
10	—	CD	NUMBER	—	num	11	SENT_36	[p3l383t3334r773b3406],
11	i1e	NN	O	i1e	prep_with	4	SENT_36	[p3l383t3334r773b3406],
12	,	,	O	,	_	0	SENT_36	[p3l383t3334r773b3406],
13	and	CC	O	and	_	0	SENT_36	[p3l818t3334r952b3395],
14	cys	NNS	O	cy	prep_with	4	SENT_36	[p3l993t3337r1403b3409],
15	—	VBP	O	—	_	0	SENT_36	[p3l993t3337r1403b3409],
16	59-arg	JJ	O	59-arg	nsubj	24	SENT_36	[p3l993t3337r1403b3409],
17	,	,	O	,	_	0	SENT_36	[p3l993t3337r1403b3409],
18	plus	CC	O	plus	_	0	SENT_36	[p3l1445t3334r1597b3409],
19	dhps	NNS	O	dhp	conj_plus	16	SENT_36	[p3l1638t3335r1794b3409],
20	ala437gly	RB	O	ala437gly	advmod	19	SENT_36	[p3l1834t3334r2141b3395, p3l19t3427r126b3502],
21	and	CC	O	and	_	0	SENT_36	[p3l160t3427r294b3487],
22	lys-540-glu	NN	O	lys-540-glu	conj_plus	16	SENT_36	[p3l328t3427r770b3502],
23	,	,	O	,	_	0	SENT_36	[p3l328t3427r770b3502],
24	retain	VBP	O	retain	ccomp	15	SENT_36	[p3l806t3427r1020b3487],
25	sensitivity	NN	O	sensitivity	dobj	24	SENT_36	[p3l1055t3427r1424b3502],
26	to	TO	O	to	_	0	SENT_36	[p3l1455t3440r1526b3487],
27	chlorproguanil	NN	O	chlorproguanil	nn	28	SENT_36	[p3l1563t3427r2141b3502, p3l80t3598r91b3624],
28	]	NN	O	]	prep_to	24	SENT_36	[p3l1563t3427r2141b3502, p3l80t3598r91b3624],

1	136	CD	NUMBER	136	_	0	SENT_37	[p3l101t3598r156b3624],
2	THE	DT	O	the	det	3	SENT_37	[p3l1196t3603r1257b3624],
3	LANCET	NN	O	lancet	dep	1	SENT_37	[p3l1267t3602r1391b3624],
4	-	:	O	-	_	0	SENT_37	[p3l1401t3610r1409b3618],
5	Vol	NN	O	vol	dep	1	SENT_37	[p3l1418t3603r1462b3624],
6	360	CD	NUMBER	360	num	5	SENT_37	[p3l1472t3604r1518b3624],
7	-	:	O	-	_	0	SENT_37	[p3l1529t3610r1536b3618],
8	October	NNP	DATE	October	dep	5	SENT_37	[p3l1547t3603r1650b3624],
9	12	CD	DATE	12	num	8	SENT_37	[p3l1661t3604r1697b3628],
10	,	,	DATE	,	_	0	SENT_37	[p3l1661t3604r1697b3628],
11	2002	CD	DATE	2002	num	8	SENT_37	[p3l1708t3604r1769b3624],
12	-	:	O	-	_	0	SENT_37	[p3l1780t3610r1788b3618],
13	www.thelancet.com	NN	O	www.thelancet.com	dep	8	SENT_37	[p3l1797t3603r2048b3624],

1	For	IN	O	for	_	0	SENT_38	[p3l81t3703r149b3738],
2	personal	JJ	O	personal	amod	3	SENT_38	[p3l174t3703r362b3746],
3	use	NN	O	use	pobj	1	SENT_38	[p3l390t3712r479b3738],
4	.	.	O	.	_	0	SENT_38	[p3l390t3712r479b3738],

1	Only	RB	O	only	advmod	2	SENT_39	[p3l527t3703r623b3747],
2	reproduce	VB	O	reproduce	_	0	SENT_39	[p3l648t3703r871b3746],
3	with	IN	O	with	_	0	SENT_39	[p3l895t3703r989b3738],
4	permission	NN	O	permission	prep_with	2	SENT_39	[p3l1017t3703r1258b3746],
5	from	IN	O	from	_	0	SENT_39	[p3l1283t3703r1381b3738],
6	The	DT	O	the	det	9	SENT_39	[p3l1406t3703r1486b3738],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_39	[p3l1512t3703r1662b3738],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_39	[p3l1688t3703r1921b3747],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_39	[p3l1944t3703r2088b3746],
10	.	.	O	.	_	0	SENT_39	[p3l1944t3703r2088b3746],

1	ARTICLES	NNS	O	article	_	0	SENT_40	[p4l1913t44r2067b65],

1	dapsone	NN	O	dapsone	_	0	SENT_41	[p4l10t236r316b312],
2	in	FW	O	in	nn	3	SENT_41	[p4l384t236r454b296],
3	vivo	FW	O	vivo	dep	1	SENT_41	[p4l519t236r745b297],
4	.	.	O	.	_	0	SENT_41	[p4l519t236r745b297],

1	”	NN	O	”	nn	2	SENT_42	[p4l519t236r745b297],
2	Chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubj	3	SENT_42	[p4l816t236r1735b312],
3	is	VBZ	O	be	_	0	SENT_42	[p4l1803t236r1856b297],
4	under	IN	O	under	_	0	SENT_42	[p4l1924t236r2146b297],
5	development	NN	O	development	prep_under	3	SENT_42	[p4l10t329r493b405],
6	as	IN	O	as	_	0	SENT_42	[p4l533t349r602b390],
7	an	DT	O	a	det	10	SENT_42	[p4l644t349r730b390],
8	inexpensive	JJ	O	inexpensive	amod	10	SENT_42	[p4l769t330r1203b405],
9	fixed-ratio	JJ	O	fixed-ratio	amod	10	SENT_42	[p4l1243t329r1630b390],
10	tablet	NN	O	tablet	prep_as	5	SENT_42	[p4l1671t329r1882b390],
11	in	IN	O	in	_	0	SENT_42	[p4l1921t329r1990b389],
12	the	DT	O	the	det	13	SENT_42	[p4l2028t329r2143b390],
13	hope	NN	O	hope	prep_in	10	SENT_42	[p4l7t423r188b499],
14	that	IN	O	that	complm	17	SENT_42	[p4l219t423r365b483],
15	it	PRP	O	it	nsubj	17	SENT_42	[p4l393t423r443b483],
16	will	MD	O	will	aux	17	SENT_42	[p4l470t423r602b483],
17	play	VB	O	play	ccomp	3	SENT_42	[p4l631t423r786b499],
18	a	DT	O	a	det	20	SENT_42	[p4l815t443r850b483],
19	useful	JJ	O	useful	amod	20	SENT_42	[p4l879t423r1102b483],
20	part	NN	O	part	dobj	17	SENT_42	[p4l1131t437r1281b499],
21	in	IN	O	in	_	0	SENT_42	[p4l1309t423r1379b482],
22	malaria	NN	O	malaria	nn	23	SENT_42	[p4l1408t423r1684b483],
23	control	NN	O	control	prep_in	17	SENT_42	[p4l1716t423r2002b483],
24	.	.	O	.	_	0	SENT_42	[p4l1716t423r2002b483],

1	However	RB	O	however	advmod	7	SENT_43	[p4l94t516r452b588],
2	,	,	O	,	_	0	SENT_43	[p4l94t516r452b588],
3	rapid	JJ	O	rapid	amod	5	SENT_43	[p4l559t515r753b591],
4	drug	NN	O	drug	nn	5	SENT_43	[p4l858t515r1030b591],
5	elimination	NN	O	elimination	nsubj	7	SENT_43	[p4l1135t515r1559b576],
6	could	MD	O	could	aux	7	SENT_43	[p4l1665t515r1871b576],
7	have	VB	O	have	_	0	SENT_43	[p4l1974t515r2143b576],
8	disadvantages	NNS	O	disadvantage	dobj	7	SENT_43	[p4l10t608r551b684],
9	;	:	O	;	_	0	SENT_43	[p4l10t608r551b684],
10	unlike	IN	O	unlike	_	0	SENT_43	[p4l704t608r933b669],
11	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_unlike	16	SENT_43	[p4l1085t608r2141b684],
12	,	,	O	,	_	0	SENT_43	[p4l1085t608r2141b684],
13	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubj	16	SENT_43	[p4l10t702r905b778],
14	does	VBZ	O	do	aux	16	SENT_43	[p4l936t702r1102b762],
15	not	RB	O	not	neg	16	SENT_43	[p4l1132t716r1255b762],
16	give	VB	O	give	parataxis	7	SENT_43	[p4l1284t702r1429b778],
17	chemoprophylaxis	NN	O	chemoprophylaxi	dobj	16	SENT_43	[p4l1460t702r2142b778],
18	after	IN	O	after	mark	32	SENT_43	[p4l10t793r179b854],
19	successful	JJ	O	successful	amod	20	SENT_43	[p4l259t793r631b854],
20	treatment	NN	O	treatment	nsubjpass	32	SENT_43	[p4l712t794r1151b865],
21	,	,	O	,	_	0	SENT_43	[p4l712t794r1151b865],
22	”	NN	O	”	nsubjpass	32	SENT_43	[p4l712t794r1151b865],
23	and	CC	O	and	_	0	SENT_43	[p4l1235t793r1370b854],
24	the	DT	O	the	det	25	SENT_43	[p4l1450t793r1565b854],
25	workload	NN	O	workload	conj_and	20	SENT_43	[p4l1645t793r1992b854],
26	of	IN	O	of	_	0	SENT_43	[p4l2075t793r2154b854],
27	overstretched	JJ	O	overstretched	amod	29	SENT_43	[p4l10t886r515b947],
28	health	NN	O	health	nn	29	SENT_43	[p4l562t886r793b947],
29	facilities	NNS	O	facility	prep_of	25	SENT_43	[p4l841t886r1147b947],
30	could	MD	O	could	aux	32	SENT_43	[p4l1199t886r1404b947],
31	be	VB	O	be	auxpass	32	SENT_43	[p4l1451t886r1537b947],
32	increased	VBN	O	increase	advcl	16	SENT_43	[p4l1586t886r1938b947],
33	as	IN	O	as	_	0	SENT_43	[p4l1988t906r2057b947],
34	a	DT	O	a	det	35	SENT_43	[p4l2108t906r2143b947],
35	result	NN	O	result	prep_as	32	SENT_43	[p4l8t980r237b1040],
36	.	.	O	.	_	0	SENT_43	[p4l8t980r237b1040],

1	The	DT	O	the	det	3	SENT_44	[p4l305t980r455b1040],
2	main	JJ	O	main	amod	3	SENT_44	[p4l519t980r706b1040],
3	aim	NN	O	aim	nsubj	7	SENT_44	[p4l771t980r905b1040],
4	of	IN	O	of	_	0	SENT_44	[p4l970t980r1048b1040],
5	our	PRP$	O	we	poss	6	SENT_44	[p4l1103t999r1229b1040],
6	trial	NN	O	trial	prep_of	3	SENT_44	[p4l1290t980r1438b1040],
7	was	VBD	O	be	_	0	SENT_44	[p4l1501t999r1635b1040],
8	to	TO	O	to	aux	9	SENT_44	[p4l1700t994r1771b1040],
9	test	VB	O	test	xcomp	7	SENT_44	[p4l1835t994r1966b1040],
10	the	DT	O	the	det	11	SENT_44	[p4l2029t980r2143b1040],
11	hypothesis	NN	O	hypothesis	dobj	9	SENT_44	[p4l7t1072r402b1148],
12	that	IN	O	that	complm	17	SENT_44	[p4l469t1072r615b1133],
13	ch1orproguanil	NN	O	ch1orproguanil	nn	15	SENT_44	[p4l681t1072r1576b1148],
14	—	NN	O	—	nn	15	SENT_44	[p4l681t1072r1576b1148],
15	dapsone	NN	O	dapsone	nsubjpass	17	SENT_44	[p4l681t1072r1576b1148],
16	is	VBZ	O	be	auxpass	17	SENT_44	[p4l1642t1072r1695b1133],
17	associated	VBN	O	associate	ccomp	9	SENT_44	[p4l1764t1072r2144b1133],
18	with	IN	O	with	_	0	SENT_44	[p4l7t1165r170b1226],
19	a	DT	O	a	det	23	SENT_44	[p4l198t1185r233b1226],
20	higher	JJR	O	higher	amod	23	SENT_44	[p4l259t1165r497b1241],
21	annual	JJ	SET	annual	amod	23	SENT_44	[p4l524t1165r775b1226],
22	malaria	NN	O	malaria	nn	23	SENT_44	[p4l802t1165r1079b1226],
23	incidence	NN	O	incidence	prep_with	17	SENT_44	[p4l1106t1165r1463b1226],
24	than	IN	O	than	_	0	SENT_44	[p4l1490t1165r1656b1226],
25	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_than	23	SENT_44	[p4l1684t1165r2143b1226, p4l7t1259r576b1335],
26	when	WRB	O	when	advmod	27	SENT_44	[p4l630t1259r830b1319],
27	used	VBN	O	use	advcl	17	SENT_44	[p4l883t1259r1055b1319],
28	for	IN	O	for	_	0	SENT_44	[p4l1109t1259r1215b1319],
29	sequential	JJ	O	sequential	amod	30	SENT_44	[p4l1269t1259r1647b1335],
30	episodes	NNS	O	episode	prep_for	27	SENT_44	[p4l1703t1259r2017b1335],
31	of	IN	O	of	_	0	SENT_44	[p4l2075t1259r2154b1319],
32	clinical	JJ	O	clinical	amod	33	SENT_44	[p4l10t1351r274b1412],
33	malaria	NN	O	malaria	prep_of	30	SENT_44	[p4l323t1351r620b1412],
34	.	.	O	.	_	0	SENT_44	[p4l323t1351r620b1412],

1	We	PRP	O	we	nsubj	3	SENT_45	[p4l672t1352r796b1412],
2	also	RB	O	also	advmod	3	SENT_45	[p4l847t1351r987b1412],
3	wanted	VBD	O	want	_	0	SENT_45	[p4l1036t1351r1308b1412],
4	to	TO	O	to	aux	5	SENT_45	[p4l1356t1365r1427b1412],
5	ﬁnd	VB	O	ﬁnd	xcomp	3	SENT_45	[p4l1477t1351r1624b1412],
6	out	RP	O	out	prt	5	SENT_45	[p4l1674t1365r1795b1412],
7	whether	IN	O	whether	complm	11	SENT_45	[p4l1842t1351r2146b1412],
8	treatment	NN	O	treatment	nn	9	SENT_45	[p4l8t1458r374b1505],
9	failure	NN	O	failure	nsubj	11	SENT_45	[p4l462t1444r699b1505],
10	is	VBZ	O	be	cop	11	SENT_45	[p4l789t1445r841b1505],
11	commoner	NN	O	commoner	ccomp	5	SENT_45	[p4l934t1464r1338b1505],
12	after	IN	O	after	_	0	SENT_45	[p4l1427t1444r1595b1505],
13	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_after	11	SENT_45	[p4l1684t1444r2143b1505, p4l7t1538r576b1614],
14	than	IN	O	than	advmod	11	SENT_45	[p4l636t1538r803b1598],
15	after	IN	O	after	_	0	SENT_45	[p4l864t1538r1033b1598],
16	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_after	14	SENT_45	[p4l1093t1538r2011b1614],
17	,	,	O	,	_	0	SENT_45	[p4l1093t1538r2011b1614],
18	in	IN	O	in	_	0	SENT_45	[p4l2075t1538r2144b1597],
19	view	NN	O	view	prep_in	14	SENT_45	[p4l7t1630r175b1691],
20	of	IN	O	of	_	0	SENT_45	[p4l254t1630r332b1691],
21	the	DT	O	the	det	22	SENT_45	[p4l400t1630r514b1691],
22	decline	NN	O	decline	prep_of	19	SENT_45	[p4l594t1630r858b1691],
23	in	IN	O	in	_	0	SENT_45	[p4l936t1630r1007b1690],
24	sensitivity	NN	O	sensitivity	prep_in	22	SENT_45	[p4l1085t1630r1457b1706],
25	to	TO	O	to	_	0	SENT_45	[p4l1532t1644r1603b1691],
26	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_to	14	SENT_45	[p4l1684t1630r2143b1691, p4l7t1723r597b1799],
27	.	.	O	.	_	0	SENT_45	[p4l1684t1630r2143b1691, p4l7t1723r597b1799],

1	We	PRP	O	we	nsubj	2	SENT_46	[p4l91t1818r215b1877],
2	wanted	VBD	O	want	_	0	SENT_46	[p4l242t1817r514b1877],
3	to	TO	O	to	aux	4	SENT_46	[p4l541t1831r612b1877],
4	work	VB	O	work	xcomp	2	SENT_46	[p4l640t1817r827b1877],
5	in	IN	O	in	_	0	SENT_46	[p4l852t1817r922b1876],
6	more	JJR	O	more	mwe	7	SENT_46	[p4l949t1836r1140b1877],
7	than	IN	O	than	quantmod	8	SENT_46	[p4l1168t1817r1334b1877],
8	one	CD	NUMBER	one	num	9	SENT_46	[p4l1363t1837r1494b1877],
9	location	NN	O	location	prep_in	4	SENT_46	[p4l1522t1817r1823b1877],
10	because	IN	O	because	mark	15	SENT_46	[p4l1849t1817r2143b1877],
11	patterns	NNS	O	pattern	nsubjpass	21	SENT_46	[p4l7t1923r310b1985],
12	of	IN	O	of	_	0	SENT_46	[p4l375t1909r453b1970],
13	drug	NN	O	drug	nn	14	SENT_46	[p4l506t1909r678b1985],
14	resistance	NN	O	resistance	prep_of	11	SENT_46	[p4l737t1909r1103b1970],
15	vary	VBP	O	vary	advcl	4	SENT_46	[p4l1162t1929r1320b1985],
16	geographically	RB	O	geographically	advmod	15	SENT_46	[p4l1380t1909r1943b1985],
17	,	,	O	,	_	0	SENT_46	[p4l1380t1909r1943b1985],
18	and	CC	O	and	_	0	SENT_46	[p4l2009t1909r2144b1970],
19	could	MD	O	could	aux	21	SENT_46	[p4l10t2002r216b2063],
20	be	VB	O	be	auxpass	21	SENT_46	[p4l242t2002r329b2063],
21	expected	VBN	O	expect	conj_and	15	SENT_46	[p4l359t2002r689b2078],
22	to	TO	O	to	aux	23	SENT_46	[p4l716t2017r787b2063],
23	have	VB	O	have	xcomp	21	SENT_46	[p4l816t2002r985b2063],
24	a	DT	O	a	det	26	SENT_46	[p4l1015t2022r1051b2063],
25	great	JJ	O	great	amod	26	SENT_46	[p4l1080t2016r1265b2078],
26	effect	NN	O	effect	dobj	23	SENT_46	[p4l1294t2002r1496b2063],
27	on	IN	O	on	_	0	SENT_46	[p4l1525t2022r1616b2063],
28	the	DT	O	the	det	29	SENT_46	[p4l1643t2002r1758b2063],
29	incidence	NN	O	incidence	prep_on	26	SENT_46	[p4l1787t2002r2143b2063],
30	of	IN	O	of	_	0	SENT_46	[p4l10t2096r89b2156],
31	retreatment	NN	O	retreatment	prep_of	29	SENT_46	[p4l218t2110r678b2156],
32	.	.	O	.	_	0	SENT_46	[p4l218t2110r678b2156],

1	Malawi	NNP	LOCATION	Malawi	nsubj	2	SENT_47	[p4l822t2096r1100b2156],
2	adopted	VBD	O	adopt	_	0	SENT_47	[p4l1242t2096r1543b2172],
3	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	dobj	2	SENT_47	[p4l1684t2096r2143b2156, p4l7t2188r576b2264],
4	as	IN	O	as	_	0	SENT_47	[p4l638t2208r707b2249],
5	its	PRP$	O	its	poss	8	SENT_47	[p4l769t2188r851b2249],
6	uniform	JJ	O	uniform	amod	8	SENT_47	[p4l912t2188r1214b2249],
7	ﬁrst-line	JJ	O	ﬁrst-line	amod	8	SENT_47	[p4l1274t2188r1588b2249],
8	treatment	NN	O	treatment	prep_as	2	SENT_47	[p4l1649t2202r2015b2249],
9	in	IN	O	in	_	0	SENT_47	[p4l2075t2188r2144b2248],
10	1993	CD	DATE	1993	prep_in	2	SENT_47	[p4l18t2284r217b2342],
11	.	.	O	.	_	0	SENT_47	[p4l18t2284r217b2342],

1	By	IN	O	by	_	0	SENT_48	[p4l265t2282r363b2357],
2	contrast	NN	O	contrast	prep_by	5	SENT_48	[p4l405t2296r728b2354],
3	,	,	O	,	_	0	SENT_48	[p4l405t2296r728b2354],
4	Kenya	NNP	LOCATION	Kenya	nsubj	5	SENT_48	[p4l774t2282r1012b2357],
5	made	VBD	O	make	_	0	SENT_48	[p4l1055t2281r1257b2342],
6	the	DT	O	the	det	8	SENT_48	[p4l1300t2281r1414b2342],
7	policy	NN	O	policy	nn	8	SENT_48	[p4l1456t2281r1681b2357],
8	decision	NN	O	decision	dobj	5	SENT_48	[p4l1724t2281r2030b2342],
9	to	TO	O	to	aux	10	SENT_48	[p4l2071t2296r2142b2342],
10	use	VB	O	use	xcomp	5	SENT_48	[p4l8t2395r129b2435],
11	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	dobj	10	SENT_48	[p4l162t2375r1194b2451],
12	as	IN	O	as	_	0	SENT_48	[p4l1228t2395r1297b2435],
13	first-line	JJ	O	first-line	amod	14	SENT_48	[p4l1330t2375r1645b2435],
14	treatment	NN	O	treatment	prep_as	10	SENT_48	[p4l1677t2389r2043b2435],
15	in	IN	O	in	_	0	SENT_48	[p4l2075t2375r2144b2434],
16	1997	CD	DATE	1997	prep_in	14	SENT_48	[p4l17t2470r219b2540],
17	,	,	O	,	_	0	SENT_48	[p4l17t2470r219b2540],
18	but	CC	O	but	_	0	SENT_48	[p4l274t2467r400b2528],
19	chloroquine	NN	O	chloroquine	nsubj	21	SENT_48	[p4l454t2467r902b2543],
20	remains	VBZ	O	remain	cop	21	SENT_48	[p4l956t2467r1249b2528],
21	available	JJ	O	available	conj_but	5	SENT_48	[p4l1306t2467r1652b2540],
22	,	,	O	,	_	0	SENT_48	[p4l1306t2467r1652b2540],
23	and	CC	O	and	_	0	SENT_48	[p4l1710t2467r1845b2528],
24	use	NN	O	use	nsubj	29	SENT_48	[p4l1898t2487r2019b2528],
25	of	IN	O	of	_	0	SENT_48	[p4l2075t2467r2154b2528],
26	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_of	24	SENT_48	[p4l10t2560r1042b2636],
27	has	VBZ	O	have	aux	29	SENT_48	[p4l1107t2560r1227b2621],
28	become	VBN	O	become	cop	29	SENT_48	[p4l1294t2560r1583b2621],
29	routine	JJ	O	routine	conj_and	21	SENT_48	[p4l1649t2561r1919b2621],
30	only	RB	O	only	advmod	31	SENT_48	[p4l1987t2560r2145b2636],
31	recently	RB	DATE	recently	advmod	29	SENT_48	[p4l8t2654r325b2730],
32	.	.	O	.	_	0	SENT_48	[p4l8t2654r325b2730],

1	We	PRP	O	we	nsubj	3	SENT_49	[p4l369t2655r493b2714],
2	therefore	RB	O	therefore	advmod	3	SENT_49	[p4l533t2654r870b2714],
3	expected	VBD	O	expect	_	0	SENT_49	[p4l913t2654r1242b2730],
4	a	DT	O	a	det	6	SENT_49	[p4l1284t2674r1319b2714],
5	higher	JJR	O	higher	amod	6	SENT_49	[p4l1358t2654r1597b2730],
6	prevalence	NN	O	prevalence	dobj	3	SENT_49	[p4l1633t2654r2032b2730],
7	of	IN	O	of	_	0	SENT_49	[p4l2075t2654r2154b2714],
8	sulfadoxine	NN	O	sulfadoxine	nn	12	SENT_49	[p4l10t2746r1042b2822],
9	—	NN	O	—	nn	12	SENT_49	[p4l10t2746r1042b2822],
10	pyrimethamine	NN	O	pyrimethamine	nn	12	SENT_49	[p4l10t2746r1042b2822],
11	treatment	NN	O	treatment	nn	12	SENT_49	[p4l1080t2760r1447b2807],
12	failure	NN	O	failure	prep_of	6	SENT_49	[p4l1484t2746r1720b2807],
13	in	IN	O	in	_	0	SENT_49	[p4l1759t2746r1828b2806],
14	Malawi	NNP	LOCATION	Malawi	prep_in	12	SENT_49	[p4l1866t2746r2144b2807],
15	than	IN	O	than	prep	3	SENT_49	[p4l8t2839r174b2900],
16	in	IN	O	in	pcomp	15	SENT_49	[p4l203t2840r273b2899],
17	Kenya	NNP	LOCATION	Kenya	pobj	16	SENT_49	[p4l302t2840r562b2915],
18	.	.	O	.	_	0	SENT_49	[p4l302t2840r562b2915],

1	Patients	NNS	O	patient	_	0	SENT_50	[p4l11t3021r399b3089],
2	and	CC	O	and	_	0	SENT_50	[p4l432t3022r594b3089],
3	methods	NNS	O	method	conj_and	1	SENT_50	[p4l632t3022r1029b3089],

1	Drugs	NNS	O	drug	nsubj	3	SENT_51	[p5l10t24r220b96],
2	We	PRP	O	we	nsubj	3	SENT_51	[p5l6t115r129b174],
3	formulated	VBD	O	formulate	_	0	SENT_51	[p5l164t114r572b174],
4	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	dobj	3	SENT_51	[p5l607t114r1486b190],
5	and	CC	O	and	_	0	SENT_51	[p5l1522t114r1656b174],
6	sulfadoXinepyrimethamine	NN	O	sulfadoxinepyrimethamine	dobj	3	SENT_51	[p5l1691t114r2143b174, p5l7t206r568b282],
7	as	IN	O	as	_	0	SENT_51	[p5l596t226r664b267],
8	syrups	NNS	O	syrup	prep_as	3	SENT_51	[p5l693t226r925b282],
9	to	TO	O	to	aux	10	SENT_51	[p5l952t220r1022b267],
10	permit	VB	O	permit	xcomp	3	SENT_51	[p5l1048t206r1293b282],
11	optimisation	NN	O	optimisation	dobj	10	SENT_51	[p5l1320t206r1782b282],
12	of	IN	O	of	_	0	SENT_51	[p5l1809t206r1887b267],
13	dosing	NN	O	dosing	nn	14	SENT_51	[p5l1904t206r2145b282],
14	accuracy	NN	O	accuracy	prep_of	11	SENT_51	[p5l10t319r350b375],
15	.	.	O	.	_	0	SENT_51	[p5l10t319r350b375],

1	Chlorproguanil	NNP	O	Chlorproguanil	nn	4	SENT_52	[p5l417t299r983b375],
2	(	CD	NUMBER	(	num	4	SENT_52	[p5l1048t299r1500b375],
3	SmithKline	NNP	ORGANIZATION	SmithKline	nn	4	SENT_52	[p5l1048t299r1500b375],
4	Beecham	NNP	ORGANIZATION	Beecham	nsubj	31	SENT_52	[p5l1561t299r1921b372],
5	,	,	O	,	_	0	SENT_52	[p5l1561t299r1921b372],
6	UK	NNP	LOCATION	UK	appos	4	SENT_52	[p5l1982t300r2141b372],
7	,	,	O	,	_	0	SENT_52	[p5l1982t300r2141b372],
8	batch	NN	O	batch	nn	11	SENT_52	[p5l7t393r212b453],
9	number	NN	O	number	nn	11	SENT_52	[p5l245t393r536b453],
10	EB/01/96	NN	O	eb/01/96	nn	11	SENT_52	[p5l568t393r946b468],
11	)	NN	O	)	appos	4	SENT_52	[p5l568t393r946b468],
12	and	CC	O	and	_	0	SENT_52	[p5l988t393r1122b453],
13	dapsone	NN	O	dapsone	nn	16	SENT_52	[p5l1158t393r1460b469],
14	(	CD	NUMBER	(	num	16	SENT_52	[p5l1501t393r1756b469],
15	Sigma	NNP	ORGANIZATION	Sigma	nn	16	SENT_52	[p5l1501t393r1756b469],
16	Ltd	NNP	ORGANIZATION	Ltd	appos	4	SENT_52	[p5l1791t393r1945b466],
17	,	,	O	,	_	0	SENT_52	[p5l1791t393r1945b466],
18	UK	NNP	LOCATION	UK	appos	4	SENT_52	[p5l1982t394r2138b453],
19	:	:	O	:	_	0	SENT_52	[p5l1982t394r2138b453],
20	batch	NN	O	batch	nn	23	SENT_52	[p5l7t485r212b546],
21	number	NN	O	number	nn	23	SENT_52	[p5l268t485r560b546],
22	94H0684	NN	O	94h0684	nn	23	SENT_52	[p5l619t486r1025b560],
23	)	NN	O	)	dep	18	SENT_52	[p5l619t486r1025b560],
24	,	,	O	,	_	0	SENT_52	[p5l619t486r1025b560],
25	were	VBD	O	be	aux	26	SENT_52	[p5l1085t505r1257b546],
26	dissolved	VBN	O	dissolve	_	0	SENT_52	[p5l1317t485r1654b546],
27	in	IN	O	in	_	0	SENT_52	[p5l1712t485r1781b545],
28	ethanolpropylene	NN	O	ethanolpropylene	nn	29	SENT_52	[p5l1840t485r2143b546, p5l7t578r373b654],
29	glycol	NN	O	glycol	prep_in	26	SENT_52	[p5l407t578r620b654],
30	and	CC	O	and	_	0	SENT_52	[p5l655t578r789b639],
31	diluted	VBN	O	dilute	conj_and	26	SENT_52	[p5l823t578r1081b639],
32	to	TO	O	to	_	0	SENT_52	[p5l1114t593r1184b639],
33	ﬁnal	JJ	O	ﬁnal	amod	35	SENT_52	[p5l1218t578r1378b639],
34	strength	NN	O	strength	nn	35	SENT_52	[p5l1413t578r1713b654],
35	(	NN	O	(	prep_to	31	SENT_52	[p5l1751t579r1819b653],
36	4	CD	NUMBER	4	num	37	SENT_52	[p5l1751t579r1819b653],
37	g/L	NN	O	g/l	dobj	26	SENT_52	[p5l1854t578r1979b654],
38	and	CC	O	and	_	0	SENT_52	[p5l2010t578r2144b639],
39	5	CD	NUMBER	5	num	40	SENT_52	[p5l12t674r47b732],
40	g/L	NN	O	g/l	conj_and	37	SENT_52	[p5l92t672r235b748],
41	,	,	O	,	_	0	SENT_52	[p5l92t672r235b748],
42	respectively	RB	O	respectively	advmod	43	SENT_52	[p5l278t672r735b748],
43	)	CD	NUMBER	)	dep	26	SENT_52	[p5l278t672r735b748],
44	with	IN	O	with	_	0	SENT_52	[p5l780t672r941b732],
45	aqueous	JJ	O	aqueous	amod	46	SENT_52	[p5l982t692r1283b748],
46	syrup	NN	O	syrup	prep_with	43	SENT_52	[p5l1326t691r1548b748],
47	,	,	O	,	_	0	SENT_52	[p5l1326t691r1548b748],
48	preserved	VBN	O	preserve	dep	26	SENT_52	[p5l1589t672r1945b748],
49	with	IN	O	with	_	0	SENT_52	[p5l1983t672r2144b732],
50	sodium	NN	O	sodium	nn	51	SENT_52	[p5l10t764r281b825],
51	benzoate	NN	O	benzoate	prep_with	48	SENT_52	[p5l321t764r669b825],
52	.	.	O	.	_	0	SENT_52	[p5l321t764r669b825],

1	Pyrimethamine	NN	O	pyrimethamine	nn	2	SENT_53	[p5l717t764r1282b840],
2	hydrochloride	NN	O	hydrochloride	_	0	SENT_53	[p5l1323t764r1840b840],
3	(	CD	NUMBER	(	num	5	SENT_53	[p5l1888t764r2143b840],
4	Sigma	NNP	LOCATION	Sigma	nn	5	SENT_53	[p5l1888t764r2143b840],
5	UK	NNP	LOCATION	UK	dep	2	SENT_53	[p5l8t858r167b930],
6	;	:	O	;	_	0	SENT_53	[p5l8t858r167b930],
7	batches	NNS	O	batch	nn	8	SENT_53	[p5l218t857r495b918],
8	122H0821	NN	O	122h0821	dep	2	SENT_53	[p5l556t858r937b918],
9	and	CC	O	and	_	0	SENT_53	[p5l998t857r1132b918],
10	P-7771	NN	O	p-7771	nn	11	SENT_53	[p5l1183t858r1480b933],
11	)	NN	O	)	dep	2	SENT_53	[p5l1183t858r1480b933],
12	and	CC	O	and	_	0	SENT_53	[p5l1538t857r1672b918],
13	sulfadoxine	NN	O	sulfadoxine	nn	15	SENT_53	[p5l1723t857r2143b918],
14	(	CD	NUMBER	(	num	15	SENT_53	[p5l15t951r297b1026],
15	Roche	NNP	PERSON	Roche	dep	2	SENT_53	[p5l15t951r297b1026],
16	;	:	O	;	_	0	SENT_53	[p5l15t951r297b1026],
17	batch	NN	O	batch	nn	18	SENT_53	[p5l345t951r549b1011],
18	number	NN	O	number	dep	2	SENT_53	[p5l595t951r887b1011],
19	00504470	CD	NUMBER	00504470	num	20	SENT_53	[p5l933t951r1333b1026],
20	)	NN	O	)	nsubjpass	22	SENT_53	[p5l933t951r1333b1026],
21	were	VBD	O	be	auxpass	22	SENT_53	[p5l1384t970r1557b1011],
22	formulated	VBN	O	formulate	rcmod	18	SENT_53	[p5l1604t951r2012b1011],
23	by	IN	O	by	_	0	SENT_53	[p5l2057t951r2145b1027],
24	the	DT	O	the	det	29	SENT_53	[p5l8t1043r121b1104],
25	same	JJ	O	same	amod	29	SENT_53	[p5l176t1063r359b1104],
26	method	NN	O	method	nn	29	SENT_53	[p5l413t1043r696b1104],
27	(	NN	O	(	nn	29	SENT_53	[p5l754t1043r941b1118],
28	ﬁnal	JJ	O	ﬁnal	amod	29	SENT_53	[p5l754t1043r941b1118],
29	strength	NN	O	strength	agent	22	SENT_53	[p5l996t1043r1295b1119],
30	2-5	CD	NUMBER	2-5	num	31	SENT_53	[p5l1350t1046r1459b1104],
31	g/L	NN	O	g/l	dep	29	SENT_53	[p5l1517t1043r1641b1119],
32	and	CC	O	and	_	0	SENT_53	[p5l1692t1043r1826b1104],
33	50	CD	NUMBER	50	num	34	SENT_53	[p5l1882t1046r1967b1104],
34	g/L	NN	O	g/l	agent	22	SENT_53	[p5l2023t1043r2147b1119],
35	respectively	RB	O	respectively	advmod	36	SENT_53	[p5l8t1136r491b1212],
36	)	CD	NUMBER	)	rcmod	34	SENT_53	[p5l8t1136r491b1212],
37	.	.	O	.	_	0	SENT_53	[p5l8t1136r491b1212],

1	Placebo	NN	O	placebo	nsubj	2	SENT_54	[p5l540t1136r828b1197],
2	comprised	VBD	O	comprise	_	0	SENT_54	[p5l874t1136r1257b1212],
3	calcium	NN	O	calcium	nn	4	SENT_54	[p5l1301t1136r1587b1197],
4	lactate	NN	O	lactate	iobj	2	SENT_54	[p5l1630t1136r1869b1197],
5	British	JJ	O	british	amod	7	SENT_54	[p5l1911t1137r2144b1197],
6	Pharmaceutical	NNP	O	Pharmaceutical	nn	7	SENT_54	[p5l7t1230r552b1290],
7	Codex	NNP	O	Codex	dobj	2	SENT_54	[p5l622t1230r835b1290],
8	formulated	VBN	O	formulate	partmod	7	SENT_54	[p5l907t1230r1314b1290],
9	in	IN	O	in	_	0	SENT_54	[p5l1388t1230r1457b1289],
10	the	DT	O	the	det	12	SENT_54	[p5l1530t1230r1644b1290],
11	same	JJ	O	same	amod	12	SENT_54	[p5l1719t1250r1903b1290],
12	way	NN	O	way	prep_in	8	SENT_54	[p5l1976t1250r2138b1306],
13	.	.	O	.	_	0	SENT_54	[p5l1976t1250r2138b1306],

1	Patients	NNS	O	patient	nsubj	2	SENT_55	[p5l9t1322r303b1383],
2	received	VBD	O	receive	_	0	SENT_55	[p5l382t1322r685b1383],
3	doses	NNS	O	dose	dobj	2	SENT_55	[p5l764t1322r962b1383],
4	of	IN	O	of	_	0	SENT_55	[p5l1043t1322r1121b1383],
5	0-5	CD	NUMBER	0-5	num	7	SENT_55	[p5l1190t1325r1300b1383],
6	mL	NN	O	ml	nn	7	SENT_55	[p5l1382t1323r1514b1382],
7	syrup	NN	O	syrup	prep_of	3	SENT_55	[p5l1589t1342r1786b1398],
8	per	IN	O	per	_	0	SENT_55	[p5l1865t1342r1985b1398],
9	kg	NN	O	kg	nn	10	SENT_55	[p5l2061t1322r2145b1398],
10	bodyweight	NN	O	bodyweight	prep_per	7	SENT_55	[p5l7t1415r455b1491],
11	.	.	O	.	_	0	SENT_55	[p5l7t1415r455b1491],

1	Drugs	NNS	O	drug	nsubjpass	3	SENT_56	[p5l501t1416r726b1491],
2	were	VBD	O	be	auxpass	3	SENT_56	[p5l766t1435r938b1476],
3	stored	VBN	O	store	_	0	SENT_56	[p5l980t1415r1206b1476],
4	at	IN	O	at	_	0	SENT_56	[p5l1247t1430r1312b1476],
5	ambient	JJ	O	ambient	amod	6	SENT_56	[p5l1353t1415r1653b1476],
6	temperature	NN	O	temperature	prep_at	3	SENT_56	[p5l1692t1430r2143b1491],
7	in	IN	O	in	_	0	SENT_56	[p5l8t1509r78b1568],
8	the	DT	O	the	det	10	SENT_56	[p5l102t1509r215b1569],
9	study	NN	O	study	nn	10	SENT_56	[p5l243t1509r442b1585],
10	clinics	NNS	O	clinic	prep_in	6	SENT_56	[p5l468t1509r716b1569],
11	.	.	O	.	_	0	SENT_56	[p5l468t1509r716b1569],

1	High-pressure	JJ	O	high-pressure	amod	4	SENT_57	[p5l747t1509r1271b1585],
2	liquid	JJ	O	liquid	amod	4	SENT_57	[p5l1298t1509r1511b1585],
3	chromatography	NN	O	chromatography	nn	4	SENT_57	[p5l1538t1509r2145b1585],
4	analysis	NN	O	analysis	nsubj	5	SENT_57	[p5l10t1601r290b1677],
5	showed	VBD	O	show	_	0	SENT_57	[p5l322t1601r597b1662],
6	no	DT	O	no	det	7	SENT_57	[p5l625t1621r716b1662],
7	loss	NN	O	loss	dobj	5	SENT_57	[p5l746t1601r879b1662],
8	of	IN	O	of	_	0	SENT_57	[p5l911t1601r989b1662],
9	drug	NN	O	drug	nn	10	SENT_57	[p5l1008t1601r1179b1677],
10	content	NN	O	content	prep_of	7	SENT_57	[p5l1207t1615r1485b1662],
11	over	IN	O	over	_	0	SENT_57	[p5l1514t1621r1671b1662],
12	3	CD	DURATION	3	num	13	SENT_57	[p5l1700t1604r1738b1662],
13	months	NNS	NUMBER	month	prep_over	5	SENT_57	[p5l1769t1601r2045b1662],
14	in	IN	O	in	_	0	SENT_57	[p5l2075t1601r2144b1661],
15	these	DT	O	these	det	16	SENT_57	[p5l8t1693r195b1754],
16	conditions	NNS	O	condition	prep_in	13	SENT_57	[p5l238t1693r644b1765],
17	,	,	O	,	_	0	SENT_57	[p5l238t1693r644b1765],
18	and	CC	O	and	_	0	SENT_57	[p5l689t1693r822b1754],
19	no	DT	O	no	det	22	SENT_57	[p5l861t1713r952b1754],
20	overt	JJ	O	overt	amod	22	SENT_57	[p5l995t1707r1179b1754],
21	microbial	JJ	O	microbial	amod	22	SENT_57	[p5l1218t1693r1566b1754],
22	contamination	NN	O	contamination	nsubjpass	24	SENT_57	[p5l1608t1694r2144b1754],
23	was	VBD	O	be	auxpass	24	SENT_57	[p5l7t1786r141b1827],
24	seen	VBN	O	see	conj_and	5	SENT_57	[p5l171t1786r350b1827],
25	.	.	O	.	_	0	SENT_57	[p5l171t1786r350b1827],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_58	[p5l10t1958r306b2016],
2	and	CC	O	and	_	0	SENT_58	[p5l337t1958r476b2016],
3	trial	NN	O	trial	nn	4	SENT_58	[p5l506t1958r648b2016],
4	design	NN	O	design	conj_and	1	SENT_58	[p5l677t1958r914b2030],
5	The	DT	O	the	det	6	SENT_58	[p5l8t2048r159b2108],
6	trial	NN	O	trial	dep	4	SENT_58	[p5l208t2048r356b2108],
7	was	VBD	O	be	auxpass	8	SENT_58	[p5l404t2068r539b2108],
8	done	VBN	O	do	_	0	SENT_58	[p5l591t2048r772b2108],
9	at	IN	O	at	_	0	SENT_58	[p5l824t2062r890b2108],
10	Kiliﬁ	NNP	LOCATION	Kiliﬁ	nn	12	SENT_58	[p5l939t2048r1128b2107],
11	District	NNP	LOCATION	District	nn	12	SENT_58	[p5l1177t2048r1462b2108],
12	Hospital	NNP	LOCATION	Hospital	prep_at	8	SENT_58	[p5l1510t2048r1852b2124],
13	,	,	O	,	_	0	SENT_58	[p5l1510t2048r1852b2124],
14	Kenya	NNP	LOCATION	Kenya	appos	12	SENT_58	[p5l1905t2049r2143b2124],
15	(	CD	NUMBER	(	num	14	SENT_58	[p5l15t2140r264b2215],
16	which	WDT	O	which	nsubj	17	SENT_58	[p5l15t2140r264b2215],
17	serves	VBZ	O	serve	rcmod	14	SENT_58	[p5l311t2160r530b2201],
18	a	DT	O	a	det	20	SENT_58	[p5l580t2160r615b2201],
19	rural	JJ	O	rural	amod	20	SENT_58	[p5l662t2140r839b2201],
20	population	NN	O	population	dobj	17	SENT_58	[p5l884t2140r1320b2216],
21	)	CD	NUMBER	)	num	20	SENT_58	[p5l884t2140r1320b2216],
22	from	IN	O	from	_	0	SENT_58	[p5l1372t2140r1551b2201],
23	July	NNP	DATE	July	prep_from	20	SENT_58	[p5l1592t2140r1762b2216],
24	,	,	DATE	,	_	0	SENT_58	[p5l1592t2140r1762b2216],
25	1996	CD	DATE	1996	appos	23	SENT_58	[p5l1821t2143r2022b2213],
26	,	,	O	,	_	0	SENT_58	[p5l1821t2143r2022b2213],
27	to	TO	O	to	_	0	SENT_58	[p5l2071t2154r2142b2201],
28	August	NNP	DATE	August	prep_to	20	SENT_58	[p5l7t2234r296b2309],
29	,	,	DATE	,	_	0	SENT_58	[p5l7t2234r296b2309],
30	1998	CD	DATE	1998	appos	28	SENT_58	[p5l368t2236r570b2306],
31	,	,	O	,	_	0	SENT_58	[p5l368t2236r570b2306],
32	and	CC	O	and	_	0	SENT_58	[p5l634t2233r769b2294],
33	at	IN	O	at	_	0	SENT_58	[p5l831t2248r897b2294],
34	the	DT	O	the	det	41	SENT_58	[p5l955t2233r1069b2294],
35	Ndirande	NNP	ORGANIZATION	Ndirande	nn	41	SENT_58	[p5l1128t2233r1486b2294],
36	Health	NNP	ORGANIZATION	Health	nn	41	SENT_58	[p5l1547t2233r1802b2294],
37	Centre	NNP	ORGANIZATION	Centre	nn	41	SENT_58	[p5l1864t2234r2141b2306],
38	,	,	O	,	_	0	SENT_58	[p5l1864t2234r2141b2306],
39	Blantyre	NNP	LOCATION	Blantyre	appos	41	SENT_58	[p5l9t2327r347b2403],
40	,	,	O	,	_	0	SENT_58	[p5l9t2327r347b2403],
41	Malawi	NNP	LOCATION	Malawi	prep_at	20	SENT_58	[p5l427t2327r705b2387],
42	(	CD	NUMBER	(	num	41	SENT_58	[p5l788t2327r1038b2402],
43	which	WDT	O	which	nsubj	44	SENT_58	[p5l788t2327r1038b2402],
44	serves	VBZ	O	serve	rcmod	41	SENT_58	[p5l1116t2346r1335b2387],
45	a	DT	O	a	det	50	SENT_58	[p5l1415t2347r1450b2387],
46	crowded	JJ	O	crowded	amod	50	SENT_58	[p5l1529t2327r1848b2387],
47	urban	JJ	O	urban	amod	50	SENT_58	[p5l1924t2327r2144b2387],
48	housing	NN	O	housing	nn	50	SENT_58	[p5l7t2419r304b2495],
49	estate	NN	O	estate	nn	50	SENT_58	[p5l356t2420r595b2494],
50	)	NN	O	)	dobj	44	SENT_58	[p5l356t2420r595b2494],
51	between	IN	O	between	_	0	SENT_58	[p5l652t2419r963b2480],
52	January	NNP	DATE	January	prep_between	50	SENT_58	[p5l1010t2420r1323b2495],
53	,	,	DATE	,	_	0	SENT_58	[p5l1010t2420r1323b2495],
54	1997	CD	DATE	1997	conj_and	14	SENT_58	[p5l1387t2422r1588b2492],
55	,	,	O	,	_	0	SENT_58	[p5l1387t2422r1588b2492],
56	and	CC	O	and	_	0	SENT_58	[p5l1646t2419r1781b2480],
57	January	NNP	DATE	January	conj_and	14	SENT_58	[p5l1828t2420r2141b2495],
58	,	,	DATE	,	_	0	SENT_58	[p5l1828t2420r2141b2495],
59	1999	CD	DATE	1999	appos	57	SENT_58	[p5l18t2515r217b2573],
60	.	.	O	.	_	0	SENT_58	[p5l18t2515r217b2573],

1	Both	DT	O	both	det	2	SENT_59	[p5l255t2512r435b2573],
2	areas	NNS	O	area	nsubj	3	SENT_59	[p5l469t2532r653b2573],
3	have	VBP	O	have	_	0	SENT_59	[p5l686t2512r855b2573],
4	year-round	JJ	O	year-round	amod	6	SENT_59	[p5l886t2512r1303b2588],
5	malaria	NN	O	malaria	nn	6	SENT_59	[p5l1335t2512r1611b2573],
6	transmission	NN	O	transmission	dobj	3	SENT_59	[p5l1644t2513r2138b2573],
7	.	.	O	.	_	0	SENT_59	[p5l1644t2513r2138b2573],

1	Kiliﬁ	NNP	PERSON	Kiliﬁ	nsubj	2	SENT_60	[p5l9t2606r197b2665],
2	has	VBZ	O	have	_	0	SENT_60	[p5l267t2606r388b2666],
3	two	CD	NUMBER	two	num	6	SENT_60	[p5l460t2620r594b2666],
4	major	JJ	O	major	amod	6	SENT_60	[p5l666t2606r884b2681],
5	rainy	JJ	O	rainy	amod	6	SENT_60	[p5l952t2606r1140b2682],
6	seasons	NNS	O	season	dobj	2	SENT_60	[p5l1211t2626r1488b2666],
7	annually	RB	SET	annually	advmod	6	SENT_60	[p5l1562t2606r1902b2682],
8	,	,	O	,	_	0	SENT_60	[p5l1562t2606r1902b2682],
9	each	DT	O	each	dobj	2	SENT_60	[p5l1977t2606r2144b2666],
10	followed	VBN	O	follow	partmod	9	SENT_60	[p5l8t2698r328b2759],
11	by	IN	O	by	_	0	SENT_60	[p5l438t2698r528b2774],
12	periods	NNS	O	period	agent	10	SENT_60	[p5l637t2698r910b2774],
13	of	IN	O	of	_	0	SENT_60	[p5l1026t2698r1104b2759],
14	increased	VBN	O	increase	prepc_of	12	SENT_60	[p5l1206t2698r1558b2759],
15	transmission	NN	O	transmission	nn	17	SENT_60	[p5l1669t2698r2144b2759],
16	(	CD	NUMBER	(	num	17	SENT_60	[p5l15t2791r440b2866],
17	November	NNP	DATE	November	dobj	14	SENT_60	[p5l15t2791r440b2866],
18	to	TO	O	to	_	0	SENT_60	[p5l485t2806r556b2852],
19	January	NNP	DATE	January	prep_to	17	SENT_60	[p5l600t2792r891b2867],
20	and	CC	O	and	_	0	SENT_60	[p5l939t2791r1074b2852],
21	May	NNP	DATE	May	conj_and	19	SENT_60	[p5l1122t2792r1290b2867],
22	to	TO	O	to	_	0	SENT_60	[p5l1335t2806r1406b2852],
23	August	NNP	DATE	August	nn	24	SENT_60	[p5l1453t2792r1775b2867],
24	)	NN	O	)	prep_to	14	SENT_60	[p5l1453t2792r1775b2867],
25	.	.	O	.	_	0	SENT_60	[p5l1453t2792r1775b2867],

1	Blantyre	NNP	LOCATION	Blantyre	nsubj	12	SENT_61	[p5l1828t2791r2143b2867],
2	has	VBZ	O	have	aux	12	SENT_61	[p5l7t2885r127b2945],
3	one	CD	NUMBER	one	num	7	SENT_61	[p5l176t2905r307b2945],
4	major	JJ	O	major	amod	7	SENT_61	[p5l352t2885r570b2961],
5	annual	JJ	SET	annual	amod	7	SENT_61	[p5l614t2885r864b2945],
6	rainy	JJ	O	rainy	amod	7	SENT_61	[p5l909t2885r1097b2961],
7	season	NN	O	season	npadvmod	11	SENT_61	[p5l1142t2904r1386b2945],
8	and	CC	O	and	_	0	SENT_61	[p5l1432t2885r1567b2945],
9	one	CD	NUMBER	one	num	10	SENT_61	[p5l1613t2905r1744b2945],
10	period	NN	O	period	npadvmod	11	SENT_61	[p5l1788t2885r2029b2961],
11	of	IN	O	of	advmod	12	SENT_61	[p5l2075t2885r2154b2945],
12	increased	VBN	O	increase	_	0	SENT_61	[p5l8t2977r360b3038],
13	transmission	NN	O	transmission	nn	15	SENT_61	[p5l432t2977r907b3038],
14	(	CD	NUMBER	(	num	15	SENT_61	[p5l985t2978r1299b3053],
15	January	NNP	DATE	January	dobj	12	SENT_61	[p5l985t2978r1299b3053],
16	to	TO	O	to	_	0	SENT_61	[p5l1370t2991r1440b3038],
17	June	NNP	DATE	June	prep_to	15	SENT_61	[p5l1510t2978r1736b3052],
18	)	CD	DATE	)	num	17	SENT_61	[p5l1510t2978r1736b3052],
19	.	.	O	.	_	0	SENT_61	[p5l1510t2978r1736b3052],

1	Identical	JJ	O	identical	amod	3	SENT_62	[p5l1814t2977r2143b3038],
2	study	NN	O	study	nn	3	SENT_62	[p5l10t3070r211b3146],
3	protocols	NNS	O	protocol	nsubjpass	5	SENT_62	[p5l272t3070r620b3146],
4	were	VBD	O	be	auxpass	5	SENT_62	[p5l683t3090r857b3131],
5	used	VBN	O	use	_	0	SENT_62	[p5l921t3070r1093b3131],
6	in	IN	O	in	_	0	SENT_62	[p5l1156t3071r1226b3130],
7	the	DT	O	the	det	9	SENT_62	[p5l1289t3070r1403b3131],
8	two	CD	NUMBER	two	num	9	SENT_62	[p5l1467t3085r1601b3131],
9	centres	NNS	O	centre	prep_in	5	SENT_62	[p5l1668t3085r1952b3131],
10	.	.	O	.	_	0	SENT_62	[p5l1668t3085r1952b3131],

1	We	PRP	O	we	nsubj	2	SENT_63	[p5l2019t3071r2143b3131],
2	obtained	VBD	O	obtain	_	0	SENT_63	[p5l10t3164r336b3224],
3	scientific	JJ	O	scientific	amod	6	SENT_63	[p5l417t3164r747b3224],
4	and	CC	O	and	_	0	SENT_63	[p5l830t3164r965b3224],
5	ethical	JJ	O	ethical	conj_and	3	SENT_63	[p5l1046t3164r1289b3224],
6	approval	NN	O	approval	dobj	2	SENT_63	[p5l1371t3164r1692b3240],
7	from	IN	O	from	_	0	SENT_63	[p5l1771t3164r1949b3224],
8	the	DT	O	the	det	12	SENT_63	[p5l2029t3164r2143b3224],
9	National	NNP	ORGANIZATION	National	nn	12	SENT_63	[p5l7t3256r334b3317],
10	Ethical	NNP	ORGANIZATION	Ethical	nn	12	SENT_63	[p5l377t3256r640b3317],
11	Review	NNP	ORGANIZATION	Review	nn	12	SENT_63	[p5l683t3256r951b3317],
12	Committee	NNP	ORGANIZATION	Committee	prep_from	2	SENT_63	[p5l995t3256r1415b3317],
13	of	IN	ORGANIZATION	of	_	0	SENT_63	[p5l1459t3256r1538b3317],
14	Kenya	NNP	ORGANIZATION	Kenya	prep_of	12	SENT_63	[p5l1570t3257r1809b3332],
15	and	CC	O	and	_	0	SENT_63	[p5l1853t3256r1988b3317],
16	the	DT	O	the	det	20	SENT_63	[p5l2029t3256r2143b3317],
17	Health	NNP	ORGANIZATION	Health	nn	20	SENT_63	[p5l9t3349r263b3410],
18	Sciences	NNP	ORGANIZATION	Sciences	nn	20	SENT_63	[p5l316t3350r631b3410],
19	Research	NNP	ORGANIZATION	Research	nn	20	SENT_63	[p5l684t3349r1023b3410],
20	Committee	NNP	ORGANIZATION	Committee	conj_and	12	SENT_63	[p5l1075t3349r1496b3410],
21	of	IN	O	of	_	0	SENT_63	[p5l1548t3349r1627b3410],
22	Malawi	NNP	LOCATION	Malawi	prep_of	20	SENT_63	[p5l1667t3349r1965b3410],
23	.	.	O	.	_	0	SENT_63	[p5l1667t3349r1965b3410],

1	We	PRP	O	we	nsubj	2	SENT_64	[p5l2019t3350r2143b3410],
2	obtained	VBD	O	obtain	_	0	SENT_64	[p6l10t23r336b83],
3	written	JJ	O	written	amod	5	SENT_64	[p6l399t23r666b83],
4	informed	VBN	O	inform	amod	5	SENT_64	[p6l731t23r1074b83],
5	consent	NN	O	consent	dobj	2	SENT_64	[p6l1140t37r1428b83],
6	from	IN	O	from	_	0	SENT_64	[p6l1492t23r1670b83],
7	parents	NNS	O	parent	prep_from	2	SENT_64	[p6l1733t37r2007b99],
8	of	IN	O	of	_	0	SENT_64	[p6l2075t23r2154b83],
9	patients	NNS	O	patient	prep_of	7	SENT_64	[p6l6t115r324b191],
10	,	,	O	,	_	0	SENT_64	[p6l6t115r324b191],
11	in	IN	O	in	_	0	SENT_64	[p6l386t115r457b175],
12	their	PRP$	O	they	poss	14	SENT_64	[p6l514t115r689b176],
13	own	JJ	O	own	amod	14	SENT_64	[p6l747t135r901b176],
14	language	NN	O	language	prep_in	2	SENT_64	[p6l960t115r1312b191],
15	.	.	O	.	_	0	SENT_64	[p6l960t115r1312b191],

1	Parents	NNS	O	parent	nsubj	2	SENT_65	[p6l1376t116r1655b176],
2	understood	VBD	O	understand	_	0	SENT_65	[p6l1715t115r2143b176],
3	their	PRP$	O	they	poss	4	SENT_65	[p6l7t208r181b269],
4	right	NN	O	right	dobj	2	SENT_65	[p6l221t208r397b284],
5	to	TO	O	to	aux	6	SENT_65	[p6l438t223r509b269],
6	withdraw	VB	O	withdraw	infmod	4	SENT_65	[p6l551t208r903b269],
7	their	PRP$	O	they	poss	8	SENT_65	[p6l943t208r1118b269],
8	children	NNS	O	child	dobj	6	SENT_65	[p6l1160t208r1466b269],
9	from	IN	O	from	_	0	SENT_65	[p6l1508t208r1686b269],
10	the	DT	O	the	det	11	SENT_65	[p6l1727t208r1842b269],
11	trial	NN	O	trial	prep_from	6	SENT_65	[p6l1885t208r2033b269],
12	at	IN	O	at	_	0	SENT_65	[p6l2077t223r2143b269],
13	any	DT	O	any	det	14	SENT_65	[p6l9t321r138b378],
14	time	NN	O	time	prep_at	11	SENT_65	[p6l165t302r350b362],
15	.	.	O	.	_	0	SENT_65	[p6l165t302r350b362],

1	Transport	NN	O	transport	nn	2	SENT_66	[p6l384t303r765b378],
2	costs	NNS	O	cost	nsubjpass	4	SENT_66	[p6l795t316r974b362],
3	were	VBD	O	be	auxpass	4	SENT_66	[p6l1004t321r1178b362],
4	refunded	VBN	O	refund	_	0	SENT_66	[p6l1208t302r1566b362],
5	.	.	O	.	_	0	SENT_66	[p6l1208t302r1566b362],

1	The	DT	O	the	det	3	SENT_67	[p6l91t394r242b455],
2	main	JJ	O	main	amod	3	SENT_67	[p6l282t394r469b455],
3	aim	NN	O	aim	nsubj	7	SENT_67	[p6l510t394r645b455],
4	of	IN	O	of	_	0	SENT_67	[p6l686t394r764b455],
5	the	DT	O	the	det	6	SENT_67	[p6l794t394r908b455],
6	trial	NN	O	trial	prep_of	3	SENT_67	[p6l948t394r1096b455],
7	was	VBD	O	be	_	0	SENT_67	[p6l1135t414r1270b455],
8	to	TO	O	to	aux	9	SENT_67	[p6l1311t408r1381b455],
9	test	VB	O	test	xcomp	7	SENT_67	[p6l1423t408r1554b455],
10	the	DT	O	the	det	11	SENT_67	[p6l1593t394r1707b455],
11	hypothesis	NN	O	hypothesis	dobj	9	SENT_67	[p6l1746t394r2141b470],
12	that	IN	O	that	complm	15	SENT_67	[p6l7t487r153b548],
13	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubjpass	15	SENT_67	[p6l191t487r1086b563],
14	is	VBZ	O	be	auxpass	15	SENT_67	[p6l1124t488r1177b548],
15	associated	VBN	O	associate	ccomp	9	SENT_67	[p6l1218t487r1597b548],
16	with	IN	O	with	_	0	SENT_67	[p6l1633t487r1796b548],
17	a	DT	O	a	det	21	SENT_67	[p6l1835t507r1870b548],
18	higher	JJR	O	higher	amod	21	SENT_67	[p6l1906t487r2144b563],
19	annual	JJ	SET	annual	amod	21	SENT_67	[p6l9t581r259b641],
20	malaria	NN	O	malaria	nn	21	SENT_67	[p6l373t581r650b641],
21	incidence	NN	O	incidence	prep_with	15	SENT_67	[p6l764t581r1120b641],
22	than	IN	O	than	mark	24	SENT_67	[p6l1234t581r1400b641],
23	is	VBZ	O	be	cop	24	SENT_67	[p6l1513t581r1566b641],
24	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	advcl	15	SENT_67	[p6l1683t581r2142b641, p6l6t673r598b749],
25	,	,	O	,	_	0	SENT_67	[p6l1683t581r2142b641, p6l6t673r598b749],

1	and	CC	O	and	cc	6	SENT_68	[p6l644t673r779b734],
2	the	DT	O	the	det	4	SENT_68	[p6l820t673r934b734],
3	sample	NN	O	sample	nn	4	SENT_68	[p6l978t673r1236b749],
4	size	NN	O	size	nsubjpass	6	SENT_68	[p6l1280t673r1411b734],
5	was	VBD	O	be	auxpass	6	SENT_68	[p6l1451t693r1586b734],
6	calculated	VBN	O	calculate	_	0	SENT_68	[p6l1631t673r2009b734],
7	on	IN	O	on	_	0	SENT_68	[p6l2051t693r2143b734],
8	this	DT	O	this	det	9	SENT_68	[p6l7t766r138b827],
9	basis	NN	O	basis	prep_on	6	SENT_68	[p6l168t766r369b827],
10	.	.	O	.	_	0	SENT_68	[p6l168t766r369b827],

1	We	PRP	O	we	nsubj	2	SENT_69	[p6l402t767r526b827],
2	used	VBD	O	use	_	0	SENT_69	[p6l555t766r727b827],
3	the	DT	O	the	det	4	SENT_69	[p6l755t766r870b827],
4	formula	NN	O	formulum	dobj	2	SENT_69	[p6l900t766r1214b827],
5	:	:	O	:	_	0	SENT_69	[p6l900t766r1214b827],

1	n	NN	O	n	nsubj	2	SENT_70	[p6l91t858r637b935],
2	=	JJ	O	=	_	0	SENT_70	[p6l91t858r637b935],
3	2	CD	NUMBER	2	num	4	SENT_70	[p6l91t858r637b935],
4	[	CD	NUMBER	[	iobj	2	SENT_70	[p6l91t858r637b935],
5	o/A	NN	O	o/a	nn	6	SENT_70	[p6l91t858r637b935],
6	]	NN	O	]	dobj	2	SENT_70	[p6l91t858r637b935],
7	2	CD	NUMBER	2	num	6	SENT_70	[p6l91t858r637b935],
8	.	.	O	.	_	0	SENT_70	[p6l91t858r637b935],

1	[	NN	O	[	nn	3	SENT_71	[p6l91t858r637b935],
2	Zo	NN	O	zo	nn	3	SENT_71	[p6l91t858r637b935],
3	¢	NN	O	¢	nsubjpass	60	SENT_71	[p6l91t858r637b935],
4	+	CC	O	+	_	0	SENT_71	[p6l670t869r717b915],
5	Z	NN	O	z	nn	6	SENT_71	[p6l750t860r914b937],
6	|	NN	O	|	conj_+	3	SENT_71	[p6l750t860r914b937],
7	3	CD	NUMBER	3	num	8	SENT_71	[p6l750t860r914b937],
8	]	NN	O	]	dep	6	SENT_71	[p6l750t860r914b937],
9	2	CD	NUMBER	2	dep	8	SENT_71	[p6l750t860r914b937],
10	where	WRB	O	where	advmod	49	SENT_71	[p6l91t952r313b1013],
11	n	NN	O	n	nsubjpass	49	SENT_71	[p6l370t952r593b1013],
12	=	VBG	O	=	partmod	11	SENT_71	[p6l370t952r593b1013],
13	the	DT	O	the	det	14	SENT_71	[p6l370t952r593b1013],
14	size	NN	O	size	dobj	12	SENT_71	[p6l652t952r784b1013],
15	of	IN	O	of	_	0	SENT_71	[p6l843t952r922b1013],
16	each	DT	O	each	det	18	SENT_71	[p6l971t952r1138b1013],
17	treatment	NN	O	treatment	nn	18	SENT_71	[p6l1194t966r1560b1013],
18	group	NN	O	group	prep_of	14	SENT_71	[p6l1616t972r1857b1028],
19	,	,	O	,	_	0	SENT_71	[p6l1616t972r1857b1028],
20	o	NN	O	o	dobj	12	SENT_71	[p6l1918t952r2142b1013],
21	=	JJ	O	=	rcmod	20	SENT_71	[p6l1918t952r2142b1013],
22	the	DT	O	the	det	24	SENT_71	[p6l1918t952r2142b1013],
23	standard	JJ	O	standard	amod	24	SENT_71	[p6l8t1045r333b1106],
24	deviation	NN	O	deviation	dobj	21	SENT_71	[p6l454t1045r798b1106],
25	of	IN	O	of	_	0	SENT_71	[p6l919t1045r998b1106],
26	malaria	NN	O	malaria	nn	27	SENT_71	[p6l1107t1045r1384b1106],
27	incidence	NN	O	incidence	prep_of	24	SENT_71	[p6l1504t1045r1860b1106],
28	with	IN	O	with	_	0	SENT_71	[p6l1980t1045r2143b1106],
29	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	30	SENT_71	[p6l8t1139r1040b1215],
30	treatment	NN	O	treatment	prep_with	21	SENT_71	[p6l1155t1153r1543b1212],
31	,	,	O	,	_	0	SENT_71	[p6l1155t1153r1543b1212],
32	and	CC	O	and	_	0	SENT_71	[p6l1663t1139r1798b1199],
33	A	NN	O	a	conj_and	14	SENT_71	[p6l1914t1137r2142b1199],
34	=	JJ	O	=	amod	37	SENT_71	[p6l1914t1137r2142b1199],
35	the	DT	O	the	det	37	SENT_71	[p6l1914t1137r2142b1199],
36	anticipated	JJ	O	anticipated	amod	37	SENT_71	[p6l9t1231r424b1307],
37	difference	NN	O	difference	dep	33	SENT_71	[p6l519t1231r888b1292],
38	between	IN	O	between	_	0	SENT_71	[p6l981t1231r1292b1292],
39	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_between	37	SENT_71	[p6l1387t1231r2142b1307, p6l7t1324r311b1385],
40	and	CC	O	and	_	0	SENT_71	[p6l364t1324r499b1385],
41	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	conj_and	39	SENT_71	[p6l550t1324r1469b1400],
42	;	:	O	;	_	0	SENT_71	[p6l550t1324r1469b1400],
43	type-I	NN	O	type-i	nn	44	SENT_71	[p6l1521t1325r1743b1400],
44	error	NN	O	error	dep	37	SENT_71	[p6l1795t1344r1978b1385],
45	(	CD	NUMBER	(	dep	44	SENT_71	[p6l2032t1325r2136b1400],
46	or	CC	O	or	_	0	SENT_71	[p6l2032t1325r2136b1400],
47	)	CD	NUMBER	)	dep	44	SENT_71	[p6l2032t1325r2136b1400],
48	was	VBD	O	be	auxpass	49	SENT_71	[p6l6t1438r141b1478],
49	set	VBN	O	set	rcmod	3	SENT_71	[p6l191t1432r291b1478],
50	at	IN	O	at	_	0	SENT_71	[p6l339t1432r405b1478],
51	0-05	CD	NUMBER	0-05	prep_at	49	SENT_71	[p6l453t1420r640b1491],
52	,	,	O	,	_	0	SENT_71	[p6l453t1420r640b1491],
53	type-II	JJ	O	type-ii	amod	55	SENT_71	[p6l690t1419r944b1494],
54	error	NN	O	error	nn	55	SENT_71	[p6l994t1437r1177b1478],
55	(	NN	O	(	appos	51	SENT_71	[p6l1228t1418r1332b1495],
56	[	CD	NUMBER	[	number	57	SENT_71	[p6l1228t1418r1332b1495],
57	3	CD	NUMBER	3	num	58	SENT_71	[p6l1228t1418r1332b1495],
58	)	NN	O	)	dep	55	SENT_71	[p6l1228t1418r1332b1495],
59	was	VBD	O	be	auxpass	60	SENT_71	[p6l1383t1437r1518b1478],
60	set	VBN	O	set	_	0	SENT_71	[p6l1569t1432r1669b1478],
61	at	IN	O	at	_	0	SENT_71	[p6l1717t1432r1783b1478],
62	0-1	CD	NUMBER	0-1	prep_at	60	SENT_71	[p6l1831t1420r1967b1478],
63	.	.	O	.	_	0	SENT_71	[p6l1831t1420r1967b1478],

1	We	PRP	O	we	nsubj	2	SENT_72	[p6l2018t1419r2142b1478],
2	estimated	VBD	O	estimate	_	0	SENT_72	[p6l9t1510r368b1571],
3	that	IN	O	that	complm	18	SENT_72	[p6l420t1510r566b1571],
4	the	DT	O	the	det	7	SENT_72	[p6l617t1510r732b1571],
5	mean	JJ	O	mean	amod	7	SENT_72	[p6l785t1530r988b1571],
6	annual	JJ	SET	annual	amod	7	SENT_72	[p6l1041t1510r1292b1571],
7	incidence	NN	O	incidence	nsubj	18	SENT_72	[p6l1345t1510r1701b1571],
8	of	IN	O	of	_	0	SENT_72	[p6l1756t1510r1834b1571],
9	clinical	JJ	O	clinical	amod	10	SENT_72	[p6l1878t1510r2142b1571],
10	malaria	NN	O	malaria	prep_of	7	SENT_72	[p6l7t1603r283b1664],
11	when	WRB	O	when	advmod	14	SENT_72	[p6l326t1603r526b1664],
12	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nsubjpass	14	SENT_72	[p6l570t1603r1602b1679],
13	was	VBD	O	be	auxpass	14	SENT_72	[p6l1645t1623r1780b1664],
14	used	VBN	O	use	dep	10	SENT_72	[p6l1824t1603r1996b1664],
15	for	IN	O	for	_	0	SENT_72	[p6l2039t1603r2144b1664],
16	each	DT	O	each	det	17	SENT_72	[p6l9t1697r176b1757],
17	episode	NN	O	episode	prep_for	14	SENT_72	[p6l218t1697r497b1773],
18	was	VBD	O	be	ccomp	2	SENT_72	[p6l539t1717r674b1757],
19	2-0	CD	NUMBER	2-0	npadvmod	20	SENT_72	[p6l718t1699r831b1757],
20	at	IN	O	at	advmod	18	SENT_72	[p6l877t1711r943b1757],
21	both	CC	O	both	dep	18	SENT_72	[p6l982t1697r1154b1757],
22	centres	NNS	O	centre	nsubj	27	SENT_72	[p6l1196t1711r1482b1770],
23	;	:	O	;	_	0	SENT_72	[p6l1196t1711r1482b1770],
24	o	NN	O	o	dep	22	SENT_72	[p6l1528t1719r1575b1757],
25	'	''	O	'	_	0	SENT_72	[p6l1528t1719r1575b1757],
26	was	VBD	O	be	cop	27	SENT_72	[p6l1615t1717r1750b1757],
27	unknown	JJ	O	unknown	conj	18	SENT_72	[p6l1793t1697r2143b1757],
28	and	CC	O	and	_	0	SENT_72	[p6l9t1789r144b1850],
29	a	DT	O	a	det	30	SENT_72	[p6l191t1809r227b1850],
30	value	NN	O	value	nsubjpass	34	SENT_72	[p6l271t1789r466b1850],
31	of	IN	O	of	_	0	SENT_72	[p6l514t1789r593b1850],
32	3-0	CD	NUMBER	3-0	prep_of	30	SENT_72	[p6l631t1792r744b1850],
33	was	VBD	O	be	auxpass	34	SENT_72	[p6l790t1809r925b1850],
34	assumed	VBN	O	assume	conj_and	2	SENT_72	[p6l975t1789r1316b1850],
35	.	.	O	.	_	0	SENT_72	[p6l975t1789r1316b1850],

1	We	PRP	O	we	nsubj	2	SENT_73	[p6l1365t1790r1488b1850],
2	reasoned	VBD	O	reason	_	0	SENT_73	[p6l1535t1789r1869b1850],
3	that	IN	O	that	complm	20	SENT_73	[p6l1914t1789r2060b1850],
4	a	DT	O	a	det	5	SENT_73	[p6l2107t1809r2142b1850],
5	difference	NN	O	difference	nsubj	20	SENT_73	[p6l8t1882r377b1943],
6	between	IN	O	between	_	0	SENT_73	[p6l471t1882r783b1943],
7	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_between	5	SENT_73	[p6l878t1882r1910b1958],
8	and	CC	O	and	_	0	SENT_73	[p6l2007t1882r2142b1943],
9	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_between	5	SENT_73	[p6l9t1976r904b2052],
10	of	IN	O	of	_	0	SENT_73	[p6l957t1976r1036b2036],
11	one	CD	NUMBER	one	num	16	SENT_73	[p6l1078t1995r1209b2036],
12	or	CC	O	or	_	0	SENT_73	[p6l1263t1995r1339b2036],
13	more	JJR	O	more	num	16	SENT_73	[p6l1388t1995r1578b2036],
14	extra	JJ	O	extra	amod	16	SENT_73	[p6l1631t1990r1814b2036],
15	malaria	NN	O	malaria	nn	16	SENT_73	[p6l1865t1976r2142b2036],
16	episodes	NNS	O	episode	prep_of	7	SENT_73	[p6l9t2068r322b2144],
17	per	IN	O	per	_	0	SENT_73	[p6l390t2088r512b2144],
18	year	NN	DURATION	year	prep_per	16	SENT_73	[p6l575t2088r732b2144],
19	would	MD	O	would	aux	20	SENT_73	[p6l796t2068r1027b2129],
20	have	VB	O	have	ccomp	2	SENT_73	[p6l1093t2068r1262b2129],
21	major	JJ	O	major	amod	24	SENT_73	[p6l1330t2068r1548b2144],
22	public	JJ	O	public	amod	24	SENT_73	[p6l1612t2068r1845b2144],
23	health	NN	O	health	nn	24	SENT_73	[p6l1912t2068r2143b2129],
24	implications	NNS	O	implication	dobj	20	SENT_73	[p6l7t2161r487b2237],
25	.	.	O	.	_	0	SENT_73	[p6l7t2161r487b2237],

1	A	DT	O	a	det	3	SENT_74	[p6l535t2162r597b2221],
2	sample	NN	O	sample	nn	3	SENT_74	[p6l641t2161r899b2237],
3	size	NN	O	size	nsubjpass	11	SENT_74	[p6l946t2162r1078b2222],
4	of	IN	O	of	_	0	SENT_74	[p6l1125t2161r1204b2222],
5	189	CD	NUMBER	189	num	6	SENT_74	[p6l1247t2164r1374b2222],
6	patients	NNS	O	patient	prep_of	3	SENT_74	[p6l1421t2161r1715b2237],
7	per	IN	O	per	_	0	SENT_74	[p6l1760t2181r1882b2237],
8	group	NN	O	group	prep_per	6	SENT_74	[p6l1924t2181r2141b2237],
9	was	VBD	O	be	auxpass	11	SENT_74	[p6l6t2275r141b2315],
10	therefore	RB	O	therefore	advmod	11	SENT_74	[p6l173t2255r511b2315],
11	required	VBN	O	require	_	0	SENT_74	[p6l543t2255r880b2331],
12	.	.	O	.	_	0	SENT_74	[p6l543t2255r880b2331],

1	A	DT	O	a	det	3	SENT_75	[p6l915t2256r976b2314],
2	dropout	NN	O	dropout	nn	3	SENT_75	[p6l1008t2255r1308b2331],
3	rate	NN	O	rate	nsubjpass	10	SENT_75	[p6l1339t2269r1479b2315],
4	of	IN	O	of	_	0	SENT_75	[p6l1513t2255r1592b2315],
5	less	JJR	O	less	mwe	6	SENT_75	[p6l1614t2255r1742b2315],
6	than	IN	O	than	quantmod	7	SENT_75	[p6l1775t2255r1942b2315],
7	10	CD	PERCENT	10	num	8	SENT_75	[p6l1982t2255r2138b2317],
8	%	NN	PERCENT	%	prep_of	3	SENT_75	[p6l1982t2255r2138b2317],
9	was	VBD	O	be	auxpass	10	SENT_75	[p6l6t2367r141b2408],
10	anticipated	VBN	O	anticipate	_	0	SENT_75	[p6l186t2347r601b2423],
11	at	IN	O	at	_	0	SENT_75	[p6l645t2361r711b2408],
12	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_at	10	SENT_75	[p6l753t2347r941b2407],
13	from	IN	O	from	_	0	SENT_75	[p6l983t2347r1161b2408],
14	past	JJ	DATE	past	amod	15	SENT_75	[p6l1202t2361r1354b2423],
15	experience	NN	O	experience	prep_from	10	SENT_75	[p6l1398t2347r1818b2423],
16	,	,	O	,	_	0	SENT_75	[p6l1398t2347r1818b2423],
17	and	CC	O	and	_	0	SENT_75	[p6l1865t2347r2001b2408],
18	we	PRP	O	we	nsubj	19	SENT_75	[p6l2042t2367r2142b2408],
19	aimed	VBD	O	aim	conj_and	10	SENT_75	[p6l9t2440r234b2501],
20	to	TO	O	to	aux	21	SENT_75	[p6l272t2455r342b2501],
21	recruit	VB	O	recruit	xcomp	19	SENT_75	[p6l382t2441r630b2501],
22	205	CD	NUMBER	205	num	23	SENT_75	[p6l669t2443r802b2501],
23	patients	NNS	O	patient	dobj	21	SENT_75	[p6l844t2441r1138b2516],
24	per	IN	O	per	_	0	SENT_75	[p6l1177t2460r1298b2516],
25	group	NN	O	group	prep_per	23	SENT_75	[p6l1335t2460r1573b2516],
26	.	.	O	.	_	0	SENT_75	[p6l1335t2460r1573b2516],

1	A	DT	O	a	det	3	SENT_76	[p6l1614t2441r1676b2500],
2	higher	JJR	O	higher	amod	3	SENT_76	[p6l1711t2440r1949b2516],
3	(	NN	O	(	nsubjpass	10	SENT_76	[p6l1991t2440r2143b2516],
4	but	CC	O	but	prep	3	SENT_76	[p6l1991t2440r2143b2516],
5	unknown	JJ	O	unknown	amod	8	SENT_76	[p6l7t2534r384b2609],
6	)	NN	O	)	nn	8	SENT_76	[p6l7t2534r384b2609],
7	dropout	NN	O	dropout	nn	8	SENT_76	[p6l454t2534r754b2610],
8	rate	NN	O	rate	dep	4	SENT_76	[p6l816t2548r956b2594],
9	was	VBD	O	be	auxpass	10	SENT_76	[p6l1019t2554r1153b2594],
10	anticipated	VBN	O	anticipate	_	0	SENT_76	[p6l1219t2534r1635b2610],
11	at	IN	O	at	_	0	SENT_76	[p6l1699t2548r1765b2594],
12	Blantyre	NNP	LOCATION	Blantyre	nn	13	SENT_76	[p6l1827t2534r2142b2610],
13	(	NN	O	(	prep_at	10	SENT_76	[p6l13t2626r333b2701],
14	because	IN	O	because	_	0	SENT_76	[p6l13t2626r333b2701],
15	of	IN	O	of	prepc_because_of	10	SENT_76	[p6l374t2626r453b2687],
16	greater	JJR	O	greater	amod	19	SENT_76	[p6l481t2640r742b2702],
17	population	NN	O	population	nn	19	SENT_76	[p6l777t2626r1184b2702],
18	mobility	NN	O	mobility	nn	19	SENT_76	[p6l1222t2626r1589b2702],
19	)	NN	O	)	pobj	10	SENT_76	[p6l1222t2626r1589b2702],
20	,	,	O	,	_	0	SENT_76	[p6l1222t2626r1589b2702],
21	and	CC	O	and	_	0	SENT_76	[p6l1632t2626r1767b2687],
22	therefore	RB	O	therefore	advmod	24	SENT_76	[p6l1804t2626r2142b2687],
23	we	PRP	O	we	nsubj	24	SENT_76	[p6l6t2739r106b2780],
24	aimed	VBD	O	aim	conj_and	10	SENT_76	[p6l137t2719r363b2780],
25	to	TO	O	to	aux	26	SENT_76	[p6l392t2734r462b2780],
26	recruit	VB	O	recruit	xcomp	24	SENT_76	[p6l493t2720r741b2780],
27	250	CD	NUMBER	250	num	28	SENT_76	[p6l771t2722r907b2780],
28	patients	NNS	O	patient	dobj	26	SENT_76	[p6l937t2720r1232b2795],
29	per	IN	O	per	_	0	SENT_76	[p6l1261t2739r1382b2795],
30	group	NN	O	group	prep_per	28	SENT_76	[p6l1409t2739r1648b2795],
31	.	.	O	.	_	0	SENT_76	[p6l1409t2739r1648b2795],

1	Febrile	JJ	O	febrile	amod	2	SENT_77	[p6l92t2813r356b2873],
2	children	NNS	O	child	nsubj	3	SENT_77	[p6l390t2813r695b2873],
3	(	VBP	O	(	_	0	SENT_77	[p6l733t2813r932b2889],
4	aged	JJ	O	aged	acomp	3	SENT_77	[p6l733t2813r932b2889],
5	3	CD	DURATION	3	number	7	SENT_77	[p6l966t2815r1004b2873],
6	to	TO	DURATION	to	dep	7	SENT_77	[p6l1038t2827r1109b2873],
7	71	CD	DURATION	71	num	8	SENT_77	[p6l1145t2815r1225b2872],
8	months	NNS	NUMBER	month	tmod	12	SENT_77	[p6l1266t2813r1544b2873],
9	inclusive	JJ	O	inclusive	amod	10	SENT_77	[p6l1577t2813r1931b2888],
10	)	NN	O	)	nsubjpass	12	SENT_77	[p6l1577t2813r1931b2888],
11	were	VBD	O	be	auxpass	12	SENT_77	[p6l1967t2832r2142b2873],
12	recruited	VBN	O	recruit	ccomp	4	SENT_77	[p6l7t2905r345b2966],
13	if	IN	O	if	mark	17	SENT_77	[p6l386t2905r443b2965],
14	they	PRP	O	they	nsubj	43	SENT_77	[p6l474t2905r632b2981],
15	were	VBD	O	be	cop	17	SENT_77	[p6l670t2925r845b2966],
16	well	RB	O	well	advmod	17	SENT_77	[p6l885t2905r1034b2966],
17	enough	JJ	O	enough	advcl	12	SENT_77	[p6l1077t2905r1352b2981],
18	for	IN	O	for	_	0	SENT_77	[p6l1392t2905r1498b2966],
19	outpatient	NN	O	outpatient	nn	20	SENT_77	[p6l1538t2905r1924b2981],
20	care	NN	O	care	prep_for	17	SENT_77	[p6l1966t2925r2139b2978],
21	,	,	O	,	_	0	SENT_77	[p6l1966t2925r2139b2978],
22	lived	VBD	O	live	advcl	12	SENT_77	[p6l7t2998r184b3059],
23	in	IN	O	in	_	0	SENT_77	[p6l221t2999r290b3058],
24	defined	VBN	O	define	amod	26	SENT_77	[p6l328t2998r605b3059],
25	study	NN	O	study	nn	26	SENT_77	[p6l643t2998r845b3074],
26	areas	NNS	O	area	prep_in	22	SENT_77	[p6l882t3018r1090b3071],
27	,	,	O	,	_	0	SENT_77	[p6l882t3018r1090b3071],
28	had	VBD	O	have	advcl	12	SENT_77	[p6l1129t2998r1266b3059],
29	capillary	JJ	O	capillary	amod	30	SENT_77	[p6l1305t2998r1621b3074],
30	haemoglobin	NN	O	haemoglobin	dobj	28	SENT_77	[p6l1655t2998r2143b3074],
31	70	CD	NUMBER	70	num	32	SENT_77	[p6l9t3094r96b3152],
32	g/L	NN	O	g/l	dep	30	SENT_77	[p6l134t3092r260b3168],
33	or	CC	O	or	_	0	SENT_77	[p6l293t3111r369b3152],
34	greater	JJR	O	greater	conj_or	30	SENT_77	[p6l402t3106r663b3168],
35	(	CD	NUMBER	(	num	37	SENT_77	[p6l702t3092r1154b3168],
36	packed-cell	NN	O	packed-cell	nn	37	SENT_77	[p6l702t3092r1154b3168],
37	volume	NN	O	volume	dep	34	SENT_77	[p6l1187t3092r1463b3152],
38	221	CD	PERCENT	221	num	39	SENT_77	[p6l1503t3092r1796b3167],
39	%	NN	PERCENT	%	dep	34	SENT_77	[p6l1503t3092r1796b3167],
40	)	CD	NUMBER	)	tmod	28	SENT_77	[p6l1503t3092r1796b3167],
41	,	,	O	,	_	0	SENT_77	[p6l1503t3092r1796b3167],
42	and	CC	O	and	_	0	SENT_77	[p6l1836t3092r1972b3152],
43	had	VBD	O	have	advcl	12	SENT_77	[p6l2005t3092r2143b3152],
44	P	NN	O	p	nn	46	SENT_77	[p6l6t3185r64b3244],
45	falciparum	NN	O	falciparum	nn	46	SENT_77	[p6l90t3184r478b3260],
46	parasitaemia	NN	O	parasitaemia	iobj	43	SENT_77	[p6l525t3184r998b3260],
47	below	IN	O	below	_	0	SENT_77	[p6l1044t3184r1266b3245],
48	250	CD	NUMBER	250	num	50	SENT_77	[p6l1314t3187r1449b3245],
49	ooo	NN	O	ooo	nn	50	SENT_77	[p6l1500t3187r1636b3245],
50	pL	NN	O	pl	prep_below	46	SENT_77	[p6l1690t3185r1839b3261],
51	‘‘	CD	NUMBER	‘‘	num	52	SENT_77	[p6l1690t3185r1839b3261],
52	(	NN	O	(	dobj	43	SENT_77	[p6l1895t3184r2144b3259],
53	below	IN	O	below	_	0	SENT_77	[p6l1895t3184r2144b3259],
54	10	CD	PERCENT	10	number	55	SENT_77	[p6l16t3278r172b3340],
55	%	NN	PERCENT	%	amod	56	SENT_77	[p6l16t3278r172b3340],
56	parasitaemia	NN	O	parasitaemia	prep_below	43	SENT_77	[p6l204t3278r677b3353],
57	if	IN	O	if	mark	58	SENT_77	[p6l706t3277r763b3337],
58	counted	VBN	O	count	advcl	3	SENT_77	[p6l783t3277r1085b3338],
59	from	IN	O	from	_	0	SENT_77	[p6l1113t3277r1291b3338],
60	a	DT	O	a	det	63	SENT_77	[p6l1321t3297r1356b3338],
61	thin	JJ	O	thin	amod	63	SENT_77	[p6l1384t3277r1533b3338],
62	ﬁlm	NN	O	ﬁlm	nn	63	SENT_77	[p6l1561t3277r1761b3353],
63	)	NN	O	)	prep_from	58	SENT_77	[p6l1561t3277r1761b3353],
64	.	.	O	.	_	0	SENT_77	[p6l1561t3277r1761b3353],

1	No	DT	O	no	det	3	SENT_78	[p6l1793t3278r1909b3338],
2	lower	JJR	O	lower	amod	3	SENT_78	[p6l1939t3277r2144b3338],
3	limit	NN	O	limit	nsubjpass	7	SENT_78	[p6l7t3371r180b3431],
4	of	IN	O	of	_	0	SENT_78	[p6l252t3371r330b3431],
5	parasitaemia	NN	O	parasitaemia	prep_of	3	SENT_78	[p6l390t3371r864b3447],
6	was	VBD	O	be	auxpass	7	SENT_78	[p6l934t3391r1069b3431],
7	enforced	VBN	O	enforce	_	0	SENT_78	[p6l1143t3371r1488b3431],
8	.	.	O	.	_	0	SENT_78	[p6l1143t3371r1488b3431],

1	Children	NNS	O	child	nsubjpass	3	SENT_79	[p6l1568t3371r1898b3431],
2	were	VBD	O	be	auxpass	3	SENT_79	[p6l1967t3390r2142b3431],
3	excluded	VBN	O	exclude	_	0	SENT_79	[p6l9t3463r342b3524],
4	for	IN	O	for	_	0	SENT_79	[p6l465t3463r571b3524],
5	concurrent	JJ	O	concurrent	amod	6	SENT_79	[p6l693t3477r1103b3524],
6	infection	NN	O	infection	prep_for	3	SENT_79	[p6l1224t3463r1577b3536],
7	,	,	O	,	_	0	SENT_79	[p6l1224t3463r1577b3536],
8	allergy	NN	O	allergy	prep_for	3	SENT_79	[p6l1704t3463r1949b3539],
9	to	TO	O	to	_	0	SENT_79	[p6l2070t3477r2141b3524],
10	sulphonamides	NNS	O	sulphonamide	prep_to	8	SENT_79	[p6l8t3556r595b3632],
11	,	,	O	,	_	0	SENT_79	[p6l8t3556r595b3632],
12	or	CC	O	or	_	0	SENT_79	[p6l636t3576r712b3617],
13	treatment	NN	O	treatment	prep_for	3	SENT_79	[p6l747t3571r1113b3617],
14	within	IN	O	within	_	0	SENT_79	[p6l1148t3556r1385b3617],
15	the	DT	DATE	the	det	17	SENT_79	[p6l1421t3556r1535b3617],
16	past	JJ	DATE	past	amod	17	SENT_79	[p6l1571t3571r1724b3632],
17	week	NN	DATE	week	prep_within	3	SENT_79	[p6l1758t3556r1947b3617],
18	with	IN	O	with	_	0	SENT_79	[p6l1980t3556r2143b3617],
19	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_with	17	SENT_79	[p6l8t3650r1064b3726],
20	,	,	O	,	_	0	SENT_79	[p6l8t3650r1064b3726],
21	pyrimethamine-sulfalene	NN	O	pyrimethamine-sulfalene	appos	19	SENT_79	[p6l1181t3650r2139b3726],
22	,	,	O	,	_	0	SENT_79	[p6l1181t3650r2139b3726],
23	meﬂoquine	NN	O	meﬂoquine	appos	19	SENT_79	[p6l7t3742r453b3818],
24	,	,	O	,	_	0	SENT_79	[p6l7t3742r453b3818],
25	amodiaquine	NN	O	amodiaquine	appos	19	SENT_79	[p6l535t3742r1044b3818],
26	,	,	O	,	_	0	SENT_79	[p6l535t3742r1044b3818],
27	halofantrine	NN	O	halofantrine	conj_or	21	SENT_79	[p6l1123t3742r1601b3815],
28	,	,	O	,	_	0	SENT_79	[p6l1123t3742r1601b3815],
29	or	CC	O	or	_	0	SENT_79	[p6l1682t3762r1759b3803],
30	quinine	NN	O	quinine	appos	19	SENT_79	[p6l1835t3742r2137b3818],
31	.	.	O	.	_	0	SENT_79	[p6l1835t3742r2137b3818],

1	Chloroquine	NN	O	chloroquine	nn	2	SENT_80	[p7l10t16r483b92],
2	treatment	NN	O	treatment	nsubj	11	SENT_80	[p7l534t30r900b77],
3	at	IN	O	at	_	0	SENT_80	[p7l952t31r1018b77],
4	an	DT	O	a	det	6	SENT_80	[p7l1069t36r1155b77],
5	earlier	JJR	O	earlier	amod	6	SENT_80	[p7l1207t16r1440b77],
6	date	NN	O	date	prep_at	2	SENT_80	[p7l1491t16r1646b77],
7	was	VBD	O	be	cop	11	SENT_80	[p7l1696t36r1831b77],
8	not	RB	O	not	neg	11	SENT_80	[p7l1882t31r2006b77],
9	an	DT	O	a	det	11	SENT_80	[p7l2057t36r2143b77],
10	exclusion	NN	O	exclusion	nn	11	SENT_80	[p7l9t110r358b170],
11	criterion	NN	O	criterion	_	0	SENT_80	[p7l389t110r726b170],
12	.	.	O	.	_	0	SENT_80	[p7l389t110r726b170],

1	Treatment	NN	O	treatment	nn	2	SENT_81	[p7l91t203r494b263],
2	instructions	NNS	O	instruction	nsubjpass	16	SENT_81	[p7l553t202r994b263],
3	were	VBD	O	be	auxpass	4	SENT_81	[p7l1054t222r1228b263],
4	produced	VBN	O	produce	_	0	SENT_81	[p7l1288t202r1645b278],
5	by	IN	O	by	_	0	SENT_81	[p7l1703t202r1792b278],
6	random	JJ	O	random	amod	8	SENT_81	[p7l1851t202r2143b263],
7	number	NN	O	number	nn	8	SENT_81	[p7l6t295r302b356],
8	generation	NN	O	generation	agent	4	SENT_81	[p7l335t296r732b371],
9	in	IN	O	in	_	0	SENT_81	[p7l767t296r837b355],
10	blocks	NNS	O	block	prep_in	8	SENT_81	[p7l871t295r1107b356],
11	of	IN	O	of	_	0	SENT_81	[p7l1146t295r1225b356],
12	ten	CD	NUMBER	ten	prep_of	10	SENT_81	[p7l1250t310r1389b368],
13	,	,	O	,	_	0	SENT_81	[p7l1250t310r1389b368],
14	and	CC	O	and	_	0	SENT_81	[p7l1430t295r1565b356],
15	were	VBD	O	be	auxpass	16	SENT_81	[p7l1599t315r1773b356],
16	prepared	VBN	O	prepare	conj_and	4	SENT_81	[p7l1809t295r2142b371],
17	in	IN	O	in	_	0	SENT_81	[p7l7t389r77b448],
18	advance	NN	O	advance	nn	19	SENT_81	[p7l116t389r416b449],
19	(	NN	O	(	prep_in	16	SENT_81	[p7l460t389r576b465],
20	by	IN	O	by	_	0	SENT_81	[p7l460t389r576b465],
21	the	DT	O	the	det	23	SENT_81	[p7l611t389r726b449],
22	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	23	SENT_81	[p7l764t389r1139b465],
23	Department	NNP	ORGANIZATION	Department	agent	16	SENT_81	[p7l1175t390r1633b465],
24	of	IN	ORGANIZATION	of	_	0	SENT_81	[p7l1671t389r1750b449],
25	the	DT	ORGANIZATION	the	det	30	SENT_81	[p7l1777t389r1892b449],
26	Royal	NNP	ORGANIZATION	Royal	nn	30	SENT_81	[p7l1931t389r2142b465],
27	Liverpool	NNP	ORGANIZATION	Liverpool	nn	30	SENT_81	[p7l7t481r368b557],
28	University	NNP	ORGANIZATION	University	nn	30	SENT_81	[p7l404t481r794b557],
29	Hospital	NNP	ORGANIZATION	Hospital	nn	30	SENT_81	[p7l828t481r1175b557],
30	)	NN	O	)	prep_of	23	SENT_81	[p7l828t481r1175b557],
31	in	IN	O	in	_	0	SENT_81	[p7l1217t481r1287b541],
32	sealed	JJ	O	sealed	prep_in	16	SENT_81	[p7l1324t481r1551b542],
33	and	CC	O	and	_	0	SENT_81	[p7l1588t481r1723b542],
34	numbered	VBD	O	number	conj_and	4	SENT_81	[p7l1759t481r2142b542],
35	envelopes	NNS	O	envelope	dobj	34	SENT_81	[p7l9t574r392b650],
36	.	.	O	.	_	0	SENT_81	[p7l9t574r392b650],

1	Codes	NNS	O	code	nsubjpass	8	SENT_82	[p7l461t574r692b635],
2	for	IN	O	for	_	0	SENT_82	[p7l754t574r859b635],
3	both	DT	O	both	det	4	SENT_82	[p7l916t574r1087b635],
4	Kiliﬁ	NN	PERSON	kiliﬁ	prep_for	1	SENT_82	[p7l1147t574r1336b634],
5	and	CC	O	and	_	0	SENT_82	[p7l1398t574r1533b635],
6	Blantyre	NNP	LOCATION	Blantyre	prep_for	1	SENT_82	[p7l1594t574r1908b650],
7	were	VBD	O	be	auxpass	8	SENT_82	[p7l1967t594r2142b635],
8	retained	VBN	O	retain	_	0	SENT_82	[p7l7t668r313b728],
9	in	IN	O	in	_	0	SENT_82	[p7l374t668r443b727],
10	sealed	VBN	O	seal	amod	11	SENT_82	[p7l506t668r732b728],
11	envelopes	NNS	O	envelope	prep_in	8	SENT_82	[p7l795t668r1156b744],
12	at	IN	O	at	_	0	SENT_82	[p7l1221t682r1286b728],
13	the	DT	O	the	det	15	SENT_82	[p7l1346t668r1461b728],
14	study	NN	O	study	nn	15	SENT_82	[p7l1524t668r1725b744],
15	sites	NNS	O	site	prep_at	11	SENT_82	[p7l1786t668r1943b728],
16	and	CC	O	and	_	0	SENT_82	[p7l2007t668r2143b728],
17	duplicates	NNS	O	duplicate	nsubjpass	19	SENT_82	[p7l8t760r386b836],
18	were	VBD	O	be	auxpass	19	SENT_82	[p7l420t780r594b821],
19	kept	VBN	O	keep	conj_and	8	SENT_82	[p7l629t760r788b836],
20	in	IN	O	in	_	0	SENT_82	[p7l822t760r891b820],
21	Liverpool	NNP	LOCATION	Liverpool	prep_in	19	SENT_82	[p7l925t760r1309b836],
22	;	:	O	;	_	0	SENT_82	[p7l925t760r1309b836],
23	these	DT	O	these	det	24	SENT_82	[p7l1346t760r1535b821],
24	codes	NNS	O	code	nsubjpass	27	SENT_82	[p7l1572t760r1778b821],
25	were	VBD	O	be	auxpass	27	SENT_82	[p7l1812t780r1986b821],
26	not	RB	O	not	neg	27	SENT_82	[p7l2020t774r2143b821],
27	broken	VBN	O	break	parataxis	8	SENT_82	[p7l6t853r267b914],
28	during	IN	O	during	_	0	SENT_82	[p7l320t853r566b929],
29	the	DT	O	the	det	30	SENT_82	[p7l616t853r730b914],
30	study	NN	O	study	prep_during	27	SENT_82	[p7l785t853r1004b929],
31	.	.	O	.	_	0	SENT_82	[p7l785t853r1004b929],

1	Envelopes	NNS	O	envelope	nsubjpass	3	SENT_83	[p7l1062t853r1443b929],
2	were	VBD	O	be	auxpass	3	SENT_83	[p7l1495t873r1669b914],
3	opened	VBN	O	open	_	0	SENT_83	[p7l1724t853r2018b929],
4	,	,	O	,	_	0	SENT_83	[p7l1724t853r2018b929],
5	in	IN	O	in	_	0	SENT_83	[p7l2073t854r2143b913],
6	numerical	JJ	O	numerical	amod	7	SENT_83	[p7l6t947r382b1007],
7	sequence	NN	O	sequence	prep_in	3	SENT_83	[p7l439t966r803b1023],
8	,	,	O	,	_	0	SENT_83	[p7l439t966r803b1023],
9	by	IN	O	by	_	0	SENT_83	[p7l861t947r950b1023],
10	one	CD	NUMBER	one	num	12	SENT_83	[p7l1006t966r1137b1007],
11	laboratory	NN	O	laboratory	nn	12	SENT_83	[p7l1194t947r1579b1023],
12	technician	NN	O	technician	agent	3	SENT_83	[p7l1633t947r2020b1007],
13	at	IN	O	at	_	0	SENT_83	[p7l2077t961r2143b1007],
14	each	DT	O	each	det	15	SENT_83	[p7l9t1039r176b1100],
15	site	NN	O	site	prep_at	12	SENT_83	[p7l220t1039r342b1100],
16	who	WP	O	who	nsubj	17	SENT_83	[p7l386t1039r540b1100],
17	took	VBD	O	take	rcmod	15	SENT_83	[p7l585t1039r751b1100],
18	no	DT	O	no	det	19	SENT_83	[p7l792t1059r883b1100],
19	part	NN	O	part	dobj	17	SENT_83	[p7l927t1053r1078b1115],
20	in	IN	O	in	_	0	SENT_83	[p7l1121t1039r1191b1099],
21	patient	NN	O	patient	nn	22	SENT_83	[p7l1233t1039r1494b1115],
22	assessment	NN	O	assessment	prep_in	17	SENT_83	[p7l1539t1053r1972b1112],
23	,	,	O	,	_	0	SENT_83	[p7l1539t1053r1972b1112],
24	but	CC	O	but	_	0	SENT_83	[p7l2017t1039r2143b1100],
25	who	WP	O	who	nsubj	29	SENT_83	[p7l6t1132r160b1193],
26	were	VBD	O	be	cop	29	SENT_83	[p7l189t1152r364b1193],
27	the	DT	O	the	det	29	SENT_83	[p7l393t1132r508b1193],
28	drug	NN	O	drug	nn	29	SENT_83	[p7l539t1132r711b1208],
29	dispensers	NNS	O	dispenser	conj_but	17	SENT_83	[p7l740t1132r1124b1208],
30	throughout	IN	O	throughout	_	0	SENT_83	[p7l1155t1132r1578b1208],
31	the	DT	O	the	det	32	SENT_83	[p7l1606t1132r1721b1193],
32	trial	NN	O	trial	prep_throughout	29	SENT_83	[p7l1750t1132r1919b1193],
33	.	.	O	.	_	0	SENT_83	[p7l1750t1132r1919b1193],

1	Treatment	NN	O	treatment	nsubj	2	SENT_84	[p7l91t1227r494b1286],
2	was	VBD	O	be	_	0	SENT_84	[p7l533t1246r668b1286],
3	with	IN	O	with	_	0	SENT_84	[p7l710t1226r872b1286],
4	syrups	NNS	O	syrup	prep_with	2	SENT_84	[p7l915t1245r1150b1302],
5	of	IN	O	of	_	0	SENT_84	[p7l1194t1226r1273b1286],
6	either	CC	O	either	dep	7	SENT_84	[p7l1306t1226r1519b1286],
7	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	4	SENT_84	[p7l1560t1226r2142b1302, p7l8t1318r315b1394],
8	(	NN	O	(	nn	11	SENT_84	[p7l403t1319r472b1393],
9	2	CD	NUMBER	2	num	11	SENT_84	[p7l403t1319r472b1393],
10	mg/kg	NN	O	mg/kg	nn	11	SENT_84	[p7l556t1318r785b1394],
11	chlorproguanil	NN	O	chlorproguanil	dep	19	SENT_84	[p7l866t1318r1416b1394],
12	and	CC	O	and	_	0	SENT_84	[p7l1500t1318r1635b1379],
13	2-5	CD	NUMBER	2-5	num	14	SENT_84	[p7l1719t1321r1830b1379],
14	mg/kg	NN	O	mg/kg	conj_and	11	SENT_84	[p7l1916t1318r2144b1394],
15	dapsone	NN	O	dapsone	dep	19	SENT_84	[p7l8t1411r343b1487],
16	)	CD	NUMBER	)	num	15	SENT_84	[p7l8t1411r343b1487],
17	every	DT	O	every	det	19	SENT_84	[p7l404t1431r599b1487],
18	24	CD	NUMBER	24	num	19	SENT_84	[p7l653t1414r740b1471],
19	h	NN	O	h	dep	32	SENT_84	[p7l794t1411r840b1471],
20	for	IN	O	for	_	0	SENT_84	[p7l893t1411r999b1472],
21	3	CD	DURATION	3	num	22	SENT_84	[p7l1052t1414r1090b1472],
22	days	NNS	NUMBER	day	prep_for	19	SENT_84	[p7l1148t1411r1309b1487],
23	or	CC	O	or	_	0	SENT_84	[p7l1366t1431r1442b1472],
24	a	DT	O	a	det	26	SENT_84	[p7l1495t1431r1530b1472],
25	single	JJ	O	single	amod	26	SENT_84	[p7l1586t1411r1797b1487],
26	dose	NN	O	dose	conj_or	19	SENT_84	[p7l1852t1411r2018b1472],
27	of	IN	O	of	_	0	SENT_84	[p7l2074t1411r2153b1472],
28	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_of	26	SENT_84	[p7l8t1505r1040b1581],
29	(	CD	NUMBER	(	num	28	SENT_84	[p7l1074t1505r1264b1580],
30	1-25	CD	NUMBER	1-25	num	32	SENT_84	[p7l1074t1505r1264b1580],
31	mg/kg	NN	O	mg/kg	nn	32	SENT_84	[p7l1295t1505r1524b1581],
32	sulfadoxine	NN	O	sulfadoxine	dep	7	SENT_84	[p7l1551t1505r1978b1565],
33	and	CC	O	and	_	0	SENT_84	[p7l2007t1505r2142b1565],
34	25	CD	NUMBER	25	num	37	SENT_84	[p7l9t1600r94b1658],
35	mg/kg	NN	O	mg/kg	nn	37	SENT_84	[p7l165t1597r394b1673],
36	pyrimethamine	NN	O	pyrimethamine	nn	37	SENT_84	[p7l458t1597r1085b1673],
37	)	NN	O	)	conj_and	32	SENT_84	[p7l458t1597r1085b1673],
38	,	,	O	,	_	0	SENT_84	[p7l458t1597r1085b1673],
39	followed	VBN	O	follow	_	0	SENT_84	[p7l1155t1597r1474b1658],
40	by	IN	O	by	prepc_followed_by	2	SENT_84	[p7l1540t1597r1629b1673],
41	placebo	NN	O	placebo	pobj	2	SENT_84	[p7l1693t1597r1981b1673],
42	on	IN	O	on	_	0	SENT_84	[p7l2051t1617r2143b1658],
43	days	NNS	DURATION	day	prep_on	41	SENT_84	[p7l8t1690r169b1766],
44	1	CD	NUMBER	1	num	43	SENT_84	[p7l242t1693r267b1750],
45	and	CC	O	and	_	0	SENT_84	[p7l341t1690r476b1751],
46	2	CD	NUMBER	2	conj_and	43	SENT_84	[p7l540t1693r602b1751],
47	.	.	O	.	_	0	SENT_84	[p7l540t1693r602b1751],

1	Chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubj	22	SENT_85	[p7l673t1690r1616b1766],
2	,	,	O	,	_	0	SENT_85	[p7l673t1690r1616b1766],
3	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	nsubj	22	SENT_85	[p7l1683t1690r2142b1751, p7l6t1784r598b1860],
4	,	,	O	,	_	0	SENT_85	[p7l1683t1690r2142b1751, p7l6t1784r598b1860],
5	and	CC	O	and	_	0	SENT_85	[p7l648t1784r783b1844],
6	placebo	NN	O	placebo	nsubj	22	SENT_85	[p7l827t1784r1114b1860],
7	were	VBD	O	be	cop	12	SENT_85	[p7l1159t1803r1334b1844],
8	all	DT	O	all	dep	9	SENT_85	[p7l1381t1784r1465b1844],
9	off	IN	O	off	advmod	12	SENT_85	[p7l1512t1784r1845b1844],
10	—	CD	NUMBER	—	num	12	SENT_85	[p7l1512t1784r1845b1844],
11	white	JJ	O	white	amod	12	SENT_85	[p7l1512t1784r1845b1844],
12	liquids	NNS	O	liquid	rcmod	1	SENT_85	[p7l1891t1784r2141b1860],
13	which	WDT	O	which	nsubjpass	15	SENT_85	[p7l6t1876r229b1937],
14	were	VBD	O	be	auxpass	15	SENT_85	[p7l266t1896r440b1937],
15	dispensed	VBN	O	dispense	rcmod	12	SENT_85	[p7l481t1876r849b1952],
16	from	IN	O	from	_	0	SENT_85	[p7l888t1876r1066b1937],
17	common	JJ	O	common	amod	18	SENT_85	[p7l1106t1896r1435b1937],
18	bottles	NNS	O	bottle	prep_from	15	SENT_85	[p7l1472t1876r1722b1937],
19	into	IN	O	into	_	0	SENT_85	[p7l1762t1876r1906b1937],
20	small	JJ	O	small	amod	21	SENT_85	[p7l1949t1876r2142b1937],
21	containers	NNS	O	container	prep_into	15	SENT_85	[p7l9t1970r393b2030],
22	(	VBP	O	(	_	0	SENT_85	[p7l437t1969r634b2045],
23	each	DT	O	each	nsubj	24	SENT_85	[p7l437t1969r634b2045],
24	containing	VBG	O	contain	dep	22	SENT_85	[p7l672t1970r1069b2045],
25	one	CD	NUMBER	one	num	27	SENT_85	[p7l1105t1989r1236b2030],
26	dose	NN	O	dose	nn	27	SENT_85	[p7l1276t1969r1470b2045],
27	)	NN	O	)	dobj	24	SENT_85	[p7l1276t1969r1470b2045],
28	on	IN	O	on	_	0	SENT_85	[p7l1515t1989r1607b2030],
29	an	DT	O	a	det	32	SENT_85	[p7l1645t1989r1731b2030],
30	individual	JJ	O	individual	amod	32	SENT_85	[p7l1768t1969r2142b2030],
31	patient	NN	O	patient	nn	32	SENT_85	[p7l6t2063r268b2139],
32	basis	NN	O	basis	prep_on	24	SENT_85	[p7l305t2063r507b2123],
33	.	.	O	.	_	0	SENT_85	[p7l305t2063r507b2123],

1	The	DT	O	the	det	2	SENT_86	[p7l551t2063r702b2123],
2	taste	NN	O	taste	nsubj	22	SENT_86	[p7l743t2077r914b2123],
3	of	IN	O	of	_	0	SENT_86	[p7l957t2063r1035b2123],
4	the	DT	O	the	det	5	SENT_86	[p7l1064t2063r1179b2123],
5	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	2	SENT_86	[p7l1221t2063r2139b2139],
6	,	,	O	,	_	0	SENT_86	[p7l1221t2063r2139b2139],
7	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_of	2	SENT_86	[p7l8t2155r1064b2231],
8	,	,	O	,	_	0	SENT_86	[p7l8t2155r1064b2231],
9	and	CC	O	and	_	0	SENT_86	[p7l1128t2155r1263b2216],
10	placebo	NN	O	placebo	nn	11	SENT_86	[p7l1321t2155r1609b2231],
11	liquids	NNS	O	liquid	conj_and	5	SENT_86	[p7l1670t2155r1943b2231],
12	,	,	O	,	_	0	SENT_86	[p7l1670t2155r1943b2231],
13	and	CC	O	and	_	0	SENT_86	[p7l2007t2155r2142b2216],
14	the	DT	O	the	det	15	SENT_86	[p7l7t2248r121b2309],
15	amount	NN	O	amount	conj_and	2	SENT_86	[p7l156t2263r444b2309],
16	of	IN	O	of	_	0	SENT_86	[p7l478t2248r557b2309],
17	sediment	NN	O	sediment	prep_of	15	SENT_86	[p7l581t2248r921b2309],
18	in	IN	O	in	_	0	SENT_86	[p7l953t2249r1023b2308],
19	each	DT	O	each	det	20	SENT_86	[p7l1057t2248r1224b2309],
20	liquid	NN	O	liquid	prep_in	17	SENT_86	[p7l1258t2248r1497b2324],
21	,	,	O	,	_	0	SENT_86	[p7l1258t2248r1497b2324],
22	differed	VBD	O	differ	_	0	SENT_86	[p7l1534t2248r1843b2309],
23	.	.	O	.	_	0	SENT_86	[p7l1534t2248r1843b2309],

1	Bottles	NNS	O	bottle	nsubjpass	5	SENT_87	[p7l1882t2248r2141b2309],
2	of	IN	O	of	_	0	SENT_87	[p7l9t2342r87b2402],
3	medication	NN	O	medication	prep_of	1	SENT_87	[p7l157t2342r577b2402],
4	were	VBD	O	be	auxpass	5	SENT_87	[p7l654t2361r829b2402],
5	shaken	VBN	O	shake	_	0	SENT_87	[p7l911t2342r1166b2402],
6	before	IN	O	before	mark	10	SENT_87	[p7l1245t2342r1480b2402],
7	the	DT	O	the	det	8	SENT_87	[p7l1560t2342r1674b2402],
8	drug	NN	O	drug	nsubjpass	10	SENT_87	[p7l1757t2342r1929b2418],
9	was	VBD	O	be	auxpass	10	SENT_87	[p7l2006t2362r2141b2402],
10	dispensed	VBN	O	dispense	advcl	5	SENT_87	[p7l8t2434r397b2510],
11	.	.	O	.	_	0	SENT_87	[p7l8t2434r397b2510],

1	The	DT	O	the	det	3	SENT_88	[p7l449t2434r600b2495],
2	first	JJ	ORDINAL	first	amod	3	SENT_88	[p7l648t2434r794b2495],
3	dose	NN	O	dose	nsubjpass	7	SENT_88	[p7l842t2434r1008b2495],
4	of	IN	O	of	_	0	SENT_88	[p7l1058t2434r1137b2495],
5	drug	NN	O	drug	prep_of	3	SENT_88	[p7l1175t2434r1347b2510],
6	was	VBD	O	be	auxpass	7	SENT_88	[p7l1392t2454r1527b2495],
7	taken	VBN	O	take	_	0	SENT_88	[p7l1576t2434r1779b2495],
8	in	IN	O	in	_	0	SENT_88	[p7l1826t2434r1895b2494],
9	clinic	NN	O	clinic	prep_in	7	SENT_88	[p7l1944t2434r2142b2495],
10	with	IN	O	with	_	0	SENT_88	[p7l6t2527r168b2588],
11	supervision	NN	O	supervision	prep_with	7	SENT_88	[p7l204t2528r650b2603],
12	,	,	O	,	_	0	SENT_88	[p7l204t2528r650b2603],
13	and	CC	O	and	_	0	SENT_88	[p7l691t2527r826b2588],
14	patients	NNS	O	patient	nsubjpass	16	SENT_88	[p7l859t2528r1154b2603],
15	were	VBD	O	be	auxpass	16	SENT_88	[p7l1189t2547r1363b2588],
16	watched	VBN	O	watch	conj_and	7	SENT_88	[p7l1398t2527r1709b2588],
17	for	IN	O	for	_	0	SENT_88	[p7l1744t2527r1850b2588],
18	half	PDT	O	half	quantmod	20	SENT_88	[p7l1881t2527r2030b2588],
19	an	DT	DURATION	a	quantmod	20	SENT_88	[p7l2057t2547r2143b2588],
20	hour	NN	DURATION	hour	prep_for	16	SENT_88	[p7l6t2621r202b2681],
21	.	.	O	.	_	0	SENT_88	[p7l6t2621r202b2681],

1	If	IN	O	if	mark	8	SENT_89	[p7l250t2621r316b2680],
2	the	DT	O	the	det	4	SENT_89	[p7l348t2621r462b2681],
3	ﬁrst	NN	O	ﬁrst	nn	4	SENT_89	[p7l506t2621r651b2681],
4	dose	NN	O	dose	nsubjpass	8	SENT_89	[p7l694t2621r861b2681],
5	of	IN	O	of	_	0	SENT_89	[p7l906t2621r984b2681],
6	medication	NN	O	medication	prep_of	4	SENT_89	[p7l1017t2621r1436b2681],
7	was	VBD	O	be	auxpass	8	SENT_89	[p7l1476t2640r1611b2681],
8	vomited	VBN	O	vomit	_	0	SENT_89	[p7l1654t2621r1982b2693],
9	,	,	O	,	_	0	SENT_89	[p7l1654t2621r1982b2693],
10	the	DT	O	the	dobj	8	SENT_89	[p7l2027t2621r2142b2681],

1	THE	DT	O	the	det	2	SENT_90	[p7l78t2795r140b2816],
2	LANCET	NN	O	lancet	_	0	SENT_90	[p7l149t2795r274b2816],
3	-	:	O	-	_	0	SENT_90	[p7l284t2802r291b2810],
4	Vol	NN	O	vol	nn	6	SENT_90	[p7l300t2795r344b2816],
5	360	CD	NUMBER	360	num	6	SENT_90	[p7l354t2796r400b2816],
6	o	NN	O	o	dep	2	SENT_90	[p7l411t2802r418b2810],
7	October	NNP	DATE	October	tmod	6	SENT_90	[p7l429t2795r532b2816],
8	12	CD	DATE	12	num	7	SENT_90	[p7l543t2796r579b2820],
9	,	,	DATE	,	_	0	SENT_90	[p7l543t2796r579b2820],
10	2002	CD	DATE	2002	num	7	SENT_90	[p7l590t2796r652b2816],
11	-	:	O	-	_	0	SENT_90	[p7l662t2802r670b2810],
12	www.thelancet.com	NN	O	www.thelancet.com	dep	6	SENT_90	[p7l680t2795r930b2816],
13	1	CD	NUMBER	1	number	14	SENT_90	[p7l1972t2790r1983b2816],
14	137	CD	NUMBER	137	dep	12	SENT_90	[p7l1993t2790r2048b2816],

1	For	IN	O	for	_	0	SENT_91	[p7l79t2895r148b2930],
2	personal	JJ	O	personal	amod	3	SENT_91	[p7l173t2895r361b2938],
3	use	NN	O	use	pobj	1	SENT_91	[p7l388t2904r477b2930],
4	.	.	O	.	_	0	SENT_91	[p7l388t2904r477b2930],

1	Only	RB	O	only	advmod	2	SENT_92	[p7l525t2895r621b2939],
2	reproduce	VB	O	reproduce	_	0	SENT_92	[p7l647t2895r869b2938],
3	with	IN	O	with	_	0	SENT_92	[p7l893t2895r987b2930],
4	permission	NN	O	permission	prep_with	2	SENT_92	[p7l1015t2895r1256b2939],
5	from	IN	O	from	_	0	SENT_92	[p7l1281t2895r1379b2930],
6	The	DT	O	the	det	9	SENT_92	[p7l1404t2895r1484b2930],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_92	[p7l1510t2895r1660b2930],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_92	[p7l1687t2895r1919b2939],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_92	[p7l1942t2895r2086b2938],
10	.	.	O	.	_	0	SENT_92	[p7l1942t2895r2086b2938],

1	ARTICLES	NNS	O	article	_	0	SENT_93	[p7l91t3014r244b3035],

1	Kilifi	NNP	LOCATION	Kilifi	_	0	SENT_94	[p7l1015t3179r1103b3212],

1	410	CD	NUMBER	410	nsubj	2	SENT_95	[p8l884t74r966b108],
2	randomised	VBN	O	randomise	_	0	SENT_95	[p8l985t75r1219b108],

1	205	CD	NUMBER	205	_	0	SENT_96	[p8l555t290r635b323],
2	assigned	VBN	O	assign	partmod	1	SENT_96	[p8l653t290r833b332],
3	205	CD	NUMBER	205	dobj	2	SENT_96	[p8l1116t290r1197b323],
4	assigned	VBN	O	assign	partmod	3	SENT_96	[p8l1214t290r1394b332],
5	ch	NN	O	ch	nn	7	SENT_96	[p8l653t347r948b388],
6	|	NN	O	|	nn	7	SENT_96	[p8l653t347r948b388],
7	orproguanil	NN	O	orproguanil	dobj	4	SENT_96	[p8l653t347r948b388],
8	-	:	O	-	_	0	SENT_96	[p8l653t347r948b388],
9	sulfadoxinedapsone	NN	O	sulfadoxinedapsone	dep	1	SENT_96	[p8l1214t346r1456b380, p8l653t404r825b444],
10	pyrimethamine	NN	O	pyrimethamine	dep	9	SENT_96	[p8l1216t404r1510b445],

1	7	CD	NUMBER	7	_	0	SENT_97	[p8l118t564r140b596],
2	multiple	JJ	O	multiple	amod	3	SENT_97	[p8l160t564r318b604],
3	recruitment	NN	O	recruitment	dep	1	SENT_97	[p8l160t621r391b653],

1	_	RB	O	_	dep	2	SENT_98	[p8l20t807r37b811],
2	_	CD	NUMBER	_	dep	3	SENT_98	[p8l53t807r70b811],
3	5	CD	NUMBER	5	dep	5	SENT_98	[p8l117t759r141b793],
4	protocol	NN	O	protocol	nn	5	SENT_98	[p8l161t759r318b800],
5	violations	NNS	O	violation	_	0	SENT_98	[p8l157t816r350b849],

1	5	CD	NUMBER	5	nsubj	2	SENT_99	[p8l117t958r141b991],
2	vomited	VBD	O	vomit	_	0	SENT_99	[p8l157t958r315b991],
3	medication	NN	O	medication	dobj	2	SENT_99	[p8l160t1014r379b1048],
4	three	CD	NUMBER	three	num	5	SENT_99	[p8l157t1071r261b1104],
5	times	NNS	O	time	tmod	2	SENT_99	[p8l277t1071r389b1104],

1	3	CD	NUMBER	3	_	0	SENT_100	[p8l1683t563r1707b597],
2	multiple	JJ	O	multiple	amod	3	SENT_100	[p8l1726t564r1884b604],
3	recruitment	NN	O	recruitment	dep	1	SENT_100	[p8l1727t621r1957b653],

1	7	CD	NUMBER	7	num	2	SENT_101	[p8l1685t759r1707b792],
2	protocol	NN	O	protocol	_	0	SENT_101	[p8l1727t759r1885b800],
3	_	CD	NUMBER	_	num	5	SENT_101	[p8l2050t807r2067b811],
4	_	NN	O	_	nn	5	SENT_101	[p8l2084t807r2100b811],
5	violations	NNS	O	violation	dep	2	SENT_101	[p8l1724t816r1916b849],

1	1	CD	NUMBER	1	_	0	SENT_102	[p8l115t1212r138b1245],
2	excluded	VBN	O	exclude	partmod	1	SENT_102	[p8l155t1212r331b1246],
3	from	IN	O	from	_	0	SENT_102	[p8l348t1212r438b1246],
4	188	CD	NUMBER	188	prep_from	2	SENT_102	[p8l558t1212r637b1246],
5	included	VBD	O	include	rcmod	4	SENT_102	[p8l656t1212r821b1246],
6	in	IN	O	in	dep	5	SENT_102	[p8l841t1212r871b1245],
7	per	IN	O	per	_	0	SENT_102	[p8l892t1220r964b1253],
8	—	NN	O	—	prep_per	5	SENT_102	[p8l892t1220r964b1253],
9	195	CD	NUMBER	195	num	8	SENT_102	[p8l1119t1212r1198b1246],
10	included	VBD	O	include	rcmod	8	SENT_102	[p8l1217t1212r1382b1246],
11	in	IN	O	in	dep	10	SENT_102	[p8l1402t1212r1432b1245],
12	per	IN	O	per	_	0	SENT_102	[p8l1453t1220r1525b1253],
13	—	NN	O	—	prep_per	10	SENT_102	[p8l1453t1220r1525b1253],
14	2	CD	NUMBER	2	num	13	SENT_102	[p8l1680t1212r1703b1245],
15	excluded	VBN	O	exclude	partmod	13	SENT_102	[p8l1721t1212r1897b1246],
16	from	IN	O	from	_	0	SENT_102	[p8l1915t1212r2004b1246],
17	intention	NN	O	intention	prep_from	15	SENT_102	[p8l157t1269r393b1302],
18	—	CD	NUMBER	—	dep	30	SENT_102	[p8l157t1269r393b1302],
19	to	TO	O	to	_	0	SENT_102	[p8l157t1269r393b1302],
20	—	CD	NUMBER	—	num	23	SENT_102	[p8l157t1269r393b1302],
21	protocol	NN	O	protocol	nn	23	SENT_102	[p8l656t1269r814b1310],
22	analysis	NN	O	analysis	nn	23	SENT_102	[p8l833t1269r996b1310],
23	protocol	NN	O	protocol	prep_to	18	SENT_102	[p8l1217t1269r1375b1310],
24	analysis	NN	O	analysis	nn	25	SENT_102	[p8l1394t1269r1557b1310],
25	intention	NN	O	intention	dep	30	SENT_102	[p8l1723t1269r1959b1302],
26	—	CD	NUMBER	—	number	28	SENT_102	[p8l1723t1269r1959b1302],
27	to	TO	O	to	dep	28	SENT_102	[p8l1723t1269r1959b1302],
28	—	CD	NUMBER	—	num	30	SENT_102	[p8l1723t1269r1959b1302],
29	treat	NN	O	treat	nn	30	SENT_102	[p8l153t1328r249b1359],
30	analysis	NN	O	analysis	dep	38	SENT_102	[p8l264t1326r428b1367],
31	of	IN	O	of	_	0	SENT_102	[p8l654t1325r693b1359],
32	malaria	NN	O	malaria	prep_of	30	SENT_102	[p8l709t1326r855b1359],
33	of	IN	O	of	_	0	SENT_102	[p8l1216t1325r1254b1359],
34	malaria	NN	O	malaria	nn	36	SENT_102	[p8l1270t1326r1416b1359],
35	treat	NN	O	treat	nn	36	SENT_102	[p8l1720t1328r1815b1359],
36	analysis	NN	O	analysis	prep_of	32	SENT_102	[p8l1831t1326r1994b1367],
37	incidence	NN	O	incidence	nn	38	SENT_102	[p8l656t1383r844b1416],
38	incidence	NN	O	incidence	dep	1	SENT_102	[p8l1217t1383r1405b1416],

1	4	CD	NUMBER	4	_	0	SENT_103	[p8l113t1545r138b1577],
2	included	VBN	O	include	partmod	1	SENT_103	[p8l157t1545r322b1578],
3	in	IN	O	in	_	0	SENT_103	[p8l342t1545r372b1578],
4	197	CD	NUMBER	197	prep_in	2	SENT_103	[p8l558t1544r636b1578],
5	included	VBN	O	include	partmod	4	SENT_103	[p8l656t1545r821b1578],
6	in	IN	O	in	_	0	SENT_103	[p8l841t1545r871b1578],
7	200	CD	NUMBER	200	prep_in	5	SENT_103	[p8l1118t1544r1198b1578],
8	included	VBN	O	include	partmod	7	SENT_103	[p8l1217t1545r1382b1578],
9	in	IN	O	in	_	0	SENT_103	[p8l1402t1545r1432b1578],
10	5	CD	NUMBER	5	prep_in	8	SENT_103	[p8l1680t1545r1704b1578],
11	included	VBN	O	include	partmod	10	SENT_103	[p8l1723t1545r1888b1578],
12	in	IN	O	in	_	0	SENT_103	[p8l1908t1545r1938b1577],
13	intention	NN	O	intention	prep_in	11	SENT_103	[p8l157t1601r393b1635],
14	—	CD	NUMBER	—	num	13	SENT_103	[p8l157t1601r393b1635],
15	to	TO	O	to	_	0	SENT_103	[p8l157t1601r393b1635],
16	—	CD	NUMBER	—	num	18	SENT_103	[p8l157t1601r393b1635],
17	intention-to-treat	NN	O	intention-to-treat	nn	18	SENT_103	[p8l656t1601r987b1635],
18	intention-to-treat	NN	O	intention-to-treat	prep_to	11	SENT_103	[p8l1217t1601r1549b1635],
19	intentiontotreat	NN	O	intentiontotreat	nn	21	SENT_103	[p8l1723t1601r1959b1635, p8l153t1660r249b1691],
20	analysis	NN	O	analysis	nn	21	SENT_103	[p8l264t1658r428b1699],
21	analysis	NN	O	analysis	dep	28	SENT_103	[p8l654t1658r817b1699],
22	of	IN	O	of	_	0	SENT_103	[p8l835t1658r874b1691],
23	analysis	NN	O	analysis	prep_of	21	SENT_103	[p8l1215t1658r1378b1699],
24	of	IN	O	of	_	0	SENT_103	[p8l1396t1658r1435b1691],
25	treat	NN	O	treat	prep_of	23	SENT_103	[p8l1720t1660r1815b1691],
26	analysis	NN	O	analysis	dep	28	SENT_103	[p8l1831t1658r1994b1699],
27	treatment	NN	O	treatment	nn	28	SENT_103	[p8l653t1717r852b1748],
28	failure	NN	O	failure	dep	1	SENT_103	[p8l866t1715r991b1748],
29	treatment	NN	O	treatment	nn	30	SENT_103	[p8l1214t1717r1413b1748],
30	failure	NN	O	failure	dep	28	SENT_103	[p8l1427t1715r1552b1748],

1	Blantyre	NNP	LOCATION	Blantyre	_	0	SENT_104	[p8l974t1905r1145b1946],

1	500	CD	NUMBER	500	nsubj	2	SENT_105	[p8l885t2039r966b2073],
2	randomised	VBN	O	randomise	_	0	SENT_105	[p8l985t2040r1219b2073],

1	250	CD	NUMBER	250	nsubj	2	SENT_106	[p8l555t2255r636b2288],
2	assigned	VBN	O	assign	_	0	SENT_106	[p8l653t2255r833b2297],
3	250	CD	NUMBER	250	dobj	2	SENT_106	[p8l1116t2255r1197b2288],
4	assigned	VBN	O	assign	partmod	3	SENT_106	[p8l1214t2255r1394b2297],
5	chlorproguanil	NN	O	chlorproguanil	nn	7	SENT_106	[p8l653t2312r948b2353],
6	—	NN	O	—	nn	7	SENT_106	[p8l653t2312r948b2353],
7	sulfadoxine	NN	O	sulfadoxine	dobj	4	SENT_106	[p8l1214t2311r1456b2345],
8	—	NN	O	—	nn	10	SENT_106	[p8l1214t2311r1456b2345],
9	dapsone	NN	O	dapsone	nn	10	SENT_106	[p8l653t2368r825b2409],
10	pyrimethamine	NN	O	pyrimethamine	dep	7	SENT_106	[p8l1216t2368r1510b2410],

1	2	CD	NUMBER	2	_	0	SENT_107	[p8l117t2528r141b2561],
2	multiple	JJ	O	multiple	amod	6	SENT_107	[p8l160t2529r318b2569],
3	19	CD	NUMBER	19	num	6	SENT_107	[p8l1685t2528r1736b2562],
4	protocol	NN	O	protocol	nn	6	SENT_107	[p8l1755t2529r1913b2569],
5	recruitment	NN	O	recruitment	nn	6	SENT_107	[p8l160t2586r391b2619],
6	violations	NNS	O	violation	poss	1	SENT_107	[p8l1752t2586r1945b2619],
7	'	POS	O	'	_	0	SENT_107	[p8l2041t2581r2058b2584],
8	'	''	O	'	_	0	SENT_107	[p8l2074t2581r2091b2584],

1	_	RB	O	_	dep	4	SENT_108	[p8l20t2772r37b2776],
2	_	CD	NUMBER	_	num	4	SENT_108	[p8l53t2772r70b2776],
3	22	CD	NUMBER	22	num	4	SENT_108	[p8l117t2724r169b2757],
4	protocol	NN	O	protocol	_	0	SENT_108	[p8l189t2725r346b2765],
5	6	CD	NUMBER	6	nsubj	6	SENT_108	[p8l1683t2724r1708b2758],
6	withdrew	VBD	O	withdraw	rcmod	4	SENT_108	[p8l1724t2725r1901b2758],
7	_	CD	NUMBER	_	dobj	6	SENT_108	[p8l2047t2768r2064b2771],
8	_	IN	O	_	prep	6	SENT_108	[p8l2080t2768r2097b2771],

1	violations	NNS	O	violation	_	0	SENT_109	[p8l185t2781r378b2815],
2	consent	NN	O	consent	dep	1	SENT_109	[p8l1725t2783r1886b2815],

1	I	PRP	O	I	dep	9	SENT_110	[p8l2100t2588r2104b2605],
2	I	PRP	O	I	dep	5	SENT_110	[p8l2100t2622r2104b2638],
3	I	PRP	O	I	dep	2	SENT_110	[p8l2100t2655r2104b2672],
4	I	PRP	O	I	dep	5	SENT_110	[p8l2100t2689r2104b2705],
5	I	PRP	O	I	dep	7	SENT_110	[p8l2100t2722r2104b2739],
6	I	PRP	O	I	dep	5	SENT_110	[p8l2100t2755r2104b2772],
7	I	PRP	O	I	dep	9	SENT_110	[p8l2100t2789r2104b2806],
8	I	PRP	O	I	nsubj	9	SENT_110	[p8l2100t2822r2104b2872],
9	I	PRP	O	I	_	0	SENT_110	[p8l2100t2889r2104b2906],
10	4	CD	NUMBER	4	nsubj	11	SENT_110	[p8l319t2923r344b2956],
11	withdrew	VBD	O	withdraw	rcmod	9	SENT_110	[p8l360t2923r537b2956],
12	1	CD	NUMBER	1	nsubj	13	SENT_110	[p8l1681t2923r1704b2956],
13	vomited	VBD	O	vomit	ccomp	11	SENT_110	[p8l1720t2923r1878b2956],
14	:	:	O	:	_	0	SENT_110	[p8l2100t2922r2104b2973],
15	consent	NN	O	consent	nn	16	SENT_110	[p8l361t2982r522b3013],
16	medication	NN	O	medication	dep	9	SENT_110	[p8l1722t2979r1941b3013],
17	-	:	O	-	_	0	SENT_110	[p8l2047t2994r2064b2998],
18	.	.	O	.	_	0	SENT_110	[p8l2080t2989r2104b3006, p8l1858t3036r1862b3041],

1	I	PRP	O	I	_	0	SENT_111	[p8l2100t3023r2104b3039],
2	three	CD	NUMBER	three	number	3	SENT_111	[p8l1720t3036r1824b3070],
3	times	NNS	O	time	num	1	SENT_111	[p8l1839t3039r1952b3070],
4	.	.	O	.	_	0	SENT_111	[p8l2100t3056r2104b3073],

1	I	PRP	O	I	dep	4	SENT_112	[p8l2100t3089r2104b3106],
2	I	PRP	O	I	dep	1	SENT_112	[p8l2100t3123r2104b3140],
3	I	PRP	O	I	dep	4	SENT_112	[p8l2100t3156r2104b3173],
4	I	PRP	O	I	dep	6	SENT_112	[p8l2100t3190r2104b3206],
5	I	PRP	O	I	dep	4	SENT_112	[p8l2100t3223r2104b3240],
6	I	PRP	O	I	_	0	SENT_112	[p8l2100t3257r2104b3273],

1	4	CD	NUMBER	4	_	0	SENT_113	[p8l113t3177r138b3210],
2	excluded	VBN	O	exclude	partmod	1	SENT_113	[p8l155t3177r331b3211],
3	from	IN	O	from	_	0	SENT_113	[p8l348t3177r438b3211],
4	222	CD	NUMBER	222	prep_from	2	SENT_113	[p8l557t3177r636b3210],
5	included	VBN	O	include	partmod	4	SENT_113	[p8l656t3177r821b3211],
6	in	IN	O	in	_	0	SENT_113	[p8l841t3177r871b3210],
7	per	FW	O	per	nn	8	SENT_113	[p8l892t3185r964b3218],
8	—	FW	O	—	dep	9	SENT_113	[p8l892t3185r964b3218],
9	224	CD	NUMBER	224	prep_in	5	SENT_113	[p8l1118t3177r1198b3210],
10	included	VBN	O	include	prep	5	SENT_113	[p8l1217t3177r1382b3211],
11	in	IN	O	in	pcomp	10	SENT_113	[p8l1402t3177r1432b3210],
12	per	FW	O	per	nn	13	SENT_113	[p8l1453t3185r1525b3218],
13	—	FW	O	—	dep	14	SENT_113	[p8l1453t3185r1525b3218],
14	5	CD	NUMBER	5	dep	11	SENT_113	[p8l1680t3177r1704b3211],
15	excluded	VBN	O	exclude	partmod	14	SENT_113	[p8l1721t3177r1897b3211],
16	from	IN	O	from	_	0	SENT_113	[p8l1915t3177r2004b3211],
17	intention	NN	O	intention	prep_from	15	SENT_113	[p8l157t3234r393b3267],
18	—	CD	NUMBER	—	dep	30	SENT_113	[p8l157t3234r393b3267],
19	to	TO	O	to	_	0	SENT_113	[p8l157t3234r393b3267],
20	—	CD	NUMBER	—	num	23	SENT_113	[p8l157t3234r393b3267],
21	protocol	NN	O	protocol	nn	23	SENT_113	[p8l656t3234r814b3275],
22	analysis	NN	O	analysis	nn	23	SENT_113	[p8l833t3234r996b3276],
23	protocol	NN	O	protocol	prep_to	18	SENT_113	[p8l1217t3234r1375b3275],
24	analysis	NN	O	analysis	nn	25	SENT_113	[p8l1394t3234r1557b3276],
25	intention	NN	O	intention	dep	30	SENT_113	[p8l1723t3234r1959b3268],
26	—	CD	NUMBER	—	number	28	SENT_113	[p8l1723t3234r1959b3268],
27	to	TO	O	to	dep	28	SENT_113	[p8l1723t3234r1959b3268],
28	—	CD	NUMBER	—	num	30	SENT_113	[p8l1723t3234r1959b3268],
29	treat	NN	O	treat	nn	30	SENT_113	[p8l153t3293r249b3324],
30	analysis	NN	O	analysis	dep	38	SENT_113	[p8l264t3291r428b3332],
31	of	IN	O	of	_	0	SENT_113	[p8l654t3291r693b3324],
32	malaria	NN	O	malaria	prep_of	30	SENT_113	[p8l709t3291r855b3324],
33	of	IN	O	of	_	0	SENT_113	[p8l1216t3291r1254b3324],
34	malaria	NN	O	malaria	nn	36	SENT_113	[p8l1270t3291r1416b3324],
35	treat	NN	O	treat	nn	36	SENT_113	[p8l1720t3293r1815b3324],
36	analysis	NN	O	analysis	prep_of	32	SENT_113	[p8l1831t3291r1994b3332],
37	incidence	NN	O	incidence	nn	38	SENT_113	[p8l656t3348r844b3381],
38	incidence	NN	O	incidence	dep	1	SENT_113	[p8l1217t3348r1405b3381],

1	18	CD	NUMBER	18	_	0	SENT_114	[p8l115t3509r166b3543],
2	included	VBN	O	include	dep	1	SENT_114	[p8l185t3510r350b3543],
3	in	IN	O	in	prep	2	SENT_114	[p8l370t3510r400b3543],
4	'	''	O	'	_	0	SENT_114	[p8l484t3503r534b3544],
5	-	:	O	-	_	0	SENT_114	[p8l484t3503r534b3544],
6	>	JJR	O	>	dep	7	SENT_114	[p8l484t3503r534b3544],
7	244	CD	NUMBER	244	advmod	8	SENT_114	[p8l557t3509r637b3543],
8	included	VBN	O	include	dep	2	SENT_114	[p8l656t3510r821b3543],
9	in	IN	O	in	_	0	SENT_114	[p8l841t3510r871b3543],
10	245	CD	NUMBER	245	prep_in	8	SENT_114	[p8l1118t3509r1198b3543],
11	included	VBN	O	include	partmod	10	SENT_114	[p8l1217t3510r1382b3543],
12	in	IN	O	in	_	0	SENT_114	[p8l1402t3510r1432b3543],
13	14	CD	NUMBER	14	prep_in	11	SENT_114	[p8l1681t3510r1733b3543],
14	included	VBN	O	include	partmod	13	SENT_114	[p8l1751t3510r1916b3543],
15	in	IN	O	in	_	0	SENT_114	[p8l1936t3510r1966b3543],
16	intention	NN	O	intention	prep_in	14	SENT_114	[p8l185t3566r421b3600],
17	—	CD	NUMBER	—	num	16	SENT_114	[p8l185t3566r421b3600],
18	to	TO	O	to	_	0	SENT_114	[p8l185t3566r421b3600],
19	—	CD	NUMBER	—	num	21	SENT_114	[p8l185t3566r421b3600],
20	intention-to-treat	NN	O	intention-to-treat	nn	21	SENT_114	[p8l656t3567r987b3600],
21	intention-to-treat	NN	O	intention-to-treat	prep_to	2	SENT_114	[p8l1217t3567r1549b3600],
22	intentiontotreat	NN	O	intentiontotreat	nn	24	SENT_114	[p8l1737t3567r1973b3600, p8l181t3625r272b3656],
23	analysis	NN	O	analysis	nn	24	SENT_114	[p8l285t3623r440b3664],
24	analysis	NN	O	analysis	dep	31	SENT_114	[p8l654t3623r817b3664],
25	of	IN	O	of	_	0	SENT_114	[p8l835t3623r874b3656],
26	analysis	NN	O	analysis	prep_of	24	SENT_114	[p8l1215t3623r1378b3664],
27	of	IN	O	of	_	0	SENT_114	[p8l1396t3623r1435b3656],
28	treat	NN	O	treat	prep_of	26	SENT_114	[p8l1734t3625r1829b3656],
29	analysis	NN	O	analysis	dep	31	SENT_114	[p8l1845t3623r2008b3664],
30	treatment	NN	O	treatment	nn	31	SENT_114	[p8l653t3682r852b3713],
31	failure	NN	O	failure	dep	1	SENT_114	[p8l866t3680r991b3713],
32	treatment	NN	O	treatment	nn	33	SENT_114	[p8l1214t3682r1413b3713],
33	failure	NN	O	failure	dep	31	SENT_114	[p8l1427t3680r1552b3713],

1	Trial	NN	O	trial	nn	3	SENT_115	[p9l7t74r108b111],
2	profile	NN	O	profile	nn	3	SENT_115	[p9l129t74r274b120],
3	patient	NN	O	patient	nsubjpass	5	SENT_115	[p9l7t240r193b294],
4	was	VBD	O	be	auxpass	5	SENT_115	[p9l223t254r319b283],
5	given	VBN	O	give	_	0	SENT_115	[p9l352t240r491b294],
6	another	DT	O	another	det	7	SENT_115	[p9l524t240r727b283],
7	dose	NN	O	dose	dobj	5	SENT_115	[p9l758t240r892b292],
8	;	:	O	;	_	0	SENT_115	[p9l758t240r892b292],
9	we	PRP	O	we	nsubj	10	SENT_115	[p9l925t254r996b283],
10	repeated	VBD	O	repeat	parataxis	5	SENT_115	[p9l1029t240r1257b294],
11	the	DT	O	the	det	13	SENT_115	[p9l1288t240r1369b283],
12	dose	NN	O	dose	nn	13	SENT_115	[p9l1402t240r1520b283],
13	tration	NN	O	tration	dobj	10	SENT_115	[p9l1674t240r1855b283],
14	of	IN	O	of	_	0	SENT_115	[p9l1886t240r1943b283],
15	50	CD	NUMBER	50	num	16	SENT_115	[p9l1968t242r2030b283],
16	g/L	NN	O	g/l	prep_of	13	SENT_115	[p9l2062t240r2152b294],

1	were	VBD	O	be	auxpass	2	SENT_116	[p9l33t579r298b641],
2	given	VBN	O	give	_	0	SENT_116	[p9l475t549r775b663],
3	paracetamol	NNP	O	paracetamol	nn	5	SENT_116	[p9l948t549r1650b663],
4	syrup	NN	O	syrup	nn	5	SENT_116	[p9l1830t579r2135b663],
5	(	NN	O	(	iobj	2	SENT_116	[p9l45t691r582b804],
6	125	CD	NUMBER	125	number	7	SENT_116	[p9l45t691r582b804],
7	—	CD	NUMBER	—	num	9	SENT_116	[p9l45t691r582b804],
8	25O	NN	O	25o	nn	9	SENT_116	[p9l45t691r582b804],
9	mg	NN	O	mg	dobj	2	SENT_116	[p9l631t720r805b804],
10	per	IN	O	per	_	0	SENT_116	[p9l847t720r1033b804],
11	6	CD	NUMBER	6	num	12	SENT_116	[p9l1080t695r1137b782],
12	h	NN	O	h	prep_per	9	SENT_116	[p9l1185t690r1254b780],
13	as	IN	O	as	_	0	SENT_116	[p9l1301t720r1407b782],
14	needed	VBN	O	need	amod	15	SENT_116	[p9l1454t690r1946b804],
15	)	NN	O	)	prep_as	12	SENT_116	[p9l1454t690r1946b804],
16	.	.	O	.	_	0	SENT_116	[p9l1454t690r1946b804],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_117	[p9l164t832r620b922],
2	were	VBD	O	be	auxpass	4	SENT_117	[p9l669t861r933b922],
3	actively	RB	O	actively	advmod	4	SENT_117	[p9l985t832r1414b946],
4	followed	VBN	O	follow	_	0	SENT_117	[p9l1459t832r1947b922],
5	up	RP	O	up	prt	4	SENT_117	[p9l1995t861r2135b946],
6	on	IN	O	on	_	0	SENT_117	[p9l38t1002r176b1064],
7	days	NNS	DURATION	day	prep_on	4	SENT_117	[p9l225t972r470b1086],
8	7	CD	NUMBER	7	num	7	SENT_117	[p9l523t977r579b1062],
9	and	CC	O	and	_	0	SENT_117	[p9l635t972r840b1064],
10	28	CD	NUMBER	28	conj_and	7	SENT_117	[p9l890t977r1021b1064],
11	(	CD	NUMBER	(	num	14	SENT_117	[p9l1082t972r1244b1086],
12	or	CC	O	or	_	0	SENT_117	[p9l1082t972r1244b1086],
13	one	CD	DATE	one	num	14	SENT_117	[p9l1289t1002r1489b1064],
14	day	NN	DATE	day	npadvmod	15	SENT_117	[p9l1539t972r1736b1086],
15	earlier	RBR	DATE	earlier	advmod	4	SENT_117	[p9l1783t972r2141b1064],
16	or	CC	O	or	_	0	SENT_117	[p9l38t1143r154b1205],
17	later	RBR	O	later	conj_or	15	SENT_117	[p9l295t1113r589b1227],
18	)	RB	O	)	advmod	4	SENT_117	[p9l295t1113r589b1227],
19	for	IN	O	for	_	0	SENT_117	[p9l742t1113r902b1205],
20	completion	NN	O	completion	prep_for	4	SENT_117	[p9l1046t1113r1688b1227],
21	of	IN	O	of	_	0	SENT_117	[p9l1833t1113r1953b1205],
22	a	DT	O	a	det	24	SENT_117	[p9l2085t1143r2136b1205],
23	standard	JJ	O	standard	amod	24	SENT_117	[p9l38t1255r533b1345],
24	questionnaire	NN	O	questionnaire	prep_of	20	SENT_117	[p9l698t1255r1511b1369],
25	,	,	O	,	_	0	SENT_117	[p9l698t1255r1511b1369],
26	physical	JJ	O	physical	amod	27	SENT_117	[p9l1677t1255r2136b1369],
27	examination	NN	O	examination	prep_of	20	SENT_117	[p9l38t1395r776b1504],
28	,	,	O	,	_	0	SENT_117	[p9l38t1395r776b1504],
29	and	CC	O	and	_	0	SENT_117	[p9l898t1395r1103b1487],
30	capillary	JJ	O	capillary	amod	32	SENT_117	[p9l1220t1395r1703b1509],
31	blood	NN	O	blood	nn	32	SENT_117	[p9l1813t1395r2138b1487],
32	sampling	NN	O	sampling	prep_of	20	SENT_117	[p9l38t1536r552b1650],
33	for	IN	O	for	_	0	SENT_117	[p9l696t1536r856b1628],
34	haemoglobin	NN	O	haemoglobin	nn	35	SENT_117	[p9l997t1536r1740b1650],
35	concentration	NN	O	concentration	prep_for	4	SENT_117	[p9l1888t1566r2136b1628, p9l38t1678r620b1768],
36	and	CC	O	and	_	0	SENT_117	[p9l790t1678r995b1768],
37	parasite	NN	O	parasite	nn	38	SENT_117	[p9l1160t1678r1604b1792],
38	count	NN	O	count	prep_for	4	SENT_117	[p9l1777t1698r2129b1768],
39	.	.	O	.	_	0	SENT_117	[p9l1777t1698r2129b1768],

1	Thereafter	RB	O	thereafter	advmod	5	SENT_118	[p9l35t1818r678b1927],
2	,	,	O	,	_	0	SENT_118	[p9l35t1818r678b1927],
3	active	JJ	O	active	amod	4	SENT_118	[p9l810t1818r1133b1910],
4	follow-up	NN	O	follow-up	nsubj	5	SENT_118	[p9l1259t1818r1805b1932],
5	was	VBD	O	be	_	0	SENT_118	[p9l1930t1848r2136b1910],
6	every	DT	SET	every	det	8	SENT_118	[p9l38t1989r334b2073],
7	28	CD	SET	28	num	8	SENT_118	[p9l441t1964r572b2051],
8	days	NNS	NUMBER	day	tmod	5	SENT_118	[p9l686t1959r969b2073],
9	,	,	O	,	_	0	SENT_118	[p9l686t1959r969b2073],
10	with	IN	O	with	_	0	SENT_118	[p9l1079t1959r1327b2051],
11	the	DT	O	the	det	12	SENT_118	[p9l1432t1959r1606b2051],
12	aim	NN	O	aim	prep_with	5	SENT_118	[p9l1718t1959r1922b2051],
13	to	TO	O	to	aux	14	SENT_118	[p9l2027t1981r2135b2051],
14	complete	VB	O	complete	infmod	12	SENT_118	[p9l38t2101r557b2215],
15	12	CD	DURATION	12	num	16	SENT_118	[p9l652t2104r773b2190],
16	months	NNS	NUMBER	month	dobj	14	SENT_118	[p9l856t2101r1280b2191],
17	of	IN	O	of	_	0	SENT_118	[p9l1364t2101r1485b2191],
18	follow-up	NN	O	follow-up	prep_of	16	SENT_118	[p9l1549t2101r2129b2215],
19	.	.	O	.	_	0	SENT_118	[p9l1549t2101r2129b2215],

1	Symptoms	NNS	O	symptom	nsubjpass	8	SENT_119	[p9l40t2241r676b2355],
2	,	,	O	,	_	0	SENT_119	[p9l40t2241r676b2355],
3	temperature	NN	O	temperature	conj_and	1	SENT_119	[p9l726t2263r1461b2355],
4	,	,	O	,	_	0	SENT_119	[p9l726t2263r1461b2355],
5	and	CC	O	and	_	0	SENT_119	[p9l1514t2241r1718b2333],
6	weight	NN	O	weight	conj_and	1	SENT_119	[p9l1762t2241r2139b2355],
7	were	VBD	O	be	auxpass	8	SENT_119	[p9l33t2411r298b2473],
8	recorded	VBN	O	record	_	0	SENT_119	[p9l403t2381r909b2473],
9	at	IN	O	at	_	0	SENT_119	[p9l1015t2403r1115b2473],
10	each	DT	O	each	det	11	SENT_119	[p9l1220t2381r1473b2473],
11	visit	NN	O	visit	prep_at	8	SENT_119	[p9l1575t2381r1842b2490],
12	,	,	O	,	_	0	SENT_119	[p9l1575t2381r1842b2490],
13	but	CC	O	but	_	0	SENT_119	[p9l1947t2381r2139b2473],
14	blood	NN	O	blood	nsubjpass	17	SENT_119	[p9l33t2524r360b2614],
15	was	VBD	O	be	auxpass	17	SENT_119	[p9l460t2553r664b2614],
16	not	RB	O	not	neg	17	SENT_119	[p9l767t2544r955b2614],
17	drawn	VBN	O	draw	conj_but	8	SENT_119	[p9l1057t2524r1410b2614],
18	unless	IN	O	unless	mark	23	SENT_119	[p9l1510t2524r1859b2614],
19	the	DT	O	the	det	20	SENT_119	[p9l1962t2524r2136b2614],
20	child	NN	O	child	nsubj	23	SENT_119	[p9l38t2664r316b2756],
21	was	VBD	O	be	cop	23	SENT_119	[p9l419t2694r625b2756],
22	ill	JJ	O	ill	amod	23	SENT_119	[p9l733t2664r837b2754],
23	(	NN	O	(	advcl	17	SENT_119	[p9l953t2664r1101b2778],
24	in	IN	O	in	_	0	SENT_119	[p9l953t2664r1101b2778],
25	the	DT	O	the	det	26	SENT_119	[p9l1206t2664r1381b2756],
26	opinion	NN	O	opinion	prep_in	23	SENT_119	[p9l1490t2664r1925b2778],
27	of	IN	O	of	_	0	SENT_119	[p9l2034t2664r2153b2756],
28	parent	NN	O	parent	prep_of	26	SENT_119	[p9l35t2827r402b2919],
29	or	CC	O	or	_	0	SENT_119	[p9l472t2835r588b2897],
30	the	DT	O	the	det	33	SENT_119	[p9l653t2805r827b2897],
31	clinic	NN	O	clinic	nn	33	SENT_119	[p9l900t2805r1201b2897],
32	team	NN	O	team	nn	33	SENT_119	[p9l1271t2806r1633b2919],
33	)	NN	O	)	conj_or	28	SENT_119	[p9l1271t2806r1633b2919],
34	.	.	O	.	_	0	SENT_119	[p9l1271t2806r1633b2919],

1	Parents	NNS	O	parent	nsubjpass	3	SENT_120	[p9l1711t2807r2136b2897],
2	were	VBD	O	be	auxpass	3	SENT_120	[p9l33t2976r298b3037],
3	encouraged	VBN	O	encourage	_	0	SENT_120	[p9l385t2947r1043b3061],
4	to	TO	O	to	aux	5	SENT_120	[p9l1126t2967r1234b3037],
5	return	VB	O	return	xcomp	3	SENT_120	[p9l1320t2967r1674b3037],
6	at	IN	O	at	_	0	SENT_120	[p9l1760t2967r1859b3037],
7	any	DT	O	any	det	8	SENT_120	[p9l1944t2976r2140b3061],
8	time	NN	O	time	prep_at	5	SENT_120	[p9l35t3086r285b3178],
9	if	IN	O	if	mark	13	SENT_120	[p9l344t3086r431b3176],
10	the	DT	O	the	det	11	SENT_120	[p9l472t3086r645b3178],
11	child	NN	O	child	nsubj	13	SENT_120	[p9l706t3086r984b3178],
12	was	VBD	O	be	cop	13	SENT_120	[p9l1039t3116r1244b3178],
13	ill	RB	O	ill	advcl	5	SENT_120	[p9l1303t3086r1439b3178],
14	.	.	O	.	_	0	SENT_120	[p9l1303t3086r1439b3178],

1	If	IN	O	if	mark	4	SENT_121	[p9l1505t3086r1606b3176],
2	the	DT	O	the	det	3	SENT_121	[p9l1646t3086r1820b3178],
3	slide	NN	O	slide	nsubj	4	SENT_121	[p9l1881t3086r2136b3178],
4	showed	VBD	O	show	advcl	12	SENT_121	[p9l38t3228r462b3320],
5	P	NN	O	p	nn	7	SENT_121	[p9l548t3230r637b3318],
6	falciparum	NN	O	falciparum	nn	7	SENT_121	[p9l694t3229r1286b3342],
7	parasitaemia	NN	O	parasitaemia	dobj	4	SENT_121	[p9l1374t3228r2133b3342],
8	,	,	O	,	_	0	SENT_121	[p9l1374t3228r2133b3342],
9	the	DT	O	the	det	10	SENT_121	[p9l35t3370r208b3460],
10	patient	NN	O	patient	nsubjpass	12	SENT_121	[p9l285t3370r684b3484],
11	was	VBD	O	be	auxpass	12	SENT_121	[p9l757t3399r963b3460],
12	treated	VBN	O	treat	_	0	SENT_121	[p9l1041t3370r1439b3460],
13	again	RB	O	again	advmod	12	SENT_121	[p9l1519t3370r1817b3484],
14	with	IN	O	with	_	0	SENT_121	[p9l1891t3370r2138b3460],
15	paracetamol	NNP	O	paracetamol	prep_with	12	SENT_121	[p9l35t3510r737b3624],
16	and	CC	O	and	_	0	SENT_121	[p9l810t3510r1014b3602],
17	study	NN	O	study	nn	18	SENT_121	[p9l1085t3510r1393b3624],
18	medication	NN	O	medication	prep_with	12	SENT_121	[p9l1459t3510r2129b3602],
19	.	.	O	.	_	0	SENT_121	[p9l1459t3510r2129b3602],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_122	[p9l37t3651r492b3743],
2	were	VBD	O	be	auxpass	3	SENT_122	[p9l577t3681r842b3743],
3	reviewed	VBN	O	review	_	0	SENT_122	[p9l927t3651r1431b3743],
4	on	IN	O	on	_	0	SENT_122	[p9l1517t3681r1655b3743],
5	days	NNS	DURATION	day	prep_on	3	SENT_122	[p9l1741t3651r1985b3765],
6	7	CD	NUMBER	7	number	5	SENT_122	[p9l2075t3656r2131b3741],

1	and	CC	O	and	cc	2	SENT_123	[p10l38t21r244b112],
2	28	CD	NUMBER	28	_	0	SENT_123	[p10l300t24r431b112],
3	after	IN	O	after	_	0	SENT_123	[p10l490t21r749b111],
4	retreatment	NN	O	retreatment	prep_after	2	SENT_123	[p10l798t41r1504b130],
5	,	,	O	,	_	0	SENT_123	[p10l798t41r1504b130],
6	as	IN	O	as	prep	2	SENT_123	[p10l1563t50r1667b111],
7	on	IN	O	on	pcomp	6	SENT_123	[p10l1726t50r1864b111],
8	first	JJ	ORDINAL	first	amod	9	SENT_123	[p10l1916t21r2138b111],
9	recruitment	NN	O	recruitment	pobj	7	SENT_123	[p10l35t160r742b252],
10	.	.	O	.	_	0	SENT_123	[p10l35t160r742b252],

1	Children	NNS	O	child	nsubjpass	15	SENT_124	[p10l824t160r1327b252],
2	who	WP	O	who	nsubj	4	SENT_124	[p10l1395t160r1628b252],
3	were	VBD	O	be	cop	4	SENT_124	[p10l1697t190r1963b252],
4	ill	RB	O	ill	rcmod	1	SENT_124	[p10l2034t160r2136b250],
5	during	IN	O	during	_	0	SENT_124	[p10l38t302r412b416],
6	follow-up	NN	O	follow-up	prep_during	4	SENT_124	[p10l523t302r1107b416],
7	,	,	O	,	_	0	SENT_124	[p10l523t302r1107b416],
8	but	CC	O	but	_	0	SENT_124	[p10l1223t302r1414b394],
9	who	WP	O	who	nsubj	10	SENT_124	[p10l1524t302r1757b394],
10	were	VBD	O	be	conj_but	4	SENT_124	[p10l1871t332r2136b394],
11	without	IN	O	without	_	0	SENT_124	[p10l33t444r475b534],
12	parasitaemia	NN	O	parasitaemia	prep_without	10	SENT_124	[p10l552t444r1310b558],
13	,	,	O	,	_	0	SENT_124	[p10l552t444r1310b558],
14	were	VBD	O	be	auxpass	15	SENT_124	[p10l1393t473r1657b534],
15	treated	VBN	O	treat	_	0	SENT_124	[p10l1738t444r2138b534],
16	appropriately	RB	O	appropriately	advmod	15	SENT_124	[p10l38t584r830b698],
17	.	.	O	.	_	0	SENT_124	[p10l38t584r830b698],

1	In	IN	O	in	_	0	SENT_125	[p10l164t726r282b814],
2	addition	NN	O	addition	_	0	SENT_125	[p10l348t724r822b816],
3	to	TO	O	to	_	0	SENT_125	[p10l885t746r992b816],
4	the	DT	O	the	det	7	SENT_125	[p10l1057t724r1231b816],
5	main	JJ	O	main	amod	7	SENT_125	[p10l1296t724r1579b816],
6	outcome	NN	O	outcome	nn	7	SENT_125	[p10l1645t746r2136b816],
7	measure	NN	O	measure	prep_in_addition_to	14	SENT_125	[p10l35t896r509b957],
8	of	IN	O	of	_	0	SENT_125	[p10l597t867r717b957],
9	malaria	NN	O	malaria	nn	10	SENT_125	[p10l786t867r1208b957],
10	incidence	NN	O	incidence	prep_of	7	SENT_125	[p10l1293t867r1873b976],
11	,	,	O	,	_	0	SENT_125	[p10l1293t867r1873b976],
12	the	DT	O	the	det	13	SENT_125	[p10l1962t867r2136b957],
13	trial	NN	O	trial	nsubj	14	SENT_125	[p10l35t1007r261b1099],
14	addressed	VBD	O	address	_	0	SENT_125	[p10l309t1007r873b1099],
15	the	DT	O	the	det	18	SENT_125	[p10l915t1007r1089b1099],
16	following	VBG	O	follow	amod	18	SENT_125	[p10l1135t1007r1665b1121],
17	efﬁcacy	NN	O	efﬁcacy	nn	18	SENT_125	[p10l1709t1007r2140b1121],
18	endpoints	NNS	O	endpoint	dobj	14	SENT_125	[p10l38t1148r632b1262],
19	:	:	O	:	_	0	SENT_125	[p10l38t1148r632b1262],
20	severe	JJ	O	severe	amod	21	SENT_125	[p10l686t1178r1030b1240],
21	malaria	NN	O	malaria	dep	18	SENT_125	[p10l1075t1148r1533b1257],
22	,	,	O	,	_	0	SENT_125	[p10l1075t1148r1533b1257],
23	treatment	NN	O	treatment	nn	24	SENT_125	[p10l1580t1170r2138b1240],
24	failure	NN	O	failure	dep	18	SENT_125	[p10l35t1290r433b1399],
25	,	,	O	,	_	0	SENT_125	[p10l35t1290r433b1399],
26	and	CC	O	and	_	0	SENT_125	[p10l497t1290r701b1380],
27	completion	NN	O	completion	dep	18	SENT_125	[p10l761t1290r1402b1404],
28	of	IN	O	of	_	0	SENT_125	[p10l1461t1290r1580b1380],
29	1	CD	DURATION	1	num	30	SENT_125	[p10l1634t1293r1672b1379],
30	year	NN	NUMBER	year	prep_of	14	SENT_125	[p10l1738t1319r1978b1404],
31	of	IN	O	of	prep	30	SENT_125	[p10l2034t1290r2153b1380],
32	follow	VB	O	follow	dep	31	SENT_125	[p10l35t1430r616b1544],
33	—	RB	O	—	advmod	32	SENT_125	[p10l35t1430r616b1544],
34	up	RB	O	up	advmod	32	SENT_125	[p10l35t1430r616b1544],
35	.	.	O	.	_	0	SENT_125	[p10l35t1430r616b1544],

1	We	PRP	O	we	nsubj	2	SENT_126	[p10l677t1432r864b1522],
2	judged	VBD	O	judge	dep	54	SENT_126	[p10l922t1430r1307b1544],
3	malaria	NN	O	malaria	dobj	2	SENT_126	[p10l1363t1430r1786b1521],
4	to	TO	O	to	aux	6	SENT_126	[p10l1842t1450r1949b1521],
5	be	VB	O	be	cop	6	SENT_126	[p10l2005t1430r2136b1521],
6	severe	JJ	O	severe	xcomp	2	SENT_126	[p10l38t1601r382b1663],
7	if	IN	O	if	mark	14	SENT_126	[p10l450t1571r557b1680],
8	,	,	O	,	_	0	SENT_126	[p10l450t1571r557b1680],
9	at	IN	O	at	_	0	SENT_126	[p10l631t1593r731b1663],
10	any	DT	O	any	det	11	SENT_126	[p10l799t1601r995b1685],
11	time	NN	O	time	prep_at	14	SENT_126	[p10l1058t1571r1344b1680],
12	,	,	O	,	_	0	SENT_126	[p10l1058t1571r1344b1680],
13	parasitaemia	NN	O	parasitaemia	nsubj	14	SENT_126	[p10l1414t1571r2136b1685],
14	exceeded	VBD	O	exceed	dep	6	SENT_126	[p10l38t1714r559b1805],
15	250	CD	NUMBER	250	num	20	SENT_126	[p10l631t1717r836b1805],
16	ooo	NN	O	ooo	nn	20	SENT_126	[p10l888t1717r1094b1805],
17	pL	NN	O	pl	nn	20	SENT_126	[p10l1174t1715r1400b1830],
18	'	''	O	'	_	0	SENT_126	[p10l1174t1715r1400b1830],
19	1	CD	NUMBER	1	num	20	SENT_126	[p10l1174t1715r1400b1830],
20	(	NN	O	(	dobj	14	SENT_126	[p10l1481t1714r1665b1827],
21	on	IN	O	on	_	0	SENT_126	[p10l1481t1714r1665b1827],
22	a	DT	O	a	det	25	SENT_126	[p10l1736t1743r1789b1805],
23	thick	JJ	O	thick	amod	25	SENT_126	[p10l1857t1714r2141b1805],
24	ﬁlm	NN	O	ﬁlm	nn	25	SENT_126	[p10l35t1854r300b1967],
25	)	NN	O	)	prep_on	20	SENT_126	[p10l35t1854r300b1967],
26	or	CC	O	or	_	0	SENT_126	[p10l356t1884r472b1946],
27	10	CD	PERCENT	10	number	28	SENT_126	[p10l526t1854r762b1948],
28	%	NN	PERCENT	%	amod	30	SENT_126	[p10l526t1854r762b1948],
29	parasitaemia	NN	O	parasitaemia	nn	30	SENT_126	[p10l810t1854r1533b1968],
30	(	NN	O	(	conj_or	25	SENT_126	[p10l1587t1855r1769b1967],
31	on	IN	O	on	_	0	SENT_126	[p10l1587t1855r1769b1967],
32	a	DT	O	a	det	35	SENT_126	[p10l1816t1884r1869b1946],
33	thin	JJ	O	thin	amod	35	SENT_126	[p10l1912t1854r2138b1946],
34	ﬁlm	NN	O	ﬁlm	nn	35	SENT_126	[p10l35t1995r346b2109],
35	)	NN	O	)	prep_on	14	SENT_126	[p10l35t1995r346b2109],
36	,	,	O	,	_	0	SENT_126	[p10l35t1995r346b2109],
37	or	CC	O	or	_	0	SENT_126	[p10l407t2025r523b2087],
38	if	IN	O	if	mark	42	SENT_126	[p10l575t1995r662b2085],
39	the	DT	O	the	det	41	SENT_126	[p10l701t1995r876b2087],
40	parasitaemic	JJ	O	parasitaemic	amod	41	SENT_126	[p10l931t1995r1652b2109],
41	episode	NN	O	episode	nsubj	42	SENT_126	[p10l1709t1995r2136b2109],
42	required	VBN	O	require	dep	6	SENT_126	[p10l35t2137r518b2251],
43	inpatient	JJ	O	inpatient	amod	44	SENT_126	[p10l586t2137r1097b2251],
44	treatment	NN	O	treatment	dobj	42	SENT_126	[p10l1163t2157r1722b2227],
45	in	IN	O	in	_	0	SENT_126	[p10l1789t2137r1895b2226],
46	the	DT	O	the	det	47	SENT_126	[p10l1962t2137r2136b2227],
47	opinion	NN	O	opinion	prep_in	42	SENT_126	[p10l38t2277r473b2391],
48	of	IN	O	of	_	0	SENT_126	[p10l665t2277r784b2369],
49	the	DT	O	the	det	50	SENT_126	[p10l958t2277r1132b2369],
50	doctor	NN	O	doctor	prep_of	47	SENT_126	[p10l1325t2277r1696b2369],
51	(	CD	NUMBER	(	num	50	SENT_126	[p10l1893t2277r2135b2390],
52	this	DT	O	this	det	53	SENT_126	[p10l1893t2277r2135b2390],
53	definition	NN	O	definition	nsubj	54	SENT_126	[p10l38t2418r591b2510],
54	encompassed	VBD	O	encompass	_	0	SENT_126	[p10l682t2418r1441b2532],
55	the	DT	O	the	dobj	54	SENT_126	[p10l1531t2418r1705b2510],
56	WHO	WP	O	who	dep	57	SENT_126	[p10l1794t2419r2133b2510],
57	definition	NN	O	definition	rcmod	55	SENT_126	[p10l38t2560r591b2650],
58	of	IN	O	of	_	0	SENT_126	[p10l639t2560r758b2650],
59	severe	JJ	O	severe	amod	64	SENT_126	[p10l791t2589r1136b2650],
60	and	CC	O	and	_	0	SENT_126	[p10l1186t2560r1392b2650],
61	complicated	JJ	O	complicated	conj_and	59	SENT_126	[p10l1440t2560r2138b2674],
62	malaria	NN	O	malaria	nn	64	SENT_126	[p10l35t2700r615b2812],
63	”	CD	NUMBER	”	num	64	SENT_126	[p10l35t2700r615b2812],
64	)	NN	O	)	prep_of	57	SENT_126	[p10l35t2700r615b2812],
65	.	.	O	.	_	0	SENT_126	[p10l35t2700r615b2812],

1	Treatment	NN	O	treatment	nn	2	SENT_127	[p10l734t2702r1347b2792],
2	failure	NN	O	failure	nsubjpass	4	SENT_127	[p10l1458t2700r1820b2792],
3	was	VBD	O	be	auxpass	4	SENT_127	[p10l1930t2730r2135b2792],
4	defined	VBN	O	define	_	0	SENT_127	[p10l38t2841r460b2933],
5	as	IN	O	as	_	0	SENT_127	[p10l523t2871r628b2933],
6	any	DT	O	any	det	7	SENT_127	[p10l693t2871r888b2955],
7	one	CD	NUMBER	one	prep_as	4	SENT_127	[p10l949t2871r1147b2933],
8	of	IN	O	of	_	0	SENT_127	[p10l1211t2841r1347b2933],
9	:	:	O	:	_	0	SENT_127	[p10l1211t2841r1347b2933],
10	parasitaemia	NN	O	parasitaemia	prep_of	7	SENT_127	[p10l1414t2841r2136b2955],
11	greater	JJR	O	greater	mwe	12	SENT_127	[p10l36t3003r433b3097],
12	than	IN	O	than	quantmod	13	SENT_127	[p10l478t2983r732b3073],
13	50	CD	PERCENT	50	num	14	SENT_127	[p10l785t2983r1030b3077],
14	%	NN	PERCENT	%	dep	10	SENT_127	[p10l785t2983r1030b3077],
15	of	IN	O	of	_	0	SENT_127	[p10l1089t2983r1208b3073],
16	the	DT	O	the	det	18	SENT_127	[p10l1242t2983r1415b3073],
17	initial	JJ	O	initial	amod	18	SENT_127	[p10l1466t2983r1791b3073],
18	value	NN	O	value	prep_of	14	SENT_127	[p10l1839t2983r2136b3073],
19	on	IN	O	on	_	0	SENT_127	[p10l38t3153r176b3215],
20	days	NNS	DURATION	day	prep_on	18	SENT_127	[p10l247t3123r492b3237],
21	1	CD	NUMBER	1	num	20	SENT_127	[p10l577t3128r615b3213],
22	or	CC	O	or	_	0	SENT_127	[p10l700t3153r815b3215],
23	2	CD	NUMBER	2	prep_on	18	SENT_127	[p10l885t3128r943b3213],
24	after	IN	O	after	_	0	SENT_127	[p10l1019t3123r1276b3215],
25	the	DT	O	the	det	26	SENT_127	[p10l1342t3123r1516b3215],
26	start	NN	O	start	prep_after	20	SENT_127	[p10l1588t3145r1837b3215],
27	of	IN	O	of	_	0	SENT_127	[p10l1908t3123r2027b3215],
28	a	DT	O	a	det	30	SENT_127	[p10l2085t3153r2138b3215],
29	treatment	NN	O	treatment	nn	30	SENT_127	[p10l35t3286r593b3356],
30	episode	NN	O	episode	prep_of	26	SENT_127	[p10l771t3264r1234b3378],
31	,	,	O	,	_	0	SENT_127	[p10l771t3264r1234b3378],
32	parasitaemia	NN	O	parasitaemia	appos	10	SENT_127	[p10l1414t3264r2136b3378],
33	greater	JJR	O	greater	mwe	34	SENT_127	[p10l36t3426r433b3520],
34	than	IN	O	than	quantmod	35	SENT_127	[p10l478t3406r732b3496],
35	10	CD	PERCENT	10	num	36	SENT_127	[p10l794t3406r1030b3500],
36	%	NN	PERCENT	%	dep	32	SENT_127	[p10l794t3406r1030b3500],
37	of	IN	O	of	_	0	SENT_127	[p10l1089t3406r1208b3496],
38	the	DT	O	the	det	40	SENT_127	[p10l1242t3406r1415b3496],
39	initial	JJ	O	initial	amod	40	SENT_127	[p10l1466t3406r1791b3496],
40	value	NN	O	value	prep_of	36	SENT_127	[p10l1839t3406r2136b3496],
41	between	IN	O	between	_	0	SENT_127	[p10l33t3546r508b3638],
42	days	NNS	DURATION	day	prep_between	40	SENT_127	[p10l567t3546r812b3660],
43	3	CD	NUMBER	3	num	42	SENT_127	[p10l876t3551r933b3638],
44	and	CC	O	and	_	0	SENT_127	[p10l999t3546r1204b3638],
45	6	CD	NUMBER	6	prep_between	40	SENT_127	[p10l1267t3551r1363b3655],
46	,	,	O	,	_	0	SENT_127	[p10l1267t3551r1363b3655],
47	inclusive	JJ	O	inclusive	amod	36	SENT_127	[p10l1427t3546r1959b3655],
48	,	,	O	,	_	0	SENT_127	[p10l1427t3546r1959b3655],
49	or	CC	O	or	_	0	SENT_127	[p10l2025t3576r2141b3638],
50	parasitaemia	NN	O	parasitaemia	conj_or	10	SENT_127	[p10l35t3687r757b3801],
51	that	WDT	O	that	nsubj	52	SENT_127	[p10l875t3687r1097b3779],
52	persisted	VBD	O	persist	rcmod	50	SENT_127	[p10l1213t3687r1721b3801],
53	7	CD	NUMBER	7	num	56	SENT_127	[p10l1843t3692r1900b3777],
54	or	CC	O	or	_	0	SENT_127	[p10l2025t3717r2141b3779],
55	more	JJR	O	more	num	56	SENT_127	[p11l35t50r324b111],
56	days	NNS	DURATION	day	tmod	52	SENT_127	[p11l375t21r620b135],
57	after	IN	O	after	_	0	SENT_127	[p11l671t21r929b111],
58	treatment	NN	O	treatment	prep_after	52	SENT_127	[p11l971t41r1560b111],
59	.	.	O	.	_	0	SENT_127	[p11l971t41r1560b111],

1	Thus	RB	O	thus	advmod	13	SENT_128	[p11l1614t21r1946b130],
2	,	,	O	,	_	0	SENT_128	[p11l1614t21r1946b130],
3	no	DT	O	no	det	4	SENT_128	[p11l1996t50r2135b111],
4	episode	NN	O	episode	nsubj	13	SENT_128	[p11l38t161r465b275],
5	of	IN	O	of	_	0	SENT_128	[p11l563t161r683b253],
6	parasitaemia	NN	O	parasitaemia	prep_of	4	SENT_128	[p11l761t161r1483b275],
7	of	IN	O	of	_	0	SENT_128	[p11l1582t161r1701b253],
8	longer	JJR	O	longer	amod	12	SENT_128	[p11l1781t161r2141b275],
9	than	IN	O	than	_	0	SENT_128	[p11l35t302r288b394],
10	6	CD	DURATION	6	num	11	SENT_128	[p11l421t307r477b394],
11	days	NNS	NUMBER	day	prep_than	8	SENT_128	[p11l611t302r856b416],
12	duration	NN	O	duration	prep_of	6	SENT_128	[p11l988t302r1475b394],
13	remained	VBD	O	remain	_	0	SENT_128	[p11l1604t302r2138b394],
14	within	IN	O	within	_	0	SENT_128	[p11l33t444r394b534],
15	the	DT	O	the	det	16	SENT_128	[p11l455t444r630b534],
16	study	NN	O	study	prep_within	13	SENT_128	[p11l696t444r1031b558],
17	.	.	O	.	_	0	SENT_128	[p11l696t444r1031b558],

1	Treatment	NN	O	treatment	nn	2	SENT_129	[p11l1101t445r1714b534],
2	failure	NN	O	failure	nsubjpass	4	SENT_129	[p11l1775t444r2136b534],
3	was	VBD	O	be	auxpass	4	SENT_129	[p11l33t614r239b676],
4	managed	VBN	O	manage	_	0	SENT_129	[p11l298t584r812b698],
5	with	IN	O	with	_	0	SENT_129	[p11l866t584r1115b676],
6	oral	JJ	O	oral	amod	10	SENT_129	[p11l1174t584r1386b676],
7	halofantrine	NN	O	halofantrine	nn	10	SENT_129	[p11l1442t584r2136b676],
8	(	NN	O	(	nn	10	SENT_129	[p11l45t726r149b839],
9	8	CD	NUMBER	8	num	10	SENT_129	[p11l45t726r149b839],
10	mg/kg	NN	O	mg/kg	prep_with	4	SENT_129	[p11l198t725r545b839],
11	every	DT	O	every	det	13	SENT_129	[p11l592t755r888b839],
12	8	CD	NUMBER	8	num	13	SENT_129	[p11l936t730r992b817],
13	h	NN	O	h	dobj	4	SENT_129	[p11l1041t725r1110b815],
14	for	IN	O	for	_	0	SENT_129	[p11l1155t725r1315b817],
15	three	CD	NUMBER	three	num	16	SENT_129	[p11l1357t725r1645b817],
16	doses	NNS	O	dose	prep_for	13	SENT_129	[p11l1694t725r2085b839],
17	)	RB	O	)	advmod	16	SENT_129	[p11l1694t725r2085b839],
18	.	.	O	.	_	0	SENT_129	[p11l1694t725r2085b839],

1	The	DT	O	the	det	4	SENT_130	[p11l162t867r390b957],
2	following	VBG	O	follow	amod	4	SENT_130	[p11l501t867r1033b981],
3	safety	NN	O	safety	nn	4	SENT_130	[p11l1142t867r1466b981],
4	endpoints	NNS	O	endpoint	nsubjpass	6	SENT_130	[p11l1575t867r2135b981],
5	were	VBD	O	be	auxpass	6	SENT_130	[p11l33t1036r298b1098],
6	recorded	VBN	O	record	_	0	SENT_130	[p11l496t1006r1033b1098],
7	:	:	O	:	_	0	SENT_130	[p11l496t1006r1033b1098],
8	death	NN	O	death	dobj	6	SENT_130	[p11l1240t1006r1587b1115],
9	,	,	O	,	_	0	SENT_130	[p11l1240t1006r1587b1115],
10	severe	JJ	O	severe	amod	11	SENT_130	[p11l1791t1036r2136b1098],
11	anaemia	NN	O	anaemia	conj_and	8	SENT_130	[p11l38t1148r543b1257],
12	,	,	O	,	_	0	SENT_130	[p11l38t1148r543b1257],
13	vomiting	NN	O	vomiting	dobj	6	SENT_130	[p11l769t1148r1278b1262],
14	of	IN	O	of	_	0	SENT_130	[p11l1502t1148r1621b1240],
15	study	NN	O	study	nn	16	SENT_130	[p11l1833t1148r2140b1262],
16	medication	NN	O	medication	prep_of	13	SENT_130	[p11l35t1290r708b1399],
17	,	,	O	,	_	0	SENT_130	[p11l35t1290r708b1399],
18	and	CC	O	and	_	0	SENT_130	[p11l847t1290r1053b1381],
19	serious	JJ	O	serious	amod	22	SENT_130	[p11l1186t1290r1579b1380],
20	adverse	JJ	O	adverse	amod	22	SENT_130	[p11l1715t1290r2136b1381],
21	drug	NN	O	drug	nn	22	SENT_130	[p11l38t1430r299b1544],
22	reactions	NNS	O	reaction	conj_and	8	SENT_130	[p11l355t1430r902b1522],
23	.	.	O	.	_	0	SENT_130	[p11l355t1430r902b1522],

1	Severe	JJ	O	severe	amod	2	SENT_131	[p11l973t1430r1341b1522],
2	anaemia	NN	O	anaemia	nsubjpass	4	SENT_131	[p11l1403t1430r1873b1522],
3	was	VBD	O	be	auxpass	4	SENT_131	[p11l1930t1460r2135b1522],
4	defined	VBN	O	define	_	0	SENT_131	[p11l38t1571r460b1663],
5	as	IN	O	as	dep	4	SENT_131	[p11l587t1601r691b1663],
6	haemoglobin	NN	O	haemoglobin	nn	7	SENT_131	[p11l817t1571r1560b1685],
7	concenor	NN	O	concenor	npadvmod	10	SENT_131	[p11l1687t1601r2136b1663, p11l6t1742r120b1803],
8	less	RBR	O	less	advmod	9	SENT_131	[p11l183t1713r378b1803],
9	(	JJ	O	(	amod	7	SENT_131	[p11l455t1713r897b1827],
10	packed	JJ	O	packed	amod	12	SENT_131	[p11l455t1713r897b1827],
11	cell	NN	O	cell	nn	12	SENT_131	[p11l965t1713r1154b1803],
12	volume	NN	O	volume	pobj	5	SENT_131	[p11l1216t1713r1635b1803],
13	15	CD	PERCENT	15	number	14	SENT_131	[p11l1714t1713r1951b1807],
14	%	NN	PERCENT	%	amod	12	SENT_131	[p11l1714t1713r1951b1807],
15	or	CC	O	or	_	0	SENT_131	[p11l2025t1742r2141b1803],
16	again	RB	O	again	dep	4	SENT_131	[p11l72t1835r159b1869],
17	if	IN	O	if	mark	20	SENT_131	[p11l174t1835r199b1862],
18	the	DT	O	the	det	19	SENT_131	[p11l210t1835r260b1862],
19	patient	NN	O	patient	nsubj	20	SENT_131	[p11l275t1835r391b1869],
20	vomited	VBD	O	vomit	dep	4	SENT_131	[p11l405t1835r540b1862],
21	a	DT	O	a	det	23	SENT_131	[p11l555t1844r571b1862],
22	secon	NN	O	secon	nn	23	SENT_131	[p11l587t1844r679b1862],
23	ime	NN	O	ime	dobj	20	SENT_131	[p11l729t1835r799b1868],
24	,	,	O	,	_	0	SENT_131	[p11l729t1835r799b1868],
25	but	CC	O	but	_	0	SENT_131	[p11l815t1835r870b1862],
26	patients	NNS	O	patient	npadvmod	27	SENT_131	[p11l885t1835r1015b1869],
27	less	RBR	O	less	advmod	4	SENT_131	[p11l1111t1835r1182b1869],
28	)	RB	O	)	advmod	29	SENT_131	[p11l1111t1835r1182b1869],
29	at	IN	O	at	conj_but	4	SENT_131	[p11l1203t1841r1232b1862],
30	any	DT	O	any	det	31	SENT_131	[p11l1250t1844r1308b1869],
31	time	NN	O	time	pobj	29	SENT_131	[p11l1324t1835r1397b1862],
32	after	IN	O	after	_	0	SENT_131	[p11l1415t1835r1491b1862],
33	recruitment	NN	O	recruitment	prep_after	4	SENT_131	[p11l1507t1835r1715b1862],
34	:	:	O	:	_	0	SENT_131	[p11l1507t1835r1715b1862],
35	such	JJ	O	such	amod	36	SENT_131	[p11l1735t1835r1811b1862],
36	patients	NNS	O	patient	nsubj	37	SENT_131	[p11l1827t1835r1959b1869],
37	were	VBD	O	be	parataxis	4	SENT_131	[p11l1977t1844r2054b1862],
38	who	WP	O	who	nsubj	39	SENT_131	[p11l71t1876r139b1904],
39	vomited	VBD	O	vomit	ccomp	37	SENT_131	[p11l163t1876r298b1904],
40	a	DT	O	a	det	42	SENT_131	[p11l322t1885r338b1903],
41	third	JJ	ORDINAL	third	amod	42	SENT_131	[p11l362t1876r442b1903],
42	time	NN	O	time	nsubj	45	SENT_131	[p11l465t1876r538b1903],
43	were	VBD	O	be	cop	45	SENT_131	[p11l561t1885r638b1903],
44	wi	NN	O	wus	nn	45	SENT_131	[p11l662t1876r699b1903],
45	rawn	NN	O	rawn	ccomp	39	SENT_131	[p11l757t1885r839b1903],
46	from	IN	O	from	_	0	SENT_131	[p11l862t1876r941b1903],
47	the	DT	O	the	prep_from	45	SENT_131	[p11l965t1876r1015b1903],
48	removed	VBN	O	remove	dep	47	SENT_131	[p11l1111t1876r1256b1903],
49	from	IN	O	from	_	0	SENT_131	[p11l1275t1876r1355b1903],
50	the	DT	O	the	det	51	SENT_131	[p11l1373t1876r1425b1903],
51	trial	NN	O	trial	prep_from	48	SENT_131	[p11l1444t1876r1510b1903],
52	and	CC	O	and	_	0	SENT_131	[p11l1530t1876r1591b1903],
53	treated	VBN	O	treat	dep	47	SENT_131	[p11l1609t1876r1727b1903],
54	appropriately	RB	O	appropriately	advmod	53	SENT_131	[p11l1746t1876r1979b1910],
55	.	.	O	.	_	0	SENT_131	[p11l1746t1876r1979b1910],

1	We	PRP	O	we	nsubj	2	SENT_132	[p11l1999t1877r2055b1904],
2	study	VBP	O	study	_	0	SENT_132	[p11l72t1918r171b1952],
3	,	,	O	,	_	0	SENT_132	[p11l72t1918r171b1952],
4	and	CC	O	and	_	0	SENT_132	[p11l205t1918r265b1945],
5	treated	VBN	O	treat	csubj	11	SENT_132	[p11l297t1918r413b1945],
6	with	IN	O	with	prep	5	SENT_132	[p11l444t1918r516b1945],
7	in	IN	O	in	dep	6	SENT_132	[p11l548t1918r579b1945],
8	rarnuscular	JJ	O	rarnuscular	amod	9	SENT_132	[p11l594t1918r780b1945],
9	sulfadoXine	NN	O	sulfadoxine	pobj	7	SENT_132	[p11l812t1918r1015b1945],
10	-	:	O	-	_	0	SENT_132	[p11l812t1918r1015b1945],
11	gave	VBD	O	give	conj_and	2	SENT_132	[p11l1111t1927r1184b1952],
12	study	NN	O	study	nn	13	SENT_132	[p11l1206t1918r1297b1952],
13	medication	NN	O	medication	dobj	11	SENT_132	[p11l1317t1918r1505b1945],
14	during	IN	O	during	_	0	SENT_132	[p11l1526t1918r1637b1952],
15	follow-up	NN	O	follow-up	prep_during	11	SENT_132	[p11l1657t1918r1817b1952],
16	by	IN	O	by	_	0	SENT_132	[p11l1838t1918r1878b1952],
17	the	DT	O	the	det	19	SENT_132	[p11l1898t1918r1950b1945],
18	same	JJ	O	same	amod	19	SENT_132	[p11l1972t1927r2054b1945],
19	pyrimethamine	NN	O	pyrimethamine	prep_by	11	SENT_132	[p11l71t1959r332b1993],
20	.	.	O	.	_	0	SENT_132	[p11l71t1959r332b1993],

1	At	IN	O	at	_	0	SENT_133	[p11l346t1959r386b1986],
2	the	DT	O	the	det	4	SENT_133	[p11l398t1959r449b1986],
3	end	NN	O	end	nn	4	SENT_133	[p11l462t1959r522b1986],
4	o	NN	O	o	prep_at	32	SENT_133	[p11l535t1968r553b1986],
5	is	VBZ	O	be	cop	6	SENT_133	[p11l613t1959r636b1986],
6	period	NN	O	period	rcmod	4	SENT_133	[p11l649t1959r756b1993],
7	of	IN	O	of	_	0	SENT_133	[p11l769t1959r804b1986],
8	observation	NN	O	observation	prep_of	6	SENT_133	[p11l813t1959r1014b1992],
9	,	,	O	,	_	0	SENT_133	[p11l813t1959r1014b1992],
10	methods	NNS	O	method	rcmod	4	SENT_133	[p11l1111t1959r1254b1986],
11	used	VBN	O	use	partmod	10	SENT_133	[p11l1292t1959r1368b1986],
12	at	IN	O	at	_	0	SENT_133	[p11l1406t1965r1436b1986],
13	recruitment	NN	O	recruitment	prep_at	11	SENT_133	[p11l1472t1959r1681b1992],
14	,	,	O	,	_	0	SENT_133	[p11l1472t1959r1681b1992],
15	and	CC	O	and	_	0	SENT_133	[p11l1720t1959r1780b1986],
16	patients	NNS	O	patient	conj_and	6	SENT_133	[p11l1816t1959r1948b1993],
17	who	WP	O	who	dobj	19	SENT_133	[p11l1985t1959r2054b1986],
18	mothers	NNS	O	mother	nsubj	19	SENT_133	[p11l72t2000r205b2027],
19	were	VBD	O	be	rcmod	16	SENT_133	[p11l238t2009r315b2028],
20	'	POS	O	'	_	0	SENT_133	[p11l370t2000r375b2005],
21	n	NN	O	n	nsubjpass	32	SENT_133	[p11l415t2009r435b2027],
22	the	DT	O	the	det	25	SENT_133	[p11l468t2000r518b2027],
23	remaining	VBG	O	remain	amod	25	SENT_133	[p11l552t2000r719b2034],
24	two	CD	NUMBER	two	num	25	SENT_133	[p11l751t2006r810b2027],
25	containers	NNS	O	container	nsubj	26	SENT_133	[p11l845t2000r1015b2027],
26	vomited	VBD	O	vomit	rcmod	21	SENT_133	[p11l1110t2000r1247b2027],
27	three	CD	NUMBER	three	num	28	SENT_133	[p11l1263t2000r1348b2027],
28	times	NNS	O	time	dobj	26	SENT_133	[p11l1364t2000r1453b2027],
29	or	CC	O	or	cc	30	SENT_133	[p11l1471t2009r1505b2027],
30	more	JJR	O	more	num	28	SENT_133	[p11l1520t2009r1605b2027],
31	were	VBD	O	be	auxpass	32	SENT_133	[p11l1621t2009r1699b2027],
32	given	VBN	O	give	_	0	SENT_133	[p11l1716t2000r1804b2034],
33	intramuscular	JJ	O	intramuscular	dobj	32	SENT_133	[p11l1820t2000r2056b2027],
34	of	IN	O	of	_	0	SENT_133	[p11l72t2042r107b2069],
35	medicine	NN	O	medicine	prep_of	33	SENT_133	[p11l127t2042r278b2069],
36	to	TO	O	to	_	0	SENT_133	[p11l302t2048r334b2069],
37	a	DT	O	a	det	38	SENT_133	[p11l360t2051r375b2069],
38	minister	NN	O	minister	prep_to	32	SENT_133	[p11l399t2042r536b2069],
39	unsupervised	JJ	O	unsupervised	amod	38	SENT_133	[p11l559t2042r787b2076],
40	.	.	O	.	_	0	SENT_133	[p11l559t2042r787b2076],

1	All	DT	O	all	det	2	SENT_134	[p11l813t2042r860b2069],
2	patients	NNS	O	patient	_	0	SENT_134	[p11l884t2042r1015b2076],
3	treatment	NN	O	treatment	amod	2	SENT_134	[p11l1111t2048r1276b2069],
4	and	CC	O	and	_	0	SENT_134	[p11l1296t2042r1357b2069],
5	withdrawn	VBN	O	withdraw	amod	2	SENT_134	[p11l1376t2042r1565b2069],
6	.	.	O	.	_	0	SENT_134	[p11l1376t2042r1565b2069],

1	Mothers	NNS	O	mother	nsubjpass	3	SENT_135	[p11l1587t2042r1728b2069],
2	were	VBD	O	be	auxpass	3	SENT_135	[p11l1748t2051r1826b2069],
3	asked	VBN	O	ask	_	0	SENT_135	[p11l1847t2042r1940b2069],
4	about	IN	O	about	prep	3	SENT_135	[p11l1960t2042r2055b2069],

1	1	CD	NUMBER	1	num	2	SENT_136	[p11l80t2172r91b2198],
2	138	CD	NUMBER	138	_	0	SENT_136	[p11l101t2172r156b2198],
3	THE	DT	O	the	det	4	SENT_136	[p11l1196t2177r1257b2198],
4	LANCET	NN	O	lancet	dep	2	SENT_136	[p11l1267t2176r1391b2198],
5	-	:	O	-	_	0	SENT_136	[p11l1401t2184r1409b2192],
6	Vol	NN	O	vol	dep	2	SENT_136	[p11l1418t2177r1462b2198],
7	360	CD	NUMBER	360	dep	6	SENT_136	[p11l1472t2178r1518b2198],
8	-	:	O	-	_	0	SENT_136	[p11l1529t2184r1536b2192],
9	October	NNP	DATE	October	dep	6	SENT_136	[p11l1547t2177r1650b2198],
10	12	CD	DATE	12	num	9	SENT_136	[p11l1661t2178r1697b2202],
11	,	,	DATE	,	_	0	SENT_136	[p11l1661t2178r1697b2202],
12	2002	CD	DATE	2002	num	9	SENT_136	[p11l1708t2178r1769b2198],
13	-	:	O	-	_	0	SENT_136	[p11l1780t2184r1788b2192],
14	www.the1ancet.com	NN	O	www.the1ancet.com	dep	9	SENT_136	[p11l1797t2177r2048b2198],

1	For	IN	O	for	_	0	SENT_137	[p11l81t2277r149b2312],
2	personal	JJ	O	personal	amod	3	SENT_137	[p11l174t2277r362b2320],
3	use	NN	O	use	pobj	1	SENT_137	[p11l390t2286r479b2312],
4	.	.	O	.	_	0	SENT_137	[p11l390t2286r479b2312],

1	Only	RB	O	only	advmod	2	SENT_138	[p11l527t2277r623b2321],
2	reproduce	VB	O	reproduce	_	0	SENT_138	[p11l648t2277r871b2320],
3	with	IN	O	with	_	0	SENT_138	[p11l895t2277r989b2312],
4	permission	NN	O	permission	prep_with	2	SENT_138	[p11l1017t2277r1258b2320],
5	from	IN	O	from	_	0	SENT_138	[p11l1283t2277r1381b2312],
6	The	DT	O	the	det	9	SENT_138	[p11l1406t2277r1486b2312],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_138	[p11l1512t2277r1662b2312],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_138	[p11l1688t2277r1921b2321],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_138	[p11l1944t2277r2088b2320],
10	.	.	O	.	_	0	SENT_138	[p11l1944t2277r2088b2320],

1	ARTICLES	NNS	O	article	_	0	SENT_139	[p11l1913t2396r2066b2417],

1	Kilifi	NNP	LOCATION	Kilifi	_	0	SENT_140	[p11l899t2536r994b2572],

1	Ch	NN	O	ch	nn	3	SENT_141	[p11l898t2627r1412b2672],
2	|	NN	O	|	nn	3	SENT_141	[p11l898t2627r1412b2672],
3	orproguani	NNS	O	orproguanus	nsubj	4	SENT_141	[p11l898t2627r1412b2672],
4	|	VBP	O	|	_	0	SENT_141	[p11l898t2627r1412b2672],
5	.	.	O	.	_	0	SENT_141	[p11l898t2627r1412b2672],

1	—	NN	O	—	_	0	SENT_142	[p11l898t2627r1412b2672],
2	.	.	O	.	_	0	SENT_142	[p11l898t2627r1412b2672],

1	dapsone	NN	O	dapsone	_	0	SENT_143	[p11l898t2627r1412b2672],
2	Su	FW	O	su	nn	1	SENT_143	[p11l1540t2627r2129b2671],
3	|	FW	O	|	nn	1	SENT_143	[p11l1540t2627r2129b2671],
4	fadoxine	FW	O	fadoxine	nn	1	SENT_143	[p11l1540t2627r2129b2671],
5	—	FW	O	—	dep	1	SENT_143	[p11l1540t2627r2129b2671],
6	pyrimethamine	NN	O	pyrimethamine	nn	8	SENT_143	[p11l1540t2627r2129b2671],
7	(	NN	O	(	nn	8	SENT_143	[p11l898t2686r1073b2730],
8	n	NN	O	n	dep	1	SENT_143	[p11l898t2686r1073b2730],
9	=	JJ	O	=	quantmod	11	SENT_143	[p11l898t2686r1073b2730],
10	188	CD	NUMBER	188	number	11	SENT_143	[p11l898t2686r1073b2730],
11	)	CD	NUMBER	)	num	16	SENT_143	[p11l898t2686r1073b2730],
12	(	NN	O	(	nn	16	SENT_143	[p11l1540t2686r1714b2730],
13	n	NN	O	n	nn	16	SENT_143	[p11l1540t2686r1714b2730],
14	=	JJ	O	=	amod	16	SENT_143	[p11l1540t2686r1714b2730],
15	195	CD	NUMBER	195	num	16	SENT_143	[p11l1540t2686r1714b2730],
16	)	NN	O	)	dep	8	SENT_143	[p11l1540t2686r1714b2730],

1	Age	NNP	O	Age	dep	13	SENT_144	[p11l7t2799r93b2843],
2	(	CD	NUMBER	(	num	3	SENT_144	[p11l112t2799r309b2842],
3	months	NNS	NUMBER	month	dep	1	SENT_144	[p11l112t2799r309b2842],
4	,	,	O	,	_	0	SENT_144	[p11l112t2799r309b2842],
5	median	JJ	O	median	amod	7	SENT_144	[p11l330t2798r490b2834],
6	[	NN	O	[	nn	7	SENT_144	[p11l511t2799r689b2843],
7	range	NN	O	range	appos	3	SENT_144	[p11l511t2799r689b2843],
8	]	CD	NUMBER	]	number	9	SENT_144	[p11l511t2799r689b2843],
9	)	CD	NUMBER	)	dep	7	SENT_144	[p11l511t2799r689b2843],
10	31	CD	NUMBER	31	num	11	SENT_144	[p11l973t2798r1030b2834],
11	(	NN	O	(	dep	13	SENT_144	[p11l1050t2799r1192b2842],
12	4-71	CD	NUMBER	4-71	num	13	SENT_144	[p11l1050t2799r1192b2842],
13	)	CD	NUMBER	)	dep	17	SENT_144	[p11l1050t2799r1192b2842],
14	36	CD	NUMBER	36	num	15	SENT_144	[p11l1596t2798r1653b2834],
15	(	NN	O	(	dep	13	SENT_144	[p11l1672t2798r1815b2842],
16	4-70	CD	NUMBER	4-70	num	17	SENT_144	[p11l1672t2798r1815b2842],
17	)	NN	O	)	_	0	SENT_144	[p11l1672t2798r1815b2842],

1	Sex	NN	O	sex	nn	3	SENT_145	[p11l7t2911r91b2947],
2	(	CD	NUMBER	(	num	3	SENT_145	[p11l108t2911r433b2955],
3	male/female	NN	O	male/female	_	0	SENT_145	[p11l108t2911r433b2955],
4	)	CD	NUMBER	)	number	5	SENT_145	[p11l108t2911r433b2955],
5	49/51	CD	NUMBER	49/51	dep	3	SENT_145	[p11l973t2911r1118b2955],
6	48/52	CD	NUMBER	48/52	dep	5	SENT_145	[p11l1595t2911r1739b2955],

1	Parasitaemia	NN	O	parasitaemia	nsubj	5	SENT_146	[p11l9t3001r303b3037],
2	from	IN	O	from	_	0	SENT_146	[p11l320t3001r419b3037],
3	thick	JJ	O	thick	amod	4	SENT_146	[p11l436t3001r552b3037],
4	films	NNS	O	film	prep_from	1	SENT_146	[p11l567t3001r674b3037],
5	(	VBP	O	(	_	0	SENT_146	[p11l692t3001r820b3047],
6	p.	NN	O	p.	nn	7	SENT_146	[p11l692t3001r820b3047],
7	L'	NN	O	l'	dobj	5	SENT_146	[p11l692t3001r820b3047],
8	1	CD	NUMBER	1	number	9	SENT_146	[p11l692t3001r820b3047],
9	)	CD	NUMBER	)	dep	7	SENT_146	[p11l692t3001r820b3047],
10	Geometric	JJ	O	geometric	amod	12	SENT_146	[p11l9t3060r231b3096],
11	mean	NN	O	mean	nn	12	SENT_146	[p11l251t3068r368b3096],
12	(	NN	O	(	dep	18	SENT_146	[p11l389t3060r497b3104],
13	95	CD	PERCENT	95	num	14	SENT_146	[p11l389t3060r497b3104],
14	%	NN	PERCENT	%	dep	12	SENT_146	[p11l389t3060r497b3104],
15	CI	NN	O	ci	dep	18	SENT_146	[p11l515t3060r571b3104],
16	)	CD	NUMBER	)	num	15	SENT_146	[p11l515t3060r571b3104],
17	6340	CD	NUMBER	6340	num	18	SENT_146	[p11l913t3060r1031b3096],
18	(	CD	NUMBER	(	dep	23	SENT_146	[p11l1050t3060r1371b3104],
19	4784-8404	CD	DURATION	4784-8404	num	20	SENT_146	[p11l1050t3060r1371b3104],
20	)	NN	O	)	dep	18	SENT_146	[p11l1050t3060r1371b3104],
21	*	CD	NUMBER	*	number	22	SENT_146	[p11l1050t3060r1371b3104],
22	7389	CD	NUMBER	7389	dep	20	SENT_146	[p11l1536t3060r1653b3096],
23	(	NN	O	(	dep	26	SENT_146	[p11l1672t3060r1994b3104],
24	5756-9484	CD	DURATION	5756-9484	num	23	SENT_146	[p11l1672t3060r1994b3104],
25	)	CD	NUMBER	)	num	26	SENT_146	[p11l1672t3060r1994b3104],
26	*	NN	O	*	dep	27	SENT_146	[p11l1672t3060r1994b3104],
27	Range	NNP	O	Range	dep	32	SENT_146	[p11l10t3120r143b3164],
28	52-67	CD	NUMBER	52-67	num	27	SENT_146	[p11l974t3119r1115b3155],
29	608	CD	NUMBER	608	num	30	SENT_146	[p11l1130t3119r1217b3155],
30	58-98	CD	NUMBER	58-98	dep	27	SENT_146	[p11l1597t3119r1740b3155],
31	209	CD	NUMBER	209	num	32	SENT_146	[p11l1752t3119r1839b3155],
32	Parasitaemia	NN	O	parasitaemia	dep	7	SENT_146	[p11l9t3209r303b3245],
33	from	IN	O	from	_	0	SENT_146	[p11l320t3209r419b3245],
34	thin	JJ	O	thin	amod	35	SENT_146	[p11l436t3209r521b3245],
35	films	NNS	O	film	prep_from	32	SENT_146	[p11l539t3209r646b3245],
36	(	CD	PERCENT	(	num	37	SENT_146	[p11l664t3209r732b3253],
37	%	NN	PERCENT	%	dep	46	SENT_146	[p11l664t3209r732b3253],
38	)	CD	NUMBER	)	num	39	SENT_146	[p11l664t3209r732b3253],
39	Mean	NN	O	mean	dep	37	SENT_146	[p11l10t3270r127b3305],
40	(	CD	PERCENT	(	number	41	SENT_146	[p11l148t3269r256b3313],
41	95	CD	PERCENT	95	num	42	SENT_146	[p11l148t3269r256b3313],
42	%	NN	PERCENT	%	dep	39	SENT_146	[p11l148t3269r256b3313],
43	Cl	NN	O	cl	dep	46	SENT_146	[p11l274t3269r329b3313],
44	)	CD	NUMBER	)	num	43	SENT_146	[p11l274t3269r329b3313],
45	6-1	CD	NUMBER	6-1	num	46	SENT_146	[p11l1004t3269r1076b3305],
46	(	CD	NUMBER	(	dep	63	SENT_146	[p11l1095t3269r1325b3314],
47	5-3-6-8	CD	NUMBER	5-3-6-8	num	48	SENT_146	[p11l1095t3269r1325b3314],
48	)	NN	O	)	dep	46	SENT_146	[p11l1095t3269r1325b3314],
49	i	FW	O	i	dep	48	SENT_146	[p11l1095t3269r1325b3314],
50	;	:	O	;	_	0	SENT_146	[p11l1095t3269r1325b3314],
51	6-0	CD	NUMBER	6-0	number	52	SENT_146	[p11l1626t3269r1699b3305],
52	(	CD	NUMBER	(	dep	48	SENT_146	[p11l1718t3269r1947b3314],
53	5-3-6-6	CD	NUMBER	5-3-6-6	num	54	SENT_146	[p11l1718t3269r1947b3314],
54	)	NN	O	)	dep	52	SENT_146	[p11l1718t3269r1947b3314],
55	:	:	O	:	_	0	SENT_146	[p11l1718t3269r1947b3314],
56	]	CD	NUMBER	]	dep	48	SENT_146	[p11l1718t3269r1947b3314],
57	:	:	O	:	_	0	SENT_146	[p11l1718t3269r1947b3314],
58	Range	NNP	O	Range	dep	56	SENT_146	[p11l10t3329r144b3374],
59	1-9	CD	NUMBER	1-9	num	58	SENT_146	[p11l1006t3329r1086b3365],
60	3-9	CD	NUMBER	3-9	num	61	SENT_146	[p11l1626t3329r1709b3365],
61	Haemoglobin	NN	O	haemoglobin	dep	58	SENT_146	[p11l9t3418r298b3462],
62	(	NN	O	(	nn	63	SENT_146	[p11l317t3418r392b3462],
63	g	NN	O	g	dep	5	SENT_146	[p11l317t3418r392b3462],
64	/	:	O	/	punct	63	SENT_146	[p11l317t3418r392b3462],
65	L	NN	O	l	nn	68	SENT_146	[p11l396t3418r434b3462],
66	)	CD	NUMBER	)	num	68	SENT_146	[p11l396t3418r434b3462],
67	Mean	NN	O	mean	nn	68	SENT_146	[p11l10t3478r127b3514],
68	(	NN	O	(	dep	76	SENT_146	[p11l148t3478r297b3523],
69	range	NN	O	range	dep	68	SENT_146	[p11l148t3478r297b3523],
70	)	CD	NUMBER	)	number	71	SENT_146	[p11l148t3478r297b3523],
71	95	CD	NUMBER	95	dep	69	SENT_146	[p11l974t3478r1030b3514],
72	(	NN	O	(	dep	76	SENT_146	[p11l1050t3478r1222b3522],
73	93-97	CD	NUMBER	93-97	num	72	SENT_146	[p11l1050t3478r1222b3522],
74	)	CD	NUMBER	)	num	76	SENT_146	[p11l1050t3478r1222b3522],
75	91	CD	NUMBER	91	num	76	SENT_146	[p11l1596t3478r1653b3514],
76	(	NN	O	(	dep	81	SENT_146	[p11l1672t3478r1845b3522],
77	89-93	CD	NUMBER	89-93	number	78	SENT_146	[p11l1672t3478r1845b3522],
78	)	CD	NUMBER	)	dep	76	SENT_146	[p11l1672t3478r1845b3522],
79	Range	NNP	O	Range	dep	78	SENT_146	[p11l10t3538r143b3583],
80	70-144	CD	NUMBER	70-144	num	81	SENT_146	[p11l975t3538r1147b3574],
81	70-145	CD	NUMBER	70-145	dep	63	SENT_146	[p11l1598t3538r1769b3574],

1	Packed-cell	JJ	O	packed-cell	amod	2	SENT_147	[p11l9t3629r266b3664],
2	volume	NN	O	volume	_	0	SENT_147	[p11l285t3629r444b3664],
3	(	CD	PERCENT	(	num	4	SENT_147	[p11l462t3629r531b3672],
4	%	NN	PERCENT	%	dep	2	SENT_147	[p11l462t3629r531b3672],
5	)	CD	NUMBER	)	num	7	SENT_147	[p11l462t3629r531b3672],
6	Mean	NN	O	mean	nn	7	SENT_147	[p11l10t3689r127b3725],
7	(	NN	O	(	dep	4	SENT_147	[p11l148t3689r297b3734],
8	range	NN	O	range	nn	10	SENT_147	[p11l148t3689r297b3734],
9	)	CD	NUMBER	)	num	10	SENT_147	[p11l148t3689r297b3734],
10	Range	NNP	O	Range	dep	2	SENT_147	[p11l10t3749r143b3794],

1	Blantyre	NNP	LOCATION	Blantyre	_	0	SENT_148	[p12l7t211r326b287],

1	Ch	NN	O	ch	nn	3	SENT_149	[p12l6t366r892b444],
2	|	NN	O	|	nn	3	SENT_149	[p12l6t366r892b444],
3	orproguani	NNS	O	orproguanus	nsubj	4	SENT_149	[p12l6t366r892b444],
4	|	VBP	O	|	_	0	SENT_149	[p12l6t366r892b444],
5	.	.	O	.	_	0	SENT_149	[p12l6t366r892b444],

1	—	NN	O	—	_	0	SENT_150	[p12l6t366r892b444],
2	.	.	O	.	_	0	SENT_150	[p12l6t366r892b444],

1	dapsone	NN	O	dapsone	_	0	SENT_151	[p12l6t366r892b444],
2	Su	FW	O	su	nn	1	SENT_151	[p12l1109t366r2124b443],
3	|	FW	O	|	nn	1	SENT_151	[p12l1109t366r2124b443],
4	fadoxine	FW	O	fadoxine	nn	1	SENT_151	[p12l1109t366r2124b443],
5	—	FW	O	—	dep	1	SENT_151	[p12l1109t366r2124b443],
6	pyrimethamine	NN	O	pyrimethamine	nn	8	SENT_151	[p12l1109t366r2124b443],
7	(	NN	O	(	nn	8	SENT_151	[p12l6t495r307b571],
8	n	NN	O	n	dep	1	SENT_151	[p12l6t495r307b571],
9	=	JJ	O	=	quantmod	11	SENT_151	[p12l6t495r307b571],
10	222	CD	NUMBER	222	number	11	SENT_151	[p12l6t495r307b571],
11	)	CD	NUMBER	)	num	16	SENT_151	[p12l6t495r307b571],
12	(	NN	O	(	nn	16	SENT_151	[p12l1108t495r1409b571],
13	n	NN	O	n	nn	16	SENT_151	[p12l1108t495r1409b571],
14	=	JJ	O	=	amod	16	SENT_151	[p12l1108t495r1409b571],
15	224	CD	NUMBER	224	num	16	SENT_151	[p12l1108t495r1409b571],
16	)	NN	O	)	dep	8	SENT_151	[p12l1108t495r1409b571],

1	1378	CD	DATE	1378	num	3	SENT_152	[p12l25t1066r226b1128],
2	(	NN	O	(	nn	3	SENT_152	[p12l259t1066r762b1144],
3	985	NNS	NUMBER	985	_	0	SENT_152	[p12l259t1066r762b1144],
4	—	VBP	O	—	dep	3	SENT_152	[p12l259t1066r762b1144],
5	1928	CD	DATE	1928	number	6	SENT_152	[p12l259t1066r762b1144],
6	)	CD	NUMBER	)	acomp	4	SENT_152	[p12l259t1066r762b1144],
7	1	LS	NUMBER	1	dep	6	SENT_152	[p12l259t1066r762b1144],
8	-	:	O	-	_	0	SENT_152	[p12l259t1066r762b1144],
9	1349	CD	DATE	1349	num	10	SENT_152	[p12l1100t1066r1301b1128],
10	(	NN	O	(	dep	3	SENT_152	[p12l1334t1066r1837b1144],
11	958	CD	NUMBER	958	number	12	SENT_152	[p12l1334t1066r1837b1144],
12	—	CD	NUMBER	—	dep	10	SENT_152	[p12l1334t1066r1837b1144],
13	1900	CD	DATE	1900	num	14	SENT_152	[p12l1334t1066r1837b1144],
14	)	CD	NUMBER	)	dep	12	SENT_152	[p12l1334t1066r1837b1144],
15	Jr	NNP	O	Jr	dep	12	SENT_152	[p12l1334t1066r1837b1144],

1	30-2	CD	NUMBER	30-2	num	2	SENT_153	[p12l127t2165r303b2228],
2	(	CD	NUMBER	(	_	0	SENT_153	[p12l338t2165r792b2241],
3	29-6-30-8	CD	NUMBER	29-6-30-8	num	4	SENT_153	[p12l338t2165r792b2241],
4	)	NN	O	)	dep	2	SENT_153	[p12l338t2165r792b2241],
5	30-9	CD	NUMBER	30-9	num	6	SENT_153	[p12l1202t2165r1379b2228],
6	(	CD	NUMBER	(	dep	4	SENT_153	[p12l1413t2165r1868b2241],
7	30-3-31-5	CD	NUMBER	30-3-31-5	num	8	SENT_153	[p12l1413t2165r1868b2241],
8	)	NN	O	)	dep	2	SENT_153	[p12l1413t2165r1868b2241],
9	21-42	CD	NUMBER	21-42	dep	8	SENT_153	[p12l128t2269r373b2331],
10	21-45	CD	NUMBER	21-45	num	12	SENT_153	[p12l1203t2269r1449b2332],
11	*	NN	O	*	nn	12	SENT_153	[p12l90t2362r182b2382],
12	n	NN	O	n	dep	2	SENT_153	[p12l90t2362r182b2382],
13	=	JJ	O	=	amod	12	SENT_153	[p12l90t2362r182b2382],
14	161	CD	NUMBER	161	num	15	SENT_153	[p12l90t2362r182b2382],
15	slides	NNS	O	slide	dep	13	SENT_153	[p12l192t2362r261b2382],
16	(	CD	NUMBER	(	num	18	SENT_153	[p12l271t2362r550b2387],
17	chlorproguanildapsone	NN	O	chlorproguanildapsone	nn	18	SENT_153	[p12l271t2362r550b2387],
18	group	NN	O	group	dep	2	SENT_153	[p12l560t2362r633b2387],
19	)	CD	NUMBER	)	num	22	SENT_153	[p12l560t2362r633b2387],
20	and	CC	O	and	_	0	SENT_153	[p12l643t2362r684b2382],
21	173	CD	NUMBER	173	num	22	SENT_153	[p12l696t2362r742b2382],
22	slides	NNS	O	slide	dep	18	SENT_153	[p12l752t2362r820b2382],
23	(	CD	NUMBER	(	num	25	SENT_153	[p12l831t2362r1151b2387],
24	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	25	SENT_153	[p12l831t2362r1151b2387],
25	group	NN	O	group	dep	2	SENT_153	[p12l1160t2362r1240b2387],
26	)	CD	NUMBER	)	dep	25	SENT_153	[p12l1160t2362r1240b2387],
27	.	.	O	.	_	0	SENT_153	[p12l1160t2362r1240b2387],

1	-	:	O	-	_	0	SENT_154	[p12l1251t2362r1327b2387],
2	fn	NN	O	fn	dep	8	SENT_154	[p12l1251t2362r1327b2387],
3	=	JJ	O	=	dep	2	SENT_154	[p12l1251t2362r1327b2387],
4	96	CD	NUMBER	96	num	5	SENT_154	[p12l1251t2362r1327b2387],
5	slides	NNS	O	slide	dep	8	SENT_154	[p12l1337t2362r1405b2382],
6	(	CD	NUMBER	(	num	8	SENT_154	[p12l1416t2362r1695b2387],
7	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	8	SENT_154	[p12l1416t2362r1695b2387],
8	group	NN	O	group	dep	16	SENT_154	[p12l1704t2362r1777b2387],
9	)	CD	NUMBER	)	num	12	SENT_154	[p12l1704t2362r1777b2387],
10	and	CC	O	and	_	0	SENT_154	[p12l1788t2362r1829b2382],
11	102	CD	NUMBER	102	num	12	SENT_154	[p12l1840t2362r1886b2382],
12	slides	NNS	O	slide	dep	8	SENT_154	[p12l1897t2362r1965b2382],
13	(	CD	NUMBER	(	num	15	SENT_154	[p12l88t2399r409b2424],
14	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	15	SENT_154	[p12l88t2399r409b2424],
15	group	NN	O	group	dep	12	SENT_154	[p12l418t2399r498b2424],
16	)	CD	NUMBER	)	_	0	SENT_154	[p12l418t2399r498b2424],
17	.	.	O	.	_	0	SENT_154	[p12l418t2399r498b2424],

1	fpn	NN	O	fpn	_	0	SENT_155	[p12l509t2399r584b2424],
2	=	JJ	O	=	amod	4	SENT_155	[p12l509t2399r584b2424],
3	27	CD	NUMBER	27	tmod	2	SENT_155	[p12l509t2399r584b2424],
4	slides	NNS	O	slide	dep	1	SENT_155	[p12l595t2399r663b2419],
5	(	CD	NUMBER	(	num	7	SENT_155	[p12l673t2399r953b2424],
6	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	7	SENT_155	[p12l673t2399r953b2424],
7	group	NN	O	group	dep	4	SENT_155	[p12l962t2399r1035b2424],
8	)	CD	NUMBER	)	dep	1	SENT_155	[p12l962t2399r1035b2424],
9	and	CC	O	and	_	0	SENT_155	[p12l1045t2399r1087b2419],
10	22	CD	NUMBER	22	num	11	SENT_155	[p12l1097t2399r1127b2419],
11	slides	NNS	O	slide	dep	1	SENT_155	[p12l1138t2399r1206b2419],
12	(	CD	NUMBER	(	num	14	SENT_155	[p12l1217t2399r1537b2424],
13	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	14	SENT_155	[p12l1217t2399r1537b2424],
14	group	NN	O	group	dep	1	SENT_155	[p12l1547t2399r1627b2424],
15	)	CD	NUMBER	)	dep	14	SENT_155	[p12l1547t2399r1627b2424],
16	.	.	O	.	_	0	SENT_155	[p12l1547t2399r1627b2424],

1	§	NN	O	§	nn	2	SENT_156	[p12l1638t2399r1731b2424],
2	n	NN	O	n	_	0	SENT_156	[p12l1638t2399r1731b2424],
3	=	JJ	O	=	amod	5	SENT_156	[p12l1638t2399r1731b2424],
4	126	CD	NUMBER	126	tmod	3	SENT_156	[p12l1638t2399r1731b2424],
5	slides	NNS	O	slide	dep	2	SENT_156	[p12l1742t2399r1810b2419],
6	(	CD	NUMBER	(	num	8	SENT_156	[p12l1820t2399r1999b2424, p12l7t2440r234b2492],
7	chlorproguanildapsone	NN	O	chlorproguanildapsone	nn	8	SENT_156	[p12l1820t2399r1999b2424, p12l7t2440r234b2492],
8	group	NN	O	group	dep	5	SENT_156	[p12l255t2440r419b2494],
9	)	CD	NUMBER	)	dep	2	SENT_156	[p12l255t2440r419b2494],
10	and	CC	O	and	_	0	SENT_156	[p12l443t2440r536b2483],
11	122	CD	NUMBER	122	num	12	SENT_156	[p12l563t2439r665b2482],
12	slides	NNS	O	slide	dep	2	SENT_156	[p12l690t2440r844b2483],
13	(	JJ	O	(	amod	17	SENT_156	[p12l868t2439r1593b2493],
14	sulfadoxine	NN	O	sulfadoxine	nn	17	SENT_156	[p12l868t2439r1593b2493],
15	—	NN	O	—	nn	17	SENT_156	[p12l868t2439r1593b2493],
16	pyrimethamine	NN	O	pyrimethamine	nn	17	SENT_156	[p12l868t2439r1593b2493],
17	group	NN	O	group	dep	2	SENT_156	[p12l1615t2440r1796b2494],
18	)	CD	NUMBER	)	dep	17	SENT_156	[p12l1615t2440r1796b2494],
19	.	.	O	.	_	0	SENT_156	[p12l1615t2440r1796b2494],

1	Table	NNP	O	Table	_	0	SENT_157	[p12l6t2537r180b2591],
2	1	CD	NUMBER	1	num	1	SENT_157	[p12l212t2537r268b2590],
3	:	:	O	:	_	0	SENT_157	[p12l212t2537r268b2590],
4	Characteristics	NNS	O	characteristic	dep	1	SENT_157	[p12l299t2537r812b2591],
5	of	IN	O	of	_	0	SENT_157	[p12l839t2537r902b2591],
6	patients	NNS	O	patient	prep_of	4	SENT_157	[p12l927t2537r1199b2603],
7	at	IN	O	at	_	0	SENT_157	[p12l1225t2539r1291b2591],
8	recruitment	NN	O	recruitment	prep_at	6	SENT_157	[p12l1320t2537r1707b2591],
9	new	JJ	O	new	amod	11	SENT_157	[p12l7t2793r159b2833],
10	adverse	JJ	O	adverse	amod	11	SENT_157	[p12l216t2773r497b2833],
11	events	NNS	O	event	nsubjpass	24	SENT_157	[p12l556t2787r790b2833],
12	at	IN	O	at	_	0	SENT_157	[p12l850t2787r917b2833],
13	each	DT	O	each	det	14	SENT_157	[p12l974t2773r1144b2833],
14	visit	NN	O	visit	prep_at	11	SENT_157	[p12l1198t2773r1376b2846],
15	;	:	O	;	_	0	SENT_157	[p12l1198t2773r1376b2846],
16	severity	NN	O	severity	nn	19	SENT_157	[p12l1438t2773r1725b2849],
17	and	CC	O	and	_	0	SENT_157	[p12l1782t2773r1917b2833],
18	drug	NN	O	drug	nn	19	SENT_157	[p12l1973t2773r2144b2849],
19	causality	NN	O	causality	dep	14	SENT_157	[p12l9t2865r332b2941],
20	of	IN	O	of	_	0	SENT_157	[p12l387t2865r465b2926],
21	these	DT	O	these	det	22	SENT_157	[p12l510t2865r699b2926],
22	events	NNS	O	event	prep_of	19	SENT_157	[p12l756t2879r985b2926],
23	were	VBD	O	be	auxpass	24	SENT_157	[p12l1041t2885r1214b2926],
24	assessed	VBN	O	assess	rcmod	8	SENT_157	[p12l1272t2865r1577b2926],
25	by	IN	O	by	_	0	SENT_157	[p12l1631t2865r1720b2941],
26	the	DT	O	the	det	28	SENT_157	[p12l1773t2865r1887b2926],
27	study	NN	O	study	nn	28	SENT_157	[p12l1944t2865r2145b2941],
28	doctor	NN	O	doctor	agent	24	SENT_157	[p12l9t2958r270b3019],
29	.	.	O	.	_	0	SENT_157	[p12l9t2958r270b3019],

1	Protocol	NNP	O	Protocol	nn	2	SENT_158	[p12l93t3052r410b3112],
2	violations	NNS	O	violation	nsubj	3	SENT_158	[p12l448t3052r807b3112],
3	included	VBD	O	include	_	0	SENT_158	[p12l849t3052r1172b3112],
4	failure	NN	O	failure	dobj	3	SENT_158	[p12l1212t3052r1447b3112],
5	to	TO	O	to	aux	6	SENT_158	[p12l1488t3066r1559b3112],
6	return	VB	O	return	xcomp	3	SENT_158	[p12l1600t3066r1832b3112],
7	for	IN	O	for	_	0	SENT_158	[p12l1871t3052r1976b3112],
8	any	DT	O	any	det	9	SENT_158	[p12l2016t3071r2145b3128],
9	day	NN	DURATION	day	prep_for	6	SENT_158	[p12l9t3144r211b3220],
10	—	CD	NUMBER	—	number	11	SENT_158	[p12l9t3144r211b3220],
11	7	CD	NUMBER	7	num	12	SENT_158	[p12l9t3144r211b3220],
12	assessment	NN	O	assessment	dep	6	SENT_158	[p12l246t3158r674b3205],
13	.	.	O	.	_	0	SENT_158	[p12l246t3158r674b3205],

1	Default	NNP	O	Default	nsubj	4	SENT_159	[p12l708t3144r989b3205],
2	from	IN	O	from	_	0	SENT_159	[p12l1017t3144r1194b3205],
3	clinic	NN	O	clinic	prep_from	1	SENT_159	[p12l1224t3144r1420b3205],
4	caused	VBD	O	cause	_	0	SENT_159	[p12l1451t3144r1702b3205],
5	withdrawal	NN	O	withdrawal	dobj	4	SENT_159	[p12l1729t3144r2142b3205],
6	from	IN	O	from	_	0	SENT_159	[p12l7t3237r185b3298],
7	the	DT	O	the	det	8	SENT_159	[p12l228t3237r342b3298],
8	trial	NN	O	trial	prep_from	4	SENT_159	[p12l386t3237r534b3298],
9	when	WRB	O	when	advmod	17	SENT_159	[p12l576t3237r776b3298],
10	56	CD	DURATION	56	num	11	SENT_159	[p12l822t3240r908b3298],
11	days	NNS	NUMBER	day	dep	9	SENT_159	[p12l956t3237r1116b3313],
12	or	CC	O	or	cc	13	SENT_159	[p12l1163t3257r1239b3298],
13	more	JJR	O	more	num	14	SENT_159	[p12l1280t3257r1471b3298],
14	elapsed	JJ	O	elapsed	nsubj	17	SENT_159	[p12l1517t3237r1791b3313],
15	between	IN	O	between	_	0	SENT_159	[p12l1833t3237r2143b3298],
16	regular	JJ	O	regular	prep_between	14	SENT_159	[p12l7t3331r270b3407],
17	follow	VBP	O	follow	advcl	4	SENT_159	[p12l297t3331r652b3407],
18	—	CD	NUMBER	—	dobj	17	SENT_159	[p12l297t3331r652b3407],
19	up	IN	O	up	_	0	SENT_159	[p12l297t3331r652b3407],
20	visits	NNS	O	visit	prep_up	17	SENT_159	[p12l681t3331r887b3391],
21	.	.	O	.	_	0	SENT_159	[p12l681t3331r887b3391],

1	Statistical	JJ	O	statistical	amod	3	SENT_160	[p12l6t3520r371b3581],
2	analysis	NN	O	analysis	nn	3	SENT_160	[p12l399t3522r692b3594],
3	Data	NNS	O	datum	nsubjpass	5	SENT_160	[p12l8t3614r187b3673],
4	were	VBD	O	be	auxpass	5	SENT_160	[p12l241t3632r415b3673],
5	doubled-entered	JJ	O	doubled-entered	_	0	SENT_160	[p12l472t3613r1091b3673],
6	and	CC	O	and	_	0	SENT_160	[p12l1148t3613r1282b3673],
7	veriﬁed	VBN	O	veriﬁed	conj_and	5	SENT_160	[p12l1335t3613r1613b3673],
8	on	IN	O	on	_	0	SENT_160	[p12l1670t3632r1761b3673],
9	site	NN	O	site	prep_on	7	SENT_160	[p12l1817t3613r1960b3673],
10	.	.	O	.	_	0	SENT_160	[p12l1817t3613r1960b3673],

1	We	PRP	O	we	nsubj	2	SENT_161	[p12l2019t3614r2142b3673],
2	completed	VBD	O	complete	_	0	SENT_161	[p13l9t23r398b99],
3	analysis	NN	O	analysis	dobj	2	SENT_161	[p13l444t23r727b99],
4	before	IN	O	before	mark	6	SENT_161	[p13l771t23r1004b84],
5	we	PRP	O	we	nsubj	6	SENT_161	[p13l1047t43r1147b84],
6	broke	VBD	O	break	advcl	2	SENT_161	[p13l1191t23r1400b84],
7	the	DT	O	the	det	9	SENT_161	[p13l1444t23r1558b84],
8	randomisation	NN	O	randomisation	nn	9	SENT_161	[p13l1603t23r2143b84],
9	code	NN	O	code	dobj	6	SENT_161	[p13l9t116r201b177],
10	.	.	O	.	_	0	SENT_161	[p13l9t116r201b177],

1	The	DT	O	the	det	4	SENT_162	[p13l266t116r417b177],
2	two	CD	NUMBER	two	num	4	SENT_162	[p13l477t131r610b177],
3	data	NNS	O	datum	nn	4	SENT_162	[p13l673t116r829b177],
4	sets	NNS	O	set	nsubj	5	SENT_162	[p13l891t130r1023b177],
5	(	VBP	O	(	_	0	SENT_162	[p13l1090t116r1306b192],
6	Kiliﬁ	NN	O	kiliﬁ	nsubjpass	11	SENT_162	[p13l1090t116r1306b192],
7	and	CC	O	and	_	0	SENT_162	[p13l1367t116r1502b177],
8	Blantyre	NNP	LOCATION	Blantyre	nsubjpass	11	SENT_162	[p13l1563t116r1904b192],
9	)	CD	NUMBER	)	num	8	SENT_162	[p13l1563t116r1904b192],
10	were	VBD	O	be	auxpass	11	SENT_162	[p13l1969t136r2142b177],
11	analysed	VBN	O	analyse	dep	5	SENT_162	[p13l9t210r327b286],
12	separately	RB	O	separately	advmod	11	SENT_162	[p13l357t210r728b286],
13	with	IN	O	with	_	0	SENT_162	[p13l754t210r916b270],
14	Excel	NNP	MISC	Excel	prep_with	11	SENT_162	[p13l945t210r1148b270],
15	and	CC	O	and	_	0	SENT_162	[p13l1179t210r1314b270],
16	SAS	NNP	O	SAS	nn	18	SENT_162	[p13l1346t210r1500b270],
17	(	CD	NUMBER	(	num	18	SENT_162	[p13l1538t210r1832b285],
18	Version	NNP	O	Version	dep	20	SENT_162	[p13l1538t210r1832b285],
19	6.1	CD	NUMBER	6.1	num	20	SENT_162	[p13l1864t210r2005b285],
20	)	NN	O	)	dep	5	SENT_162	[p13l1864t210r2005b285],
21	for	IN	O	for	_	0	SENT_162	[p13l2040t210r2145b270],
22	Unix	NNP	O	Unix	prep_for	20	SENT_162	[p13l7t301r212b362],
23	.	.	O	.	_	0	SENT_162	[p13l7t301r212b362],

1	Rates	NNS	O	rate	nsubjpass	12	SENT_163	[p13l279t302r480b362],
2	of	IN	O	of	_	0	SENT_163	[p13l544t301r623b362],
3	clinical	JJ	O	clinical	amod	4	SENT_163	[p13l676t301r938b362],
4	malaria	NN	O	malaria	prep_of	1	SENT_163	[p13l998t301r1296b373],
5	,	,	O	,	_	0	SENT_163	[p13l998t301r1296b373],
6	and	CC	O	and	_	0	SENT_163	[p13l1363t301r1497b362],
7	95	CD	PERCENT	95	number	8	SENT_163	[p13l1560t301r1723b363],
8	%	NN	PERCENT	%	amod	9	SENT_163	[p13l1560t301r1723b363],
9	CI	NN	O	ci	nsubjpass	12	SENT_163	[p13l1791t301r1906b373],
10	,	,	O	,	_	0	SENT_163	[p13l1791t301r1906b373],
11	were	VBD	O	be	auxpass	12	SENT_163	[p13l1969t321r2142b362],
12	calculated	VBN	O	calculate	_	0	SENT_163	[p13l9t394r385b455],
13	by	IN	O	by	_	0	SENT_163	[p13l416t394r505b470],
14	Poisson	NNP	PERSON	Poisson	nn	15	SENT_163	[p13l537t395r823b455],
15	regression	NN	O	regression	agent	12	SENT_163	[p13l856t395r1252b470],
16	.	.	O	.	_	0	SENT_163	[p13l856t395r1252b470],

1	We	PRP	O	we	nsubj	2	SENT_164	[p13l1288t395r1412b455],
2	assumed	VBD	O	assume	_	0	SENT_164	[p13l1447t394r1766b455],
3	that	IN	O	that	complm	7	SENT_164	[p13l1798t394r1944b455],
4	each	DT	O	each	det	6	SENT_164	[p13l1977t394r2143b455],
5	malaria	NN	O	malaria	nn	6	SENT_164	[p13l7t488r282b548],
6	episode	NN	O	episode	nsubj	7	SENT_164	[p13l317t488r596b564],
7	lasted	VBD	O	last	ccomp	2	SENT_164	[p13l630t488r845b548],
8	7	CD	DURATION	7	num	9	SENT_164	[p13l881t490r918b547],
9	days	NNS	NUMBER	day	tmod	7	SENT_164	[p13l957t488r1140b564],
10	,	,	O	,	_	0	SENT_164	[p13l957t488r1140b564],
11	and	CC	O	and	_	0	SENT_164	[p13l1179t488r1313b548],
12	that	IN	O	that	complm	18	SENT_164	[p13l1346t488r1492b548],
13	during	IN	O	during	_	0	SENT_164	[p13l1526t488r1770b564],
14	that	DT	O	that	det	15	SENT_164	[p13l1801t488r1947b548],
15	time	NN	O	time	prep_during	18	SENT_164	[p13l1979t488r2142b548],
16	the	DT	O	the	det	17	SENT_164	[p13l7t580r120b641],
17	child	NN	O	child	nsubj	18	SENT_164	[p13l151t580r331b641],
18	was	VBD	O	be	conj_and	7	SENT_164	[p13l357t600r492b641],
19	not	RB	O	not	neg	18	SENT_164	[p13l520t594r642b641],
20	at	IN	O	at	_	0	SENT_164	[p13l671t594r736b641],
21	risk	NN	O	risk	prep_at	18	SENT_164	[p13l762t580r896b641],
22	of	IN	O	of	_	0	SENT_164	[p13l923t580r1001b641],
23	a	DT	O	a	det	25	SENT_164	[p13l1020t600r1055b641],
24	new	JJ	O	new	amod	25	SENT_164	[p13l1082t600r1233b641],
25	episode	NN	O	episode	prep_of	21	SENT_164	[p13l1261t580r1539b656],
26	of	IN	O	of	_	0	SENT_164	[p13l1569t580r1647b641],
27	malaria	NN	O	malaria	prep_of	25	SENT_164	[p13l1664t580r1960b641],
28	.	.	O	.	_	0	SENT_164	[p13l1664t580r1960b641],

1	The	DT	O	the	det	2	SENT_165	[p13l1992t580r2142b641],
2	periods	NNS	O	period	nsubjpass	8	SENT_165	[p13l6t673r279b749],
3	of	IN	O	of	_	0	SENT_165	[p13l321t673r399b734],
4	exposure	NN	O	exposure	prep_of	2	SENT_165	[p13l430t693r761b749],
5	to	TO	O	to	aux	6	SENT_165	[p13l801t688r871b734],
6	risk	VB	O	risk	infmod	4	SENT_165	[p13l912t673r1045b734],
7	were	VBD	O	be	auxpass	8	SENT_165	[p13l1081t693r1255b734],
8	calculated	VBN	O	calculate	_	0	SENT_165	[p13l1297t673r1672b734],
9	as	IN	O	as	_	0	SENT_165	[p13l1714t693r1782b734],
10	the	DT	O	the	det	12	SENT_165	[p13l1822t673r1936b734],
11	total	JJ	O	total	amod	12	SENT_165	[p13l1976t673r2143b734],
12	time	NN	O	time	prep_as	8	SENT_165	[p13l7t767r170b827],
13	in	IN	O	in	_	0	SENT_165	[p13l211t767r281b826],
14	the	DT	O	the	det	15	SENT_165	[p13l320t767r434b827],
15	study	NN	O	study	prep_in	12	SENT_165	[p13l477t767r698b843],
16	,	,	O	,	_	0	SENT_165	[p13l477t767r698b843],
17	minus	CC	O	minus	_	0	SENT_165	[p13l740t767r967b827],
18	the	DT	O	the	det	19	SENT_165	[p13l1009t767r1122b827],
19	times	NNS	O	time	prep_as	8	SENT_165	[p13l1163t767r1360b827],
20	for	IN	O	for	_	0	SENT_165	[p13l1401t767r1507b827],
21	each	DT	O	each	det	22	SENT_165	[p13l1546t767r1713b827],
22	episode	NN	O	episode	prep_for	19	SENT_165	[p13l1753t767r2032b843],
23	of	IN	O	of	_	0	SENT_165	[p13l2075t767r2153b827],
24	malaria	NN	O	malaria	prep_of	22	SENT_165	[p13l7t859r303b920],
25	.	.	O	.	_	0	SENT_165	[p13l7t859r303b920],

1	The	DT	O	the	det	2	SENT_166	[p13l360t859r511b920],
2	proportions	NNS	O	proportion	nsubjpass	10	SENT_166	[p13l564t859r1000b935],
3	of	IN	O	of	_	0	SENT_166	[p13l1055t859r1134b920],
4	episodes	NNS	O	episode	prep_of	2	SENT_166	[p13l1178t859r1490b935],
5	ending	VBG	O	end	partmod	4	SENT_166	[p13l1546t859r1799b935],
6	in	IN	O	in	_	0	SENT_166	[p13l1850t859r1920b919],
7	drug	NN	O	drug	nn	8	SENT_166	[p13l1973t859r2144b935],
8	failure	NN	O	failure	prep_in	5	SENT_166	[p13l7t952r242b1013],
9	were	VBD	O	be	auxpass	10	SENT_166	[p13l297t972r470b1013],
10	compared	VBN	O	compare	_	0	SENT_166	[p13l529t952r898b1028],
11	by	IN	O	by	_	0	SENT_166	[p13l952t952r1041b1028],
12	Pearson	NNP	PERSON	Pearson	poss	15	SENT_166	[p13l1096t952r1450b1013],
13	’s	POS	O	’s	_	0	SENT_166	[p13l1096t952r1450b1013],
14	X2	NN	O	x2	nn	15	SENT_166	[p13l1508t954r1575b1030],
15	test	NN	O	test	agent	10	SENT_166	[p13l1630t967r1780b1013],
16	.	.	O	.	_	0	SENT_166	[p13l1630t967r1780b1013],

1	For	IN	O	for	_	0	SENT_167	[p13l1841t954r1975b1013],
2	the	DT	O	the	det	7	SENT_167	[p13l2028t953r2142b1013],
3	primary	JJ	O	primary	amod	7	SENT_167	[p13l6t1046r300b1122],
4	efﬁcacy	NN	O	efﬁcacy	nn	7	SENT_167	[p13l331t1046r611b1122],
5	Variable	JJ	O	variable	amod	7	SENT_167	[p13l638t1046r930b1106],
6	(	NN	O	(	nn	7	SENT_167	[p13l968t1046r1270b1121],
7	malaria	NN	O	malaria	prep_for	15	SENT_167	[p13l968t1046r1270b1121],
8	rate	NN	O	rate	amod	7	SENT_167	[p13l1302t1046r1498b1121],
9	)	RB	O	)	advmod	8	SENT_167	[p13l1302t1046r1498b1121],
10	,	,	O	,	_	0	SENT_167	[p13l1302t1046r1498b1121],
11	the	DT	O	the	det	13	SENT_167	[p13l1531t1046r1645b1106],
12	per-protocol	JJ	O	per-protocol	amod	13	SENT_167	[p13l1676t1046r2142b1122],
13	population	NN	O	population	nsubjpass	15	SENT_167	[p13l6t1138r412b1214],
14	was	VBD	O	be	auxpass	15	SENT_167	[p13l440t1158r575b1199],
15	used	VBN	O	use	_	0	SENT_167	[p13l606t1138r797b1199],
16	.	.	O	.	_	0	SENT_167	[p13l606t1138r797b1199],

1	For	IN	O	for	_	0	SENT_168	[p13l833t1139r966b1199],
2	the	DT	O	the	det	4	SENT_168	[p13l994t1138r1108b1199],
3	secondary	JJ	O	secondary	amod	4	SENT_168	[p13l1140t1138r1515b1214],
4	efﬁcacy	NN	O	efﬁcacy	prep_for	9	SENT_168	[p13l1544t1138r1824b1214],
5	Variable	JJ	O	variable	amod	8	SENT_168	[p13l1851t1138r2142b1199],
6	(	NN	O	(	nn	8	SENT_168	[p13l13t1232r405b1307],
7	treatment	NN	O	treatment	nn	8	SENT_168	[p13l13t1232r405b1307],
8	failure	NN	O	failure	nsubj	9	SENT_168	[p13l434t1231r697b1307],
9	)	VBD	O	)	_	0	SENT_168	[p13l434t1231r697b1307],
10	the	DT	O	the	det	12	SENT_168	[p13l733t1231r847b1292],
11	per-protocol	JJ	O	per-protocol	amod	12	SENT_168	[p13l876t1231r1343b1307],
12	population	NN	O	population	nsubjpass	14	SENT_168	[p13l1372t1231r1778b1307],
13	was	VBD	O	be	auxpass	14	SENT_168	[p13l1806t1251r1941b1292],
14	used	VBN	O	use	ccomp	9	SENT_168	[p13l1972t1231r2143b1292],
15	for	IN	O	for	_	0	SENT_168	[p13l7t1325r112b1385],
16	the	DT	O	the	det	18	SENT_168	[p13l170t1325r285b1385],
17	principal	JJ	O	principal	amod	18	SENT_168	[p13l345t1325r675b1401],
18	analysis	NN	O	analysis	prep_for	14	SENT_168	[p13l738t1325r1046b1401],
19	,	,	O	,	_	0	SENT_168	[p13l738t1325r1046b1401],
20	and	CC	O	and	_	0	SENT_168	[p13l1112t1325r1247b1385],
21	the	DT	O	the	det	23	SENT_168	[p13l1307t1325r1421b1385],
22	ﬁrst	NN	O	ﬁrst	nn	23	SENT_168	[p13l1483t1325r1627b1385],
23	Visit	NN	O	visit	nsubjpass	33	SENT_168	[p13l1685t1325r1837b1385],
24	of	IN	O	of	_	0	SENT_168	[p13l1899t1325r1978b1385],
25	the	DT	O	the	det	26	SENT_168	[p13l2028t1325r2142b1385],
26	intention	NN	O	intention	prep_of	23	SENT_168	[p13l7t1417r660b1478],
27	—	CD	NUMBER	—	number	29	SENT_168	[p13l7t1417r660b1478],
28	to	TO	O	to	dep	29	SENT_168	[p13l7t1417r660b1478],
29	—	CD	NUMBER	—	num	31	SENT_168	[p13l7t1417r660b1478],
30	treat	NN	O	treat	nn	31	SENT_168	[p13l7t1417r660b1478],
31	population	NN	O	population	dep	26	SENT_168	[p13l785t1417r1191b1493],
32	was	VBD	O	be	auxpass	33	SENT_168	[p13l1316t1437r1450b1478],
33	used	VBN	O	use	conj_and	9	SENT_168	[p13l1578t1417r1749b1478],
34	for	IN	O	for	_	0	SENT_168	[p13l1875t1417r1980b1478],
35	a	DT	O	a	det	37	SENT_168	[p13l2107t1437r2142b1478],
36	conﬁrmatory	JJ	O	conﬁrmatory	amod	37	SENT_168	[p13l9t1510r493b1586],
37	analysis	NN	O	analysis	prep_for	33	SENT_168	[p13l529t1510r835b1586],
38	.	.	O	.	_	0	SENT_168	[p13l529t1510r835b1586],

1	In	IN	O	in	_	0	SENT_169	[p13l876t1511r955b1570],
2	the	DT	O	the	det	4	SENT_169	[p13l990t1510r1104b1571],
3	intention-to-treat	NN	O	intention-to-treat	nn	4	SENT_169	[p13l1142t1511r1794b1571],
4	analysis	NN	O	analysis	prep_in	7	SENT_169	[p13l1832t1510r2140b1586],
5	,	,	O	,	_	0	SENT_169	[p13l1832t1510r2140b1586],
6	we	PRP	O	we	nsubj	7	SENT_169	[p13l6t1624r106b1664],
7	assumed	VBD	O	assume	_	0	SENT_169	[p13l146t1604r465b1664],
8	that	IN	O	that	complm	12	SENT_169	[p13l503t1604r648b1664],
9	drug	NN	O	drug	nn	10	SENT_169	[p13l687t1604r858b1680],
10	failure	NN	O	failure	nsubj	12	SENT_169	[p13l894t1604r1129b1664],
11	had	VBD	O	have	aux	12	SENT_169	[p13l1167t1604r1303b1664],
12	occurred	VBN	O	occur	ccomp	7	SENT_169	[p13l1343t1604r1671b1664],
13	for	IN	O	for	_	0	SENT_169	[p13l1709t1604r1814b1664],
14	patients	NNS	O	patient	prep_for	12	SENT_169	[p13l1848t1604r2141b1680],
15	who	WP	O	who	nsubj	16	SENT_169	[p13l6t1696r160b1757],
16	failed	VBD	O	fail	rcmod	14	SENT_169	[p13l196t1696r400b1757],
17	to	TO	O	to	aux	18	SENT_169	[p13l434t1710r505b1757],
18	return	VB	O	return	xcomp	16	SENT_169	[p13l541t1710r772b1757],
19	for	IN	O	for	_	0	SENT_169	[p13l807t1696r912b1757],
20	the	DT	DATE	the	det	23	SENT_169	[p13l945t1696r1059b1757],
21	day	NN	DATE	day	nn	23	SENT_169	[p13l1096t1696r1225b1772],
22	7	CD	NUMBER	7	num	23	SENT_169	[p13l1261t1699r1298b1756],
23	Visit	NN	O	visit	prep_for	18	SENT_169	[p13l1335t1696r1507b1757],
24	.	.	O	.	_	0	SENT_169	[p13l1335t1696r1507b1757],

1	The	DT	O	the	det	2	SENT_170	[p13l1546t1696r1697b1757],
2	mean	NN	O	mean	nsubj	3	SENT_170	[p13l1732t1716r1935b1757],
3	falls	VBZ	O	fall	_	0	SENT_170	[p13l1970t1696r2140b1769],
4	,	,	O	,	_	0	SENT_170	[p13l1970t1696r2140b1769],
5	and	CC	O	and	_	0	SENT_170	[p13l10t1790r144b1850],
6	95	CD	PERCENT	95	number	7	SENT_170	[p13l182t1790r344b1852],
7	%	NN	PERCENT	%	amod	8	SENT_170	[p13l182t1790r344b1852],
8	CI	NN	O	ci	nsubjpass	20	SENT_170	[p13l387t1790r502b1863],
9	,	,	O	,	_	0	SENT_170	[p13l387t1790r502b1863],
10	in	IN	O	in	_	0	SENT_170	[p13l541t1790r610b1849],
11	haemoglobin	NN	O	haemoglobin	prep_in	8	SENT_170	[p13l644t1790r1130b1866],
12	or	CC	O	or	_	0	SENT_170	[p13l1166t1809r1242b1850],
13	packed-cell	NN	O	packed-cell	nn	14	SENT_170	[p13l1274t1790r1697b1866],
14	Volume	NN	O	volume	nsubjpass	20	SENT_170	[p13l1731t1790r2005b1850],
15	for	IN	O	for	_	0	SENT_170	[p13l2041t1790r2145b1850],
16	each	DT	O	each	det	18	SENT_170	[p13l10t1882r176b1943],
17	malaria	NN	O	malaria	nn	18	SENT_170	[p13l223t1882r498b1943],
18	episode	NN	O	episode	prep_for	14	SENT_170	[p13l549t1882r827b1958],
19	were	VBD	O	be	auxpass	20	SENT_170	[p13l875t1902r1048b1943],
20	calculated	VBN	O	calculate	conj_and	3	SENT_170	[p13l1099t1882r1475b1943],
21	from	IN	O	from	_	0	SENT_170	[p13l1522t1882r1700b1943],
22	the	DT	O	the	det	24	SENT_170	[p13l1748t1882r1861b1943],
23	paired	JJ	O	paired	amod	24	SENT_170	[p13l1909t1882r2144b1958],
24	differences	NNS	O	difference	prep_from	20	SENT_170	[p13l9t1975r410b2036],
25	in	IN	O	in	_	0	SENT_170	[p13l440t1976r510b2035],
26	haemoglobin	NN	O	haemoglobin	nn	27	SENT_170	[p13l537t1975r1023b2051],
27	levels	NNS	O	level	prep_in	24	SENT_170	[p13l1052t1975r1251b2036],
28	on	IN	O	on	_	0	SENT_170	[p13l1283t1995r1374b2036],
29	day	NN	DURATION	day	nn	30	SENT_170	[p13l1404t1975r1533b2051],
30	o	NN	O	o	prep_on	20	SENT_170	[p13l1562t1978r1601b2036],
31	and	CC	O	and	_	0	SENT_170	[p13l1634t1975r1768b2036],
32	day	NN	DURATION	day	prep_on	20	SENT_170	[p13l1799t1975r1928b2051],
33	7	CD	NUMBER	7	num	32	SENT_170	[p13l1957t1978r2018b2036],
34	.	.	O	.	_	0	SENT_170	[p13l1957t1978r2018b2036],

1	Role	NN	O	role	tmod	9	SENT_171	[p13l10t2166r168b2225],
2	of	IN	O	of	_	0	SENT_171	[p13l200t2165r275b2225],
3	the	DT	O	the	det	5	SENT_171	[p13l298t2166r410b2225],
4	funding	NN	O	funding	nn	5	SENT_171	[p13l442t2165r720b2240],
5	source	NN	O	source	prep_of	1	SENT_171	[p13l744t2180r990b2225],
6	The	DT	O	the	det	8	SENT_171	[p13l7t2257r158b2318],
7	funding	NN	O	funding	nn	8	SENT_171	[p13l187t2257r478b2333],
8	sources	NNS	O	source	nsubj	9	SENT_171	[p13l507t2277r780b2318],
9	(	VBP	O	(	_	0	SENT_171	[p13l816t2257r1375b2333],
10	UNDP/World	JJ	O	undp/world	amod	11	SENT_171	[p13l816t2257r1375b2333],
11	Bank/WHO	NNP	O	Bank/WHO	nsubj	13	SENT_171	[p13l1405t2257r1846b2318],
12	Special	JJ	O	special	amod	13	SENT_171	[p13l1880t2257r2144b2333],
13	Programme	NNP	O	Programme	xcomp	9	SENT_171	[p13l9t2352r445b2427],
14	for	IN	O	for	_	0	SENT_171	[p13l513t2351r618b2411],
15	Research	NNP	O	Research	prep_for	13	SENT_171	[p13l685t2351r1022b2411],
16	and	CC	O	and	_	0	SENT_171	[p13l1091t2351r1226b2411],
17	Training	NNP	O	Training	prep_for	13	SENT_171	[p13l1293t2351r1621b2427],
18	in	IN	O	in	_	0	SENT_171	[p13l1688t2351r1757b2410],
19	Tropical	NNP	O	Tropical	nn	20	SENT_171	[p13l1824t2351r2144b2427],
20	Medicine	NNP	O	Medicine	prep_in	9	SENT_171	[p13l8t2443r359b2504],
21	[	CD	NUMBER	[	num	22	SENT_171	[p13l456t2443r698b2519],
22	TDR	NNP	O	TDR	dep	20	SENT_171	[p13l456t2443r698b2519],
23	]	CD	NUMBER	]	num	22	SENT_171	[p13l456t2443r698b2519],
24	in	IN	O	in	_	0	SENT_171	[p13l796t2443r865b2503],
25	partnership	NN	O	partnership	prep_in	22	SENT_171	[p13l951t2443r1377b2519],
26	with	IN	O	with	_	0	SENT_171	[p13l1464t2443r1627b2504],
27	SmithKline	NNP	ORGANIZATION	SmithKline	nn	29	SENT_171	[p13l1716t2443r2143b2504],
28	Beecham	NNP	ORGANIZATION	Beecham	nn	29	SENT_171	[p13l9t2536r350b2597],
29	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_with	25	SENT_171	[p13l408t2536r1045b2609],
30	,	,	O	,	_	0	SENT_171	[p13l408t2536r1045b2609],
31	and	CC	O	and	_	0	SENT_171	[p13l1107t2536r1242b2597],
32	the	DT	O	the	det	35	SENT_171	[p13l1299t2536r1413b2597],
33	Wellcome	NNP	ORGANIZATION	Wellcome	nn	35	SENT_171	[p13l1470t2536r1844b2597],
34	Trust	NNP	ORGANIZATION	Trust	nn	35	SENT_171	[p13l1902t2537r2137b2612],
35	)	NN	O	)	nsubj	36	SENT_171	[p13l1902t2537r2137b2612],
36	had	VBD	O	have	conj_and	9	SENT_171	[p13l7t2630r144b2690],
37	no	DT	O	no	det	38	SENT_171	[p13l209t2649r300b2690],
38	role	NN	O	role	dobj	36	SENT_171	[p13l368t2630r508b2690],
39	in	IN	O	in	_	0	SENT_171	[p13l575t2630r645b2689],
40	study	NN	O	study	nn	41	SENT_171	[p13l712t2630r913b2706],
41	design	NN	O	design	prep_in	38	SENT_171	[p13l979t2630r1237b2706],
42	,	,	O	,	_	0	SENT_171	[p13l979t2630r1237b2706],
43	data	NNS	O	datum	nn	44	SENT_171	[p13l1308t2630r1464b2690],
44	collection	NN	O	collection	conj_or	41	SENT_171	[p13l1533t2630r1916b2703],
45	,	,	O	,	_	0	SENT_171	[p13l1533t2630r1916b2703],
46	data	NN	O	datum	nn	47	SENT_171	[p13l1987t2630r2143b2690],
47	analysis	NN	O	analysis	conj_or	41	SENT_171	[p13l10t2722r317b2798],
48	,	,	O	,	_	0	SENT_171	[p13l10t2722r317b2798],
49	data	NNS	O	datum	nn	50	SENT_171	[p13l351t2722r507b2783],
50	interpretation	NN	O	interpretation	conj_or	41	SENT_171	[p13l536t2722r1073b2798],
51	,	,	O	,	_	0	SENT_171	[p13l536t2722r1073b2798],
52	or	CC	O	or	_	0	SENT_171	[p13l1106t2742r1182b2783],
53	writing	NN	O	writing	conj_or	41	SENT_171	[p13l1208t2722r1472b2798],
54	of	IN	O	of	_	0	SENT_171	[p13l1501t2722r1579b2783],
55	the	DT	O	the	det	56	SENT_171	[p13l1597t2722r1712b2783],
56	report	NN	O	report	prep_of	53	SENT_171	[p13l1741t2736r1988b2798],
57	.	.	O	.	_	0	SENT_171	[p13l1741t2736r1988b2798],

1	Results	NNS	O	result	nsubjpass	5	SENT_172	[p13l11t2905r358b2971],
2	410	CD	NUMBER	410	num	3	SENT_172	[p13l9t3006r145b3064],
3	patients	NNS	O	patient	dep	1	SENT_172	[p13l204t3003r496b3079],
4	were	VBD	O	be	auxpass	5	SENT_172	[p13l554t3023r727b3064],
5	randomised	VBN	O	randomise	_	0	SENT_172	[p13l785t3003r1225b3064],
6	in	IN	O	in	_	0	SENT_172	[p13l1282t3003r1352b3063],
7	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	5	SENT_172	[p13l1410t3003r1618b3064],
8	.	.	O	.	_	0	SENT_172	[p13l1410t3003r1618b3064],

1	383	CD	NUMBER	383	nsubjpass	42	SENT_173	[p13l1682t3006r1816b3064],
2	of	IN	O	of	_	0	SENT_173	[p13l1879t3003r1957b3064],
3	410	CD	NUMBER	410	num	4	SENT_173	[p13l2006t3006r2141b3064],
4	(	NN	O	(	prep_of	1	SENT_173	[p13l14t3096r312b3172],
5	715	CD	PERCENT	715	num	6	SENT_173	[p13l14t3096r312b3172],
6	%	NN	PERCENT	%	nsubjpass	9	SENT_173	[p13l14t3096r312b3172],
7	)	CD	NUMBER	)	dep	6	SENT_173	[p13l14t3096r312b3172],
8	were	VBD	O	be	auxpass	9	SENT_173	[p13l363t3116r536b3157],
9	included	VBN	O	include	rcmod	4	SENT_173	[p13l583t3096r906b3157],
10	in	IN	O	in	_	0	SENT_173	[p13l953t3097r1022b3156],
11	the	DT	O	the	det	13	SENT_173	[p13l1067t3096r1182b3157],
12	per-protocol	JJ	O	per-protocol	amod	13	SENT_173	[p13l1227t3096r1694b3172],
13	analysis	NN	O	analysis	prep_in	9	SENT_173	[p13l1742t3096r2025b3172],
14	of	IN	O	of	_	0	SENT_173	[p13l2075t3096r2153b3157],
15	malaria	NN	O	malaria	nn	17	SENT_173	[p13l8t3190r283b3250],
16	incidence	NN	O	incidence	nn	17	SENT_173	[p13l335t3190r689b3250],
17	(	NN	O	(	prep_of	13	SENT_173	[p13l747t3190r911b3265],
18	188	CD	NUMBER	188	tmod	9	SENT_173	[p13l747t3190r911b3265],
19	in	IN	O	in	_	0	SENT_173	[p13l965t3190r1035b3249],
20	the	DT	O	the	det	22	SENT_173	[p13l1085t3190r1199b3250],
21	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	22	SENT_173	[p13l1253t3190r2143b3266],
22	group	NN	O	group	prep_in	18	SENT_173	[p13l8t3302r223b3358],
23	and	CC	O	and	_	0	SENT_173	[p13l313t3282r447b3343],
24	195	CD	NUMBER	195	prep_in	18	SENT_173	[p13l543t3285r668b3343],
25	in	IN	O	in	_	0	SENT_173	[p13l759t3282r829b3342],
26	the	DT	O	the	det	29	SENT_173	[p13l914t3282r1028b3343],
27	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	29	SENT_173	[p13l1116t3282r2143b3358],
28	group	NN	O	group	nn	29	SENT_173	[p13l8t3376r281b3451],
29	)	NN	O	)	prep_in	18	SENT_173	[p13l8t3376r281b3451],
30	;	:	O	;	_	0	SENT_173	[p13l8t3376r281b3451],
31	397	CD	NUMBER	397	dep	18	SENT_173	[p13l336t3378r469b3436],
32	of	IN	O	of	_	0	SENT_173	[p13l524t3375r602b3436],
33	410	CD	NUMBER	410	num	34	SENT_173	[p13l643t3378r779b3436],
34	(	NN	O	(	prep_of	31	SENT_173	[p13l836t3376r999b3451],
35	197	CD	NUMBER	197	dep	31	SENT_173	[p13l836t3376r999b3451],
36	and	CC	O	and	_	0	SENT_173	[p13l1054t3375r1189b3436],
37	200	CD	NUMBER	200	dep	31	SENT_173	[p13l1241t3378r1400b3448],
38	,	,	O	,	_	0	SENT_173	[p13l1241t3378r1400b3448],
39	respectively	RB	O	respectively	advmod	18	SENT_173	[p13l1453t3375r1915b3451],
40	)	CD	NUMBER	)	dep	18	SENT_173	[p13l1453t3375r1915b3451],
41	were	VBD	O	be	auxpass	42	SENT_173	[p13l1969t3395r2143b3436],
42	included	VBN	O	include	dep	51	SENT_173	[p13l8t3469r332b3529],
43	in	IN	O	in	_	0	SENT_173	[p13l389t3469r459b3528],
44	the	DT	O	the	det	45	SENT_173	[p13l515t3469r629b3529],
45	intention	NN	O	intention	prep_in	42	SENT_173	[p13l687t3469r1340b3529],
46	—	CD	NUMBER	—	num	45	SENT_173	[p13l687t3469r1340b3529],
47	to	TO	O	to	_	0	SENT_173	[p13l687t3469r1340b3529],
48	—	CD	NUMBER	—	num	50	SENT_173	[p13l687t3469r1340b3529],
49	treat	NN	O	treat	nn	50	SENT_173	[p13l687t3469r1340b3529],
50	analysis	NN	O	analysis	prep_to	42	SENT_173	[p13l1399t3469r1682b3545],
51	applied	VBD	O	apply	_	0	SENT_173	[p13l1743t3469r2014b3545],
52	to	TO	O	to	_	0	SENT_173	[p13l2071t3483r2142b3529],
53	treatment	NN	O	treatment	nn	54	SENT_173	[p13l8t3575r372b3622],
54	failure	NN	O	failure	prep_to	51	SENT_173	[p13l400t3561r634b3622],
55	(	CD	NUMBER	(	num	57	SENT_173	[p13l670t3561r965b3637],
56	ﬁgure	NN	O	ﬁgure	nn	57	SENT_173	[p13l670t3561r965b3637],
57	)	NN	O	)	nsubj	51	SENT_173	[p13l670t3561r965b3637],
58	.	.	O	.	_	0	SENT_173	[p13l670t3561r965b3637],

1	500	CD	NUMBER	500	num	2	SENT_174	[p13l96t3657r230b3715],
2	patients	NNS	O	patient	nsubjpass	4	SENT_174	[p13l275t3655r567b3730],
3	were	VBD	O	be	auxpass	4	SENT_174	[p13l612t3674r785b3715],
4	recruited	VBN	O	recruit	_	0	SENT_174	[p13l830t3654r1166b3715],
5	in	IN	O	in	_	0	SENT_174	[p13l1210t3655r1279b3714],
6	Blantyre	NNP	LOCATION	Blantyre	prep_in	4	SENT_174	[p13l1324t3654r1658b3730],
7	.	.	O	.	_	0	SENT_174	[p13l1324t3654r1658b3730],

1	446	CD	NUMBER	446	nsubjpass	9	SENT_175	[p13l1708t3657r1844b3715],
2	of	IN	O	of	_	0	SENT_175	[p13l1892t3654r1970b3715],
3	500	CD	NUMBER	500	num	4	SENT_175	[p13l2008t3657r2141b3715],
4	(	NN	O	(	prep_of	1	SENT_175	[p13l14t3748r312b3823],
5	892	CD	PERCENT	892	num	6	SENT_175	[p13l14t3748r312b3823],
6	%	NN	PERCENT	%	dep	4	SENT_175	[p13l14t3748r312b3823],
7	)	CD	NUMBER	)	dep	6	SENT_175	[p13l14t3748r312b3823],
8	were	VBD	O	be	auxpass	9	SENT_175	[p13l348t3767r521b3808],
9	included	VBN	O	include	_	0	SENT_175	[p13l554t3748r877b3808],
10	in	IN	O	in	_	0	SENT_175	[p13l909t3748r978b3807],
11	the	DT	O	the	det	14	SENT_175	[p13l1009t3748r1123b3808],
12	per-protocol	JJ	O	per-protocol	amod	14	SENT_175	[p13l1154t3748r1620b3824],
13	analysis	NN	O	analysis	nn	14	SENT_175	[p13l1654t3748r1938b3824],
14	(	NN	O	(	prep_in	9	SENT_175	[p13l1977t3748r2141b3823],
15	222	CD	NUMBER	222	advmod	9	SENT_175	[p13l1977t3748r2141b3823],

1	and	CC	O	and	cc	15	SENT_176	[p14l10t18r144b79],
2	224	CD	NUMBER	224	nsubjpass	15	SENT_176	[p14l244t21r404b91],
3	,	,	O	,	_	0	SENT_176	[p14l244t21r404b91],
4	respectively	RB	O	respectively	advmod	2	SENT_176	[p14l504t18r967b94],
5	)	CD	NUMBER	)	number	6	SENT_176	[p14l504t18r967b94],
6	489/500	CD	NUMBER	489/500	num	7	SENT_176	[p14l1071t18r1375b79],
7	(	NN	O	(	dep	2	SENT_176	[p14l1481t18r1646b93],
8	244	CD	NUMBER	244	dep	7	SENT_176	[p14l1481t18r1646b93],
9	and	CC	O	and	_	0	SENT_176	[p14l1747t18r1881b79],
10	245	CD	NUMBER	245	dep	7	SENT_176	[p14l1981t21r2141b91],
11	,	,	O	,	_	0	SENT_176	[p14l1981t21r2141b91],
12	respectively	RB	O	respectively	advmod	15	SENT_176	[p14l8t111r470b187],
13	)	CD	NUMBER	)	dep	12	SENT_176	[p14l8t111r470b187],
14	were	VBD	O	be	auxpass	15	SENT_176	[p14l542t131r716b172],
15	included	VBN	O	include	_	0	SENT_176	[p14l783t111r1107b172],
16	in	IN	O	in	_	0	SENT_176	[p14l1174t112r1243b171],
17	the	DT	O	the	det	19	SENT_176	[p14l1310t111r1424b172],
18	intention-to-treat	NN	O	intention-to-treat	nn	19	SENT_176	[p14l1492t112r2144b172],
19	analysis	NN	O	analysis	prep_in	15	SENT_176	[p14l10t205r294b281],
20	(	CD	NUMBER	(	num	22	SENT_176	[p14l351t205r646b281],
21	ﬁgure	NN	O	ﬁgure	nn	22	SENT_176	[p14l351t205r646b281],
22	)	NN	O	)	dep	19	SENT_176	[p14l351t205r646b281],
23	.	.	O	.	_	0	SENT_176	[p14l351t205r646b281],

1	Details	NNS	O	detail	nsubjpass	9	SENT_177	[p14l702t205r962b265],
2	of	IN	O	of	_	0	SENT_177	[p14l1015t205r1094b265],
3	attendance	NN	O	attendance	prep_of	1	SENT_177	[p14l1135t205r1541b265],
4	and	CC	O	and	_	0	SENT_177	[p14l1593t205r1728b265],
5	drop-outs	NNS	O	drop-out	conj_and	3	SENT_177	[p14l1779t205r2142b281],
6	during	IN	O	during	_	0	SENT_177	[p14l9t297r254b373],
7	follow-up	NN	O	follow-up	prep_during	1	SENT_177	[p14l309t297r665b373],
8	are	VBP	O	be	auxpass	9	SENT_177	[p14l726t317r834b358],
9	given	VBN	O	give	_	0	SENT_177	[p14l892t297r1088b373],
10	in	IN	O	in	_	0	SENT_177	[p14l1144t297r1214b357],
11	the	DT	O	the	det	15	SENT_177	[p14l1270t297r1384b358],
12	web	NN	O	web	nn	15	SENT_177	[p14l1441t297r1588b358],
13	table	NN	O	table	nn	15	SENT_177	[p14l1647t297r1826b358],
14	(	CD	NUMBER	(	num	15	SENT_177	[p14l1890t297r2145b373],
15	http	NN	O	http	prep_in	9	SENT_177	[p14l1890t297r2145b373],
16	:	:	O	:	_	0	SENT_177	[p14l1890t297r2145b373],
17	/	:	O	/	dep	20	SENT_177	[p14l1890t297r2145b373],
18	/	:	O	/	punct	20	SENT_177	[p14l1890t297r2145b373],
19	image.thelancet.com/extras/O1art9159webtable.pdf	NN	O	image.thelancet.com/extras/o1art9159webtable.pdf	nn	20	SENT_177	[p14l8t390r1988b466],
20	)	NN	O	)	dep	9	SENT_177	[p14l8t390r1988b466],
21	.	.	O	.	_	0	SENT_177	[p14l8t390r1988b466],

1	The	DT	O	the	det	3	SENT_178	[p14l92t484r243b544],
2	two	CD	NUMBER	two	num	3	SENT_178	[p14l284t498r418b544],
3	groups	NNS	O	group	nsubj	5	SENT_178	[p14l461t503r711b560],
4	were	VBD	O	be	cop	5	SENT_178	[p14l752t504r926b544],
5	similar	JJ	O	similar	_	0	SENT_178	[p14l969t484r1222b544],
6	at	IN	O	at	_	0	SENT_178	[p14l1262t498r1328b544],
7	entry	NN	O	entry	prep_at	5	SENT_178	[p14l1370t498r1560b560],
8	in	IN	O	in	_	0	SENT_178	[p14l1599t484r1669b543],
9	each	DT	O	each	prep_in	5	SENT_178	[p14l1711t484r1878b544],
10	of	IN	O	of	_	0	SENT_178	[p14l1920t484r1998b544],
11	the	DT	O	the	det	17	SENT_178	[p14l2028t484r2143b544],
12	two	CD	NUMBER	two	num	13	SENT_178	[p14l8t590r142b637],
13	centres	NNS	O	centre	dep	14	SENT_178	[p14l229t590r491b637],
14	(	RB	O	(	amod	17	SENT_178	[p14l583t576r790b651],
15	table	NN	O	table	nn	17	SENT_178	[p14l583t576r790b651],
16	1	CD	NUMBER	1	num	17	SENT_178	[p14l884t576r975b651],
17	)	NN	O	)	prep_of	9	SENT_178	[p14l884t576r975b651],
18	;	:	O	;	_	0	SENT_178	[p14l884t576r975b651],
19	however	RB	O	however	advmod	9	SENT_178	[p14l1061t576r1396b649],
20	,	,	O	,	_	0	SENT_178	[p14l1061t576r1396b649],
21	the	DT	O	the	det	22	SENT_178	[p14l1483t576r1597b637],
22	sulfadoxineKiliﬁ	NN	O	sulfadoxinekiliﬁ	attr	5	SENT_178	[p14l1684t576r2143b637, p14l431t725r486b746],

1	Blantyre	NNP	LOCATION	Blantyre	_	0	SENT_179	[p14l1246t726r1353b751],

1	Chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	2	SENT_180	[p14l658t803r1220b852],
2	Sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	_	0	SENT_180	[p14l1391t803r2035b852],
3	(	CD	NUMBER	(	num	4	SENT_180	[p14l659t868r849b916],
4	n	NN	O	n	dep	2	SENT_180	[p14l659t868r849b916],
5	=	JJ	O	=	quantmod	7	SENT_180	[p14l659t868r849b916],
6	188	CD	NUMBER	188	number	7	SENT_180	[p14l659t868r849b916],
7	)	CD	NUMBER	)	num	12	SENT_180	[p14l659t868r849b916],
8	(	NN	O	(	nn	12	SENT_180	[p14l1391t868r1582b916],
9	n	NN	O	n	nn	12	SENT_180	[p14l1391t868r1582b916],
10	=	JJ	O	=	amod	12	SENT_180	[p14l1391t868r1582b916],
11	195	CD	NUMBER	195	num	12	SENT_180	[p14l1391t868r1582b916],
12	)	NN	O	)	dep	4	SENT_180	[p14l1391t868r1582b916],

1	Efficacy	NN	O	efficacy	nn	2	SENT_181	[p14l10t1004r202b1052],
2	endpoints	NNS	O	endpoint	dep	8	SENT_181	[p14l220t1004r460b1052],
3	Severe	JJ	O	severe	amod	4	SENT_181	[p14l9t1069r170b1108],
4	malaria	NN	O	malaria	dep	2	SENT_181	[p14l193t1069r365b1108],
5	19	CD	PERCENT	19	dep	8	SENT_181	[p14l661t1069r721b1108],
6	(	CD	PERCENT	(	num	8	SENT_181	[p14l743t1069r926b1117],
7	10-1	CD	PERCENT	10-1	num	8	SENT_181	[p14l743t1069r926b1117],
8	%	NN	PERCENT	%	dep	16	SENT_181	[p14l743t1069r926b1117],
9	)	CD	NUMBER	)	number	10	SENT_181	[p14l743t1069r926b1117],
10	21	CD	NUMBER	21	num	11	SENT_181	[p14l1421t1069r1483b1108],
11	(	NN	O	(	dep	8	SENT_181	[p14l1504t1069r1687b1117],
12	10-7	CD	PERCENT	10-7	num	13	SENT_181	[p14l1504t1069r1687b1117],
13	%	NN	PERCENT	%	dep	11	SENT_181	[p14l1504t1069r1687b1117],
14	)	CD	NUMBER	)	num	16	SENT_181	[p14l1504t1069r1687b1117],
15	Treatment	NN	O	treatment	nn	16	SENT_181	[p14l7t1134r252b1173],
16	failure	NN	O	failure	dep	20	SENT_181	[p14l269t1134r417b1173],
17	8	CD	PERCENT	8	num	18	SENT_181	[p14l692t1134r722b1173],
18	(	NN	PERCENT	(	dep	16	SENT_181	[p14l743t1134r892b1182],
19	4-3	CD	PERCENT	4-3	num	20	SENT_181	[p14l743t1134r892b1182],
20	%	NN	PERCENT	%	dep	26	SENT_181	[p14l743t1134r892b1182],
21	)	CD	NUMBER	)	number	22	SENT_181	[p14l743t1134r892b1182],
22	22	CD	NUMBER	22	num	23	SENT_181	[p14l1421t1134r1482b1173],
23	(	NN	O	(	dep	20	SENT_181	[p14l1504t1134r1687b1182],
24	11-3	CD	PERCENT	11-3	num	25	SENT_181	[p14l1504t1134r1687b1182],
25	%	NN	PERCENT	%	dep	23	SENT_181	[p14l1504t1134r1687b1182],
26	)	CD	NUMBER	)	_	0	SENT_181	[p14l1504t1134r1687b1182],
27	Completed	VBN	O	complete	partmod	26	SENT_181	[p14l9t1199r263b1247],
28	one	CD	DURATION	one	num	29	SENT_181	[p14l285t1208r370b1238],
29	year	NN	NUMBER	year	dobj	27	SENT_181	[p14l389t1208r490b1247],
30	93	CD	PERCENT	93	number	31	SENT_181	[p14l659t1199r721b1238],
31	(	CD	PERCENT	(	dep	29	SENT_181	[p14l743t1199r926b1247],
32	49-5	CD	PERCENT	49-5	num	33	SENT_181	[p14l743t1199r926b1247],
33	%	NN	PERCENT	%	dep	38	SENT_181	[p14l743t1199r926b1247],
34	)	CD	NUMBER	)	dep	33	SENT_181	[p14l743t1199r926b1247],
35	109	CD	NUMBER	109	num	36	SENT_181	[p14l1389t1199r1483b1238],
36	(	NN	O	(	dep	38	SENT_181	[p14l1504t1199r1687b1247],
37	55-9	CD	PERCENT	55-9	num	38	SENT_181	[p14l1504t1199r1687b1247],
38	%	NN	PERCENT	%	dep	29	SENT_181	[p14l1504t1199r1687b1247],
39	)	CD	NUMBER	)	dep	38	SENT_181	[p14l1504t1199r1687b1247],

1	Safety	NN	O	safety	nn	2	SENT_182	[p14l7t1331r163b1380],
2	endpoints	NNS	O	endpoint	dep	12	SENT_182	[p14l181t1331r421b1379],
3	Death	NN	O	death	nn	4	SENT_182	[p14l11t1397r147b1436],
4	o	NN	O	o	dep	2	SENT_182	[p14l692t1396r721b1436],
5	(	CD	PERCENT	(	number	6	SENT_182	[p14l743t1396r843b1444],
6	o	NN	PERCENT	o	num	7	SENT_182	[p14l743t1396r843b1444],
7	%	NN	PERCENT	%	dep	4	SENT_182	[p14l743t1396r843b1444],
8	)	CD	NUMBER	)	num	9	SENT_182	[p14l743t1396r843b1444],
9	O	NN	O	o	dep	12	SENT_182	[p14l1454t1396r1483b1436],
10	(	NN	PERCENT	(	nn	12	SENT_182	[p14l1504t1396r1604b1444],
11	o	NN	PERCENT	o	nn	12	SENT_182	[p14l1504t1396r1604b1444],
12	%	NN	PERCENT	%	dep	26	SENT_182	[p14l1504t1396r1604b1444],
13	)	CD	NUMBER	)	num	14	SENT_182	[p14l1504t1396r1604b1444],
14	Haemoglobin	NN	O	haemoglobin	dep	12	SENT_182	[p14l11t1463r318b1512],
15	<	JJR	O	<	dep	24	SENT_182	[p14l342t1463r448b1502],
16	50	CD	NUMBER	50	number	17	SENT_182	[p14l342t1463r448b1502],
17	g/L	NN	O	g/l	dep	15	SENT_182	[p14l467t1463r550b1512],
18	13	CD	PERCENT	13	number	19	SENT_182	[p14l661t1463r721b1502],
19	(	CD	PERCENT	(	prep	15	SENT_182	[p14l743t1463r892b1511],
20	5-9	CD	PERCENT	5-9	num	21	SENT_182	[p14l743t1463r892b1511],
21	%	NN	PERCENT	%	dep	19	SENT_182	[p14l743t1463r892b1511],
22	)	CD	NUMBER	)	number	23	SENT_182	[p14l743t1463r892b1511],
23	3	CD	NUMBER	3	num	24	SENT_182	[p14l1454t1463r1483b1502],
24	(	NN	O	(	rcmod	14	SENT_182	[p14l1504t1463r1654b1511],
25	1-5	CD	PERCENT	1-5	num	26	SENT_182	[p14l1504t1463r1654b1511],
26	%	NN	PERCENT	%	dep	27	SENT_182	[p14l1504t1463r1654b1511],
27	)	CD	NUMBER	)	_	0	SENT_182	[p14l1504t1463r1654b1511],
28	Vomiting	VBG	O	vomit	rcmod	27	SENT_182	[p14l7t1527r215b1575],
29	4	CD	PERCENT	4	num	30	SENT_182	[p14l692t1527r722b1565],
30	(	CD	PERCENT	(	dobj	28	SENT_182	[p14l743t1526r892b1574],
31	2-1	CD	PERCENT	2-1	num	32	SENT_182	[p14l743t1526r892b1574],
32	%	NN	PERCENT	%	dep	40	SENT_182	[p14l743t1526r892b1574],
33	)	CD	NUMBER	)	number	34	SENT_182	[p14l743t1526r892b1574],
34	1	CD	NUMBER	1	dep	32	SENT_182	[p14l1456t1527r1483b1565],
35	(	NN	O	(	dep	34	SENT_182	[p14l1504t1526r1654b1574],
36	O-5	CD	PERCENT	o-5	num	37	SENT_182	[p14l1504t1526r1654b1574],
37	%	NN	PERCENT	%	dep	40	SENT_182	[p14l1504t1526r1654b1574],
38	)	CD	NUMBER	)	num	40	SENT_182	[p14l1504t1526r1654b1574],
39	Rash	NNP	O	Rash	nn	40	SENT_182	[p14l11t1592r126b1631],
40	O	NN	O	o	dep	48	SENT_182	[p14l692t1591r721b1631],
41	(	CD	PERCENT	(	number	42	SENT_182	[p14l743t1591r843b1639],
42	o	NN	PERCENT	o	num	43	SENT_182	[p14l743t1591r843b1639],
43	%	NN	PERCENT	%	dep	40	SENT_182	[p14l743t1591r843b1639],
44	)	CD	NUMBER	)	num	47	SENT_182	[p14l743t1591r843b1639],
45	O	NN	O	o	nn	47	SENT_182	[p14l1454t1591r1483b1631],
46	(	NN	O	(	nn	47	SENT_182	[p14l1504t1591r1604b1639],
47	o	NN	PERCENT	o	dep	43	SENT_182	[p14l1504t1591r1604b1639],
48	%	NN	PERCENT	%	dep	28	SENT_182	[p14l1504t1591r1604b1639],
49	)	CD	NUMBER	)	num	48	SENT_182	[p14l1504t1591r1604b1639],

1	Withdrawn	NNP	O	Withdrawn	nn	3	SENT_183	[p14l7t1722r269b1761],
2	Protocol	NNP	O	Protocol	nn	3	SENT_183	[p14l10t1787r198b1826],
3	violation	NN	O	violation	dep	14	SENT_183	[p14l219t1787r417b1826],
4	28	CD	PERCENT	28	num	3	SENT_183	[p14l659t1787r722b1826],
5	(	CD	PERCENT	(	num	7	SENT_183	[p14l743t1787r926b1835],
6	14-9	CD	PERCENT	14-9	num	7	SENT_183	[p14l743t1787r926b1835],
7	%	NN	PERCENT	%	dep	3	SENT_183	[p14l743t1787r926b1835],
8	)	CD	NUMBER	)	number	9	SENT_183	[p14l743t1787r926b1835],
9	19	CD	NUMBER	19	num	10	SENT_183	[p14l1423t1787r1483b1826],
10	(	NN	O	(	dep	7	SENT_183	[p14l1504t1787r1654b1835],
11	9-7	CD	PERCENT	9-7	num	12	SENT_183	[p14l1504t1787r1654b1835],
12	%	NN	PERCENT	%	dep	14	SENT_183	[p14l1504t1787r1654b1835],
13	)	CD	NUMBER	)	num	14	SENT_183	[p14l1504t1787r1654b1835],
14	Default	NNP	O	Default	dep	21	SENT_183	[p14l11t1852r180b1891],
15	23	CD	NUMBER	23	num	14	SENT_183	[p14l659t1852r721b1891],
16	(	CD	NUMBER	(	dep	14	SENT_183	[p14l743t1852r926b1900],
17	12-2	RB	PERCENT	12-2	num	18	SENT_183	[p14l743t1852r926b1900],
18	%	NN	PERCENT	%	dep	16	SENT_183	[p14l743t1852r926b1900],
19	)	CD	NUMBER	)	number	20	SENT_183	[p14l743t1852r926b1900],
20	20	CD	NUMBER	20	num	21	SENT_183	[p14l1421t1852r1483b1891],
21	(	NN	O	(	dep	24	SENT_183	[p14l1504t1852r1687b1900],
22	10-3	CD	PERCENT	10-3	num	23	SENT_183	[p14l1504t1852r1687b1900],
23	%	NN	PERCENT	%	dep	21	SENT_183	[p14l1504t1852r1687b1900],
24	)	CD	NUMBER	)	_	0	SENT_183	[p14l1504t1852r1687b1900],

1	Chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	2	SENT_184	[p14l19t2134r784b2201],
2	Sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	_	0	SENT_184	[p14l1053t2134r1930b2201],
3	(	CD	NUMBER	(	num	4	SENT_184	[p14l19t2246r279b2312],
4	n	NN	O	n	dep	2	SENT_184	[p14l19t2246r279b2312],
5	=	JJ	O	=	quantmod	7	SENT_184	[p14l19t2246r279b2312],
6	222	CD	NUMBER	222	number	7	SENT_184	[p14l19t2246r279b2312],
7	)	CD	NUMBER	)	num	12	SENT_184	[p14l19t2246r279b2312],
8	(	NN	O	(	nn	12	SENT_184	[p14l1053t2246r1313b2312],
9	n	NN	O	n	nn	12	SENT_184	[p14l1053t2246r1313b2312],
10	=	JJ	O	=	amod	12	SENT_184	[p14l1053t2246r1313b2312],
11	224	CD	NUMBER	224	num	12	SENT_184	[p14l1053t2246r1313b2312],
12	)	NN	O	)	dep	4	SENT_184	[p14l1053t2246r1313b2312],

1	Table	NNP	O	Table	_	0	SENT_185	[p14l73t3632r151b3656],
2	2	CD	NUMBER	2	num	1	SENT_185	[p14l163t3632r189b3656],
3	:	:	O	:	_	0	SENT_185	[p14l163t3632r189b3656],
4	Endpoints	NNS	O	endpoint	dep	1	SENT_185	[p14l204t3632r348b3661],

1	THE	DT	O	the	det	2	SENT_186	[p14l78t3762r140b3783],
2	LANCET	NN	O	lancet	_	0	SENT_186	[p14l149t3761r274b3783],
3	-	:	O	-	_	0	SENT_186	[p14l284t3769r291b3777],
4	Vol	NN	O	vol	dep	2	SENT_186	[p14l300t3762r344b3783],
5	360	CD	NUMBER	360	num	4	SENT_186	[p14l354t3763r400b3783],
6	-	:	O	-	_	0	SENT_186	[p14l411t3769r418b3777],
7	October	NNP	DATE	October	dep	4	SENT_186	[p14l429t3762r532b3783],
8	12	CD	DATE	12	num	7	SENT_186	[p14l543t3763r579b3787],
9	,	,	DATE	,	_	0	SENT_186	[p14l543t3763r579b3787],
10	2002	CD	DATE	2002	num	7	SENT_186	[p14l590t3763r652b3783],
11	-	:	O	-	_	0	SENT_186	[p14l662t3769r670b3777],
12	www.thelancet.com	NN	O	www.thelancet.com	dep	2	SENT_186	[p14l679t3762r930b3783],

1	For	IN	O	for	_	0	SENT_187	[p15l79t58r148b93],
2	personal	JJ	O	personal	amod	3	SENT_187	[p15l173t58r361b101],
3	use	NN	O	use	pobj	1	SENT_187	[p15l388t67r477b93],
4	.	.	O	.	_	0	SENT_187	[p15l388t67r477b93],

1	Only	RB	O	only	advmod	2	SENT_188	[p15l525t58r621b102],
2	reproduce	VB	O	reproduce	_	0	SENT_188	[p15l647t58r869b101],
3	with	IN	O	with	_	0	SENT_188	[p15l893t58r988b93],
4	permission	NN	O	permission	prep_with	2	SENT_188	[p15l1015t58r1256b101],
5	from	IN	O	from	_	0	SENT_188	[p15l1281t58r1379b93],
6	The	DT	O	the	det	9	SENT_188	[p15l1404t58r1484b93],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_188	[p15l1510t58r1660b93],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_188	[p15l1687t58r1919b102],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_188	[p15l1942t58r2086b101],
10	.	.	O	.	_	0	SENT_188	[p15l1942t58r2086b101],

1	ARTICLES	NNS	O	article	_	0	SENT_189	[p15l91t177r244b198],

1	pyrimethamine	NN	O	pyrimethamine	nn	2	SENT_190	[p15l7t369r575b445],
2	group	NN	O	group	nsubj	5	SENT_190	[p15l626t389r841b445],
3	in	IN	O	in	_	0	SENT_190	[p15l893t369r963b429],
4	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	2	SENT_190	[p15l1013t369r1201b429],
5	had	VBD	O	have	_	0	SENT_190	[p15l1250t369r1387b430],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_190	[p15l1438t369r1890b445],
7	lower	JJR	O	lower	amod	9	SENT_190	[p15l1937t369r2143b430],
8	haemoglobin	NN	O	haemoglobin	nn	9	SENT_190	[p15l7t462r495b538],
9	concentrations	NNS	O	concentration	nn	20	SENT_190	[p15l607t463r1158b523],
10	at	IN	O	at	_	0	SENT_190	[p15l1273t477r1338b523],
11	entry	NN	O	entry	prep_at	9	SENT_190	[p15l1450t477r1640b538],
12	than	IN	O	than	_	0	SENT_190	[p15l1749t462r1916b523],
13	the	DT	O	the	det	17	SENT_190	[p15l2026t462r2140b523],
14	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	17	SENT_190	[p15l10t556r904b632],
15	group	NN	O	group	nn	17	SENT_190	[p15l938t575r1153b632],
16	(	CD	NUMBER	(	num	17	SENT_190	[p15l1195t556r1548b632],
17	p	NN	O	p	prep_than	11	SENT_190	[p15l1195t556r1548b632],
18	=	JJ	O	=	amod	20	SENT_190	[p15l1195t556r1548b632],
19	0-02	CD	NUMBER	0-02	tmod	18	SENT_190	[p15l1195t556r1548b632],
20	)	NN	O	)	dobj	5	SENT_190	[p15l1195t556r1548b632],
21	.	.	O	.	_	0	SENT_190	[p15l1195t556r1548b632],

1	In	IN	O	in	_	0	SENT_191	[p15l1587t557r1665b615],
2	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	29	SENT_191	[p15l1699t556r1910b629],
3	,	,	O	,	_	0	SENT_191	[p15l1699t556r1910b629],
4	59	CD	NUMBER	59	nsubj	29	SENT_191	[p15l1949t558r2034b616],
5	of	IN	O	of	_	0	SENT_191	[p15l2072t556r2151b616],
6	188	CD	PERCENT	188	number	7	SENT_191	[p15l18t651r145b709],
7	(	CD	PERCENT	(	prep_of	4	SENT_191	[p15l205t648r504b723],
8	31-4	CD	PERCENT	31-4	num	9	SENT_191	[p15l205t648r504b723],
9	%	NN	PERCENT	%	dep	7	SENT_191	[p15l205t648r504b723],
10	)	CD	NUMBER	)	dep	7	SENT_191	[p15l205t648r504b723],
11	and	CC	O	and	_	0	SENT_191	[p15l563t648r698b709],
12	54	CD	NUMBER	54	conj_and	10	SENT_191	[p15l752t651r839b709],
13	of	IN	O	of	_	0	SENT_191	[p15l893t648r972b709],
14	195	CD	PERCENT	195	number	15	SENT_191	[p15l1023t651r1148b709],
15	(	CD	PERCENT	(	nn	23	SENT_191	[p15l1210t648r1503b723],
16	27-7	CD	PERCENT	27-7	num	17	SENT_191	[p15l1210t648r1503b723],
17	%	NN	PERCENT	%	dep	15	SENT_191	[p15l1210t648r1503b723],
18	,	,	O	,	_	0	SENT_191	[p15l1210t648r1503b723],
19	chlorproguanildapsone	NN	O	chlorproguanildapsone	nn	23	SENT_191	[p15l1560t648r2141b724, p15l10t741r316b817],
20	and	CC	O	and	_	0	SENT_191	[p15l371t741r507b802],
21	sulfadoxine	NN	O	sulfadoxine	nn	23	SENT_191	[p15l561t741r1614b817],
22	—	NN	O	—	nn	23	SENT_191	[p15l561t741r1614b817],
23	pyrimethamine	NN	O	pyrimethamine	prep_of	10	SENT_191	[p15l561t741r1614b817],
24	,	,	O	,	_	0	SENT_191	[p15l561t741r1614b817],
25	respectively	RB	O	respectively	advmod	7	SENT_191	[p15l1670t741r2135b817],
26	)	CD	NUMBER	)	num	27	SENT_191	[p15l1670t741r2135b817],
27	patients	NNS	O	patient	dep	7	SENT_191	[p15l7t835r301b911],
28	had	VBD	O	have	aux	29	SENT_191	[p15l348t835r485b895],
29	taken	VBN	O	take	_	0	SENT_191	[p15l532t835r734b895],
30	chloroquine	NN	O	chloroquine	dobj	29	SENT_191	[p15l782t835r1230b911],
31	before	IN	O	before	_	0	SENT_191	[p15l1276t835r1510b895],
32	recruitment	NN	O	recruitment	prep_before	29	SENT_191	[p15l1557t835r2021b908],
33	;	:	O	;	_	0	SENT_191	[p15l1557t835r2021b908],
34	in	IN	O	in	_	0	SENT_191	[p15l2071t835r2141b894],
35	Blantyre	NNP	LOCATION	Blantyre	prep_in	39	SENT_191	[p15l9t927r324b1003],
36	these	DT	O	these	det	37	SENT_191	[p15l359t927r549b988],
37	proportions	NNS	O	proportion	nsubj	39	SENT_191	[p15l584t927r1022b1003],
38	were	VBD	O	be	cop	39	SENT_191	[p15l1058t947r1231b988],
39	1	CD	NUMBER	1	parataxis	29	SENT_191	[p15l1277t930r1302b987],
40	of	IN	O	of	_	0	SENT_191	[p15l1348t927r1427b988],
41	222	CD	PERCENT	222	number	42	SENT_191	[p15l1454t930r1589b987],
42	(	CD	PERCENT	(	num	44	SENT_191	[p15l1633t927r1884b1002],
43	0-5	CD	PERCENT	0-5	num	44	SENT_191	[p15l1633t927r1884b1002],
44	%	NN	PERCENT	%	prep_of	39	SENT_191	[p15l1633t927r1884b1002],
45	)	CD	NUMBER	)	dep	44	SENT_191	[p15l1633t927r1884b1002],
46	and	CC	O	and	_	0	SENT_191	[p15l1927t927r2062b988],
47	o	NN	O	o	prep_of	39	SENT_191	[p15l2100t930r2139b988],
48	of	IN	O	of	_	0	SENT_191	[p15l10t1020r89b1081],
49	224	CD	NUMBER	224	prep_of	47	SENT_191	[p15l116t1023r276b1093],
50	,	,	O	,	_	0	SENT_191	[p15l116t1023r276b1093],
51	indicating	VBG	O	indicate	partmod	39	SENT_191	[p15l314t1020r689b1096],
52	the	DT	O	the	det	54	SENT_191	[p15l722t1020r836b1081],
53	restricted	JJ	O	restricted	amod	54	SENT_191	[p15l871t1020r1223b1081],
54	availability	NN	O	availability	dobj	51	SENT_191	[p15l1260t1020r1663b1096],
55	of	IN	O	of	_	0	SENT_191	[p15l1698t1020r1777b1081],
56	this	DT	O	this	det	57	SENT_191	[p15l1801t1020r1933b1081],
57	drug	NN	O	drug	prep_of	54	SENT_191	[p15l1971t1020r2143b1096],
58	in	IN	O	in	_	0	SENT_191	[p15l9t1114r79b1173],
59	Malawi	NNP	LOCATION	Malawi	prep_in	57	SENT_191	[p15l110t1114r407b1174],
60	.	.	O	.	_	0	SENT_191	[p15l110t1114r407b1174],

1	In	IN	O	in	_	0	SENT_192	[p15l444t1115r523b1173],
2	Kilifi	NNP	LOCATION	Kilifi	prep_in	24	SENT_192	[p15l554t1114r743b1173],
3	148	CD	NUMBER	148	num	2	SENT_192	[p15l783t1116r911b1174],
4	of	IN	O	of	_	0	SENT_192	[p15l947t1114r1025b1174],
5	188	CD	PERCENT	188	number	6	SENT_192	[p15l1057t1116r1184b1174],
6	(	CD	PERCENT	(	prep_of	2	SENT_192	[p15l1224t1114r1523b1189],
7	78-7	CD	PERCENT	78-7	num	8	SENT_192	[p15l1224t1114r1523b1189],
8	%	NN	PERCENT	%	nsubj	24	SENT_192	[p15l1224t1114r1523b1189],
9	)	CD	NUMBER	)	num	8	SENT_192	[p15l1224t1114r1523b1189],
10	and	CC	O	and	_	0	SENT_192	[p15l1562t1114r1698b1174],
11	149	CD	NUMBER	149	conj_and	9	SENT_192	[p15l1738t1116r1865b1174],
12	of	IN	O	of	_	0	SENT_192	[p15l1902t1114r1980b1174],
13	195	CD	PERCENT	195	number	14	SENT_192	[p15l2011t1116r2136b1174],
14	(	CD	PERCENT	(	prep_of	8	SENT_192	[p15l15t1206r309b1281],
15	76-4	CD	PERCENT	76-4	num	16	SENT_192	[p15l15t1206r309b1281],
16	%	NN	PERCENT	%	dep	14	SENT_192	[p15l15t1206r309b1281],
17	,	,	O	,	_	0	SENT_192	[p15l15t1206r309b1281],
18	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	appos	14	SENT_192	[p15l425t1206r1319b1282],
19	and	CC	O	and	_	0	SENT_192	[p15l1433t1206r1568b1267],
20	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	conj_and	18	SENT_192	[p15l1682t1206r2140b1267, p15l7t1299r599b1375],
21	,	,	O	,	_	0	SENT_192	[p15l1682t1206r2140b1267, p15l7t1299r599b1375],
22	respectively	RB	O	respectively	advmod	14	SENT_192	[p15l648t1299r1112b1375],
23	)	CD	NUMBER	)	dep	14	SENT_192	[p15l648t1299r1112b1375],
24	slept	VBD	O	sleep	_	0	SENT_192	[p15l1166t1299r1339b1375],
25	under	IN	O	under	_	0	SENT_192	[p15l1383t1299r1604b1360],
26	a	DT	O	a	det	28	SENT_192	[p15l1650t1319r1685b1360],
27	bed	NN	O	bed	nn	28	SENT_192	[p15l1730t1299r1867b1360],
28	net	NN	O	net	prep_under	24	SENT_192	[p15l1912t1314r2029b1360],
29	at	IN	O	at	_	0	SENT_192	[p15l2076t1314r2142b1360],
30	recruitment	NN	O	recruitment	prep_at	24	SENT_192	[p15l8t1393r450b1453],
31	(	CD	NUMBER	(	num	30	SENT_192	[p15l504t1393r958b1468],
32	concordant	JJ	O	concordant	amod	30	SENT_192	[p15l504t1393r958b1468],
33	with	IN	O	with	_	0	SENT_192	[p15l1005t1393r1167b1453],
34	previous	JJ	O	previous	amod	35	SENT_192	[p15l1214t1393r1529b1469],
35	studies	NNS	O	study	prep_with	32	SENT_192	[p15l1581t1393r1837b1453],
36	of	IN	O	of	_	0	SENT_192	[p15l1888t1393r1967b1453],
37	bed	NN	O	bed	nn	38	SENT_192	[p15l2005t1393r2141b1453],
38	nets	NNS	O	net	prep_of	35	SENT_192	[p15l8t1499r157b1546],
39	in	IN	O	in	_	0	SENT_192	[p15l198t1485r268b1545],
40	this	DT	O	this	det	43	SENT_192	[p15l306t1485r438b1546],
41	centre	NN	O	centre	nn	43	SENT_192	[p15l481t1486r814b1560],
42	”	CD	NUMBER	”	num	43	SENT_192	[p15l481t1486r814b1560],
43	)	NN	O	)	prep_in	38	SENT_192	[p15l481t1486r814b1560],
44	;	:	O	;	_	0	SENT_192	[p15l481t1486r814b1560],
45	by	IN	O	by	_	0	SENT_192	[p15l855t1485r944b1561],
46	contrast	NN	O	contrast	prep_by	38	SENT_192	[p15l983t1499r1306b1558],
47	,	,	O	,	_	0	SENT_192	[p15l983t1499r1306b1558],
48	at	IN	O	at	_	0	SENT_192	[p15l1350t1499r1416b1546],
49	Blantyre	NNP	LOCATION	Blantyre	nn	50	SENT_192	[p15l1455t1485r1769b1561],
50	o	NN	O	o	prep_at	38	SENT_192	[p15l1811t1488r1850b1546],
51	of	IN	O	of	_	0	SENT_192	[p15l1894t1485r1972b1546],
52	222	CD	NUMBER	222	prep_of	50	SENT_192	[p15l2004t1488r2138b1545],
53	and	CC	O	and	_	0	SENT_192	[p15l10t1578r145b1639],
54	2	CD	NUMBER	2	prep_of	50	SENT_192	[p15l176t1581r215b1638],
55	of	IN	O	of	_	0	SENT_192	[p15l249t1578r327b1639],
56	224	CD	PERCENT	224	number	57	SENT_192	[p15l349t1581r484b1638],
57	(	CD	PERCENT	(	prep_of	52	SENT_192	[p15l521t1578r772b1654],
58	0-9	CD	PERCENT	0-9	num	59	SENT_192	[p15l521t1578r772b1654],
59	%	NN	PERCENT	%	nsubj	61	SENT_192	[p15l521t1578r772b1654],
60	)	CD	NUMBER	)	dep	59	SENT_192	[p15l521t1578r772b1654],
61	slept	VBD	O	sleep	rcmod	57	SENT_192	[p15l809t1578r981b1654],
62	under	IN	O	under	_	0	SENT_192	[p15l1009t1578r1230b1639],
63	a	DT	O	a	det	64	SENT_192	[p15l1259t1598r1294b1639],
64	net	NN	O	net	prep_under	61	SENT_192	[p15l1323t1593r1460b1639],
65	.	.	O	.	_	0	SENT_192	[p15l1323t1593r1460b1639],

1	Follow-up	JJ	O	follow-up	nsubj	4	SENT_193	[p15l94t1672r480b1748],
2	in	IN	O	in	_	0	SENT_193	[p15l515t1672r585b1731],
3	Kilifi	NNP	LOCATION	Kilifi	prep_in	1	SENT_193	[p15l619t1672r807b1731],
4	lasted	VBD	O	last	dep	10	SENT_193	[p15l841t1672r1057b1732],
5	a	DT	O	a	det	6	SENT_193	[p15l1093t1692r1128b1732],
6	median	NN	O	median	dobj	4	SENT_193	[p15l1162t1672r1439b1732],
7	of	IN	O	of	_	0	SENT_193	[p15l1474t1672r1552b1732],
8	338	CD	DURATION	338	num	9	SENT_193	[p15l1578t1674r1712b1732],
9	days	NNS	NUMBER	day	prep_of	6	SENT_193	[p15l1751t1672r1911b1748],
10	(	VBP	O	(	_	0	SENT_193	[p15l1953t1672r2145b1748],
11	IQR	NN	O	iqr	nn	13	SENT_193	[p15l1953t1672r2145b1748],
12	128-360	CD	NUMBER	128-360	num	13	SENT_193	[p15l18t1765r363b1839],
13	)	NN	O	)	dobj	10	SENT_193	[p15l18t1765r363b1839],
14	and	CC	O	and	_	0	SENT_193	[p15l443t1764r579b1825],
15	342	CD	DURATION	342	num	16	SENT_193	[p15l653t1767r788b1825],
16	days	NNS	NUMBER	day	conj_and	13	SENT_193	[p15l864t1764r1024b1840],
17	(	CD	NUMBER	(	number	18	SENT_193	[p15l1105t1765r1482b1839],
18	152	CD	NUMBER	152	num	19	SENT_193	[p15l1105t1765r1482b1839],
19	—	NN	O	—	dep	16	SENT_193	[p15l1105t1765r1482b1839],
20	359	CD	NUMBER	359	nsubj	10	SENT_193	[p15l1105t1765r1482b1839],
21	,	,	O	,	_	0	SENT_193	[p15l1105t1765r1482b1839],
22	chlorproguanildapsone	NN	O	chlorproguanildapsone	appos	20	SENT_193	[p15l1560t1764r2141b1840, p15l10t1857r316b1933],
23	and	CC	O	and	_	0	SENT_193	[p15l363t1857r498b1918],
24	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	appos	20	SENT_193	[p15l543t1857r1597b1933],
25	,	,	O	,	_	0	SENT_193	[p15l543t1857r1597b1933],
26	respectively	RB	O	respectively	advmod	27	SENT_193	[p15l1644t1857r2135b1933],
27	)	CD	NUMBER	)	rcmod	20	SENT_193	[p15l1644t1857r2135b1933],
28	.	.	O	.	_	0	SENT_193	[p15l1644t1857r2135b1933],

1	In	IN	O	in	_	0	SENT_194	[p15l9t1952r87b2010],
2	Blantyre	NNP	LOCATION	Blantyre	prep_in	6	SENT_194	[p15l118t1951r456b2027],
3	,	,	O	,	_	0	SENT_194	[p15l118t1951r456b2027],
4	median	JJ	O	median	amod	5	SENT_194	[p15l488t1951r766b2011],
5	follow-up	NN	O	follow-up	nsubj	6	SENT_194	[p15l796t1951r1152b2027],
6	lasted	VBD	O	last	_	0	SENT_194	[p15l1185t1951r1401b2011],
7	120	CD	DURATION	120	num	8	SENT_194	[p15l1440t1953r1568b2011],
8	days	NNS	NUMBER	day	tmod	6	SENT_194	[p15l1602t1951r1762b2027],
9	(	CD	NUMBER	(	num	11	SENT_194	[p15l1800t1951r2135b2026],
10	33-281	CD	NUMBER	33-281	num	11	SENT_194	[p15l1800t1951r2135b2026],
11	)	NN	O	)	nsubj	15	SENT_194	[p15l1800t1951r2135b2026],
12	and	CC	O	and	_	0	SENT_194	[p15l10t2043r145b2104],
13	84	CD	DURATION	84	num	14	SENT_194	[p15l191t2046r277b2104],
14	days	NNS	NUMBER	day	conj_and	11	SENT_194	[p15l323t2043r484b2119],
15	(	VBP	O	(	ccomp	6	SENT_194	[p15l534t2043r894b2118],
16	26-224	CD	NUMBER	26-224	num	17	SENT_194	[p15l534t2043r894b2118],
17	)	CD	NUMBER	)	dobj	15	SENT_194	[p15l534t2043r894b2118],
18	.	.	O	.	_	0	SENT_194	[p15l534t2043r894b2118],

1	Overall	RB	O	overall	advmod	11	SENT_195	[p15l945t2043r1236b2116],
2	,	,	O	,	_	0	SENT_195	[p15l945t2043r1236b2116],
3	use	NN	O	use	nsubj	11	SENT_195	[p15l1282t2063r1402b2104],
4	of	IN	O	of	_	0	SENT_195	[p15l1447t2043r1525b2104],
5	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	3	SENT_195	[p15l1559t2043r2140b2119, p15l10t2136r316b2212],
6	rather	RB	O	rather	_	0	SENT_195	[p15l384t2136r608b2197],
7	than	IN	O	than	_	0	SENT_195	[p15l673t2136r839b2197],
8	sulfadoxine	JJ	O	sulfadoxine	amod	10	SENT_195	[p15l907t2136r1937b2212],
9	—	NN	O	—	nn	10	SENT_195	[p15l907t2136r1937b2212],
10	pyrimethamine	NN	O	pyrimethamine	prep_of	3	SENT_195	[p15l907t2136r1937b2212],
11	had	VBD	O	have	_	0	SENT_195	[p15l2004t2136r2141b2197],
12	little	JJ	O	little	amod	13	SENT_195	[p15l9t2230r176b2290],
13	effect	NN	O	effect	dobj	11	SENT_195	[p15l209t2230r411b2290],
14	on	IN	O	on	_	0	SENT_195	[p15l442t2249r533b2290],
15	annual	JJ	SET	annual	amod	17	SENT_195	[p15l565t2230r815b2290],
16	malaria	NN	O	malaria	nn	17	SENT_195	[p15l846t2230r1123b2290],
17	incidence	NN	O	incidence	prep_on	13	SENT_195	[p15l1154t2230r1509b2290],
18	at	IN	O	at	prep	13	SENT_195	[p15l1543t2244r1608b2290],
19	either	CC	O	either	dep	18	SENT_195	[p15l1640t2230r1853b2290],
20	site	NN	O	site	conj	18	SENT_195	[p15l1883t2230r2027b2290],
21	.	.	O	.	_	0	SENT_195	[p15l1883t2230r2027b2290],

1	In	IN	O	in	_	0	SENT_196	[p15l2063t2231r2141b2289],
2	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	7	SENT_196	[p15l9t2321r220b2393],
3	,	,	O	,	_	0	SENT_196	[p15l9t2321r220b2393],
4	antimalarial	JJ	O	antimalarial	amod	5	SENT_196	[p15l304t2321r747b2382],
5	treatment	NN	O	treatment	nsubjpass	7	SENT_196	[p15l826t2335r1192b2382],
6	was	VBD	O	be	auxpass	7	SENT_196	[p15l1268t2341r1404b2382],
7	needed	VBN	O	need	dep	11	SENT_196	[p15l1483t2321r1752b2382],
8	on	IN	O	on	_	0	SENT_196	[p15l1832t2341r1923b2382],
9	298	CD	NUMBER	298	num	10	SENT_196	[p15l2004t2324r2138b2382],
10	occasions	NNS	O	occasion	prep_on	7	SENT_196	[p15l10t2415r363b2475],
11	(	VBP	O	(	_	0	SENT_196	[p15l434t2415r585b2490],
12	not	RB	O	not	dep	16	SENT_196	[p15l434t2415r585b2490],
13	counting	VBG	O	count	amod	15	SENT_196	[p15l648t2415r978b2490],
14	first	JJ	ORDINAL	first	amod	15	SENT_196	[p15l1039t2414r1185b2475],
15	episodes	NNS	O	episode	nsubj	16	SENT_196	[p15l1248t2414r1591b2490],
16	)	VBP	O	)	ccomp	11	SENT_196	[p15l1248t2414r1591b2490],
17	over	IN	O	over	_	0	SENT_196	[p15l1661t2434r1820b2475],
18	46	CD	NUMBER	46	number	19	SENT_196	[p15l1882t2417r1970b2475],
19	730	CD	NUMBER	730	num	20	SENT_196	[p15l2004t2417r2138b2475],
20	patient-days	NNS	O	patient-day	prep_over	16	SENT_196	[p15l7t2508r467b2584],
21	(	CD	NUMBER	(	num	23	SENT_196	[p15l517t2508r796b2583],
22	annual	JJ	SET	annual	amod	23	SENT_196	[p15l517t2508r796b2583],
23	incidence	NN	O	incidence	dep	20	SENT_196	[p15l839t2508r1195b2568],
24	2-5	CD	NUMBER	2-5	num	25	SENT_196	[p15l1240t2508r1382b2583],
25	)	NN	O	)	dobj	16	SENT_196	[p15l1240t2508r1382b2583],
26	for	IN	O	for	_	0	SENT_196	[p15l1431t2508r1536b2568],
27	patients	NNS	O	patient	prep_for	25	SENT_196	[p15l1575t2508r1868b2584],
28	taking	VBG	O	take	partmod	27	SENT_196	[p15l1912t2508r2143b2584],
29	ch1orproguanil	JJ	O	ch1orproguanil	amod	30	SENT_196	[p15l10t2600r927b2676],
30	—	NN	O	—	dobj	28	SENT_196	[p15l10t2600r927b2676],
31	dapsone	NN	O	dapsone	dep	30	SENT_196	[p15l10t2600r927b2676],
32	,	,	O	,	_	0	SENT_196	[p15l10t2600r927b2676],
33	and	CC	O	and	_	0	SENT_196	[p15l971t2600r1107b2661],
34	on	IN	O	on	conj_and	30	SENT_196	[p15l1147t2620r1239b2661],
35	277	CD	NUMBER	277	num	36	SENT_196	[p15l1279t2603r1413b2660],
36	occasions	NNS	O	occasion	pobj	34	SENT_196	[p15l1458t2600r1811b2661],
37	over	IN	O	over	_	0	SENT_196	[p15l1853t2620r2012b2661],
38	50	CD	NUMBER	50	number	39	SENT_196	[p15l2052t2603r2138b2661],
39	307	CD	NUMBER	307	num	40	SENT_196	[p15l11t2696r144b2754],
40	patient-days	NNS	O	patient-day	prep_over	36	SENT_196	[p15l177t2693r636b2769],
41	(	CD	NUMBER	(	num	43	SENT_196	[p15l674t2693r954b2769],
42	annual	JJ	SET	annual	amod	43	SENT_196	[p15l674t2693r954b2769],
43	incidence	NN	O	incidence	dep	30	SENT_196	[p15l984t2693r1340b2754],
44	2-1	CD	NUMBER	2-1	num	45	SENT_196	[p15l1373t2694r1516b2768],
45	)	NN	O	)	dep	43	SENT_196	[p15l1373t2694r1516b2768],
46	for	IN	O	for	_	0	SENT_196	[p15l1553t2693r1658b2754],
47	those	DT	O	those	nsubj	48	SENT_196	[p15l1686t2693r1882b2754],
48	taking	VBG	O	take	prepc_for	16	SENT_196	[p15l1912t2693r2143b2769],
49	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	52	SENT_196	[p15l10t2787r1040b2863],
50	(	NN	O	(	nn	52	SENT_196	[p15l1088t2787r1387b2862],
51	relative	JJ	O	relative	amod	52	SENT_196	[p15l1088t2787r1387b2862],
52	risk	NN	O	risk	dobj	48	SENT_196	[p15l1429t2787r1563b2847],
53	1-16	CD	NUMBER	1-16	nsubj	11	SENT_196	[p15l1611t2789r1790b2860],
54	,	,	O	,	_	0	SENT_196	[p15l1611t2789r1790b2860],
55	95	CD	PERCENT	95	number	56	SENT_196	[p15l1837t2787r1999b2849],
56	%	NN	PERCENT	%	amod	57	SENT_196	[p15l1837t2787r1999b2849],
57	CI	NN	O	ci	appos	53	SENT_196	[p15l2048t2787r2141b2847],
58	0-98-1-37	CD	NUMBER	0-98-1-37	num	59	SENT_196	[p15l11t2880r441b2954],
59	)	NN	O	)	dep	57	SENT_196	[p15l11t2880r441b2954],
60	.	.	O	.	_	0	SENT_196	[p15l11t2880r441b2954],

1	In	IN	O	in	_	0	SENT_197	[p15l518t2880r597b2939],
2	Blantyre	NNP	LOCATION	Blantyre	nn	4	SENT_197	[p15l668t2879r982b2955],
3	antimalarial	JJ	O	antimalarial	amod	4	SENT_197	[p15l1056t2879r1499b2940],
4	treatment	NN	O	treatment	prep_in	6	SENT_197	[p15l1570t2893r1936b2940],
5	was	VBD	O	be	auxpass	6	SENT_197	[p15l2005t2899r2139b2940],
6	needed	VBN	O	need	_	0	SENT_197	[p15l8t2972r276b3033],
7	for	IN	O	for	_	0	SENT_197	[p15l341t2972r447b3033],
8	195	CD	NUMBER	195	num	9	SENT_197	[p15l519t2975r645b3033],
9	episodes	NNS	O	episode	prep_for	6	SENT_197	[p15l716t2972r1030b3048],
10	over	IN	O	over	_	0	SENT_197	[p15l1098t2992r1257b3033],
11	34	CD	NUMBER	34	number	12	SENT_197	[p15l1322t2975r1410b3033],
12	876	CD	NUMBER	876	num	13	SENT_197	[p15l1479t2975r1613b3033],
13	patient-days	NNS	O	patient-day	prep_over	9	SENT_197	[p15l1680t2972r2139b3048],
14	(	CD	NUMBER	(	num	18	SENT_197	[p15l15t3066r294b3141],
15	annual	JJ	SET	annual	amod	18	SENT_197	[p15l15t3066r294b3141],
16	incidence	NN	O	incidence	nn	18	SENT_197	[p15l437t3066r793b3126],
17	2-2	CD	NUMBER	2-2	num	18	SENT_197	[p15l938t3066r1081b3141],
18	)	NN	O	)	nsubjpass	6	SENT_197	[p15l938t3066r1081b3141],
19	for	IN	O	for	_	0	SENT_197	[p15l1230t3066r1335b3126],
20	patients	NNS	O	patient	prep_for	6	SENT_197	[p15l1475t3066r1768b3142],
21	taking	VBG	O	take	partmod	20	SENT_197	[p15l1912t3066r2143b3142],
22	ch1orproguanil	JJ	O	ch1orproguanil	amod	23	SENT_197	[p15l10t3158r927b3234],
23	—	NN	O	—	dobj	21	SENT_197	[p15l10t3158r927b3234],
24	dapsone	NN	O	dapsone	dep	23	SENT_197	[p15l10t3158r927b3234],
25	,	,	O	,	_	0	SENT_197	[p15l10t3158r927b3234],
26	and	CC	O	and	_	0	SENT_197	[p15l978t3158r1113b3219],
27	on	IN	O	on	dobj	21	SENT_197	[p15l1161t3178r1252b3219],
28	207	CD	NUMBER	207	num	29	SENT_197	[p15l1300t3161r1433b3219],
29	episodes	NNS	O	episode	pobj	27	SENT_197	[p15l1484t3158r1797b3234],
30	over	IN	O	over	_	0	SENT_197	[p15l1847t3178r2005b3219],
31	28	CD	NUMBER	28	number	32	SENT_197	[p15l2051t3161r2138b3219],
32	576	CD	NUMBER	576	num	33	SENT_197	[p15l12t3254r145b3312],
33	patient-days	NNS	O	patient-day	prep_over	29	SENT_197	[p15l177t3251r636b3327],
34	(	CD	NUMBER	(	num	36	SENT_197	[p15l674t3251r954b3327],
35	annual	JJ	SET	annual	amod	36	SENT_197	[p15l674t3251r954b3327],
36	incidence	NN	O	incidence	dep	23	SENT_197	[p15l984t3251r1340b3312],
37	2-8	CD	NUMBER	2-8	num	38	SENT_197	[p15l1373t3252r1516b3326],
38	)	NN	O	)	dep	36	SENT_197	[p15l1373t3252r1516b3326],
39	for	IN	O	for	_	0	SENT_197	[p15l1553t3251r1658b3312],
40	those	DT	O	those	nsubj	41	SENT_197	[p15l1686t3251r1882b3312],
41	taking	VBG	O	take	prepc_for	21	SENT_197	[p15l1912t3251r2143b3327],
42	sulfadoXine	NN	O	sulfadoxine	nn	45	SENT_197	[p15l10t3345r1040b3421],
43	—	NN	O	—	nn	45	SENT_197	[p15l10t3345r1040b3421],
44	pyrimethamine	NN	O	pyrimethamine	nn	45	SENT_197	[p15l10t3345r1040b3421],
45	(	NN	O	(	dobj	41	SENT_197	[p15l1088t3345r1387b3420],
46	relative	JJ	O	relative	advmod	41	SENT_197	[p15l1088t3345r1387b3420],
47	risk	NN	O	risk	dep	46	SENT_197	[p15l1429t3345r1563b3405],
48	0-77	CD	NUMBER	0-77	num	47	SENT_197	[p15l1604t3347r1790b3418],
49	,	,	O	,	_	0	SENT_197	[p15l1604t3347r1790b3418],
50	95	CD	PERCENT	95	number	51	SENT_197	[p15l1837t3345r1999b3407],
51	%	NN	PERCENT	%	amod	52	SENT_197	[p15l1837t3345r1999b3407],
52	CI	NN	O	ci	appos	47	SENT_197	[p15l2048t3345r2141b3405],
53	0-63-0-94	CD	NUMBER	0-63-0-94	num	54	SENT_197	[p15l11t3438r441b3512],
54	)	NN	O	)	dep	52	SENT_197	[p15l11t3438r441b3512],
55	.	.	O	.	_	0	SENT_197	[p15l11t3438r441b3512],

1	Additionally	RB	O	additionally	advmod	6	SENT_198	[p15l519t3437r1007b3513],
2	,	,	O	,	_	0	SENT_198	[p15l519t3437r1007b3513],
3	in	IN	O	in	_	0	SENT_198	[p15l1085t3437r1154b3497],
4	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	6	SENT_198	[p15l1229t3437r1417b3497],
5	there	EX	O	there	expl	6	SENT_198	[p15l1491t3437r1679b3498],
6	were	VBD	O	be	_	0	SENT_198	[p15l1753t3457r1926b3498],
7	575	CD	NUMBER	575	num	8	SENT_198	[p15l2005t3440r2136b3498],
8	episodes	NNS	O	episode	nsubj	6	SENT_198	[p15l10t3530r324b3606],
9	of	IN	O	of	_	0	SENT_198	[p15l362t3530r440b3591],
10	aparasitaemic	JJ	O	aparasitaemic	amod	11	SENT_198	[p15l467t3531r977b3606],
11	illness	NN	O	illness	prep_of	8	SENT_198	[p15l1012t3530r1239b3591],
12	during	IN	O	during	_	0	SENT_198	[p15l1276t3530r1522b3606],
13	46	CD	NUMBER	46	number	14	SENT_198	[p15l1556t3533r1644b3591],
14	7	CD	NUMBER	7	num	19	SENT_198	[p15l1677t3533r1715b3590],
15	30	CD	NUMBER	30	num	16	SENT_198	[p15l1725t3533r1812b3591],
16	patientdays	NNS	O	patientday	npadvmod	17	SENT_198	[p15l1848t3531r2140b3606, p15l10t3624r171b3700],
17	(	JJ	O	(	amod	19	SENT_198	[p15l242t3624r521b3699],
18	annual	JJ	SET	annual	amod	19	SENT_198	[p15l242t3624r521b3699],
19	incidence	NN	O	incidence	prep_during	6	SENT_198	[p15l585t3624r941b3684],
20	4-5	CD	NUMBER	4-5	dep	19	SENT_198	[p15l1006t3626r1145b3697],
21	;	:	O	;	_	0	SENT_198	[p15l1006t3626r1145b3697],
22	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	23	SENT_198	[p15l1213t3624r2135b3700],
23	)	NN	O	)	dep	19	SENT_198	[p15l1213t3624r2135b3700],
24	and	CC	O	and	_	0	SENT_198	[p15l10t3716r145b3777],
25	623	CD	NUMBER	623	num	26	SENT_198	[p15l197t3719r329b3777],
26	episodes	NNS	O	episode	advmod	23	SENT_198	[p15l383t3716r696b3792],
27	during	IN	O	during	_	0	SENT_198	[p15l747t3716r993b3792],
28	50	CD	NUMBER	50	number	29	SENT_198	[p15l1042t3719r1128b3777],
29	307	CD	NUMBER	307	num	30	SENT_198	[p15l1162t3719r1295b3777],
30	patient-days	NNS	O	patient-day	prep_during	26	SENT_198	[p15l1346t3716r1805b3792],
31	(	CD	NUMBER	(	num	33	SENT_198	[p15l1861t3716r2141b3791],
32	annual	JJ	SET	annual	amod	33	SENT_198	[p15l1861t3716r2141b3791],
33	incidence	NN	O	incidence	conj_and	23	SENT_198	[p16l9t15r364b76],
34	4-5	CD	NUMBER	4-5	dep	33	SENT_198	[p16l435t18r574b88],
35	;	:	O	;	_	0	SENT_198	[p16l435t18r574b88],
36	sulfadoxine	NN	O	sulfadoxine	nn	37	SENT_198	[p16l647t15r1735b91],
37	—	NN	O	—	dep	19	SENT_198	[p16l647t15r1735b91],
38	pyrimethamine	NN	O	pyrimethamine	nn	39	SENT_198	[p16l647t15r1735b91],
39	)	NN	O	)	dep	37	SENT_198	[p16l647t15r1735b91],
40	,	,	O	,	_	0	SENT_198	[p16l647t15r1735b91],
41	while	IN	O	while	mark	45	SENT_198	[p16l1805t15r2002b76],
42	in	IN	O	in	_	0	SENT_198	[p16l2071t16r2141b75],
43	Blantyre	NNP	LOCATION	Blantyre	prep_in	45	SENT_198	[p16l9t109r323b185],
44	there	EX	O	there	expl	45	SENT_198	[p16l353t109r541b169],
45	were	VBD	O	be	advcl	6	SENT_198	[p16l569t129r743b169],
46	392	CD	NUMBER	392	num	47	SENT_198	[p16l774t111r910b169],
47	episodes	NNS	O	episode	nsubj	45	SENT_198	[p16l943t109r1256b185],
48	during	IN	O	during	_	0	SENT_198	[p16l1288t109r1534b185],
49	34	CD	NUMBER	34	number	50	SENT_198	[p16l1563t111r1650b169],
50	876	CD	NUMBER	876	num	51	SENT_198	[p16l1684t111r1818b169],
51	patientdays	NNS	O	patientday	prep_during	47	SENT_198	[p16l1849t109r2141b185, p16l10t201r171b277],
52	(	JJ	O	(	amod	51	SENT_198	[p16l242t201r521b276],
53	annual	JJ	SET	annual	amod	54	SENT_198	[p16l242t201r521b276],
54	incidence	NN	O	incidence	tmod	52	SENT_198	[p16l585t201r941b262],
55	4-1	CD	NUMBER	4-1	num	54	SENT_198	[p16l1006t204r1145b274],
56	,	,	O	,	_	0	SENT_198	[p16l1006t204r1145b274],
57	chlorproguanil	NN	O	chlorproguanil	nn	60	SENT_198	[p16l1213t201r2135b277],
58	—	NN	O	—	nn	60	SENT_198	[p16l1213t201r2135b277],
59	dapsone	NN	O	dapsone	nn	60	SENT_198	[p16l1213t201r2135b277],
60	)	NN	O	)	tmod	52	SENT_198	[p16l1213t201r2135b277],
61	and	CC	O	and	_	0	SENT_198	[p16l10t294r145b355],
62	299	CD	NUMBER	299	num	63	SENT_198	[p16l214t297r347b355],
63	episodes	NNS	O	episode	conj_and	54	SENT_198	[p16l419t294r732b370],
64	during	IN	O	during	_	0	SENT_198	[p16l801t294r1047b370],
65	28	CD	NUMBER	28	number	66	SENT_198	[p16l1114t297r1200b355],
66	576	CD	NUMBER	576	num	67	SENT_198	[p16l1235t297r1369b355],
67	patient-days	NNS	O	patient-day	prep_during	45	SENT_198	[p16l1437t294r1896b370],
68	(	CD	NUMBER	(	number	69	SENT_198	[p16l1970t295r2138b370],
69	3-8	CD	NUMBER	3-8	num	67	SENT_198	[p16l1970t295r2138b370],
70	,	,	O	,	_	0	SENT_198	[p16l1970t295r2138b370],
71	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	72	SENT_198	[p16l10t388r1095b464],
72	)	NN	O	)	nsubj	45	SENT_198	[p16l10t388r1095b464],
73	.	.	O	.	_	0	SENT_198	[p16l10t388r1095b464],

1	Overall	RB	O	overall	advmod	5	SENT_199	[p16l1183t388r1475b461],
2	,	,	O	,	_	0	SENT_199	[p16l1183t388r1475b461],
3	chlorproguanildapsone	NN	O	chlorproguanildapsone	nsubjpass	5	SENT_199	[p16l1559t388r2140b464, p16l10t480r316b556],
4	was	VBD	O	be	auxpass	5	SENT_199	[p16l352t500r486b541],
5	associated	VBN	O	associate	_	0	SENT_199	[p16l526t480r904b541],
6	with	IN	O	with	_	0	SENT_199	[p16l939t480r1101b541],
7	less	JJR	O	less	amod	9	SENT_199	[p16l1137t480r1265b541],
8	treatment	NN	O	treatment	nn	9	SENT_199	[p16l1302t494r1668b541],
9	failure	NN	O	failure	prep_with	5	SENT_199	[p16l1703t480r1939b541],
10	than	IN	O	than	_	0	SENT_199	[p16l1975t480r2142b541],
11	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_than	9	SENT_199	[p16l10t573r1040b649],
12	in	IN	O	in	_	0	SENT_199	[p16l1093t574r1162b633],
13	both	DT	O	both	det	18	SENT_199	[p16l1211t573r1383b634],
14	sites	NNS	O	site	dep	18	SENT_199	[p16l1434t574r1591b634],
15	(	RB	O	(	dep	14	SENT_199	[p16l1649t573r1857b649],
16	table	NN	O	table	nn	18	SENT_199	[p16l1649t573r1857b649],
17	2	CD	NUMBER	2	num	18	SENT_199	[p16l1910t574r2006b649],
18	)	NN	O	)	prep_in	11	SENT_199	[p16l1910t574r2006b649],
19	.	.	O	.	_	0	SENT_199	[p16l1910t574r2006b649],

1	In	IN	O	in	_	0	SENT_200	[p16l2063t574r2141b633],
2	Kiliﬁ	NN	O	kiliﬁ	nn	4	SENT_200	[p16l9t667r197b726],
3	treatment	NN	O	treatment	nn	4	SENT_200	[p16l234t681r599b727],
4	failure	NN	O	failure	pobj	1	SENT_200	[p16l636t667r872b727],
5	complicated	VBN	O	complicate	partmod	4	SENT_200	[p16l911t667r1367b743],
6	8	CD	NUMBER	8	dobj	5	SENT_200	[p16l1407t669r1445b727],
7	of	IN	O	of	_	0	SENT_200	[p16l1486t667r1565b727],
8	486	CD	NUMBER	486	prep_of	6	SENT_200	[p16l1593t669r1729b727],
9	and	CC	O	and	_	0	SENT_200	[p16l1770t667r1906b727],
10	25	CD	NUMBER	25	prep_of	6	SENT_200	[p16l1944t669r2029b727],
11	of	IN	O	of	_	0	SENT_200	[p16l2072t667r2151b727],
12	472	CD	NUMBER	472	num	14	SENT_200	[p16l10t762r146b819],
13	evaluable	JJ	O	evaluable	amod	14	SENT_200	[p16l203t759r550b820],
14	episodes	NNS	O	episode	prep_of	6	SENT_200	[p16l606t759r944b835],
15	,	,	O	,	_	0	SENT_200	[p16l606t759r944b835],
16	causing	VBG	O	cause	partmod	5	SENT_200	[p16l1002t759r1282b835],
17	the	DT	O	the	det	18	SENT_200	[p16l1334t759r1448b820],
18	exit	NN	O	exit	dobj	16	SENT_200	[p16l1504t759r1637b820],
19	of	IN	O	of	_	0	SENT_200	[p16l1691t759r1770b820],
20	8	CD	NUMBER	8	prep_of	18	SENT_200	[p16l1816t762r1854b820],
21	versus	CC	O	versus	_	0	SENT_200	[p16l1909t779r2139b820],
22	25	CD	NUMBER	25	num	23	SENT_200	[p16l11t855r95b913],
23	patients	NNS	O	patient	dobj	16	SENT_200	[p16l154t853r448b928],
24	(	JJ	O	(	amod	27	SENT_200	[p16l510t852r1433b928],
25	chlorproguanil	NN	O	chlorproguanil	nn	27	SENT_200	[p16l510t852r1433b928],
26	—	NN	O	—	nn	27	SENT_200	[p16l510t852r1433b928],
27	dapsone	NN	O	dapsone	dep	23	SENT_200	[p16l510t852r1433b928],
28	and	CC	O	and	_	0	SENT_200	[p16l1490t852r1625b913],
29	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	conj_and	27	SENT_200	[p16l1682t852r2140b913, p16l7t946r599b1022],
30	,	,	O	,	_	0	SENT_200	[p16l1682t852r2140b913, p16l7t946r599b1022],
31	respectively	RB	O	respectively	advmod	23	SENT_200	[p16l673t946r1164b1022],
32	)	CD	NUMBER	)	dep	23	SENT_200	[p16l673t946r1164b1022],
33	.	.	O	.	_	0	SENT_200	[p16l673t946r1164b1022],

1	In	IN	O	in	_	0	SENT_201	[p16l1241t947r1319b1005],
2	Blantyre	NNP	LOCATION	Blantyre	nn	4	SENT_201	[p16l1390t946r1705b1022],
3	treatment	NN	O	treatment	nn	4	SENT_201	[p16l1776t960r2142b1006],
4	failure	NN	O	failure	pobj	1	SENT_201	[p16l8t1038r245b1099],
5	complicated	VBN	O	complicate	partmod	4	SENT_201	[p16l287t1038r743b1114],
6	12	CD	NUMBER	12	dobj	5	SENT_201	[p16l791t1041r872b1098],
7	of	IN	O	of	_	0	SENT_201	[p16l915t1038r994b1099],
8	379	CD	NUMBER	379	prep_of	6	SENT_201	[p16l1025t1041r1159b1099],
9	and	CC	O	and	_	0	SENT_201	[p16l1204t1038r1339b1099],
10	45	CD	NUMBER	45	prep_of	6	SENT_201	[p16l1380t1041r1465b1099],
11	of	IN	O	of	_	0	SENT_201	[p16l1511t1038r1590b1099],
12	397	CD	NUMBER	397	num	13	SENT_201	[p16l1622t1041r1755b1099],
13	episodes	NNS	O	episode	prep_of	8	SENT_201	[p16l1800t1038r2138b1114],
14	,	,	O	,	_	0	SENT_201	[p16l1800t1038r2138b1114],
15	and	CC	O	and	dep	16	SENT_201	[p16l10t1131r145b1192],
16	caused	VBD	O	cause	dep	5	SENT_201	[p16l237t1131r489b1192],
17	the	DT	O	the	det	18	SENT_201	[p16l578t1131r692b1192],
18	exit	NN	O	exit	dobj	16	SENT_201	[p16l783t1132r916b1192],
19	of	IN	O	of	_	0	SENT_201	[p16l1007t1131r1085b1192],
20	12	CD	NUMBER	12	prep_of	18	SENT_201	[p16l1174t1134r1254b1191],
21	versus	CC	O	versus	prep	20	SENT_201	[p16l1344t1151r1575b1192],
22	45	CD	NUMBER	45	num	23	SENT_201	[p16l1667t1134r1752b1192],
23	patients	NNS	O	patient	npadvmod	24	SENT_201	[p16l1845t1132r2139b1207],
24	(	JJ	O	(	amod	27	SENT_201	[p16l15t1225r937b1301],
25	chlorproguanil	NN	O	chlorproguanil	nn	27	SENT_201	[p16l15t1225r937b1301],
26	—	NN	O	—	nn	27	SENT_201	[p16l15t1225r937b1301],
27	dapsone	NN	O	dapsone	dep	21	SENT_201	[p16l15t1225r937b1301],
28	and	CC	O	and	_	0	SENT_201	[p16l1095t1225r1230b1285],
29	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	conj_and	27	SENT_201	[p16l1387t1225r2140b1301, p16l8t1317r336b1390],
30	,	,	O	,	_	0	SENT_201	[p16l1387t1225r2140b1301, p16l8t1317r336b1390],
31	respectively	RB	O	respectively	advmod	20	SENT_201	[p16l415t1317r880b1393],
32	)	CD	NUMBER	)	dep	20	SENT_201	[p16l415t1317r880b1393],
33	In	IN	O	in	_	0	SENT_201	[p16l963t1318r1041b1377],
34	Kiliﬁ	NNP	O	Kiliﬁ	prep_in	32	SENT_201	[p16l1118t1317r1306b1377],
35	93	CD	NUMBER	93	num	34	SENT_201	[p16l1384t1320r1470b1378],
36	of	IN	O	of	_	0	SENT_201	[p16l1552t1317r1630b1377],
37	118	CD	PERCENT	118	num	38	SENT_201	[p16l1705t1319r1832b1378],
38	(	CD	PERCENT	(	prep_of	32	SENT_201	[p16l1918t1317r2138b1392],
39	50	CD	PERCENT	50	number	40	SENT_201	[p16l1918t1317r2138b1392],
40	%	NN	PERCENT	%	amod	18	SENT_201	[p16l1918t1317r2138b1392],
41	,	,	O	,	_	0	SENT_201	[p16l1918t1317r2138b1392],

1	Chlorproguanil	NNP	O	Chlorproguanil	_	0	SENT_202	[p16l567t1591r1007b1649],
2	-	:	O	-	_	0	SENT_202	[p16l567t1591r1007b1649],
3	n	NN	O	n	nn	4	SENT_202	[p16l1145t1602r1175b1638],
4	Sulfadoxine	NN	O	sulfadoxine	dep	1	SENT_202	[p16l1348t1591r1707b1638],
5	-	:	O	-	_	0	SENT_202	[p16l1348t1591r1707b1638],
6	n	NN	O	n	nn	8	SENT_202	[p16l2007t1602r2036b1638],
7	dapsone	NN	O	dapsone	nn	8	SENT_202	[p16l567t1670r810b1728],
8	pyrimethamine	NN	O	pyrimethamine	dep	4	SENT_202	[p16l1352t1670r1781b1728],

1	Kilifi	NNP	LOCATION	Kilifi	nn	3	SENT_203	[p16l12t1818r171b1864],
2	*	NNP	O	*	nn	3	SENT_203	[p16l12t1818r171b1864],
3	Episode	NNP	O	Episode	dep	21	SENT_203	[p16l13t1898r234b1955],
4	1	CD	NUMBER	1	num	6	SENT_203	[p16l261t1898r294b1944],
5	6-5	CD	NUMBER	6-5	num	6	SENT_203	[p16l621t1897r715b1945],
6	(	NN	O	(	dep	3	SENT_203	[p16l740t1897r852b1955],
7	3-7	CD	NUMBER	3-7	num	9	SENT_203	[p16l740t1897r852b1955],
8	to	TO	O	to	dep	9	SENT_203	[p16l876t1901r930b1945],
9	9-2	CD	NUMBER	9-2	dep	6	SENT_203	[p16l955t1897r1068b1955],
10	)	CD	NUMBER	)	number	11	SENT_203	[p16l955t1897r1068b1955],
11	187	CD	NUMBER	187	num	17	SENT_203	[p16l1161t1897r1270b1945],
12	2-5	CD	NUMBER	2-5	number	17	SENT_203	[p16l1404t1897r1497b1945],
13	0-5	CD	NUMBER	0-5	number	17	SENT_203	[p16l1542t1897r1636b1945],
14	to	TO	O	to	dep	17	SENT_203	[p16l1658t1901r1712b1945],
15	4-6	CD	NUMBER	4-6	number	17	SENT_203	[p16l1737t1897r1850b1955],
16	)	CD	NUMBER	)	number	17	SENT_203	[p16l1737t1897r1850b1955],
17	192	CD	NUMBER	192	dep	9	SENT_203	[p16l2012t1897r2122b1945],
18	Episode	NN	O	episode	dep	21	SENT_203	[p16l13t1977r234b2034],
19	2	CD	NUMBER	2	num	18	SENT_203	[p16l260t1976r293b2023],
20	6-9	CD	NUMBER	6-9	num	21	SENT_203	[p16l622t1976r715b2024],
21	(	NN	O	(	dep	28	SENT_203	[p16l740t1977r854b2034],
22	4-1	CD	NUMBER	4-1	dep	24	SENT_203	[p16l740t1977r854b2034],
23	to	TO	O	to	dep	24	SENT_203	[p16l876t1980r930b2024],
24	9-6	CD	NUMBER	9-6	advmod	27	SENT_203	[p16l955t1976r1068b2034],
25	)	CD	NUMBER	)	number	26	SENT_203	[p16l955t1976r1068b2034],
26	111	CD	NUMBER	111	num	27	SENT_203	[p16l1161t1977r1272b2023],
27	2-4	CD	NUMBER	2-4	dep	21	SENT_203	[p16l1405t1976r1499b2023],
28	(	NN	O	(	dep	30	SENT_203	[p16l1523t1976r1669b2034],
29	-0	CD	NUMBER	-0	num	28	SENT_203	[p16l1523t1976r1669b2034],
30	-5	CD	NUMBER	-5	dep	34	SENT_203	[p16l1523t1976r1669b2034],
31	to	TO	O	to	_	0	SENT_203	[p16l1691t1980r1745b2024],
32	5-3	CD	NUMBER	5-3	num	33	SENT_203	[p16l1771t1976r1883b2034],
33	)	CD	NUMBER	)	prep_to	30	SENT_203	[p16l1771t1976r1883b2034],
34	122	CD	NUMBER	122	dep	35	SENT_203	[p16l2012t1976r2122b2023],
35	Episode	NN	O	episode	dep	38	SENT_203	[p16l13t2056r234b2113],
36	3	CD	NUMBER	3	num	35	SENT_203	[p16l259t2055r293b2103],
37	6-4	CD	NUMBER	6-4	num	38	SENT_203	[p16l621t2055r716b2103],
38	(	NN	O	(	dep	41	SENT_203	[p16l740t2055r853b2113],
39	2-3	CD	NUMBER	2-3	num	41	SENT_203	[p16l740t2055r853b2113],
40	to	TO	O	to	dep	41	SENT_203	[p16l876t2059r930b2103],
41	10-5	CD	NUMBER	10-5	dep	47	SENT_203	[p16l957t2055r1107b2113],
42	)	CD	NUMBER	)	number	43	SENT_203	[p16l957t2055r1107b2113],
43	74	CD	NUMBER	74	dep	41	SENT_203	[p16l1200t2056r1273b2102],
44	1-0	CD	NUMBER	1-0	num	45	SENT_203	[p16l1406t2055r1498b2103],
45	(	NN	O	(	dep	43	SENT_203	[p16l1523t2055r1669b2113],
46	-1	CD	NUMBER	-1	num	47	SENT_203	[p16l1523t2055r1669b2113],
47	-9	CD	NUMBER	-9	dep	52	SENT_203	[p16l1523t2055r1669b2113],
48	to	TO	O	to	_	0	SENT_203	[p16l1692t2059r1745b2103],
49	3-9	CD	NUMBER	3-9	num	50	SENT_203	[p16l1770t2055r1883b2113],
50	)	CD	NUMBER	)	prep_to	47	SENT_203	[p16l1770t2055r1883b2113],
51	64	CD	NUMBER	64	num	52	SENT_203	[p16l2049t2055r2124b2103],
52	Episode	NN	O	episode	dep	55	SENT_203	[p16l13t2135r234b2192],
53	4	CD	NUMBER	4	num	55	SENT_203	[p16l259t2135r294b2181],
54	8-3	CD	NUMBER	8-3	num	55	SENT_203	[p16l621t2134r715b2182],
55	(	NN	O	(	dep	64	SENT_203	[p16l740t2134r853b2192],
56	2-5	CD	NUMBER	2-5	number	59	SENT_203	[p16l740t2134r853b2192],
57	to	TO	O	to	dep	59	SENT_203	[p16l876t2138r930b2182],
58	14-2	CD	NUMBER	14-2	number	59	SENT_203	[p16l957t2134r1107b2192],
59	)	CD	NUMBER	)	dep	55	SENT_203	[p16l957t2134r1107b2192],
60	35	CD	NUMBER	35	num	62	SENT_203	[p16l1197t2134r1272b2182],
61	3-9	CD	NUMBER	3-9	num	62	SENT_203	[p16l1403t2134r1498b2182],
62	(	NN	O	(	dep	59	SENT_203	[p16l1523t2134r1669b2192],
63	-2	CD	NUMBER	-2	num	64	SENT_203	[p16l1523t2134r1669b2192],
64	-8	CD	NUMBER	-8	dep	68	SENT_203	[p16l1523t2134r1669b2192],
65	to	TO	O	to	_	0	SENT_203	[p16l1691t2138r1745b2182],
66	10-6	CD	NUMBER	10-6	prep_to	64	SENT_203	[p16l1772t2134r1923b2192],
67	)	CD	NUMBER	)	num	68	SENT_203	[p16l1772t2134r1923b2192],
68	35	CD	NUMBER	35	_	0	SENT_203	[p16l2049t2134r2123b2182],

1	Blantyre1Episode	NN	O	blantyre1episode	dep	14	SENT_204	[p16l12t2291r287b2351, p16l13t2370r234b2428],
2	1	CD	NUMBER	1	num	1	SENT_204	[p16l261t2370r294b2417],
3	o	NN	O	o	dep	1	SENT_204	[p16l621t2370r656b2417],
4	(	CD	NUMBER	(	num	3	SENT_204	[p16l681t2370r827b2428],
5	-0	CD	NUMBER	-0	number	10	SENT_204	[p16l681t2370r827b2428],
6	-6	CD	NUMBER	-6	number	10	SENT_204	[p16l681t2370r827b2428],
7	to	TO	O	to	dep	10	SENT_204	[p16l849t2373r904b2417],
8	0-6	CD	NUMBER	0-6	number	10	SENT_204	[p16l928t2370r1041b2428],
9	)	CD	NUMBER	)	number	10	SENT_204	[p16l928t2370r1041b2428],
10	221	CD	NUMBER	221	dep	3	SENT_204	[p16l1159t2370r1272b2417],
11	0-2	CD	NUMBER	0-2	num	12	SENT_204	[p16l1404t2370r1497b2417],
12	(	NN	O	(	dep	14	SENT_204	[p16l1523t2370r1670b2428],
13	-0	CD	NUMBER	-0	num	14	SENT_204	[p16l1523t2370r1670b2428],
14	-4	CD	NUMBER	-4	dep	19	SENT_204	[p16l1523t2370r1670b2428],
15	to	TO	O	to	_	0	SENT_204	[p16l1692t2373r1745b2417],
16	0-8	CD	NUMBER	0-8	num	17	SENT_204	[p16l1770t2370r1883b2428],
17	)	CD	NUMBER	)	prep_to	14	SENT_204	[p16l1770t2370r1883b2428],
18	221	CD	NUMBER	221	num	19	SENT_204	[p16l2010t2370r2124b2417],
19	Episode	NN	O	episode	dep	22	SENT_204	[p16l13t2449r234b2507],
20	2	CD	NUMBER	2	num	22	SENT_204	[p16l260t2449r293b2496],
21	20-9	CD	NUMBER	20-9	num	22	SENT_204	[p16l582t2449r715b2496],
22	(	NN	O	(	dep	32	SENT_204	[p16l740t2449r886b2507],
23	-1	CD	NUMBER	-1	number	28	SENT_204	[p16l740t2449r886b2507],
24	-9	CD	NUMBER	-9	number	28	SENT_204	[p16l740t2449r886b2507],
25	to	TO	O	to	dep	28	SENT_204	[p16l909t2452r963b2496],
26	0-1	CD	NUMBER	0-1	number	28	SENT_204	[p16l988t2449r1101b2507],
27	)	CD	NUMBER	)	number	28	SENT_204	[p16l988t2449r1101b2507],
28	101	CD	NUMBER	101	dep	22	SENT_204	[p16l1161t2449r1272b2496],
29	0-5	CD	NUMBER	0-5	num	30	SENT_204	[p16l1404t2449r1498b2496],
30	(	NN	O	(	dep	28	SENT_204	[p16l1523t2449r1669b2507],
31	-0	CD	NUMBER	-0	num	32	SENT_204	[p16l1523t2449r1669b2507],
32	-3	CD	NUMBER	-3	dep	36	SENT_204	[p16l1523t2449r1669b2507],
33	to	TO	O	to	_	0	SENT_204	[p16l1692t2452r1745b2496],
34	1-4	CD	NUMBER	1-4	num	35	SENT_204	[p16l1772t2449r1883b2507],
35	)	CD	NUMBER	)	prep_to	32	SENT_204	[p16l1772t2449r1883b2507],
36	98	CD	NUMBER	98	dep	37	SENT_204	[p16l2050t2449r2124b2496],
37	Episode	NN	O	episode	dep	40	SENT_204	[p16l13t2528r234b2586],
38	3	CD	NUMBER	3	num	37	SENT_204	[p16l259t2528r293b2575],
39	20-1	CD	NUMBER	20-1	num	40	SENT_204	[p16l582t2528r715b2575],
40	(	NN	O	(	dep	42	SENT_204	[p16l740t2528r886b2586],
41	-1	CD	NUMBER	-1	num	42	SENT_204	[p16l740t2528r886b2586],
42	-5	CD	NUMBER	-5	dep	46	SENT_204	[p16l740t2528r886b2586],
43	to	TO	O	to	_	0	SENT_204	[p16l909t2531r963b2575],
44	1-2	CD	NUMBER	1-2	num	45	SENT_204	[p16l990t2528r1101b2586],
45	)	CD	NUMBER	)	prep_to	42	SENT_204	[p16l990t2528r1101b2586],
46	42	CD	NUMBER	42	dep	47	SENT_204	[p16l1198t2528r1271b2575],
47	o-o	NN	O	o-o	dep	50	SENT_204	[p16l1404t2528r1498b2575],
48	(	CD	NUMBER	(	num	47	SENT_204	[p16l1523t2528r1668b2586],
49	-1	CD	NUMBER	-1	num	50	SENT_204	[p16l1523t2528r1668b2586],
50	-2	CD	NUMBER	-2	dep	54	SENT_204	[p16l1523t2528r1668b2586],
51	to	TO	O	to	_	0	SENT_204	[p16l1692t2531r1745b2575],
52	1-2	CD	NUMBER	1-2	num	53	SENT_204	[p16l1772t2528r1883b2586],
53	)	CD	NUMBER	)	prep_to	50	SENT_204	[p16l1772t2528r1883b2586],
54	42	CD	NUMBER	42	dep	55	SENT_204	[p16l2049t2528r2122b2575],
55	Episode	NN	O	episode	dep	58	SENT_204	[p16l13t2607r234b2665],
56	4	CD	NUMBER	4	num	55	SENT_204	[p16l259t2607r294b2654],
57	21-7	CD	NUMBER	21-7	num	58	SENT_204	[p16l582t2607r714b2654],
58	(	NN	O	(	dep	60	SENT_204	[p16l740t2607r886b2665],
59	-4	CD	NUMBER	-4	num	60	SENT_204	[p16l740t2607r886b2665],
60	-5	CD	NUMBER	-5	dep	66	SENT_204	[p16l740t2607r886b2665],
61	to	TO	O	to	_	0	SENT_204	[p16l909t2610r963b2654],
62	1-1	CD	NUMBER	1-1	num	63	SENT_204	[p16l990t2607r1101b2665],
63	)	CD	NUMBER	)	prep_to	60	SENT_204	[p16l990t2607r1101b2665],
64	14	CD	NUMBER	14	num	66	SENT_204	[p16l1200t2607r1273b2654],
65	20-5	CD	NUMBER	20-5	num	66	SENT_204	[p16l1365t2607r1497b2654],
66	(	NN	O	(	dep	72	SENT_204	[p16l1523t2607r1669b2665],
67	-1	CD	NUMBER	-1	num	68	SENT_204	[p16l1523t2607r1669b2665],
68	-6	CD	NUMBER	-6	dep	66	SENT_204	[p16l1523t2607r1669b2665],
69	to	TO	O	to	_	0	SENT_204	[p16l1691t2610r1745b2654],
70	0-5	CD	NUMBER	0-5	prep_to	68	SENT_204	[p16l1770t2607r1883b2665],
71	)	CD	NUMBER	)	num	72	SENT_204	[p16l1770t2607r1883b2665],
72	21	CD	NUMBER	21	_	0	SENT_204	[p16l2050t2607r2123b2654],

1	Values	NNS	O	value	nsubj	4	SENT_205	[p16l8t2763r185b2806],
2	are	VBP	O	be	cop	4	SENT_205	[p16l208t2773r289b2806],
3	mean	JJ	O	mean	amod	4	SENT_205	[p16l314t2773r456b2806],
4	(	NN	O	(	_	0	SENT_205	[p16l481t2763r611b2816],
5	95	CD	PERCENT	95	num	8	SENT_205	[p16l481t2763r611b2816],
6	%	NN	PERCENT	%	nn	8	SENT_205	[p16l481t2763r611b2816],
7	Cl	NN	O	cl	nn	8	SENT_205	[p16l633t2763r716b2816],
8	)	NN	O	)	dep	4	SENT_205	[p16l633t2763r716b2816],
9	.	.	O	.	_	0	SENT_205	[p16l633t2763r716b2816],

1	*	NN	O	*	nn	2	SENT_206	[p16l746t2763r1028b2806],
2	Decrease	NN	O	decrease	_	0	SENT_206	[p16l746t2763r1028b2806],
3	in	IN	O	in	_	0	SENT_206	[p16l1052t2763r1092b2806],
4	haemoglobin	NN	O	haemoglobin	nn	5	SENT_206	[p16l1118t2763r1452b2817],
5	concentration	NN	O	concentration	prep_in	2	SENT_206	[p16l1476t2763r1834b2806],
6	(	CD	NUMBER	(	num	8	SENT_206	[p16l1859t2763r1999b2817],
7	g/L	NN	O	g/l	nn	8	SENT_206	[p16l1859t2763r1999b2817],
8	)	NN	O	)	dep	5	SENT_206	[p16l1859t2763r1999b2817],
9	.	.	O	.	_	0	SENT_206	[p16l1859t2763r1999b2817],

1	1	CD	NUMBER	1	number	2	SENT_207	[p16l9t2839r291b2894],
2	“	CD	NUMBER	“	num	3	SENT_207	[p16l9t2839r291b2894],
3	Decrease	NN	O	decrease	dep	10	SENT_207	[p16l9t2839r291b2894],
4	in	IN	O	in	_	0	SENT_207	[p16l316t2840r355b2882],
5	packed	JJ	O	packed	amod	7	SENT_207	[p16l382t2840r670b2892],
6	—	NN	O	—	nn	7	SENT_207	[p16l382t2840r670b2892],
7	ce	NN	O	ce	prep_in	3	SENT_207	[p16l382t2840r670b2892],
8	|	CD	NUMBER	|	num	10	SENT_207	[p16l382t2840r670b2892],
9	|	NN	O	|	nn	10	SENT_207	[p16l382t2840r670b2892],
10	volume	NN	O	volume	_	0	SENT_207	[p16l693t2840r882b2883],
11	(	CD	PERCENT	(	num	12	SENT_207	[p16l905t2839r996b2892],
12	%	NN	PERCENT	%	dep	10	SENT_207	[p16l905t2839r996b2892],
13	)	CD	NUMBER	)	dep	12	SENT_207	[p16l905t2839r996b2892],
14	.	.	O	.	_	0	SENT_207	[p16l905t2839r996b2892],

1	Table	NNP	O	Table	_	0	SENT_208	[p16l8t2937r182b2991],
2	3	CD	NUMBER	3	num	1	SENT_208	[p16l210t2937r269b2991],
3	:	:	O	:	_	0	SENT_208	[p16l210t2937r269b2991],
4	Decreases	NNS	O	decrease	dep	1	SENT_208	[p16l303t2937r650b2991],
5	in	IN	O	in	_	0	SENT_208	[p16l679t2937r732b2990],
6	haemoglobin	NN	O	haemoglobin	nn	7	SENT_208	[p16l762t2937r1183b3003],
7	concentration	NN	O	concentration	prep_in	4	SENT_208	[p16l1210t2937r1674b2991],
8	or	CC	O	or	_	0	SENT_208	[p16l1701t2950r1766b2991],
9	packedcell	NN	O	packedcell	nn	10	SENT_208	[p16l1792t2937r2052b3003, p16l9t3029r124b3083],
10	volume	NN	O	volume	prep_in	4	SENT_208	[p16l152t3029r388b3083],
11	between	IN	O	between	_	0	SENT_208	[p16l417t3029r697b3083],
12	days	NNS	DURATION	day	nn	13	SENT_208	[p16l725t3029r876b3095],
13	o	NN	O	o	prep_between	7	SENT_208	[p16l903t3029r944b3083],
14	and	CC	O	and	_	0	SENT_208	[p16l971t3029r1088b3083],
15	7	CD	NUMBER	7	num	16	SENT_208	[p16l1118t3029r1156b3082],
16	chlorproguanil	NN	O	chlorproguanil	conj_and	7	SENT_208	[p16l10t3115r933b3191],
17	—	NN	O	—	nn	19	SENT_208	[p16l10t3115r933b3191],
18	dapsone	NN	O	dapsone	nn	19	SENT_208	[p16l10t3115r933b3191],
19	)	NN	O	)	dep	16	SENT_208	[p16l10t3115r933b3191],
20	and	CC	O	and	_	0	SENT_208	[p16l1039t3115r1174b3176],
21	109	CD	NUMBER	109	conj_and	16	SENT_208	[p16l1281t3118r1408b3176],
22	of	IN	O	of	_	0	SENT_208	[p16l1511t3115r1589b3176],
23	195	CD	PERCENT	195	num	24	SENT_208	[p16l1686t3118r1812b3176],
24	(	CD	PERCENT	(	prep_of	21	SENT_208	[p16l1921t3115r2141b3190],
25	56	CD	PERCENT	56	number	26	SENT_208	[p16l1921t3115r2141b3190],
26	%	NN	PERCENT	%	amod	4	SENT_208	[p16l1921t3115r2141b3190],
27	,	,	O	,	_	0	SENT_208	[p16l1921t3115r2141b3190],
28	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	30	SENT_208	[p16l10t3208r1070b3284],
29	)	NN	O	)	nn	30	SENT_208	[p16l10t3208r1070b3284],
30	patients	NNS	O	patient	appos	4	SENT_208	[p16l1121t3209r1415b3284],
31	completed	VBD	O	complete	rcmod	30	SENT_208	[p16l1465t3208r1855b3284],
32	1	CD	DURATION	1	num	33	SENT_208	[p16l1910t3211r1935b3268],
33	year	NN	NUMBER	year	dobj	31	SENT_208	[p16l1989t3228r2146b3284],
34	of	IN	O	of	_	0	SENT_208	[p16l10t3302r89b3362],
35	follow-up	NN	O	follow-up	prep_of	33	SENT_208	[p16l109t3302r466b3378],
36	without	IN	O	without	_	0	SENT_208	[p16l497t3302r786b3362],
37	severe	JJ	O	severe	amod	38	SENT_208	[p16l817t3321r1043b3362],
38	malaria	NN	O	malaria	prep_without	31	SENT_208	[p16l1073t3302r1350b3362],
39	or	CC	O	or	_	0	SENT_208	[p16l1382t3321r1458b3362],
40	treatment	NN	O	treatment	nn	41	SENT_208	[p16l1485t3316r1852b3362],
41	failure	NN	O	failure	prep_without	31	SENT_208	[p16l1881t3302r2141b3375],
42	,	,	O	,	_	0	SENT_208	[p16l1881t3302r2141b3375],
43	in	IN	O	in	_	0	SENT_208	[p16l8t3394r79b3454],
44	Blantyre	NNP	LOCATION	Blantyre	prep_in	1	SENT_208	[p16l109t3394r423b3470],
45	these	DT	O	these	det	46	SENT_208	[p16l454t3394r644b3455],
46	proportions	NNS	O	proportion	nsubj	48	SENT_208	[p16l674t3394r1112b3470],
47	were	VBD	O	be	cop	48	SENT_208	[p16l1142t3414r1317b3455],
48	43	CD	NUMBER	43	rcmod	1	SENT_208	[p16l1348t3397r1435b3455],
49	of	IN	O	of	_	0	SENT_208	[p16l1471t3394r1550b3455],
50	222	CD	PERCENT	222	number	51	SENT_208	[p16l1572t3397r1707b3454],
51	(	CD	PERCENT	(	prep_of	48	SENT_208	[p16l1745t3394r1971b3470],
52	19	CD	PERCENT	19	num	53	SENT_208	[p16l1745t3394r1971b3470],
53	%	NN	PERCENT	%	dep	51	SENT_208	[p16l1745t3394r1971b3470],
54	)	CD	NUMBER	)	num	53	SENT_208	[p16l1745t3394r1971b3470],
55	and	CC	O	and	_	0	SENT_208	[p16l2009t3394r2144b3455],
56	29	CD	NUMBER	29	num	53	SENT_208	[p16l10t3490r97b3548],
57	of	IN	O	of	_	0	SENT_208	[p16l134t3487r213b3548],
58	224	CD	PERCENT	224	number	59	SENT_208	[p16l237t3490r373b3547],
59	(	CD	PERCENT	(	prep_of	53	SENT_208	[p16l413t3488r665b3563],
60	13	CD	PERCENT	13	number	61	SENT_208	[p16l413t3488r665b3563],
61	%	NN	PERCENT	%	amod	53	SENT_208	[p16l413t3488r665b3563],
62	)	CD	NUMBER	)	dep	53	SENT_208	[p16l413t3488r665b3563],
63	.	.	O	.	_	0	SENT_208	[p16l413t3488r665b3563],

1	Severe	JJ	O	severe	amod	3	SENT_209	[p16l706t3488r947b3548],
2	malaria	NN	O	malaria	nn	3	SENT_209	[p16l980t3487r1257b3548],
3	syndromes	NNS	O	syndrome	nsubj	4	SENT_209	[p16l1291t3487r1690b3563],
4	caused	VBD	O	cause	_	0	SENT_209	[p16l1726t3487r1978b3548],
5	exit	NN	O	exit	dobj	4	SENT_209	[p16l2012t3488r2145b3548],
6	from	IN	O	from	_	0	SENT_209	[p16l8t3581r186b3641],
7	the	DT	O	the	det	8	SENT_209	[p16l221t3581r335b3641],
8	trial	NN	O	trial	prep_from	4	SENT_209	[p16l371t3581r519b3641],
9	at	IN	O	at	_	0	SENT_209	[p16l557t3595r623b3641],
10	both	DT	O	both	det	11	SENT_209	[p16l656t3581r828b3641],
11	sites	NNS	O	site	prep_at	8	SENT_209	[p16l864t3581r1020b3641],
12	in	IN	O	in	_	0	SENT_209	[p16l1057t3581r1127b3640],
13	similar	JJ	O	similar	amod	14	SENT_209	[p16l1163t3581r1416b3641],
14	proportions	NNS	O	proportion	prep_in	4	SENT_209	[p16l1448t3581r1887b3657],
15	of	IN	O	of	_	0	SENT_209	[p16l1925t3581r2004b3641],
16	the	DT	O	the	det	19	SENT_209	[p16l2028t3581r2143b3641],
17	chlorproguanil	NN	O	chlorproguanil	nn	19	SENT_209	[p16l10t3673r905b3749],
18	—	NN	O	—	nn	19	SENT_209	[p16l10t3673r905b3749],
19	dapsone	NN	O	dapsone	prep_of	14	SENT_209	[p16l10t3673r905b3749],
20	and	CC	O	and	_	0	SENT_209	[p16l941t3673r1076b3734],
21	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	22	SENT_209	[p16l1111t3673r2143b3749],
22	groups	NNS	O	group	prep_of	14	SENT_209	[p17l8t35r284b91],
23	,	,	O	,	_	0	SENT_209	[p17l8t35r284b91],
24	and	CC	O	and	_	0	SENT_209	[p17l342t15r477b76],
25	similar	JJ	O	similar	amod	26	SENT_209	[p17l531t15r784b76],
26	proportions	NNS	O	proportion	nsubj	27	SENT_209	[p17l833t16r1271b91],
27	completed	VBN	O	complete	conj_and	4	SENT_209	[p17l1328t15r1718b91],
28	1	CD	DURATION	1	num	29	SENT_209	[p17l1780t18r1805b75],
29	year	NN	NUMBER	year	dobj	27	SENT_209	[p17l1865t35r2023b91],
30	of	IN	O	of	_	0	SENT_209	[p17l2075t15r2154b76],
31	follow-up	JJ	O	follow-up	amod	35	SENT_209	[p17l8t109r366b185],
32	(	NN	O	(	nn	35	SENT_209	[p17l403t109r611b184],
33	table	NN	O	table	nn	35	SENT_209	[p17l403t109r611b184],
34	2	CD	NUMBER	2	num	35	SENT_209	[p17l643t109r739b184],
35	)	NN	O	)	prep_of	29	SENT_209	[p17l643t109r739b184],
36	.	.	O	.	_	0	SENT_209	[p17l643t109r739b184],

1	One	CD	NUMBER	one	num	2	SENT_210	[p17l96t201r249b262],
2	child	NN	O	child	nsubj	3	SENT_210	[p17l293t201r475b262],
3	died	VBD	O	die	_	0	SENT_210	[p17l518t201r677b262],
4	in	IN	O	in	_	0	SENT_210	[p17l719t201r789b261],
5	the	DT	O	the	det	7	SENT_210	[p17l830t201r944b262],
6	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	7	SENT_210	[p17l988t201r1883b277],
7	group	NN	O	group	prep_in	3	SENT_210	[p17l1926t221r2142b277],
8	in	IN	O	in	_	0	SENT_210	[p17l8t295r79b354],
9	Blantyre	NNP	LOCATION	Blantyre	prep_in	7	SENT_210	[p17l107t294r422b370],
10	after	IN	O	after	_	0	SENT_210	[p17l453t294r621b355],
11	3	CD	DURATION	3	num	12	SENT_210	[p17l650t297r687b355],
12	months	NNS	NUMBER	month	prep_after	3	SENT_210	[p17l719t294r998b355],
13	of	IN	O	of	_	0	SENT_210	[p17l1030t294r1108b355],
14	follow-up	NN	O	follow-up	prep_of	12	SENT_210	[p17l1126t294r1507b370],
15	.	.	O	.	_	0	SENT_210	[p17l1126t294r1507b370],

1	This	DT	O	this	det	3	SENT_211	[p17l1540t294r1708b355],
2	10monthold	JJ	O	10monthold	amod	3	SENT_211	[p17l1747t294r2143b355, p17l10t388r125b448],
3	boy	NN	O	boy	nsubj	4	SENT_211	[p17l192t388r328b464],
4	weighed	VBD	O	weigh	_	0	SENT_211	[p17l393t388r702b464],
5	5-5	CD	NUMBER	5-5	num	6	SENT_211	[p17l773t390r882b448],
6	kg	NN	O	kg	dobj	4	SENT_211	[p17l956t388r1041b464],
7	on	IN	O	on	_	0	SENT_211	[p17l1109t407r1200b448],
8	recruitment	NN	O	recruitment	prep_on	6	SENT_211	[p17l1268t388r1732b461],
9	,	,	O	,	_	0	SENT_211	[p17l1268t388r1732b461],
10	and	CC	O	and	_	0	SENT_211	[p17l1805t388r1940b448],
11	was	VBD	O	be	auxpass	13	SENT_211	[p17l2007t408r2142b448],
12	successfully	RB	O	successfully	advmod	13	SENT_211	[p17l10t480r450b556],
13	treated	VBN	O	treat	conj_and	4	SENT_211	[p17l566t480r827b541],
14	for	IN	O	for	_	0	SENT_211	[p17l944t480r1050b541],
15	uncomplicated	JJ	O	uncomplicated	amod	16	SENT_211	[p17l1165t480r1723b556],
16	malaria	NN	O	malaria	prep_for	13	SENT_211	[p17l1840t480r2138b541],
17	.	.	O	.	_	0	SENT_211	[p17l1840t480r2138b541],

1	However	RB	O	however	advmod	7	SENT_212	[p17l9t574r367b646],
2	,	,	O	,	_	0	SENT_212	[p17l9t574r367b646],
3	his	PRP$	O	he	poss	5	SENT_212	[p17l413t573r516b634],
4	low	JJ	O	low	amod	5	SENT_212	[p17l562t573r693b634],
5	weight	NN	O	weight	nsubjpass	7	SENT_212	[p17l734t573r982b649],
6	was	VBD	O	be	auxpass	7	SENT_212	[p17l1023t593r1158b634],
7	noted	VBN	O	note	_	0	SENT_212	[p17l1203t573r1417b634],
8	with	IN	O	with	_	0	SENT_212	[p17l1459t573r1622b634],
9	concern	NN	O	concern	prep_with	7	SENT_212	[p17l1667t593r1984b634],
10	.	.	O	.	_	0	SENT_212	[p17l1667t593r1984b634],

1	He	PRP	O	he	nsubj	2	SENT_213	[p17l2034t574r2143b634],
2	returned	VBD	O	return	_	0	SENT_213	[p17l8t667r331b727],
3	to	TO	O	to	_	0	SENT_213	[p17l386t681r457b727],
4	hospital	NN	O	hospital	prep_to	2	SENT_213	[p17l513t667r809b743],
5	one	CD	DATE	one	num	6	SENT_213	[p17l866t686r998b727],
6	month	NN	DATE	month	npadvmod	7	SENT_213	[p17l1054t667r1300b727],
7	later	RB	DATE	later	advmod	2	SENT_213	[p17l1355t667r1522b727],
8	with	IN	O	with	_	0	SENT_213	[p17l1574t667r1738b727],
9	a	DT	O	a	det	11	SENT_213	[p17l1794t687r1829b727],
10	further	JJ	O	further	amod	11	SENT_213	[p17l1886t667r2146b727],
11	episode	NN	O	episode	prep_with	2	SENT_213	[p17l10t759r290b835],
12	of	IN	O	of	_	0	SENT_213	[p17l334t759r412b820],
13	parasitaemia	NN	O	parasitaemia	nn	14	SENT_213	[p17l443t759r916b835],
14	(	NN	O	(	prep_of	11	SENT_213	[p17l964t759r1098b835],
15	for	IN	O	for	_	0	SENT_213	[p17l964t759r1098b835],
16	which	WDT	O	which	rel	20	SENT_213	[p17l1136t759r1359b820],
17	he	PRP	O	he	nsubj	26	SENT_213	[p17l1399t759r1484b820],
18	was	VBD	O	be	cop	20	SENT_213	[p17l1526t779r1661b820],
19	successfully	RB	O	successfully	advmod	20	SENT_213	[p17l1705t759r2145b835],
20	re-treated	JJ	O	re-treated	rcmod	11	SENT_213	[p17l8t852r375b913],
21	with	IN	O	with	_	0	SENT_213	[p17l472t852r635b913],
22	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	23	SENT_213	[p17l734t852r1686b928],
23	)	NN	O	)	prep_with	20	SENT_213	[p17l734t852r1686b928],
24	,	,	O	,	_	0	SENT_213	[p17l734t852r1686b928],
25	but	CC	O	but	_	0	SENT_213	[p17l1785t852r1911b913],
26	had	VBD	O	have	conj_but	20	SENT_213	[p17l2007t852r2144b913],
27	evidence	NN	O	evidence	dobj	26	SENT_213	[p17l10t946r332b1006],
28	of	IN	O	of	_	0	SENT_213	[p17l364t946r443b1006],
29	lower	JJR	O	lower	amod	31	SENT_213	[p17l462t946r668b1006],
30	respiratory	JJ	O	respiratory	amod	31	SENT_213	[p17l694t946r1100b1022],
31	infection	NN	O	infection	prep_of	27	SENT_213	[p17l1127t946r1479b1019],
32	,	,	O	,	_	0	SENT_213	[p17l1127t946r1479b1019],
33	for	IN	O	for	_	0	SENT_213	[p17l1511t946r1617b1006],
34	which	WDT	O	which	rel	37	SENT_213	[p17l1642t946r1866b1006],
35	he	PRP	O	he	nsubjpass	37	SENT_213	[p17l1893t946r1979b1006],
36	was	VBD	O	be	auxpass	37	SENT_213	[p17l2008t966r2142b1006],
37	admitted	VBN	O	admit	rcmod	31	SENT_213	[p17l10t1038r365b1099],
38	.	.	O	.	_	0	SENT_213	[p17l10t1038r365b1099],

1	The	DT	O	the	det	3	SENT_214	[p17l410t1038r560b1099],
2	clinical	JJ	O	clinical	amod	3	SENT_214	[p17l603t1038r866b1099],
3	impression	NN	O	impression	nsubj	4	SENT_214	[p17l908t1038r1315b1114],
4	was	VBD	O	be	_	0	SENT_214	[p17l1354t1058r1489b1099],
5	of	IN	O	of	_	0	SENT_214	[p17l1532t1038r1611b1099],
6	possible	JJ	O	possible	amod	8	SENT_214	[p17l1640t1038r1939b1114],
7	HIV	NN	MISC	hiv	nn	8	SENT_214	[p17l1981t1039r2145b1099],
8	disease	NN	O	disease	prep_of	4	SENT_214	[p17l10t1131r294b1204],
9	,	,	O	,	_	0	SENT_214	[p17l10t1131r294b1204],
10	but	CC	O	but	_	0	SENT_214	[p17l342t1131r468b1192],
11	no	DT	O	no	det	13	SENT_214	[p17l514t1151r605b1192],
12	HIV	NN	MISC	hiv	nn	13	SENT_214	[p17l654t1132r819b1192],
13	test	NN	O	test	nsubjpass	15	SENT_214	[p17l863t1146r994b1192],
14	was	VBD	O	be	auxpass	15	SENT_214	[p17l1039t1151r1174b1192],
15	done	VBN	O	do	conj_but	4	SENT_214	[p17l1224t1131r1426b1192],
16	.	.	O	.	_	0	SENT_214	[p17l1224t1131r1426b1192],

1	Fever	NN	O	fever	nsubj	6	SENT_215	[p17l1478t1132r1689b1192],
2	and	CC	O	and	_	0	SENT_215	[p17l1736t1131r1871b1192],
3	cough	NN	O	cough	conj_and	1	SENT_215	[p17l1920t1131r2144b1207],
4	remained	VBD	O	remain	cop	6	SENT_215	[p17l8t1225r359b1285],
5	a	DT	O	a	det	6	SENT_215	[p17l398t1245r433b1285],
6	problem	NN	O	problem	_	0	SENT_215	[p17l470t1225r784b1301],
7	1	CD	DATE	1	num	8	SENT_215	[p17l830t1227r855b1284],
8	month	NN	DATE	month	npadvmod	9	SENT_215	[p17l901t1225r1147b1285],
9	later	RB	DATE	later	advmod	6	SENT_215	[p17l1184t1225r1372b1298],
10	,	,	O	,	_	0	SENT_215	[p17l1184t1225r1372b1298],
11	but	CC	O	but	_	0	SENT_215	[p17l1410t1225r1536b1285],
12	the	DT	O	the	det	14	SENT_215	[p17l1572t1225r1687b1285],
13	blood	NN	O	blood	nn	14	SENT_215	[p17l1723t1225r1937b1285],
14	slide	NN	O	slide	nsubj	16	SENT_215	[p17l1976t1225r2143b1285],
15	was	VBD	O	be	cop	16	SENT_215	[p17l7t1337r142b1378],
16	negative	JJ	O	negative	conj_but	6	SENT_215	[p17l179t1317r487b1393],
17	at	IN	O	at	_	0	SENT_215	[p17l525t1331r591b1378],
18	this	DT	O	this	det	19	SENT_215	[p17l626t1317r757b1378],
19	point	NN	O	point	prep_at	16	SENT_215	[p17l793t1317r1010b1393],
20	.	.	O	.	_	0	SENT_215	[p17l793t1317r1010b1393],

1	1	CD	DATE	1	num	2	SENT_216	[p17l1061t1320r1086b1377],
2	month	NN	DATE	month	npadvmod	3	SENT_216	[p17l1131t1317r1377b1378],
3	later	RB	DATE	later	advmod	8	SENT_216	[p17l1412t1317r1600b1390],
4	,	,	O	,	_	0	SENT_216	[p17l1412t1317r1600b1390],
5	the	DT	O	the	det	6	SENT_216	[p17l1638t1317r1753b1378],
6	child	NN	O	child	nsubjpass	8	SENT_216	[p17l1791t1317r1973b1378],
7	was	VBD	O	be	auxpass	8	SENT_216	[p17l2007t1337r2142b1378],
8	taken	VBN	O	take	_	0	SENT_216	[p17l8t1410r211b1471],
9	to	TO	O	to	_	0	SENT_216	[p17l237t1425r308b1471],
10	Queen	NNP	LOCATION	Queen	nn	13	SENT_216	[p17l340t1411r585b1486],
11	Elizabeth	NNP	LOCATION	Elizabeth	nn	13	SENT_216	[p17l612t1410r963b1471],
12	Central	NNP	LOCATION	Central	nn	13	SENT_216	[p17l993t1410r1271b1471],
13	Hospital	NNP	LOCATION	Hospital	prep_to	8	SENT_216	[p17l1299t1410r1641b1486],
14	,	,	O	,	_	0	SENT_216	[p17l1299t1410r1641b1486],
15	Blantyre	NNP	LOCATION	Blantyre	appos	13	SENT_216	[p17l1672t1410r2010b1486],
16	,	,	O	,	_	0	SENT_216	[p17l1672t1410r2010b1486],
17	for	IN	O	for	_	0	SENT_216	[p17l2041t1410r2146b1471],
18	a	DT	O	a	det	20	SENT_216	[p17l10t1524r45b1564],
19	febrile	JJ	O	febrile	amod	20	SENT_216	[p17l79t1504r314b1564],
20	illness	NN	O	illness	prep_for	8	SENT_216	[p17l348t1504r599b1577],
21	,	,	O	,	_	0	SENT_216	[p17l348t1504r599b1577],
22	but	CC	O	but	_	0	SENT_216	[p17l635t1504r761b1564],
23	he	PRP	O	he	nsubjpass	26	SENT_216	[p17l792t1504r878b1564],
24	was	VBD	O	be	auxpass	26	SENT_216	[p17l911t1524r1046b1564],
25	not	RB	O	not	neg	26	SENT_216	[p17l1081t1518r1204b1564],
26	seen	VBN	O	see	conj_but	8	SENT_216	[p17l1238t1523r1399b1564],
27	by	IN	O	by	_	0	SENT_216	[p17l1431t1504r1520b1580],
28	the	DT	O	the	det	30	SENT_216	[p17l1552t1504r1666b1564],
29	study	NN	O	study	nn	30	SENT_216	[p17l1702t1504r1904b1580],
30	team	NN	O	team	agent	26	SENT_216	[p17l1935t1518r2138b1564],
31	.	.	O	.	_	0	SENT_216	[p17l1935t1518r2138b1564],

1	No	DT	O	no	det	3	SENT_217	[p17l7t1597r122b1657],
2	ﬁrm	NN	O	ﬁrm	nn	3	SENT_217	[p17l164t1596r320b1656],
3	diagnosis	NN	O	diagnosis	nsubjpass	5	SENT_217	[p17l362t1596r705b1672],
4	was	VBD	O	be	auxpass	5	SENT_217	[p17l746t1616r881b1657],
5	reached	VBN	O	reach	_	0	SENT_217	[p17l923t1596r1238b1669],
6	;	:	O	;	_	0	SENT_217	[p17l923t1596r1238b1669],
7	he	PRP	O	he	nsubjpass	17	SENT_217	[p17l1281t1596r1367b1657],
8	was	VBD	O	be	auxpass	9	SENT_217	[p17l1407t1616r1542b1657],
9	discharged	VBN	O	discharge	parataxis	5	SENT_217	[p17l1586t1596r1988b1672],
10	the	DT	DATE	the	det	12	SENT_217	[p17l2028t1596r2143b1657],
11	following	VBG	DATE	follow	amod	12	SENT_217	[p17l8t1689r356b1765],
12	day	NN	DATE	day	tmod	9	SENT_217	[p17l453t1689r604b1765],
13	,	,	O	,	_	0	SENT_217	[p17l453t1689r604b1765],
14	but	CC	O	but	prep	9	SENT_217	[p17l703t1689r828b1750],
15	deteriorated	JJ	O	deteriorated	dep	14	SENT_217	[p17l926t1689r1381b1750],
16	and	CC	O	and	_	0	SENT_217	[p17l1479t1689r1615b1750],
17	died	VBD	O	die	parataxis	5	SENT_217	[p17l1713t1689r1872b1750],
18	soon	RB	O	soon	advmod	17	SENT_217	[p17l1971t1709r2144b1750],
19	afterwards	RB	O	afterwards	advmod	9	SENT_217	[p17l10t1783r420b1843],
20	.	.	O	.	_	0	SENT_217	[p17l10t1783r420b1843],

1	The	DT	O	the	det	2	SENT_218	[p17l454t1783r605b1843],
2	cause	NN	O	cause	nsubj	10	SENT_218	[p17l637t1803r839b1843],
3	of	IN	O	of	_	0	SENT_218	[p17l871t1783r949b1843],
4	death	NN	O	death	prep_of	2	SENT_218	[p17l970t1783r1176b1843],
5	was	VBD	O	be	cop	10	SENT_218	[p17l1203t1803r1338b1843],
6	most	RBS	O	most	advmod	7	SENT_218	[p17l1369t1797r1552b1843],
7	probably	RB	O	probably	advmod	10	SENT_218	[p17l1579t1783r1913b1859],
8	lower	RBR	O	lower	advmod	9	SENT_218	[p17l1940t1783r2146b1843],
9	respiratory	JJ	O	respiratory	amod	10	SENT_218	[p17l8t1875r414b1951],
10	infection	NN	O	infection	_	0	SENT_218	[p17l468t1875r820b1948],
11	,	,	O	,	_	0	SENT_218	[p17l468t1875r820b1948],
12	but	CC	O	but	_	0	SENT_218	[p17l878t1875r1003b1936],
13	we	PRP	O	we	nsubj	16	SENT_218	[p17l1057t1895r1158b1936],
14	can	MD	O	can	aux	16	SENT_218	[p17l1216t1889r1470b1936],
15	not	RB	O	not	neg	16	SENT_218	[p17l1216t1889r1470b1936],
16	exclude	VB	O	exclude	conj_but	10	SENT_218	[p17l1527t1875r1810b1936],
17	malaria	NN	O	malaria	dobj	16	SENT_218	[p17l1867t1875r2143b1936],
18	since	IN	O	since	mark	23	SENT_218	[p17l10t1969r194b2029],
19	no	DT	O	no	det	21	SENT_218	[p17l221t1988r313b2029],
20	blood	NN	O	blood	nn	21	SENT_218	[p17l341t1968r555b2029],
21	slide	NN	O	slide	nsubjpass	23	SENT_218	[p17l583t1968r750b2029],
22	was	VBD	O	be	auxpass	23	SENT_218	[p17l777t1988r912b2029],
23	done	VBN	O	do	advcl	16	SENT_218	[p17l942t1968r1145b2029],
24	.	.	O	.	_	0	SENT_218	[p17l942t1968r1145b2029],

1	Death	NN	O	death	nsubj	2	SENT_219	[p17l1178t1968r1407b2029],
2	occurred	VBD	O	occur	_	0	SENT_219	[p17l1436t1968r1766b2029],
3	2	CD	DURATION	2	num	4	SENT_219	[p17l1795t1971r1834b2028],
4	months	NNS	NUMBER	month	tmod	2	SENT_219	[p17l1863t1968r2142b2029],
5	after	IN	O	after	_	0	SENT_219	[p17l10t2062r179b2122],
6	the	DT	O	the	det	10	SENT_219	[p17l205t2062r320b2122],
7	most	RBS	O	most	advmod	10	SENT_219	[p17l350t2076r532b2122],
8	recent	JJ	O	recent	amod	10	SENT_219	[p17l560t2076r792b2122],
9	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	10	SENT_219	[p17l822t2062r1717b2138],
10	treatment	NN	O	treatment	prep_after	2	SENT_219	[p17l1746t2076r2133b2122],
11	.	.	O	.	_	0	SENT_219	[p17l1746t2076r2133b2122],

1	In	IN	O	in	_	0	SENT_220	[p17l93t2155r172b2214],
2	Kiliﬁ	NNP	O	Kiliﬁ	nn	4	SENT_220	[p17l256t2154r444b2214],
3	16	CD	NUMBER	16	num	4	SENT_220	[p17l538t2157r617b2215],
4	patients	NNS	O	patient	prep_in	5	SENT_220	[p17l702t2154r996b2230],
5	exited	VBD	O	exit	_	0	SENT_220	[p17l1083t2154r1306b2215],
6	because	IN	O	because	mark	8	SENT_220	[p17l1389t2154r1683b2215],
7	they	PRP	O	they	nsubj	8	SENT_220	[p17l1767t2154r1926b2230],
8	had	VBD	O	have	advcl	5	SENT_220	[p17l2007t2154r2144b2215],
9	haemoglobin	NN	O	haemoglobin	dep	10	SENT_220	[p17l7t2247r495b2323],
10	lower	JJR	O	lower	dobj	8	SENT_220	[p17l565t2247r770b2308],
11	than	IN	O	than	_	0	SENT_220	[p17l837t2247r1003b2308],
12	50	CD	NUMBER	50	num	15	SENT_220	[p17l1075t2250r1162b2308],
13	g/L	NN	O	g/l	nn	15	SENT_220	[p17l1233t2247r1359b2323],
14	(	NN	O	(	nn	15	SENT_220	[p17l1431t2247r1639b2323],
15	table	NN	O	table	prep_than	8	SENT_220	[p17l1431t2247r1639b2323],
16	2	CD	NUMBER	2	num	17	SENT_220	[p17l1711t2248r1807b2323],
17	)	NN	O	)	nsubj	5	SENT_220	[p17l1711t2248r1807b2323],
18	.	.	O	.	_	0	SENT_220	[p17l1711t2248r1807b2323],

1	In	IN	O	in	_	0	SENT_221	[p17l1881t2248r1960b2307],
2	the	DT	O	the	det	4	SENT_221	[p17l2029t2247r2143b2308],
3	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	4	SENT_221	[p17l10t2341r905b2417],
4	group	NN	O	group	prep_in	9	SENT_221	[p17l939t2360r1155b2417],
5	10	CD	NUMBER	10	nsubj	9	SENT_221	[p17l1199t2343r1279b2401],
6	of	IN	O	of	_	0	SENT_221	[p17l1316t2341r1395b2401],
7	188	CD	NUMBER	188	num	8	SENT_221	[p17l1427t2343r1554b2401],
8	cases	NNS	O	case	prep_of	5	SENT_221	[p17l1592t2361r1778b2401],
9	occurred	VBD	O	occur	_	0	SENT_221	[p17l1814t2341r2144b2401],
10	before	IN	O	before	_	0	SENT_221	[p17l7t2433r242b2493],
11	retreatment	NN	O	retreatment	prep_before	9	SENT_221	[p17l292t2447r732b2493],
12	and	CC	O	and	_	0	SENT_221	[p17l783t2433r918b2493],
13	3	CD	DATE	3	nsubj	16	SENT_221	[p17l970t2436r1008b2493],
14	of	IN	O	of	_	0	SENT_221	[p17l1063t2433r1141b2493],
15	188	CD	NUMBER	188	prep_of	13	SENT_221	[p17l1190t2435r1318b2493],
16	occurred	VBD	O	occur	conj_and	9	SENT_221	[p17l1372t2433r1702b2493],
17	soon	RB	O	soon	advmod	16	SENT_221	[p17l1753t2453r1926b2493],
18	after	IN	O	after	_	0	SENT_221	[p17l1977t2433r2146b2493],
19	retreatment	NN	O	retreatment	prep_after	16	SENT_221	[p17l8t2541r470b2599],
20	;	:	O	;	_	0	SENT_221	[p17l8t2541r470b2599],
21	in	IN	O	in	_	0	SENT_221	[p17l512t2526r581b2586],
22	the	DT	O	the	det	25	SENT_221	[p17l619t2526r733b2587],
23	sulfadoxine	NN	O	sulfadoxine	nn	25	SENT_221	[p17l773t2526r1805b2602],
24	—	NN	O	—	nn	25	SENT_221	[p17l773t2526r1805b2602],
25	pyrimethamine	NN	O	pyrimethamine	prep_in	30	SENT_221	[p17l773t2526r1805b2602],
26	group	NN	O	group	nsubj	30	SENT_221	[p17l1845t2546r2060b2602],
27	1	CD	NUMBER	1	num	26	SENT_221	[p17l2110t2529r2134b2586],
28	of	IN	O	of	_	0	SENT_221	[p17l10t2620r89b2680],
29	195	CD	NUMBER	195	prep_of	26	SENT_221	[p17l124t2622r250b2680],
30	occurred	VBD	O	occur	parataxis	9	SENT_221	[p17l292t2620r622b2680],
31	before	IN	O	before	_	0	SENT_221	[p17l656t2620r891b2680],
32	re-treatment	NN	O	re-treatment	prep_before	30	SENT_221	[p17l927t2633r1399b2680],
33	and	CC	O	and	_	0	SENT_221	[p17l1436t2620r1571b2680],
34	2	CD	NUMBER	2	prep_before	30	SENT_221	[p17l1610t2622r1649b2679],
35	of	IN	O	of	_	0	SENT_221	[p17l1689t2620r1768b2680],
36	195	CD	NUMBER	195	prep_of	34	SENT_221	[p17l1803t2622r1929b2680],
37	soon	RB	O	soon	advmod	30	SENT_221	[p17l1971t2639r2144b2680],
38	after	IN	O	after	prep	30	SENT_221	[p17l10t2712r197b2772],
39	.	.	O	.	_	0	SENT_221	[p17l10t2712r197b2772],

1	The	DT	O	the	det	2	SENT_222	[p17l237t2712r388b2772],
2	degree	NN	O	degree	nsubj	12	SENT_222	[p17l426t2712r669b2788],
3	of	IN	O	of	_	0	SENT_222	[p17l707t2712r785b2772],
4	haemoglobin	NN	O	haemoglobin	nn	5	SENT_222	[p17l810t2712r1298b2788],
5	decline	NN	O	decline	prep_of	2	SENT_222	[p17l1334t2712r1598b2773],
6	between	IN	O	between	_	0	SENT_222	[p17l1633t2712r1945b2773],
7	days	NNS	DURATION	day	nn	8	SENT_222	[p17l1982t2712r2142b2788],
8	o	NN	O	o	prep_between	5	SENT_222	[p17l10t2808r49b2866],
9	and	CC	O	and	_	0	SENT_222	[p17l96t2805r231b2866],
10	7	CD	NUMBER	7	prep_between	5	SENT_222	[p17l275t2808r313b2865],
11	was	VBD	O	be	cop	12	SENT_222	[p17l357t2825r492b2866],
12	greater	JJR	O	greater	_	0	SENT_222	[p17l536t2820r796b2881],
13	with	IN	O	with	_	0	SENT_222	[p17l835t2805r998b2866],
14	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_with	12	SENT_222	[p17l1041t2805r1936b2881],
15	than	IN	O	than	prep	12	SENT_222	[p17l1978t2805r2144b2866],
16	with	IN	O	with	pcomp	15	SENT_222	[p17l7t2899r170b2959],
17	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	pobj	16	SENT_222	[p17l238t2899r1294b2975],
18	;	:	O	;	_	0	SENT_222	[p17l238t2899r1294b2975],
19	this	DT	O	this	det	20	SENT_222	[p17l1364t2899r1495b2959],
20	effect	NN	O	effect	nsubj	23	SENT_222	[p17l1566t2899r1768b2959],
21	did	VBD	O	do	aux	23	SENT_222	[p17l1836t2899r1954b2959],
22	not	RB	O	not	neg	23	SENT_222	[p17l2021t2913r2145b2959],
23	seem	VB	O	seem	parataxis	12	SENT_222	[p17l10t3011r195b3051],
24	to	TO	O	to	aux	25	SENT_222	[p17l229t3005r299b3051],
25	rise	VB	O	rise	xcomp	23	SENT_222	[p17l334t2991r462b3051],
26	with	IN	O	with	_	0	SENT_222	[p17l496t2991r659b3052],
27	increasing	VBG	O	increase	prepc_with	25	SENT_222	[p17l692t2991r1072b3067],
28	numbers	NNS	O	number	dobj	27	SENT_222	[p17l1103t2991r1430b3051],
29	of	IN	O	of	_	0	SENT_222	[p17l1467t2991r1545b3051],
30	drug	NN	O	drug	nn	31	SENT_222	[p17l1570t2991r1742b3067],
31	exposures	NNS	O	exposure	prep_of	28	SENT_222	[p17l1776t3011r2142b3067],
32	(	RB	O	(	advmod	28	SENT_222	[p17l15t3084r222b3159],
33	table	NN	O	table	nn	35	SENT_222	[p17l15t3084r222b3159],
34	3	CD	NUMBER	3	num	35	SENT_222	[p17l274t3085r370b3160],
35	)	NN	O	)	dep	28	SENT_222	[p17l274t3085r370b3160],
36	.	.	O	.	_	0	SENT_222	[p17l274t3085r370b3160],

1	The	DT	O	the	det	5	SENT_223	[p17l423t3084r574b3145],
2	mean	JJ	O	mean	amod	5	SENT_223	[p17l624t3104r828b3145],
3	annual	JJ	SET	annual	amod	5	SENT_223	[p17l878t3084r1129b3145],
4	malaria	NN	O	malaria	nn	5	SENT_223	[p17l1178t3084r1455b3145],
5	incidence	NN	O	incidence	nsubj	30	SENT_223	[p17l1504t3084r1861b3145],
6	in	IN	O	in	_	0	SENT_223	[p17l1910t3085r1980b3144],
7	the	DT	O	the	det	9	SENT_223	[p17l2028t3084r2143b3145],
8	small	JJ	O	small	amod	9	SENT_223	[p17l10t3178r203b3238],
9	group	NN	O	group	prep_in	5	SENT_223	[p17l247t3197r463b3254],
10	of	IN	O	of	_	0	SENT_223	[p17l510t3178r589b3238],
11	patients	NNS	O	patient	prep_of	9	SENT_223	[p17l621t3178r915b3254],
12	whose	WP$	O	whose	dep	14	SENT_223	[p17l959t3178r1190b3238],
13	anaemia	NN	O	anaemia	nsubj	14	SENT_223	[p17l1236t3178r1544b3238],
14	preceded	VBD	O	precede	dep	11	SENT_223	[p17l1587t3178r1929b3254],
15	drug	NN	O	drug	nn	16	SENT_223	[p17l1973t3178r2145b3254],
16	exposure	NN	O	exposure	iobj	14	SENT_223	[p17l10t3290r342b3346],
17	(	CD	NUMBER	(	number	18	SENT_223	[p17l384t3270r500b3345],
18	10	CD	TIME	10	dobj	14	SENT_223	[p17l384t3270r500b3345],
19	of	IN	TIME	of	_	0	SENT_223	[p17l539t3270r617b3330],
20	11	CD	TIME	11	num	21	SENT_223	[p17l651t3272r724b3330],
21	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	18	SENT_223	[p17l769t3270r1663b3346],
22	and	CC	O	and	_	0	SENT_223	[p17l1700t3270r1836b3331],
23	1	CD	TIME	1	conj_and	18	SENT_223	[p17l1879t3272r1904b3330],
24	of	IN	TIME	of	_	0	SENT_223	[p17l1949t3270r2028b3330],
25	11	CD	TIME	11	num	27	SENT_223	[p17l2061t3272r2135b3330],
26	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	27	SENT_223	[p17l10t3363r1070b3439],
27	)	NN	O	)	prep_of	23	SENT_223	[p17l10t3363r1070b3439],
28	was	VBD	O	be	cop	30	SENT_223	[p17l1104t3383r1239b3424],
29	6-7	CD	NUMBER	6-7	num	30	SENT_223	[p17l1272t3363r1687b3424],
30	—	CD	NUMBER	—	_	0	SENT_223	[p17l1272t3363r1687b3424],
31	much	RB	O	much	advmod	32	SENT_223	[p17l1272t3363r1687b3424],
32	higher	JJR	O	higher	advmod	30	SENT_223	[p17l1714t3363r1952b3439],
33	than	IN	O	than	dep	30	SENT_223	[p17l1978t3363r2144b3424],
34	in	IN	O	in	_	0	SENT_223	[p17l8t3457r79b3516],
35	the	DT	O	the	det	37	SENT_223	[p17l121t3457r236b3517],
36	main	JJ	O	main	amod	37	SENT_223	[p17l280t3457r467b3517],
37	analysis	NN	O	analysis	prep_in	30	SENT_223	[p17l512t3457r797b3533],
38	for	IN	O	for	_	0	SENT_223	[p17l842t3457r948b3517],
39	either	CC	O	either	preconj	40	SENT_223	[p17l992t3457r1205b3517],
40	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_for	37	SENT_223	[p17l1248t3457r2143b3533],
41	or	CC	O	or	_	0	SENT_223	[p17l10t3569r86b3609],
42	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_for	37	SENT_223	[p17l128t3549r1182b3625],
43	.	.	O	.	_	0	SENT_223	[p17l128t3549r1182b3625],

1	By	IN	O	by	_	0	SENT_224	[p17l1230t3550r1328b3625],
2	contrast	NN	O	contrast	agent	17	SENT_224	[p17l1371t3563r1694b3622],
3	,	,	O	,	_	0	SENT_224	[p17l1371t3563r1694b3622],
4	the	DT	O	the	det	5	SENT_224	[p17l1739t3549r1853b3609],
5	exit	NN	O	exit	nsubjpass	17	SENT_224	[p17l1899t3549r2032b3609],
6	of	IN	O	of	_	0	SENT_224	[p17l2075t3549r2154b3609],
7	only	RB	O	only	quantmod	8	SENT_224	[p17l10t3642r169b3718],
8	one	CD	NUMBER	one	prep_of	5	SENT_224	[p17l207t3662r338b3703],
9	patient	NN	O	patient	nn	12	SENT_224	[p17l377t3643r639b3718],
10	(	CD	NUMBER	(	num	12	SENT_224	[p17l683t3642r1744b3718],
11	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	12	SENT_224	[p17l683t3642r1744b3718],
12	group	NN	O	group	dep	8	SENT_224	[p17l1784t3643r2029b3718],
13	)	CD	NUMBER	)	dep	8	SENT_224	[p17l1784t3643r2029b3718],
14	in	IN	O	in	_	0	SENT_224	[p17l2075t3643r2144b3702],
15	Blantyre	NNP	LOCATION	Blantyre	prep_in	13	SENT_224	[p17l9t3736r324b3812],
16	was	VBD	O	be	auxpass	17	SENT_224	[p17l365t3756r499b3796],
17	caused	VBN	O	cause	_	0	SENT_224	[p17l544t3736r796b3796],
18	by	IN	O	by	_	0	SENT_224	[p17l835t3736r925b3812],
19	packed-cell	NN	O	packed-cell	nn	20	SENT_224	[p17l963t3736r1389b3812],
20	Volume	NN	O	volume	agent	17	SENT_224	[p17l1428t3736r1704b3796],
21	of	IN	O	of	_	0	SENT_224	[p17l1747t3736r1826b3796],
22	15	CD	PERCENT	15	number	23	SENT_224	[p17l1866t3736r2022b3798],
23	%	NN	PERCENT	%	prep_of	20	SENT_224	[p17l1866t3736r2022b3798],
24	or	CC	O	or	_	0	SENT_224	[p17l2070t3755r2146b3796],
25	less	JJR	O	less	conj_or	23	SENT_224	[p18l9t14r161b86],
26	,	,	O	,	_	0	SENT_224	[p18l9t14r161b86],
27	and	CC	O	and	_	0	SENT_224	[p18l283t14r418b74],
28	no	DT	O	no	det	29	SENT_224	[p18l534t34r625b74],
29	differences	NNS	O	difference	nsubjpass	31	SENT_224	[p18l745t14r1148b74],
30	were	VBD	O	be	auxpass	31	SENT_224	[p18l1264t34r1438b74],
31	seen	VBN	O	see	conj_and	17	SENT_224	[p18l1557t34r1718b74],
32	between	IN	O	between	_	0	SENT_224	[p18l1832t14r2144b74],
33	chlorproguanil	NN	O	chlorproguanil	nn	35	SENT_224	[p18l10t107r905b183],
34	—	NN	O	—	nn	35	SENT_224	[p18l10t107r905b183],
35	dapsone	NN	O	dapsone	prep_between	31	SENT_224	[p18l10t107r905b183],
36	and	CC	O	and	_	0	SENT_224	[p18l941t107r1076b168],
37	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_between	31	SENT_224	[p18l1111t107r2143b183],
38	in	IN	O	in	_	0	SENT_224	[p18l8t201r79b260],
39	terms	NNS	O	term	prep_in	31	SENT_224	[p18l125t215r332b261],
40	of	IN	O	of	_	0	SENT_224	[p18l384t201r462b261],
41	decrease	NN	O	decrease	prep_of	39	SENT_224	[p18l501t201r818b261],
42	in	IN	O	in	_	0	SENT_224	[p18l867t201r936b260],
43	packed-cell	JJ	O	packed-cell	amod	48	SENT_224	[p18l983t201r1408b277],
44	volume	NN	O	volume	nn	48	SENT_224	[p18l1454t201r1730b261],
45	(	NN	O	(	nn	48	SENT_224	[p18l1784t201r1992b276],
46	table	NN	O	table	nn	48	SENT_224	[p18l1784t201r1992b276],
47	3	CD	NUMBER	3	num	48	SENT_224	[p18l2042t201r2138b276],
48	)	NN	O	)	prep_in	41	SENT_224	[p18l2042t201r2138b276],
49	.	.	O	.	_	0	SENT_224	[p18l2042t201r2138b276],

1	Vomiting	NN	O	vomiting	nsubj	5	SENT_225	[p18l7t293r360b369],
2	of	IN	O	of	_	0	SENT_225	[p18l396t293r475b353],
3	study	NN	O	study	nn	4	SENT_225	[p18l503t293r705b369],
4	medication	NN	O	medication	prep_of	1	SENT_225	[p18l739t293r1158b354],
5	seemed	VBD	O	seem	_	0	SENT_225	[p18l1196t293r1473b354],
6	to	TO	O	to	aux	8	SENT_225	[p18l1509t307r1579b353],
7	be	VB	O	be	cop	8	SENT_225	[p18l1616t293r1702b354],
8	commoner	NN	O	commoner	xcomp	5	SENT_225	[p18l1742t313r2146b353],
9	in	IN	O	in	_	0	SENT_225	[p18l8t387r79b446],
10	the	DT	O	the	det	14	SENT_225	[p18l133t386r247b447],
11	chlorproguanil	NN	O	chlorproguanil	nn	14	SENT_225	[p18l305t386r1199b462],
12	—	NN	O	—	nn	14	SENT_225	[p18l305t386r1199b462],
13	dapsone	NN	O	dapsone	nn	14	SENT_225	[p18l305t386r1199b462],
14	group	NN	O	group	prep_in	8	SENT_225	[p18l1255t406r1471b462],
15	in	IN	O	in	prep	8	SENT_225	[p18l1529t387r1599b446],
16	both	CC	O	both	dep	15	SENT_225	[p18l1652t386r1824b447],
17	centres	NNS	O	centre	conj	15	SENT_225	[p18l1880t401r2142b447],
18	(	RB	O	(	advmod	8	SENT_225	[p18l15t480r222b555],
19	table	NN	O	table	nn	21	SENT_225	[p18l15t480r222b555],
20	2	CD	NUMBER	2	num	21	SENT_225	[p18l263t480r361b555],
21	)	NN	O	)	dep	8	SENT_225	[p18l263t480r361b555],
22	,	,	O	,	_	0	SENT_225	[p18l263t480r361b555],
23	but	CC	O	but	_	0	SENT_225	[p18l400t480r526b540],
24	the	DT	O	the	det	25	SENT_225	[p18l563t480r677b540],
25	difference	NN	O	difference	nsubj	28	SENT_225	[p18l717t480r1086b540],
26	did	VBD	O	do	aux	28	SENT_225	[p18l1126t480r1243b540],
27	not	RB	O	not	neg	28	SENT_225	[p18l1280t494r1404b540],
28	reach	VB	O	reach	conj_but	5	SENT_225	[p18l1441t480r1643b540],
29	signiﬁcance	NN	O	signiﬁcance	dobj	28	SENT_225	[p18l1681t480r2138b556],
30	.	.	O	.	_	0	SENT_225	[p18l1681t480r2138b556],

1	Other	JJ	O	other	amod	3	SENT_226	[p18l11t572r229b633],
2	adverse	JJ	O	adverse	amod	3	SENT_226	[p18l259t572r535b633],
3	events	NNS	O	event	nsubj	5	SENT_226	[p18l568t586r798b633],
4	were	VBD	O	be	cop	5	SENT_226	[p18l829t592r1002b633],
5	uncommon	JJ	O	uncommon	_	0	SENT_226	[p18l1033t592r1464b632],
6	and	CC	O	and	_	0	SENT_226	[p18l1496t572r1631b633],
7	probably	RB	O	probably	advmod	5	SENT_226	[p18l1660t572r1993b648],
8	not	RB	O	not	neg	9	SENT_226	[p18l2021t586r2145b633],
9	attributable	JJ	O	attributable	dep	5	SENT_226	[p18l10t665r445b726],
10	to	TO	O	to	aux	11	SENT_226	[p18l476t680r547b726],
11	study	VB	O	study	xcomp	9	SENT_226	[p18l581t665r782b741],
12	medication	NN	O	medication	dobj	11	SENT_226	[p18l811t665r1252b738],
13	,	,	O	,	_	0	SENT_226	[p18l811t665r1252b738],
14	but	CC	O	but	_	0	SENT_226	[p18l1284t665r1410b726],
15	one	CD	NUMBER	one	num	16	SENT_226	[p18l1442t685r1573b726],
16	case	NN	O	case	dep	25	SENT_226	[p18l1606t685r1757b726],
17	of	IN	O	of	_	0	SENT_226	[p18l1791t665r1869b726],
18	rash	NN	O	rash	prep_of	16	SENT_226	[p18l1889t665r2044b726],
19	in	IN	O	in	_	0	SENT_226	[p18l2075t665r2144b725],
20	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	18	SENT_226	[p18l9t759r197b818],
21	(	CD	NUMBER	(	num	22	SENT_226	[p18l248t759r1172b835],
22	chlorproguanil	NN	O	chlorproguanil	dep	25	SENT_226	[p18l248t759r1172b835],
23	—	NN	O	—	nn	25	SENT_226	[p18l248t759r1172b835],
24	dapsone	NN	O	dapsone	nn	25	SENT_226	[p18l248t759r1172b835],
25	group	NN	O	group	dep	39	SENT_226	[p18l1218t759r1464b835],
26	)	CD	NUMBER	)	dep	25	SENT_226	[p18l1218t759r1464b835],
27	and	CC	O	and	_	0	SENT_226	[p18l1516t759r1652b819],
28	one	CD	NUMBER	one	num	29	SENT_226	[p18l1698t778r1829b819],
29	case	NN	O	case	conj_and	25	SENT_226	[p18l1876t779r2028b819],
30	of	IN	O	of	_	0	SENT_226	[p18l2075t759r2154b819],
31	rash	NN	O	rash	prep_of	29	SENT_226	[p18l8t851r163b911],
32	in	IN	O	in	_	0	SENT_226	[p18l231t851r301b911],
33	Blantyre	NNP	LOCATION	Blantyre	prep_in	31	SENT_226	[p18l370t851r685b927],
34	(	CD	NUMBER	(	num	33	SENT_226	[p18l761t851r1822b927],
35	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	37	SENT_226	[p18l761t851r1822b927],
36	group	NN	O	group	nn	37	SENT_226	[p18l1892t851r2137b927],
37	)	NN	O	)	nsubjpass	39	SENT_226	[p18l1892t851r2137b927],
38	were	VBD	O	be	auxpass	39	SENT_226	[p18l7t964r181b1005],
39	judged	VBN	O	judge	conj_but	5	SENT_226	[p18l211t944r464b1020],
40	to	TO	O	to	aux	42	SENT_226	[p18l493t959r563b1005],
41	be	VB	O	be	cop	42	SENT_226	[p18l593t944r679b1005],
42	drug-related	JJ	O	drug-related	xcomp	39	SENT_226	[p18l710t944r1193b1020],
43	.	.	O	.	_	0	SENT_226	[p18l710t944r1193b1020],

1	Discussion	NN	O	discussion	nn	2	SENT_227	[p18l11t1126r508b1194],
2	Chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubj	3	SENT_227	[p18l12t1227r931b1303],
3	is	VBZ	O	be	_	0	SENT_227	[p18l962t1227r1016b1287],
4	under	IN	O	under	_	0	SENT_227	[p18l1047t1227r1268b1287],
5	development	NN	O	development	prep_under	3	SENT_227	[p18l1298t1227r1782b1303],
6	as	IN	O	as	_	0	SENT_227	[p18l1813t1246r1882b1287],
7	a	DT	O	a	det	9	SENT_227	[p18l1915t1246r1951b1287],
8	lowcost	JJ	O	lowcost	amod	9	SENT_227	[p18l1982t1227r2143b1287, p18l10t1334r157b1380],
9	drug	NN	O	drug	prep_as	5	SENT_227	[p18l187t1320r358b1396],
10	for	IN	O	for	_	0	SENT_227	[p18l386t1320r491b1380],
11	the	DT	O	the	det	12	SENT_227	[p18l518t1320r632b1380],
12	treatment	NN	O	treatment	prep_for	9	SENT_227	[p18l662t1334r1028b1380],
13	of	IN	O	of	_	0	SENT_227	[p18l1057t1320r1136b1380],
14	uncomplicated	JJ	O	uncomplicated	amod	16	SENT_227	[p18l1155t1320r1713b1396],
15	falciparum	NN	O	falciparum	nn	16	SENT_227	[p18l1742t1320r2144b1396],
16	malaria	NN	O	malaria	prep_of	12	SENT_227	[p18l8t1412r308b1485],
17	,	,	O	,	_	0	SENT_227	[p18l8t1412r308b1485],
18	in	IN	O	in	_	0	SENT_227	[p18l391t1412r461b1472],
19	areas	NNS	O	area	prep_in	3	SENT_227	[p18l542t1432r726b1473],
20	where	WRB	O	where	advmod	25	SENT_227	[p18l806t1412r1029b1473],
21	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	22	SENT_227	[p18l1111t1412r2143b1488],
22	resistance	NN	O	resistance	nsubj	25	SENT_227	[p18l8t1506r374b1566],
23	is	VBZ	O	be	cop	25	SENT_227	[p18l483t1506r536b1566],
24	increasingly	RB	O	increasingly	advmod	25	SENT_227	[p18l646t1505r1093b1581],
25	common	JJ	O	common	rcmod	19	SENT_227	[p18l1201t1525r1550b1566],
26	.	.	O	.	_	0	SENT_227	[p18l1201t1525r1550b1566],

1	Despite	IN	O	despite	_	0	SENT_228	[p18l1664t1506r1950b1581],
2	its	PRP$	O	its	poss	4	SENT_228	[p18l2060t1506r2142b1566],
3	theoretical	JJ	O	theoretical	amod	4	SENT_228	[p18l8t1599r404b1659],
4	advantages	NNS	O	advantage	prep_despite	14	SENT_228	[p18l443t1599r851b1675],
5	over	IN	O	over	_	0	SENT_228	[p18l890t1618r1050b1659],
6	sulfadoxine	NN	O	sulfadoxine	nn	8	SENT_228	[p18l1085t1599r2141b1675],
7	—	NN	O	—	nn	8	SENT_228	[p18l1085t1599r2141b1675],
8	pyrimethamine	NN	O	pyrimethamine	prep_over	4	SENT_228	[p18l1085t1599r2141b1675],
9	,	,	O	,	_	0	SENT_228	[p18l1085t1599r2141b1675],
10	chlorproguanil	NN	O	chlorproguanil	nn	12	SENT_228	[p18l10t1691r905b1767],
11	—	NN	O	—	nn	12	SENT_228	[p18l10t1691r905b1767],
12	dapsone	NN	O	dapsone	nsubjpass	14	SENT_228	[p18l10t1691r905b1767],
13	is	VBZ	O	be	auxpass	14	SENT_228	[p18l953t1691r1006b1752],
14	eliminated	VBN	O	eliminate	_	0	SENT_228	[p18l1056t1691r1450b1752],
15	rapidly	RB	O	rapidly	advmod	14	SENT_228	[p18l1497t1691r1758b1767],
16	from	IN	O	from	_	0	SENT_228	[p18l1804t1691r1982b1752],
17	the	DT	O	the	det	18	SENT_228	[p18l2028t1691r2143b1752],
18	body	NN	O	body	prep_from	14	SENT_228	[p18l7t1784r214b1860],
19	,	,	O	,	_	0	SENT_228	[p18l7t1784r214b1860],
20	and	CC	O	and	_	0	SENT_228	[p18l250t1784r385b1845],
21	there	EX	O	there	expl	22	SENT_228	[p18l415t1784r604b1845],
22	is	VBZ	O	be	conj_and	14	SENT_228	[p18l635t1785r688b1845],
23	real	JJ	O	real	amod	24	SENT_228	[p18l720t1784r855b1845],
24	concern	NN	O	concern	nsubj	22	SENT_228	[p18l888t1804r1185b1845],
25	that	IN	O	that	complm	32	SENT_228	[p18l1215t1784r1361b1845],
26	the	DT	O	the	det	28	SENT_228	[p18l1391t1784r1505b1845],
27	resultant	JJ	O	resultant	amod	28	SENT_228	[p18l1536t1784r1866b1845],
28	lack	NN	O	lack	nsubj	32	SENT_228	[p18l1896t1784r2045b1845],
29	of	IN	O	of	_	0	SENT_228	[p18l2075t1784r2154b1845],
30	chemoprophylaxis	NN	O	chemoprophylaxi	prep_of	28	SENT_228	[p18l10t1878r692b1954],
31	might	MD	O	might	aux	32	SENT_228	[p18l724t1878r941b1954],
32	lead	VB	O	lead	ccomp	22	SENT_228	[p18l971t1878r1124b1938],
33	to	TO	O	to	_	0	SENT_228	[p18l1154t1892r1225b1938],
34	more	JJR	O	more	amod	36	SENT_228	[p18l1257t1897r1448b1938],
35	frequent	JJ	O	frequent	amod	36	SENT_228	[p18l1479t1878r1797b1954],
36	episodes	NNS	O	episode	prep_to	32	SENT_228	[p18l1828t1878r2142b1954],

1	1	CD	NUMBER	1	num	2	SENT_229	[p18l80t2050r91b2076],
2	140	CD	NUMBER	140	_	0	SENT_229	[p18l101t2050r156b2076],
3	THE	DT	O	the	det	4	SENT_229	[p18l1196t2055r1257b2076],
4	LANCET	NN	O	lancet	dep	2	SENT_229	[p18l1267t2055r1391b2076],
5	-	:	O	-	_	0	SENT_229	[p18l1401t2062r1409b2070],
6	Vol	NN	O	vol	dep	2	SENT_229	[p18l1418t2055r1462b2076],
7	360	CD	NUMBER	360	dep	6	SENT_229	[p18l1472t2056r1518b2076],
8	-	:	O	-	_	0	SENT_229	[p18l1529t2062r1536b2070],
9	October	NNP	DATE	October	dep	6	SENT_229	[p18l1547t2055r1650b2076],
10	12	CD	DATE	12	num	9	SENT_229	[p18l1661t2056r1697b2080],
11	,	,	DATE	,	_	0	SENT_229	[p18l1661t2056r1697b2080],
12	2002	CD	DATE	2002	num	9	SENT_229	[p18l1708t2056r1769b2076],
13	-	:	O	-	_	0	SENT_229	[p18l1780t2062r1788b2070],
14	www.thelancet.com	NN	O	www.thelancet.com	dep	9	SENT_229	[p18l1797t2055r2048b2076],

1	For	IN	O	for	_	0	SENT_230	[p18l81t2155r149b2190],
2	personal	JJ	O	personal	amod	3	SENT_230	[p18l174t2155r362b2198],
3	use	NN	O	use	pobj	1	SENT_230	[p18l390t2164r479b2190],
4	.	.	O	.	_	0	SENT_230	[p18l390t2164r479b2190],

1	Only	RB	O	only	advmod	2	SENT_231	[p18l527t2155r623b2199],
2	reproduce	VB	O	reproduce	_	0	SENT_231	[p18l648t2155r871b2198],
3	with	IN	O	with	_	0	SENT_231	[p18l895t2155r989b2190],
4	permission	NN	O	permission	prep_with	2	SENT_231	[p18l1017t2155r1258b2198],
5	from	IN	O	from	_	0	SENT_231	[p18l1283t2155r1381b2190],
6	The	DT	O	the	det	9	SENT_231	[p18l1406t2155r1486b2190],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_231	[p18l1512t2155r1662b2190],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_231	[p18l1688t2155r1921b2199],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_231	[p18l1944t2155r2088b2198],
10	.	.	O	.	_	0	SENT_231	[p18l1944t2155r2088b2198],

1	ARTICLES	NNS	O	article	_	0	SENT_232	[p18l1913t2274r2067b2295],

1	of	IN	O	of	_	0	SENT_233	[p18l10t2466r89b2527],
2	malaria	NN	O	malaria	pobj	1	SENT_233	[p18l107t2466r384b2527],
3	in	IN	O	in	_	0	SENT_233	[p18l413t2466r483b2526],
4	areas	NNS	O	area	prep_in	2	SENT_233	[p18l513t2486r698b2527],
5	where	WRB	O	where	advmod	8	SENT_233	[p18l726t2466r949b2527],
6	transmission	NN	O	transmission	nsubj	8	SENT_233	[p18l978t2466r1453b2527],
7	is	VBZ	O	be	cop	8	SENT_233	[p18l1481t2466r1534b2527],
8	high	JJ	O	high	rcmod	4	SENT_233	[p18l1563t2466r1746b2542],
9	.	.	O	.	_	0	SENT_233	[p18l1563t2466r1746b2542],

1	Thus	RB	O	thus	advmod	17	SENT_234	[p18l1779t2466r1997b2539],
2	,	,	O	,	_	0	SENT_234	[p18l1779t2466r1997b2539],
3	the	DT	O	the	det	4	SENT_234	[p18l2028t2466r2143b2527],
4	usefulness	NN	O	usefulness	nsubjpass	17	SENT_234	[p18l8t2559r390b2620],
5	of	IN	O	of	_	0	SENT_234	[p18l439t2559r518b2620],
6	chlorproguanil	NN	O	chlorproguanil	nn	8	SENT_234	[p18l555t2559r1450b2635],
7	—	NN	O	—	nn	8	SENT_234	[p18l555t2559r1450b2635],
8	dapsone	NN	O	dapsone	prep_of	4	SENT_234	[p18l555t2559r1450b2635],
9	for	IN	O	for	_	0	SENT_234	[p18l1496t2559r1602b2620],
10	public	JJ	O	public	amod	13	SENT_234	[p18l1644t2559r2144b2635],
11	—	NN	O	—	nn	13	SENT_234	[p18l1644t2559r2144b2635],
12	health	NN	O	health	nn	13	SENT_234	[p18l1644t2559r2144b2635],
13	strategies	NNS	O	strategy	prep_for	8	SENT_234	[p18l10t2653r355b2729],
14	could	MD	O	could	aux	17	SENT_234	[p18l403t2653r609b2713],
15	be	VB	O	be	auxpass	17	SENT_234	[p18l653t2653r739b2713],
16	profoundly	RB	O	profoundly	advmod	17	SENT_234	[p18l783t2653r1201b2729],
17	reduced	VBN	O	reduce	_	0	SENT_234	[p18l1244t2653r1568b2726],
18	,	,	O	,	_	0	SENT_234	[p18l1244t2653r1568b2726],
19	and	CC	O	and	_	0	SENT_234	[p18l1618t2653r1753b2713],
20	the	DT	O	the	det	22	SENT_234	[p18l1798t2653r1912b2713],
21	main	JJ	O	main	amod	22	SENT_234	[p18l1958t2653r2144b2713],
22	aim	NN	O	aim	nsubj	26	SENT_234	[p18l10t2745r144b2806],
23	of	IN	O	of	_	0	SENT_234	[p18l175t2745r254b2806],
24	our	PRP$	O	we	poss	25	SENT_234	[p18l275t2765r401b2806],
25	trial	NN	O	trial	prep_of	22	SENT_234	[p18l427t2745r576b2806],
26	was	VBD	O	be	conj_and	17	SENT_234	[p18l604t2765r739b2806],
27	to	TO	O	to	aux	28	SENT_234	[p18l769t2759r840b2806],
28	clarify	VB	O	clarify	xcomp	26	SENT_234	[p18l873t2745r1102b2821],
29	that	DT	O	that	det	30	SENT_234	[p18l1129t2745r1275b2806],
30	issue	NN	O	issue	dobj	28	SENT_234	[p18l1304t2745r1504b2806],
31	.	.	O	.	_	0	SENT_234	[p18l1304t2745r1504b2806],

1	We	PRP	O	we	nsubj	3	SENT_235	[p18l91t2839r215b2899],
2	were	VBD	O	be	cop	3	SENT_235	[p18l246t2858r420b2899],
3	keen	JJ	O	keen	_	0	SENT_235	[p18l453t2838r625b2899],
4	to	TO	O	to	aux	5	SENT_235	[p18l656t2853r727b2899],
5	recruit	VB	O	recruit	xcomp	3	SENT_235	[p18l760t2839r1008b2899],
6	a	DT	O	a	det	8	SENT_235	[p18l1040t2858r1076b2899],
7	low-risk	JJ	O	low-risk	amod	8	SENT_235	[p18l1108t2838r1408b2899],
8	population	NN	O	population	dobj	5	SENT_235	[p18l1436t2838r1845b2914],
9	for	IN	O	for	_	0	SENT_235	[p18l1876t2838r1981b2899],
10	this	DT	O	this	det	12	SENT_235	[p18l2011t2838r2142b2899],
11	outpatient	NN	O	outpatient	nn	12	SENT_235	[p18l10t2932r643b3008],
12	—	NN	O	—	prep_for	5	SENT_235	[p18l10t2932r643b3008],
13	based	VBN	O	base	partmod	12	SENT_235	[p18l10t2932r643b3008],
14	study	NN	O	study	dobj	13	SENT_235	[p18l749t2932r969b3008],
15	.	.	O	.	_	0	SENT_235	[p18l749t2932r969b3008],

1	Thus	RB	O	thus	advmod	5	SENT_236	[p18l1079t2932r1297b3005],
2	,	,	O	,	_	0	SENT_236	[p18l1079t2932r1297b3005],
3	all	DT	O	all	det	4	SENT_236	[p18l1407t2932r1491b2992],
4	children	NNS	O	child	nsubj	21	SENT_236	[p18l1597t2932r1903b2992],
5	had	VBD	O	have	_	0	SENT_236	[p18l2007t2932r2144b2992],
6	parasitaemia	NN	O	parasitaemia	dobj	5	SENT_236	[p18l7t3024r480b3100],
7	less	JJR	O	less	mwe	8	SENT_236	[p18l585t3024r713b3085],
8	than	IN	O	than	quantmod	9	SENT_236	[p18l818t3024r985b3085],
9	250	CD	NUMBER	250	num	10	SENT_236	[p18l1090t3027r1225b3085],
10	ooo	NN	O	ooo	dep	6	SENT_236	[p18l1259t3027r1394b3085],
11	pLL	NN	O	pll	dep	6	SENT_236	[p18l1505t3025r1654b3101],
12	'	''	O	'	_	0	SENT_236	[p18l1505t3025r1654b3101],
13	1	CD	NUMBER	1	number	14	SENT_236	[p18l1505t3025r1654b3101],
14	(	CD	NUMBER	(	dep	11	SENT_236	[p18l1767t3025r1872b3099],
15	or	CC	O	or	_	0	SENT_236	[p18l1767t3025r1872b3099],
16	10	CD	PERCENT	10	number	17	SENT_236	[p18l1983t3024r2139b3086],
17	%	NN	PERCENT	%	amod	19	SENT_236	[p18l1983t3024r2139b3086],
18	parasitaemia	NN	O	parasitaemia	nn	19	SENT_236	[p18l7t3118r509b3193],
19	)	NN	O	)	dobj	5	SENT_236	[p18l7t3118r509b3193],
20	and	CC	O	and	_	0	SENT_236	[p18l595t3117r731b3178],
21	had	VBD	O	have	conj_and	5	SENT_236	[p18l808t3117r945b3178],
22	haemoglobin	NN	O	haemoglobin	nn	23	SENT_236	[p18l1022t3117r1510b3193],
23	concentrations	NNS	O	concentration	iobj	21	SENT_236	[p18l1590t3118r2142b3178],
24	greater	JJR	O	greater	mwe	25	SENT_236	[p18l8t3225r269b3287],
25	than	IN	O	than	quantmod	26	SENT_236	[p18l301t3211r467b3271],
26	70	CD	NUMBER	70	dep	23	SENT_236	[p18l504t3213r591b3271],
27	g/L	NN	O	g/l	nn	30	SENT_236	[p18l628t3211r754b3287],
28	(	CD	NUMBER	(	num	30	SENT_236	[p18l791t3211r1243b3287],
29	packed-cell	NN	O	packed-cell	nn	30	SENT_236	[p18l791t3211r1243b3287],
30	volume	NN	O	volume	dep	26	SENT_236	[p18l1277t3211r1552b3271],
31	above	IN	O	above	_	0	SENT_236	[p18l1589t3211r1803b3271],
32	21	CD	PERCENT	21	num	33	SENT_236	[p18l1841t3211r2036b3286],
33	%	NN	PERCENT	%	prep_above	23	SENT_236	[p18l1841t3211r2036b3286],
34	)	CD	NUMBER	)	dobj	21	SENT_236	[p18l1841t3211r2036b3286],
35	at	IN	O	at	_	0	SENT_236	[p18l2079t3225r2145b3271],
36	recruitment	NN	O	recruitment	prep_at	21	SENT_236	[p18l8t3303r470b3364],
37	.	.	O	.	_	0	SENT_236	[p18l8t3303r470b3364],

1	Such	JJ	O	such	amod	2	SENT_237	[p18l517t3303r701b3364],
2	values	NNS	O	value	nsubj	9	SENT_237	[p18l737t3303r966b3364],
3	for	IN	O	for	_	0	SENT_237	[p18l1006t3303r1111b3364],
4	parasitaemia	NN	O	parasitaemia	prep_for	2	SENT_237	[p18l1146t3303r1620b3379],
5	and	CC	O	and	_	0	SENT_237	[p18l1660t3303r1795b3364],
6	anaemia	NN	O	anaemia	conj_and	4	SENT_237	[p18l1835t3303r2143b3364],
7	are	VBP	O	be	cop	9	SENT_237	[p18l10t3416r119b3457],
8	common	JJ	O	common	amod	9	SENT_237	[p18l153t3416r481b3457],
9	features	NNS	O	feature	_	0	SENT_237	[p18l513t3396r805b3457],
10	of	IN	O	of	_	0	SENT_237	[p18l840t3396r918b3457],
11	uncomplicated	JJ	O	uncomplicated	amod	12	SENT_237	[p18l940t3396r1498b3472],
12	malaria	NN	O	malaria	prep_of	9	SENT_237	[p18l1529t3396r1829b3469],
13	,	,	O	,	_	0	SENT_237	[p18l1529t3396r1829b3469],
14	and	CC	O	and	_	0	SENT_237	[p18l1866t3396r2001b3457],
15	are	VBP	O	be	auxpass	17	SENT_237	[p18l2034t3416r2143b3457],
16	usually	RB	O	usually	advmod	17	SENT_237	[p18l8t3490r272b3566],
17	managed	VBN	O	manage	conj_and	9	SENT_237	[p18l318t3490r657b3566],
18	without	IN	O	without	_	0	SENT_237	[p18l703t3490r993b3550],
19	admission	NN	O	admission	prep_without	17	SENT_237	[p18l1043t3490r1418b3550],
20	to	TO	O	to	_	0	SENT_237	[p18l1465t3504r1536b3550],
21	hospital	NN	O	hospital	prep_to	17	SENT_237	[p18l1585t3490r1901b3566],
22	.	.	O	.	_	0	SENT_237	[p18l1585t3490r1901b3566],

1	After	IN	O	after	_	0	SENT_238	[p18l1953t3490r2146b3550],
2	recruitment	NN	O	recruitment	prep_after	6	SENT_238	[p18l8t3582r473b3655],
3	,	,	O	,	_	0	SENT_238	[p18l8t3582r473b3655],
4	children	NNS	O	child	nsubjpass	6	SENT_238	[p18l521t3582r827b3643],
5	were	VBD	O	be	auxpass	6	SENT_238	[p18l868t3602r1043b3643],
6	seen	VBN	O	see	_	0	SENT_238	[p18l1088t3602r1249b3643],
7	by	IN	O	by	_	0	SENT_238	[p18l1291t3582r1380b3658],
8	a	DT	O	a	det	9	SENT_238	[p18l1424t3602r1458b3643],
9	doctor	NN	O	doctor	agent	6	SENT_238	[p18l1504t3582r1748b3643],
10	whenever	WRB	O	whenever	advmod	13	SENT_238	[p18l1787t3582r2146b3643],
11	their	PRP$	O	they	poss	12	SENT_238	[p18l8t3675r182b3736],
12	parents	NNS	O	parent	nsubjpass	21	SENT_238	[p18l212t3690r486b3751],
13	felt	VBD	O	feel	dep	9	SENT_238	[p18l520t3675r638b3736],
14	that	IN	O	that	complm	17	SENT_238	[p18l670t3675r816b3736],
15	they	PRP	O	they	nsubj	17	SENT_238	[p18l847t3675r1006b3751],
16	were	VBD	O	be	cop	17	SENT_238	[p18l1036t3695r1209b3736],
17	ill	RB	O	ill	ccomp	13	SENT_238	[p18l1243t3675r1334b3748],
18	,	,	O	,	_	0	SENT_238	[p18l1243t3675r1334b3748],
19	and	CC	O	and	_	0	SENT_238	[p18l1372t3675r1507b3736],
20	were	VBD	O	be	auxpass	21	SENT_238	[p18l1538t3695r1712b3736],
21	withdrawn	VBN	O	withdraw	dep	9	SENT_238	[p18l1744t3675r2144b3736],
22	from	IN	O	from	_	0	SENT_238	[p19l8t16r186b76],
23	the	DT	O	the	det	24	SENT_238	[p19l255t16r369b76],
24	trial	NN	O	trial	prep_from	21	SENT_238	[p19l439t16r588b76],
25	if	IN	O	if	dep	26	SENT_238	[p19l658t16r715b75],
26	appropriate	JJ	O	appropriate	amod	24	SENT_238	[p19l776t16r1230b92],
27	,	,	O	,	_	0	SENT_238	[p19l776t16r1230b92],
28	according	VBG	O	accord	dep	9	SENT_238	[p19l1305t16r1671b92],
29	to	TO	O	to	pcomp	28	SENT_238	[p19l1739t30r1810b76],
30	criteria	NNS	O	criterion	pobj	29	SENT_238	[p19l1882t16r2143b76],
31	described	VBN	O	describe	partmod	30	SENT_238	[p19l10t108r367b169],
32	in	IN	O	in	_	0	SENT_238	[p19l396t108r467b168],
33	the	DT	O	the	det	35	SENT_238	[p19l495t108r609b169],
34	methods	NNS	O	method	nn	35	SENT_238	[p19l639t108r959b169],
35	section	NN	O	section	prep_in	31	SENT_238	[p19l991t108r1273b169],
36	.	.	O	.	_	0	SENT_238	[p19l991t108r1273b169],

1	We	PRP	O	we	nsubj	2	SENT_239	[p19l91t202r215b262],
2	wrote	VBD	O	write	_	0	SENT_239	[p19l246t216r456b262],
3	the	DT	O	the	det	4	SENT_239	[p19l488t201r603b262],
4	protocol	NN	O	protocol	dobj	2	SENT_239	[p19l634t201r949b277],
5	for	IN	O	for	_	0	SENT_239	[p19l980t201r1086b262],
6	our	PRP$	O	we	poss	7	SENT_239	[p19l1117t221r1243b262],
7	trial	NN	O	trial	prep_for	4	SENT_239	[p19l1273t201r1421b262],
8	before	IN	O	before	_	0	SENT_239	[p19l1452t201r1687b262],
9	publication	NN	O	publication	prep_before	4	SENT_239	[p19l1718t201r2144b277],
10	of	IN	O	of	_	0	SENT_239	[p19l10t295r89b355],
11	the	DT	O	the	prep_of	4	SENT_239	[p19l150t295r264b355],
12	revised	VBN	O	revise	amod	11	SENT_239	[p19l336t295r598b355],
13	WHO	WP	O	who	dep	14	SENT_239	[p19l667t295r892b355],
14	guidelines	NNS	O	guideline	rcmod	4	SENT_239	[p19l966t295r1342b371],
15	for	IN	O	for	_	0	SENT_239	[p19l1415t295r1520b355],
16	assessment	NN	O	assessment	prep_for	14	SENT_239	[p19l1591t309r2003b355],
17	of	IN	O	of	_	0	SENT_239	[p19l2075t295r2154b355],
18	therapeutic	JJ	O	therapeutic	amod	19	SENT_239	[p19l8t387r431b463],
19	efﬁcacy	NN	O	efﬁcacy	prep_of	16	SENT_239	[p19l486t387r768b463],
20	of	IN	O	of	_	0	SENT_239	[p19l820t387r898b448],
21	antimalarial	JJ	O	antimalarial	amod	22	SENT_239	[p19l942t387r1386b448],
22	drugs	NNS	O	drug	prep_of	19	SENT_239	[p19l1440t387r1720b463],
23	.	.	O	.	_	0	SENT_239	[p19l1440t387r1720b463],

1	”	NN	O	”	ccomp	7	SENT_240	[p19l1440t387r1720b463],
2	Thus	RB	O	thus	advmod	1	SENT_240	[p19l1771t387r1989b460],
3	,	,	O	,	_	0	SENT_240	[p19l1771t387r1989b460],
4	we	PRP	O	we	nsubj	7	SENT_240	[p19l2043t407r2143b448],
5	can	MD	O	can	aux	7	SENT_240	[p19l10t495r264b541],
6	not	RB	O	not	neg	7	SENT_240	[p19l10t495r264b541],
7	provide	VB	O	provide	_	0	SENT_240	[p19l301t480r583b556],
8	data	NNS	O	datum	dobj	7	SENT_240	[p19l624t480r781b541],
9	about	IN	O	about	_	0	SENT_240	[p19l823t480r1034b541],
10	treatment	NN	O	treatment	nn	11	SENT_240	[p19l1072t495r1439b541],
11	failure	NN	O	failure	prep_about	7	SENT_240	[p19l1477t480r1713b541],
12	as	IN	O	as	mark	13	SENT_240	[p19l1755t500r1824b541],
13	defined	VBN	O	define	advcl	7	SENT_240	[p19l1867t480r2144b541],
14	by	IN	O	by	_	0	SENT_240	[p19l7t574r96b650],
15	the	DT	O	the	det	16	SENT_240	[p19l123t574r238b634],
16	latest	JJS	O	latest	prep_by	13	SENT_240	[p19l268t574r464b634],
17	WHO	WP	O	who	det	18	SENT_240	[p19l491t574r716b634],
18	recommendations	NNS	O	recommendation	rcmod	16	SENT_240	[p19l747t574r1442b634],
19	.	.	O	.	_	0	SENT_240	[p19l747t574r1442b634],

1	Treatment	NN	O	treatment	nn	2	SENT_241	[p19l1476t575r1879b634],
2	failure	NN	O	failure	nsubjpass	4	SENT_241	[p19l1907t574r2143b634],
3	was	VBD	O	be	auxpass	4	SENT_241	[p19l7t686r142b727],
4	managed	VBN	O	manage	_	0	SENT_241	[p19l173t666r512b742],
5	with	IN	O	with	_	0	SENT_241	[p19l540t666r703b727],
6	oral	JJ	O	oral	amod	7	SENT_241	[p19l735t666r874b727],
7	halofantrine	NN	O	halofantrine	prep_with	4	SENT_241	[p19l904t666r1358b727],
8	unless	IN	O	unless	mark	11	SENT_241	[p19l1389t666r1618b727],
9	the	DT	O	the	det	10	SENT_241	[p19l1649t666r1763b727],
10	child	NN	O	child	nsubj	11	SENT_241	[p19l1796t666r1978b727],
11	had	VBD	O	have	advcl	4	SENT_241	[p19l2007t666r2144b727],
12	severe	JJ	O	severe	amod	13	SENT_241	[p19l10t779r236b820],
13	malaria	NN	O	malaria	dobj	11	SENT_241	[p19l267t759r567b832],
14	,	,	O	,	_	0	SENT_241	[p19l267t759r567b832],
15	in	IN	O	in	_	0	SENT_241	[p19l601t760r671b819],
16	which	WDT	O	which	det	17	SENT_241	[p19l700t759r923b820],
17	case	NN	O	case	rel	22	SENT_241	[p19l955t779r1107b820],
18	parenteral	JJ	O	parenteral	amod	19	SENT_241	[p19l1137t759r1518b835],
19	quinine	NN	O	quinine	nsubj	22	SENT_241	[p19l1551t760r1832b835],
20	was	VBD	O	be	cop	22	SENT_241	[p19l1862t779r1997b820],
21	the	DT	O	the	det	22	SENT_241	[p19l2029t759r2143b820],
22	drug	NN	O	drug	rcmod	13	SENT_241	[p19l10t853r182b929],
23	of	IN	O	of	_	0	SENT_241	[p19l219t853r298b913],
24	choice	NN	O	choice	prep_of	22	SENT_241	[p19l327t853r563b913],
25	in	IN	O	in	prep	22	SENT_241	[p19l601t853r671b912],
26	both	CC	O	both	dep	25	SENT_241	[p19l707t853r879b913],
27	trial	NN	O	trial	nn	28	SENT_241	[p19l915t853r1063b913],
28	centres	NNS	O	centre	conj	25	SENT_241	[p19l1103t867r1387b913],
29	.	.	O	.	_	0	SENT_241	[p19l1103t867r1387b913],

1	The	DT	O	the	det	2	SENT_242	[p19l1429t853r1580b913],
2	choice	NN	O	choice	nsubjpass	10	SENT_242	[p19l1620t853r1856b913],
3	of	IN	O	of	_	0	SENT_242	[p19l1896t853r1975b913],
4	oral	JJ	O	oral	amod	5	SENT_242	[p19l2003t853r2143b913],
5	medication	NN	O	medication	prep_of	2	SENT_242	[p19l8t945r427b1006],
6	for	IN	O	for	_	0	SENT_242	[p19l455t945r561b1006],
7	treatment	NN	O	treatment	nn	8	SENT_242	[p19l586t959r952b1006],
8	failure	NN	O	failure	prep_for	5	SENT_242	[p19l980t945r1216b1006],
9	is	VBZ	O	be	auxpass	10	SENT_242	[p19l1245t945r1298b1006],
10	difﬁcult	VBN	O	difﬁcult	_	0	SENT_242	[p19l1330t945r1622b1006],
11	in	IN	O	in	_	0	SENT_242	[p19l1650t945r1720b1005],
12	east	JJ	O	east	amod	13	SENT_242	[p19l1749t959r1891b1006],
13	Africa	NNP	LOCATION	Africa	prep_in	10	SENT_242	[p19l1917t945r2143b1006],
14	because	IN	O	because	mark	17	SENT_242	[p19l7t1038r301b1099],
15	options	NNS	O	option	nsubj	17	SENT_242	[p19l352t1039r625b1114],
16	are	VBP	O	be	cop	17	SENT_242	[p19l678t1058r786b1099],
17	restricted	JJ	O	restricted	advcl	10	SENT_242	[p19l835t1038r1208b1099],
18	.	.	O	.	_	0	SENT_242	[p19l835t1038r1208b1099],

1	We	PRP	O	we	nsubj	2	SENT_243	[p19l1260t1039r1384b1099],
2	chose	VBD	O	choose	_	0	SENT_243	[p19l1435t1038r1640b1099],
3	halofantrine	NN	O	halofantrine	dobj	2	SENT_243	[p19l1689t1038r2143b1099],
4	because	IN	O	because	_	0	SENT_243	[p19l7t1132r301b1192],
5	of	IN	O	of	prepc_because_of	2	SENT_243	[p19l353t1132r433b1192],
6	its	PRP$	O	its	poss	8	SENT_243	[p19l472t1132r555b1192],
7	high	JJ	O	high	amod	8	SENT_243	[p19l605t1132r768b1208],
8	efficacy	NN	O	efficacy	pobj	2	SENT_243	[p19l819t1132r1119b1208],
9	.	.	O	.	_	0	SENT_243	[p19l819t1132r1119b1208],

1	Electrocardiographic	JJ	O	electrocardiographic	amod	3	SENT_244	[p19l1175t1132r1962b1208],
2	QT	NN	O	qt	nn	3	SENT_244	[p19l2015t1132r2145b1208],
3	prolongation	NN	O	prolongation	nsubj	8	SENT_244	[p19l7t1224r490b1300],
4	is	VBZ	O	be	cop	8	SENT_244	[p19l530t1224r583b1285],
5	a	DT	O	a	det	8	SENT_244	[p19l626t1244r661b1285],
6	known	JJ	O	known	amod	8	SENT_244	[p19l703t1224r952b1285],
7	adverse	JJ	O	adverse	amod	8	SENT_244	[p19l994t1224r1269b1285],
8	effect	NN	O	effect	_	0	SENT_244	[p19l1312t1224r1514b1285],
9	of	IN	O	of	_	0	SENT_244	[p19l1555t1224r1634b1285],
10	halofantrine	NN	O	halofantrine	prep_of	8	SENT_244	[p19l1663t1224r2141b1297],
11	,	,	O	,	_	0	SENT_244	[p19l1663t1224r2141b1297],
12	and	CC	O	and	_	0	SENT_244	[p19l10t1317r145b1378],
13	arrhythmias	NNS	O	arrhythmia	nsubj	15	SENT_244	[p19l200t1317r644b1393],
14	occasionally	RB	O	occasionally	advmod	15	SENT_244	[p19l700t1317r1155b1393],
15	cause	VBP	O	cause	conj_and	8	SENT_244	[p19l1208t1337r1409b1378],
16	death	NN	O	death	dobj	15	SENT_244	[p19l1464t1317r1670b1378],
17	in	IN	O	in	_	0	SENT_244	[p19l1722t1318r1792b1377],
18	adults	NNS	O	adult	prep_in	16	SENT_244	[p19l1846t1317r2140b1378],
19	.	.	O	.	_	0	SENT_244	[p19l1846t1317r2140b1378],

1	“	NN	O	“	nsubj	5	SENT_245	[p19l1846t1317r2140b1378],
2	However	RB	O	however	advmod	5	SENT_245	[p19l9t1412r367b1483],
3	,	,	O	,	_	0	SENT_245	[p19l9t1412r367b1483],
4	we	PRP	O	we	nsubj	5	SENT_245	[p19l438t1430r538b1471],
5	felt	VBD	O	feel	_	0	SENT_245	[p19l607t1411r726b1471],
6	that	IN	O	that	complm	11	SENT_245	[p19l793t1411r940b1471],
7	the	DT	O	the	det	8	SENT_245	[p19l1006t1411r1121b1471],
8	benefits	NNS	O	benefit	nsubj	11	SENT_245	[p19l1189t1411r1481b1471],
9	of	IN	O	of	_	0	SENT_245	[p19l1553t1411r1631b1471],
10	halofantrine	NN	O	halofantrine	prep_of	8	SENT_245	[p19l1689t1411r2143b1471],
11	exceeded	VBD	O	exceed	ccomp	5	SENT_245	[p19l10t1502r352b1563],
12	its	PRP$	O	its	poss	13	SENT_245	[p19l396t1502r479b1563],
13	risks	NNS	O	risk	dobj	11	SENT_245	[p19l524t1502r714b1575],
14	,	,	O	,	_	0	SENT_245	[p19l524t1502r714b1575],
15	and	CC	O	and	_	0	SENT_245	[p19l763t1502r899b1563],
16	we	PRP	O	we	nsubj	17	SENT_245	[p19l942t1522r1042b1563],
17	noted	VBD	O	note	conj_and	5	SENT_245	[p19l1087t1502r1300b1563],
18	neither	CC	O	neither	preconj	20	SENT_245	[p19l1344t1502r1609b1563],
19	drug	NN	O	drug	nn	20	SENT_245	[p19l1653t1502r1825b1578],
20	toxicity	NN	O	toxicity	dep	17	SENT_245	[p19l1867t1502r2145b1578],
21	nor	CC	O	nor	_	0	SENT_245	[p19l8t1615r136b1656],
22	failure	NN	O	failure	dep	17	SENT_245	[p19l163t1595r399b1656],
23	of	IN	O	of	_	0	SENT_245	[p19l431t1595r510b1656],
24	halofantrine	NN	O	halofantrine	nn	26	SENT_245	[p19l528t1595r982b1656],
25	emergency	NN	O	emergency	nn	26	SENT_245	[p19l1013t1615r1416b1671],
26	treatment	NN	O	treatment	prep_of	22	SENT_245	[p19l1443t1610r1829b1656],
27	.	.	O	.	_	0	SENT_245	[p19l1443t1610r1829b1656],

1	We	PRP	O	we	nsubj	2	SENT_246	[p19l91t1690r215b1749],
2	used	VBD	O	use	_	0	SENT_246	[p19l297t1689r468b1749],
3	a	DT	O	a	det	5	SENT_246	[p19l551t1708r586b1749],
4	standard	JJ	O	standard	amod	5	SENT_246	[p19l669t1689r993b1749],
5	dose-ratio	NN	O	dose-ratio	dobj	2	SENT_246	[p19l1075t1689r1448b1749],
6	of	IN	O	of	_	0	SENT_246	[p19l1533t1689r1611b1749],
7	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_of	5	SENT_246	[p19l1684t1689r2143b1749, p19l7t1781r599b1857],
8	,	,	O	,	_	0	SENT_246	[p19l1684t1689r2143b1749, p19l7t1781r599b1857],

1	and	CC	O	and	cc	6	SENT_247	[p19l652t1781r788b1842],
2	the	DT	O	the	det	4	SENT_247	[p19l835t1781r949b1842],
3	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	4	SENT_247	[p19l1000t1781r1894b1857],
4	doseratio	NN	O	doseratio	nsubjpass	6	SENT_247	[p19l1945t1781r2143b1842, p19l8t1875r178b1935],
5	was	VBD	O	be	auxpass	6	SENT_247	[p19l256t1894r391b1935],
6	ﬁxed	VBN	O	ﬁxed	_	0	SENT_247	[p19l470t1874r652b1935],
7	with	IN	O	with	_	0	SENT_247	[p19l729t1874r891b1935],
8	reference	NN	O	reference	prep_with	6	SENT_247	[p19l969t1874r1312b1935],
9	to	TO	O	to	_	0	SENT_247	[p19l1390t1889r1461b1935],
10	previous	JJ	O	previous	amod	11	SENT_247	[p19l1539t1874r1855b1950],
11	work	NN	O	work	prep_to	6	SENT_247	[p19l1933t1874r2138b1935],
12	.	.	O	.	_	0	SENT_247	[p19l1933t1874r2138b1935],

1	Amukoye	NNP	PERSON	Amukoye	nsubj	5	SENT_248	[p19l7t1968r364b2044],
2	and	CC	O	and	_	0	SENT_248	[p19l397t1968r532b2028],
3	colleagues	NNS	O	colleague	conj_and	1	SENT_248	[p19l564t1968r993b2044],
4	”	RB	O	”	advmod	5	SENT_248	[p19l564t1968r993b2044],
5	used	VBD	O	use	_	0	SENT_248	[p19l1024t1968r1195b2028],
6	a	DT	O	a	det	8	SENT_248	[p19l1227t1988r1262b2028],
7	chlorproguanil	NN	O	chlorproguanil	nn	8	SENT_248	[p19l1295t1968r1844b2044],
8	dose	NN	O	dose	dobj	5	SENT_248	[p19l1877t1968r2042b2028],
9	of	IN	O	of	_	0	SENT_248	[p19l2075t1968r2154b2028],
10	1-2	CD	NUMBER	1-2	num	11	SENT_248	[p19l18t2063r124b2120],
11	mg/kg	NN	O	mg/kg	prep_of	8	SENT_248	[p19l160t2060r388b2136],
12	per	IN	O	per	_	0	SENT_248	[p19l419t2080r541b2136],
13	day	NN	DURATION	day	prep_per	11	SENT_248	[p19l574t2060r704b2136],
14	in	IN	O	in	_	0	SENT_248	[p19l736t2060r806b2120],
15	their	PRP$	O	they	poss	17	SENT_248	[p19l839t2060r1013b2121],
16	clinical	JJ	O	clinical	amod	17	SENT_248	[p19l1047t2060r1311b2121],
17	trial	NN	O	trial	prep_in	5	SENT_248	[p19l1345t2060r1516b2133],
18	,	,	O	,	_	0	SENT_248	[p19l1345t2060r1516b2133],
19	but	CC	O	but	_	0	SENT_248	[p19l1552t2060r1678b2121],
20	thereafter	RB	O	thereafter	advmod	29	SENT_248	[p19l1710t2060r2075b2121],
21	a	DT	O	a	det	25	SENT_248	[p19l2108t2080r2143b2121],
22	rising	VBG	O	rise	amod	25	SENT_248	[p19l8t2154r215b2229],
23	dose	NN	O	dose	nn	25	SENT_248	[p19l243t2153r409b2214],
24	tolerance	NN	O	tolerance	nn	25	SENT_248	[p19l438t2153r781b2214],
25	study	NN	O	study	nsubj	29	SENT_248	[p19l812t2153r1013b2229],
26	in	IN	O	in	_	0	SENT_248	[p19l1040t2154r1110b2213],
27	healthy	JJ	O	healthy	amod	28	SENT_248	[p19l1136t2153r1411b2229],
28	adults	NNS	O	adult	prep_in	25	SENT_248	[p19l1439t2153r1661b2214],
29	showed	VBD	O	show	conj_but	5	SENT_248	[p19l1692t2153r1971b2214],
30	that	IN	O	that	complm	39	SENT_248	[p19l1999t2153r2145b2214],
31	2-O	NN	O	2-o	nn	32	SENT_248	[p19l10t2249r124b2307],
32	mg/kg	NN	O	mg/kg	nsubj	39	SENT_248	[p19l179t2247r407b2323],
33	per	IN	O	per	_	0	SENT_248	[p19l457t2266r579b2323],
34	day	NN	DURATION	day	prep_per	32	SENT_248	[p19l632t2247r761b2323],
35	was	VBD	O	be	cop	39	SENT_248	[p19l811t2267r946b2307],
36	well-tolerated	JJ	O	well-tolerated	amod	39	SENT_248	[p19l999t2247r1517b2307],
37	(	NN	O	(	nn	39	SENT_248	[p19l1577t2247r1983b2322],
38	Blockman	NN	O	blockman	nn	39	SENT_248	[p19l1577t2247r1983b2322],
39	M	NN	O	m	ccomp	29	SENT_248	[p19l2035t2248r2141b2320],
40	,	,	O	,	_	0	SENT_248	[p19l2035t2248r2141b2320],
41	Folb	NN	O	folb	nn	42	SENT_248	[p19l9t2339r179b2400],
42	P	NN	O	p	appos	39	SENT_248	[p19l233t2340r306b2412],
43	,	,	O	,	_	0	SENT_248	[p19l233t2340r306b2412],
44	personal	JJ	O	personal	amod	46	SENT_248	[p19l360t2339r677b2415],
45	communication	NN	O	communication	nn	46	SENT_248	[p19l731t2339r1377b2414],
46	)	NN	O	)	appos	42	SENT_248	[p19l731t2339r1377b2414],
47	,	,	O	,	_	0	SENT_248	[p19l731t2339r1377b2414],
48	therefore	RB	O	therefore	advmod	29	SENT_248	[p19l1431t2339r1768b2400],
49	we	PRP	O	we	nsubj	50	SENT_248	[p19l1820t2359r1920b2400],
50	used	VBD	O	use	dep	29	SENT_248	[p19l1973t2339r2144b2400],
51	this	DT	O	this	det	52	SENT_248	[p19l8t2432r140b2493],
52	ratio	NN	O	ratio	dobj	50	SENT_248	[p19l196t2433r365b2493],
53	both	DT	O	both	preconj	50	SENT_248	[p19l420t2432r592b2493],
54	for	IN	O	for	_	0	SENT_248	[p19l646t2432r751b2493],
55	our	PRP$	O	we	poss	56	SENT_248	[p19l805t2452r932b2493],
56	trial	NN	O	trial	prep_for	50	SENT_248	[p19l984t2432r1132b2493],
57	and	CC	O	and	_	0	SENT_248	[p19l1188t2432r1324b2493],
58	for	IN	O	for	_	0	SENT_248	[p19l1378t2432r1484b2493],
59	the	DT	O	the	det	61	SENT_248	[p19l1536t2432r1650b2493],
60	commercial	JJ	O	commercial	amod	61	SENT_248	[p19l1708t2432r2143b2493],
61	development	NN	O	development	prep_for	50	SENT_248	[p19l10t2526r493b2602],
62	of	IN	O	of	_	0	SENT_248	[p19l524t2526r603b2586],
63	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	61	SENT_248	[p19l624t2526r1540b2602],
64	.	.	O	.	_	0	SENT_248	[p19l624t2526r1540b2602],

1	Our	PRP$	O	we	poss	3	SENT_249	[p19l1578t2526r1725b2586],
2	DDS	NN	O	dd	nn	3	SENT_249	[p19l1753t2526r1943b2586],
3	dose	NN	O	dose	nsubj	6	SENT_249	[p19l1977t2526r2143b2586],
4	was	VBD	O	be	cop	6	SENT_249	[p19l7t2638r142b2679],
5	2-5	CD	NUMBER	2-5	num	6	SENT_249	[p19l175t2621r286b2679],
6	mg/kg	NN	O	mg/kg	_	0	SENT_249	[p19l319t2618r547b2694],
7	per	IN	O	per	_	0	SENT_249	[p19l574t2638r695b2694],
8	day	NN	DURATION	day	prep_per	6	SENT_249	[p19l724t2618r854b2694],
9	in	IN	O	in	_	0	SENT_249	[p19l881t2618r951b2678],
10	all	DT	O	all	det	11	SENT_249	[p19l981t2618r1065b2679],
11	studies	NNS	O	study	prep_in	8	SENT_249	[p19l1096t2618r1374b2679],
12	.	.	O	.	_	0	SENT_249	[p19l1096t2618r1374b2679],

1	We	PRP	O	we	nsubj	4	SENT_250	[p19l91t2712r215b2772],
2	could	MD	O	could	aux	4	SENT_250	[p19l315t2711r521b2772],
3	not	RB	O	not	neg	4	SENT_250	[p19l618t2726r742b2772],
4	prepare	VB	O	prepare	_	0	SENT_250	[p19l838t2731r1121b2787],
5	prepacked	JJ	O	prepacked	amod	7	SENT_250	[p19l1218t2711r1604b2787],
6	randomised	JJ	O	randomised	amod	7	SENT_250	[p19l1702t2711r2144b2772],
7	medication	NN	O	medication	dobj	4	SENT_250	[p19l8t2805r427b2865],
8	for	IN	O	for	_	0	SENT_250	[p19l495t2805r600b2865],
9	reasons	NNS	O	reason	prep_for	4	SENT_250	[p19l666t2824r943b2865],
10	of	IN	O	of	_	0	SENT_250	[p19l1014t2805r1093b2865],
11	cost	NN	O	cost	prep_of	9	SENT_250	[p19l1152t2819r1319b2865],
12	:	:	O	:	_	0	SENT_250	[p19l1152t2819r1319b2865],
13	our	PRP$	O	we	poss	14	SENT_250	[p19l1394t2824r1520b2865],
14	trial	NN	O	trial	nsubj	15	SENT_250	[p19l1586t2805r1734b2865],
15	preceded	VBD	O	precede	parataxis	4	SENT_250	[p19l1802t2805r2144b2881],
16	commercial	JJ	O	commercial	amod	17	SENT_250	[p19l10t2897r446b2958],
17	development	NN	O	development	dobj	15	SENT_250	[p19l521t2897r1004b2973],
18	of	IN	O	of	_	0	SENT_250	[p19l1079t2897r1157b2958],
19	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	17	SENT_250	[p19l1222t2897r2138b2973],
20	.	.	O	.	_	0	SENT_250	[p19l1222t2897r2138b2973],

1	Randomisation	NN	O	randomisation	nn	2	SENT_251	[p19l9t2990r581b3051],
2	instructions	NNS	O	instruction	nsubjpass	4	SENT_251	[p19l636t2991r1077b3051],
3	were	VBD	O	be	auxpass	4	SENT_251	[p19l1133t3010r1307b3051],
4	followed	VBN	O	follow	_	0	SENT_251	[p19l1363t2990r1682b3051],
5	by	IN	O	by	_	0	SENT_251	[p19l1736t2990r1826b3066],
6	a	DT	O	a	det	8	SENT_251	[p19l1881t3010r1916b3051],
7	drug	NN	O	drug	nn	8	SENT_251	[p19l1973t2990r2145b3066],
8	dispenser	NN	O	dispenser	agent	4	SENT_251	[p19l10t3084r363b3160],
9	who	WP	O	who	nsubj	10	SENT_251	[p19l390t3084r544b3144],
10	took	VBD	O	take	rcmod	8	SENT_251	[p19l575t3084r742b3144],
11	no	DT	O	no	det	13	SENT_251	[p19l770t3104r861b3144],
12	other	JJ	O	other	amod	13	SENT_251	[p19l894t3084r1090b3144],
13	part	NN	O	part	dobj	10	SENT_251	[p19l1117t3098r1268b3160],
14	in	IN	O	in	_	0	SENT_251	[p19l1297t3084r1367b3143],
15	the	DT	O	the	det	16	SENT_251	[p19l1397t3084r1510b3144],
16	trial	NN	O	trial	prep_in	10	SENT_251	[p19l1541t3084r1713b3157],
17	,	,	O	,	_	0	SENT_251	[p19l1541t3084r1713b3157],
18	so	RB	O	so	advmod	24	SENT_251	[p19l1748t3104r1822b3144],
19	that	IN	O	that	dep	24	SENT_251	[p19l1853t3084r1999b3144],
20	the	DT	O	the	det	22	SENT_251	[p19l2029t3084r2143b3144],
21	clinical	JJ	O	clinical	amod	22	SENT_251	[p19l10t3176r273b3237],
22	teams	NNS	O	team	nsubjpass	24	SENT_251	[p19l317t3190r532b3237],
23	remained	VBD	O	remain	auxpass	24	SENT_251	[p19l576t3176r927b3237],
24	masked	VBN	O	mask	advcl	10	SENT_251	[p19l970t3176r1252b3237],
25	to	TO	O	to	_	0	SENT_251	[p19l1294t3190r1365b3237],
26	randomisation	NN	O	randomisation	prep_to	24	SENT_251	[p19l1409t3176r1973b3237],
27	.	.	O	.	_	0	SENT_251	[p19l1409t3176r1973b3237],

1	We	PRP	O	we	nsubj	2	SENT_252	[p19l2019t3177r2143b3237],
2	watched	VBD	O	watch	_	0	SENT_252	[p20l7t23r319b84],
3	administration	NN	O	administration	dobj	2	SENT_252	[p20l393t23r941b84],
4	of	IN	O	of	_	0	SENT_252	[p20l1014t23r1093b84],
5	the	DT	O	the	det	7	SENT_252	[p20l1155t23r1269b84],
6	first	JJ	ORDINAL	first	amod	7	SENT_252	[p20l1342t23r1488b84],
7	dose	NN	O	dose	prep_of	3	SENT_252	[p20l1561t23r1727b84],
8	of	IN	O	of	_	0	SENT_252	[p20l1802t23r1880b84],
9	study	NN	O	study	nn	10	SENT_252	[p20l1944t23r2145b99],
10	medication	NN	O	medication	prep_of	7	SENT_252	[p20l8t117r427b177],
11	directly	RB	O	directly	advmod	2	SENT_252	[p20l528t117r829b193],
12	;	:	O	;	_	0	SENT_252	[p20l528t117r829b193],
13	the	DT	O	the	det	15	SENT_252	[p20l931t117r1045b177],
14	subsequent	JJ	O	subsequent	amod	15	SENT_252	[p20l1147t117r1569b193],
15	doses	NNS	O	dose	nsubj	17	SENT_252	[p20l1669t117r1869b177],
16	were	VBD	O	be	cop	17	SENT_252	[p20l1969t136r2143b177],
17	unsupervised	JJ	O	unsupervised	parataxis	2	SENT_252	[p20l8t209r503b285],
18	for	IN	O	for	_	0	SENT_252	[p20l538t209r644b270],
19	logistical	JJ	O	logistical	amod	20	SENT_252	[p20l678t209r1007b285],
20	reasons	NNS	O	reason	prep_for	17	SENT_252	[p20l1044t229r1345b282],
21	,	,	O	,	_	0	SENT_252	[p20l1044t229r1345b282],
22	but	CC	O	but	_	0	SENT_252	[p20l1382t209r1508b270],
23	compliance	NN	O	compliance	nsubjpass	25	SENT_252	[p20l1545t209r1972b285],
24	was	VBD	O	be	auxpass	25	SENT_252	[p20l2007t229r2142b270],
25	checked	VBN	O	check	conj_but	17	SENT_252	[p20l10t302r311b363],
26	by	IN	O	by	_	0	SENT_252	[p20l339t302r428b378],
27	questionnaire	NN	O	questionnaire	agent	25	SENT_252	[p20l457t303r965b378],
28	on	IN	O	on	_	0	SENT_252	[p20l996t322r1088b363],
29	day	NN	DURATION	day	prep_on	27	SENT_252	[p20l1118t302r1248b378],
30	3	CD	NUMBER	3	num	29	SENT_252	[p20l1277t305r1339b363],
31	.	.	O	.	_	0	SENT_252	[p20l1277t305r1339b363],

1	About	IN	O	about	_	0	SENT_253	[p20l92t396r327b456],
2	half	PDT	O	half	predet	4	SENT_253	[p20l380t396r530b456],
3	the	DT	O	the	det	4	SENT_253	[p20l574t396r689b456],
4	patients	NNS	O	patient	prep_about	7	SENT_253	[p20l744t396r1038b472],
5	in	IN	O	in	_	0	SENT_253	[p20l1095t396r1165b455],
6	Kilifi	NNP	LOCATION	Kilifi	prep_in	4	SENT_253	[p20l1220t396r1409b455],
7	were	VBD	O	be	_	0	SENT_253	[p20l1463t416r1637b456],
8	followed-up	JJ	O	followed-up	nsubj	7	SENT_253	[p20l1693t396r2142b472],
9	successfully	RB	O	successfully	advmod	8	SENT_253	[p20l10t488r450b564],
10	throughout	IN	O	throughout	_	0	SENT_253	[p20l489t488r913b564],
11	an	DT	O	a	det	13	SENT_253	[p20l954t508r1040b549],
12	entire	JJ	O	entire	amod	13	SENT_253	[p20l1082t488r1293b549],
13	calendar	NN	O	calendar	prep_throughout	7	SENT_253	[p20l1337t488r1655b549],
14	year	NN	DURATION	year	dep	7	SENT_253	[p20l1692t508r1867b564],
15	.	.	O	.	_	0	SENT_253	[p20l1692t508r1867b564],

1	Fewer	JJR	O	fewer	nsubjpass	9	SENT_254	[p20l1914t489r2146b549],
2	than	IN	O	than	_	0	SENT_254	[p20l8t581r174b642],
3	half	PDT	O	half	predet	5	SENT_254	[p20l217t581r367b642],
4	the	DT	O	the	det	5	SENT_254	[p20l401t581r515b642],
5	patients	NNS	O	patient	prep_than	1	SENT_254	[p20l559t582r854b657],
6	in	IN	O	in	_	0	SENT_254	[p20l901t582r970b641],
7	Blantyre	NNP	LOCATION	Blantyre	prep_in	5	SENT_254	[p20l1015t581r1330b657],
8	were	VBD	O	be	auxpass	9	SENT_254	[p20l1374t601r1549b642],
9	followed	VBN	O	follow	_	0	SENT_254	[p20l1594t581r1914b642],
10	for	IN	O	for	_	0	SENT_254	[p20l1958t581r2064b642],
11	a	DT	O	a	det	13	SENT_254	[p20l2109t601r2144b642],
12	whole	JJ	O	whole	amod	13	SENT_254	[p20l7t675r227b735],
13	year	NN	DURATION	year	prep_for	9	SENT_254	[p20l258t695r434b751],
14	.	.	O	.	_	0	SENT_254	[p20l258t695r434b751],

1	Thus	RB	O	thus	advmod	9	SENT_255	[p20l470t675r664b735],
2	our	PRP$	O	we	poss	3	SENT_255	[p20l699t694r824b735],
3	estimates	NNS	O	estimate	nsubj	9	SENT_255	[p20l856t675r1199b735],
4	of	IN	O	of	_	0	SENT_255	[p20l1234t675r1313b735],
5	malaria	NN	O	malaria	nn	6	SENT_255	[p20l1334t675r1611b735],
6	incidence	NN	O	incidence	prep_of	3	SENT_255	[p20l1643t675r2000b735],
7	are	VBP	O	be	cop	9	SENT_255	[p20l2034t694r2143b735],
8	fairly	RB	O	fairly	advmod	9	SENT_255	[p20l8t767r198b843],
9	crude	JJ	O	crude	_	0	SENT_255	[p20l235t767r467b840],
10	,	,	O	,	_	0	SENT_255	[p20l235t767r467b840],
11	particularly	RB	O	particularly	advmod	9	SENT_255	[p20l506t767r937b843],
12	in	IN	O	in	_	0	SENT_255	[p20l972t767r1043b827],
13	Blantyre	NNP	LOCATION	Blantyre	prep_in	9	SENT_255	[p20l1080t767r1415b843],
14	.	.	O	.	_	0	SENT_255	[p20l1080t767r1415b843],

1	Even	RB	O	even	advmod	2	SENT_256	[p20l1458t768r1645b828],
2	so	RB	O	so	advmod	6	SENT_256	[p20l1684t787r1783b840],
3	,	,	O	,	_	0	SENT_256	[p20l1684t787r1783b840],
4	our	PRP$	O	we	poss	5	SENT_256	[p20l1824t787r1950b828],
5	data	NNS	O	datum	nsubj	6	SENT_256	[p20l1986t767r2143b828],
6	suggest	VBP	O	suggest	_	0	SENT_256	[p20l10t875r282b936],
7	that	IN	O	that	complm	27	SENT_256	[p20l348t860r494b921],
8	the	DT	O	the	det	10	SENT_256	[p20l560t860r675b921],
9	widespread	JJ	O	widespread	amod	10	SENT_256	[p20l742t860r1166b936],
10	use	NN	O	use	nsubj	27	SENT_256	[p20l1233t880r1354b921],
11	of	IN	O	of	_	0	SENT_256	[p20l1424t860r1502b921],
12	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	10	SENT_256	[p20l1562t860r2143b936, p20l10t954r316b1030],
13	in	IN	O	in	_	0	SENT_256	[p20l347t954r417b1013],
14	place	NN	O	place	_	0	SENT_256	[p20l445t954r637b1030],
15	of	IN	O	of	_	0	SENT_256	[p20l670t954r748b1014],
16	sulfadoxine	NN	O	sulfadoxine	nn	18	SENT_256	[p20l769t954r1801b1030],
17	—	NN	O	—	nn	18	SENT_256	[p20l769t954r1801b1030],
18	pyrimethamine	NN	O	pyrimethamine	prep_in_place_of	12	SENT_256	[p20l769t954r1801b1030],
19	in	IN	O	in	_	0	SENT_256	[p20l1831t954r1902b1013],
20	either	CC	O	either	preconj	21	SENT_256	[p20l1932t954r2146b1014],
21	Kiliﬁ	NN	O	kiliﬁ	prep_in	18	SENT_256	[p20l9t1046r197b1106],
22	or	CC	O	or	_	0	SENT_256	[p20l239t1066r315b1107],
23	Blantyre	NNP	LOCATION	Blantyre	conj_or	21	SENT_256	[p20l354t1046r668b1122],
24	would	MD	O	would	aux	27	SENT_256	[p20l708t1046r939b1107],
25	not	RB	O	not	neg	27	SENT_256	[p20l978t1060r1102b1107],
26	have	VB	O	have	aux	27	SENT_256	[p20l1140t1046r1309b1107],
27	had	VBD	O	have	ccomp	6	SENT_256	[p20l1349t1046r1486b1107],
28	an	DT	O	a	det	29	SENT_256	[p20l1528t1066r1613b1107],
29	effect	NN	O	effect	dobj	27	SENT_256	[p20l1655t1046r1857b1107],
30	on	IN	O	on	_	0	SENT_256	[p20l1898t1066r1989b1107],
31	the	DT	O	the	det	34	SENT_256	[p20l2028t1046r2143b1107],
32	annual	JJ	SET	annual	amod	34	SENT_256	[p20l10t1139r261b1200],
33	incidence	NN	O	incidence	nn	34	SENT_256	[p20l313t1139r669b1200],
34	rate	NN	O	rate	prep_on	29	SENT_256	[p20l721t1154r861b1200],
35	of	IN	O	of	_	0	SENT_256	[p20l915t1139r993b1200],
36	malaria	NN	O	malaria	prep_of	34	SENT_256	[p20l1035t1139r1332b1200],
37	.	.	O	.	_	0	SENT_256	[p20l1035t1139r1332b1200],

1	The	DT	O	the	det	5	SENT_257	[p20l1388t1139r1539b1200],
2	slightly	RB	O	slightly	advmod	3	SENT_257	[p20l1593t1139r1860b1215],
3	higher	JJR	O	higher	amod	5	SENT_257	[p20l1908t1139r2146b1215],
4	incidence	NN	O	incidence	nn	5	SENT_257	[p20l8t1233r365b1293],
5	rate	NN	O	rate	nsubj	19	SENT_257	[p20l405t1247r546b1293],
6	in	IN	O	in	_	0	SENT_257	[p20l587t1233r657b1292],
7	the	DT	O	the	det	11	SENT_257	[p20l696t1233r810b1293],
8	sulfadoxine	NN	O	sulfadoxine	nn	11	SENT_257	[p20l853t1233r1885b1309],
9	—	NN	O	—	nn	11	SENT_257	[p20l853t1233r1885b1309],
10	pyrimethamine	NN	O	pyrimethamine	nn	11	SENT_257	[p20l853t1233r1885b1309],
11	group	NN	O	group	prep_in	5	SENT_257	[p20l1926t1252r2142b1309],
12	than	IN	O	than	_	0	SENT_257	[p20l8t1325r174b1386],
13	the	DT	O	the	det	15	SENT_257	[p20l244t1325r358b1386],
14	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	15	SENT_257	[p20l432t1325r1327b1401],
15	group	NN	O	group	prep_than	11	SENT_257	[p20l1399t1345r1614b1401],
16	in	IN	O	in	_	0	SENT_257	[p20l1687t1325r1757b1385],
17	Blantyre	NNP	LOCATION	Blantyre	prep_in	15	SENT_257	[p20l1828t1325r2143b1401],
18	might	MD	O	might	aux	19	SENT_257	[p20l8t1418r225b1494],
19	result	VB	O	result	_	0	SENT_257	[p20l326t1418r535b1479],
20	from	IN	O	from	_	0	SENT_257	[p20l635t1418r813b1479],
21	drug	NN	O	drug	nn	22	SENT_257	[p20l917t1418r1088b1494],
22	resistance	NN	O	resistance	prep_from	19	SENT_257	[p20l1188t1419r1575b1479],
23	:	:	O	:	_	0	SENT_257	[p20l1188t1419r1575b1479],
24	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	nn	25	SENT_257	[p20l1684t1418r2143b1479, p20l7t1512r576b1588],
25	use	NN	O	use	nsubj	30	SENT_257	[p20l616t1532r736b1572],
26	in	IN	O	in	_	0	SENT_257	[p20l776t1512r846b1571],
27	Malawi	NNP	LOCATION	Malawi	prep_in	25	SENT_257	[p20l884t1512r1162b1572],
28	has	VBZ	O	have	aux	30	SENT_257	[p20l1200t1512r1321b1572],
29	been	VBN	O	be	cop	30	SENT_257	[p20l1360t1512r1538b1572],
30	extensive	JJ	O	extensive	parataxis	19	SENT_257	[p20l1578t1512r1918b1572],
31	for	IN	O	for	_	0	SENT_257	[p20l1958t1512r2063b1572],
32	8	CD	DURATION	8	num	33	SENT_257	[p20l2103t1514r2141b1572],
33	years	NNS	NUMBER	year	prep_for	30	SENT_257	[p20l7t1624r217b1680],
34	.	.	O	.	_	0	SENT_257	[p20l7t1624r217b1680],

1	Only	RB	O	only	advmod	4	SENT_258	[p20l285t1604r467b1680],
2	the	DT	O	the	det	4	SENT_258	[p20l525t1604r640b1665],
3	first	JJ	ORDINAL	first	amod	4	SENT_258	[p20l701t1604r847b1665],
4	dose	NN	O	dose	nsubjpass	9	SENT_258	[p20l908t1604r1074b1665],
5	of	IN	O	of	_	0	SENT_258	[p20l1138t1604r1216b1665],
6	study	NN	O	study	nn	7	SENT_258	[p20l1269t1604r1470b1680],
7	medication	NN	O	medication	prep_of	4	SENT_258	[p20l1529t1604r1948b1665],
8	was	VBD	O	be	auxpass	9	SENT_258	[p20l2007t1624r2142b1665],
9	supervised	VBN	O	supervise	_	0	SENT_258	[p20l10t1697r403b1773],
10	in	IN	O	in	_	0	SENT_258	[p20l443t1698r513b1757],
11	this	DT	O	this	det	12	SENT_258	[p20l552t1697r684b1758],
12	trial	NN	O	trial	prep_in	9	SENT_258	[p20l725t1697r897b1770],
13	,	,	O	,	_	0	SENT_258	[p20l725t1697r897b1770],
14	which	WDT	O	which	nsubj	17	SENT_258	[p20l938t1697r1162b1758],
15	could	MD	O	could	aux	17	SENT_258	[p20l1203t1697r1409b1758],
16	have	VB	O	have	aux	17	SENT_258	[p20l1448t1697r1617b1758],
17	resulted	VBN	O	result	rcmod	12	SENT_258	[p20l1658t1697r1956b1758],
18	in	IN	O	in	_	0	SENT_258	[p20l1997t1698r2067b1757],
19	a	DT	O	a	det	20	SENT_258	[p20l2108t1717r2143b1758],
20	bias	NN	O	bias	prep_in	17	SENT_258	[p20l7t1791r152b1851],
21	in	IN	O	in	_	0	SENT_258	[p20l212t1791r281b1850],
22	favour	NN	O	favour	prep_in	20	SENT_258	[p20l339t1791r578b1851],
23	of	IN	O	of	_	0	SENT_258	[p20l636t1791r715b1851],
24	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_of	22	SENT_258	[p20l764t1791r1817b1867],
25	:	:	O	:	_	0	SENT_258	[p20l764t1791r1817b1867],
26	in	IN	O	in	_	0	SENT_258	[p20l1881t1791r1951b1850],
27	fact	NN	O	fact	prep_in	32	SENT_258	[p20l2008t1791r2145b1851],
28	treatment	NN	O	treatment	nn	29	SENT_258	[p20l7t1897r373b1944],
29	failure	NN	O	failure	nsubj	32	SENT_258	[p20l497t1883r734b1944],
30	was	VBD	O	be	cop	32	SENT_258	[p20l859t1903r994b1944],
31	less	RBR	O	less	advmod	32	SENT_258	[p20l1122t1883r1250b1944],
32	common	JJ	O	common	parataxis	9	SENT_258	[p20l1379t1903r1707b1944],
33	in	IN	O	in	_	0	SENT_258	[p20l1833t1883r1902b1943],
34	the	DT	O	the	det	36	SENT_258	[p20l2027t1883r2142b1944],
35	chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	amod	36	SENT_258	[p20l9t1976r904b2052],
36	group	NN	O	group	prep_in	32	SENT_258	[p20l946t1996r1162b2052],
37	than	IN	O	than	dep	32	SENT_258	[p20l1205t1976r1371b2037],
38	in	IN	O	in	_	0	SENT_258	[p20l1413t1976r1483b2036],
39	the	DT	O	the	det	41	SENT_258	[p20l1524t1976r1638b2037],
40	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	nn	41	SENT_258	[p20l1682t1976r2142b2037, p20l6t2070r574b2146],
41	group	NN	O	group	prep_in	32	SENT_258	[p20l614t2090r830b2146],
42	in	IN	O	in	_	0	SENT_258	[p20l871t2070r941b2129],
43	both	DT	O	both	det	44	SENT_258	[p20l977t2070r1149b2130],
44	centres	NNS	O	centre	prep_in	41	SENT_258	[p20l1189t2084r1451b2130],
45	(	VBP	O	(	dep	44	SENT_258	[p20l1497t2070r1639b2145],
46	4-3	CD	NUMBER	4-3	dobj	45	SENT_258	[p20l1497t2070r1639b2145],
47	-	:	O	-	_	0	SENT_258	[p20l1683t2091r1752b2130],
48	vs	CC	O	vs	_	0	SENT_258	[p20l1683t2091r1752b2130],
49	ll-3	CD	PERCENT	ll-3	num	50	SENT_258	[p20l1799t2070r2029b2132],
50	%	NN	PERCENT	%	dobj	45	SENT_258	[p20l1799t2070r2029b2132],
51	of	IN	O	of	_	0	SENT_258	[p20l2074t2070r2153b2130],
52	patients	NNS	O	patient	prep_of	50	SENT_258	[p20l6t2162r300b2238],
53	in	IN	O	in	_	0	SENT_258	[p20l369t2162r440b2222],
54	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	52	SENT_258	[p20l507t2162r718b2235],
55	,	,	O	,	_	0	SENT_258	[p20l507t2162r718b2235],
56	and	CC	O	and	_	0	SENT_258	[p20l791t2162r926b2223],
57	5-4	JJ	O	5-4	prep_in	52	SENT_258	[p20l997t2165r1110b2223],
58	-	:	O	-	_	0	SENT_258	[p20l1182t2183r1251b2223],
59	vs	CC	O	vs	_	0	SENT_258	[p20l1182t2183r1251b2223],
60	20-5	CD	PERCENT	20-5	num	61	SENT_258	[p20l1320t2162r1557b2225],
61	%	NN	PERCENT	%	dobj	45	SENT_258	[p20l1320t2162r1557b2225],
62	in	IN	O	in	_	0	SENT_258	[p20l1630t2162r1699b2222],
63	Blantyre	NNP	LOCATION	Blantyre	prep_in	61	SENT_258	[p20l1767t2162r2137b2238],
64	)	CD	NUMBER	)	num	63	SENT_258	[p20l1767t2162r2137b2238],
65	.	.	O	.	_	0	SENT_258	[p20l1767t2162r2137b2238],

1	Reassuringly	RB	O	reassuringly	advmod	11	SENT_259	[p20l8t2255r506b2331],
2	,	,	O	,	_	0	SENT_259	[p20l8t2255r506b2331],
3	the	DT	O	the	det	5	SENT_259	[p20l544t2255r659b2316],
4	higher	JJR	O	higher	amod	5	SENT_259	[p20l694t2255r932b2331],
5	prevalence	NN	O	prevalence	nsubj	11	SENT_259	[p20l964t2255r1363b2331],
6	of	IN	O	of	_	0	SENT_259	[p20l1401t2255r1480b2316],
7	treatment	NN	O	treatment	nn	8	SENT_259	[p20l1504t2270r1871b2316],
8	failure	NN	O	failure	prep_of	5	SENT_259	[p20l1905t2255r2142b2316],
9	with	IN	O	with	_	0	SENT_259	[p20l6t2349r169b2409],
10	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_with	8	SENT_259	[p20l202t2349r1233b2425],
11	seemed	VBD	O	seem	_	0	SENT_259	[p20l1267t2349r1544b2409],
12	not	RB	O	not	neg	14	SENT_259	[p20l1575t2363r1698b2409],
13	to	TO	O	to	aux	14	SENT_259	[p20l1729t2363r1800b2409],
14	result	VB	O	result	xcomp	11	SENT_259	[p20l1833t2349r2042b2409],
15	in	IN	O	in	_	0	SENT_259	[p20l2073t2349r2143b2408],
16	increased	VBN	O	increase	amod	17	SENT_259	[p20l7t2441r359b2502],
17	risk	NN	O	risk	prep_in	14	SENT_259	[p20l388t2441r522b2502],
18	of	IN	O	of	_	0	SENT_259	[p20l551t2441r630b2502],
19	developing	VBG	O	develop	prepc_of	17	SENT_259	[p20l650t2441r1057b2517],
20	severe	JJ	O	severe	amod	22	SENT_259	[p20l1086t2461r1312b2502],
21	malaria	NN	O	malaria	nn	22	SENT_259	[p20l1341t2441r1619b2502],
22	syndromes	NNS	O	syndrome	dobj	19	SENT_259	[p20l1649t2441r2071b2517],
23	.	.	O	.	_	0	SENT_259	[p20l1649t2441r2071b2517],

1	An	DT	O	a	det	3	SENT_260	[p20l90t2535r200b2594],
2	earlier	JJR	O	earlier	amod	3	SENT_260	[p20l230t2534r463b2595],
3	comparison	NN	O	comparison	nsubj	8	SENT_260	[p20l492t2535r929b2610],
4	of	IN	O	of	_	0	SENT_260	[p20l958t2534r1037b2595],
5	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	3	SENT_260	[p20l1057t2534r1952b2610],
6	with	IN	O	with	_	0	SENT_260	[p20l1980t2534r2143b2595],
7	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	prep_with	5	SENT_260	[p20l8t2628r1040b2704],
8	took	VBD	O	take	_	0	SENT_260	[p20l1076t2628r1243b2688],
9	place	NN	O	place	dobj	8	SENT_260	[p20l1275t2628r1467b2704],
10	in	IN	O	in	_	0	SENT_260	[p20l1503t2628r1574b2687],
11	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	8	SENT_260	[p20l1609t2628r1798b2687],
12	between	IN	O	between	_	0	SENT_260	[p20l1831t2628r2143b2688],
13	1993	CD	DATE	1993	prep_between	11	SENT_260	[p20l16t2723r191b2781],
14	and	CC	O	and	_	0	SENT_260	[p20l250t2720r385b2781],
15	1995,14	CD	NUMBER	1995,14	prep_between	11	SENT_260	[p20l448t2721r700b2793],
16	although	IN	O	although	mark	18	SENT_260	[p20l755t2720r1083b2796],
17	follow-up	JJ	O	follow-up	nsubj	18	SENT_260	[p20l1136t2720r1493b2796],
18	ended	VBN	O	end	advcl	8	SENT_260	[p20l1551t2720r1776b2781],
19	after	IN	O	after	_	0	SENT_260	[p20l1831t2720r1999b2781],
20	28	CD	DURATION	28	num	21	SENT_260	[p20l2053t2723r2140b2781],
21	days	NNS	NUMBER	day	prep_after	18	SENT_260	[p20l8t2813r192b2889],
22	.	.	O	.	_	0	SENT_260	[p20l8t2813r192b2889],

1	In	IN	O	in	_	0	SENT_261	[p20l247t2814r325b2873],
2	this	DT	O	this	det	3	SENT_261	[p20l374t2813r506b2874],
3	trial	NN	O	trial	prep_in	10	SENT_261	[p20l557t2813r728b2886],
4	,	,	O	,	_	0	SENT_261	[p20l557t2813r728b2886],
5	a	DT	O	a	det	8	SENT_261	[p20l783t2833r818b2874],
6	smaller	JJR	O	smaller	amod	8	SENT_261	[p20l870t2813r1139b2874],
7	chlorproguanil	NN	O	chlorproguanil	nn	8	SENT_261	[p20l1189t2813r1739b2889],
8	dose	NN	O	dose	nsubjpass	10	SENT_261	[p20l1791t2813r1956b2874],
9	was	VBD	O	be	auxpass	10	SENT_261	[p20l2006t2833r2141b2874],
10	used	VBN	O	use	_	0	SENT_261	[p20l7t2907r178b2967],
11	(	CD	NUMBER	(	num	13	SENT_261	[p20l219t2907r361b2982],
12	1-2	CD	NUMBER	1-2	num	13	SENT_261	[p20l219t2907r361b2982],
13	mg/kg	NN	O	mg/kg	dobj	10	SENT_261	[p20l398t2907r626b2983],
14	per	IN	O	per	_	0	SENT_261	[p20l658t2926r780b2983],
15	day	NN	DURATION	day	prep_per	13	SENT_261	[p20l814t2907r943b2983],
16	-223	CD	NUMBER	-223	num	15	SENT_261	[p20l977t2928r1047b2967],
17	2-0	CD	NUMBER	2-0	num	18	SENT_261	[p20l1082t2909r1196b2967],
18	mg/kg	NN	O	mg/kg	xcomp	10	SENT_261	[p20l1232t2907r1461b2983],
19	per	IN	O	per	_	0	SENT_261	[p20l1492t2926r1614b2983],
20	day	NN	DURATION	day	prep_per	18	SENT_261	[p20l1648t2907r1832b2983],
21	)	CD	NUMBER	)	num	20	SENT_261	[p20l1648t2907r1832b2983],
22	,	,	O	,	_	0	SENT_261	[p20l1648t2907r1832b2983],
23	but	CC	O	but	_	0	SENT_261	[p20l1868t2907r1994b2967],
24	the	DT	O	the	det	25	SENT_261	[p20l2027t2907r2142b2967],
25	results	NNS	O	result	nsubj	33	SENT_261	[p20l7t2999r248b3060],
26	of	IN	O	of	_	0	SENT_261	[p20l301t2999r380b3060],
27	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	28	SENT_261	[p20l422t2999r1317b3075],
28	treatment	NN	O	treatment	prep_of	25	SENT_261	[p20l1367t3013r1734b3060],
29	by	IN	O	by	_	0	SENT_261	[p20l1782t2999r1871b3075],
30	day	NN	DURATION	day	prep_by	28	SENT_261	[p20l1921t2999r2050b3075],
31	7	CD	NUMBER	7	num	30	SENT_261	[p20l2101t3002r2138b3059],
32	were	VBD	O	be	cop	33	SENT_261	[p20l6t3112r179b3153],
33	similar	JJ	O	similar	conj_but	10	SENT_261	[p20l223t3092r477b3153],
34	to	TO	O	to	_	0	SENT_261	[p20l516t3107r587b3153],
35	those	DT	O	those	prep_to	33	SENT_261	[p20l629t3092r826b3153],
36	we	PRP	O	we	nsubj	37	SENT_261	[p20l867t3112r967b3153],
37	report	VBP	O	report	rcmod	35	SENT_261	[p20l1009t3107r1258b3168],
38	.	.	O	.	_	0	SENT_261	[p20l1009t3107r1258b3168],

1	2	CD	PERCENT	2	num	2	SENT_262	[p20l1307t3093r1422b3155],
2	%	NN	PERCENT	%	nsubj	10	SENT_262	[p20l1307t3093r1422b3155],
3	of	IN	O	of	_	0	SENT_262	[p20l1470t3092r1549b3153],
4	patients	NNS	O	patient	prep_of	2	SENT_262	[p20l1579t3093r1873b3168],
5	in	IN	O	in	_	0	SENT_262	[p20l1916t3093r1987b3152],
6	the	DT	O	the	det	8	SENT_262	[p20l2027t3092r2142b3153],
7	1993	CD	DATE	1993	num	8	SENT_262	[p20l16t3188r191b3246],
8	study	NN	O	study	prep_in	4	SENT_262	[p20l229t3186r431b3262],
9	were	VBD	O	be	cop	10	SENT_262	[p20l461t3205r635b3246],
10	slide	NN	O	slide	_	0	SENT_262	[p20l670t3186r837b3246],
11	positive	JJ	O	positive	amod	10	SENT_262	[p20l870t3186r1157b3262],
12	by	IN	O	by	_	0	SENT_262	[p20l1190t3186r1279b3262],
13	day	NN	DURATION	day	prep_by	11	SENT_262	[p20l1312t3186r1442b3262],
14	7	CD	NUMBER	7	num	13	SENT_262	[p20l1475t3188r1540b3259],
15	,	,	O	,	_	0	SENT_262	[p20l1475t3188r1540b3259],
16	compared	VBN	O	compare	_	0	SENT_262	[p20l1577t3186r1948b3262],
17	with	IN	O	with	prepc_compared_with	10	SENT_262	[p20l1980t3186r2143b3246],
18	1-9	CD	PERCENT	1-9	num	19	SENT_262	[p20l16t3278r198b3341],
19	%	NN	PERCENT	%	pobj	10	SENT_262	[p20l16t3278r198b3341],
20	of	IN	O	of	_	0	SENT_262	[p20l239t3278r318b3339],
21	evaluable	JJ	O	evaluable	amod	22	SENT_262	[p20l345t3278r692b3339],
22	episodes	NNS	O	episode	prep_of	19	SENT_262	[p20l730t3278r1044b3354],
23	in	IN	O	in	_	0	SENT_262	[p20l1080t3278r1150b3338],
24	our	PRP$	O	we	poss	25	SENT_262	[p20l1186t3298r1312b3339],
25	trial	NN	O	trial	prep_in	22	SENT_262	[p20l1345t3278r1515b3339],
26	.	.	O	.	_	0	SENT_262	[p20l1345t3278r1515b3339],

1	Fewer	JJR	O	fewer	nsubj	14	SENT_263	[p20l1555t3279r1787b3339],
2	than	IN	O	than	_	0	SENT_263	[p20l1820t3278r1986b3339],
3	1	CD	PERCENT	1	num	4	SENT_263	[p20l2030t3278r2138b3341],
4	%	NN	PERCENT	%	prep_than	1	SENT_263	[p20l2030t3278r2138b3341],
5	of	IN	O	of	_	0	SENT_263	[p20l9t3371r87b3432],
6	patients	NNS	O	patient	prep_of	4	SENT_263	[p20l147t3372r442b3447],
7	given	VBN	O	give	partmod	6	SENT_263	[p20l514t3372r711b3447],
8	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	dobj	7	SENT_263	[p20l783t3371r1815b3447],
9	in	IN	O	in	_	0	SENT_263	[p20l1887t3372r1957b3431],
10	the	DT	O	the	det	12	SENT_263	[p20l2027t3371r2142b3432],
11	earlier	JJR	O	earlier	amod	12	SENT_263	[p20l9t3465r243b3525],
12	study	NN	O	study	prep_in	8	SENT_263	[p20l269t3465r470b3541],
13	were	VBD	O	be	cop	14	SENT_263	[p20l495t3485r668b3525],
14	slide-positive	JJ	O	slide-positive	_	0	SENT_263	[p20l698t3465r1188b3541],
15	by	IN	O	by	_	0	SENT_263	[p20l1215t3465r1304b3541],
16	day	NN	DURATION	day	prep_by	14	SENT_263	[p20l1331t3465r1460b3541],
17	7	CD	NUMBER	7	num	16	SENT_263	[p20l1487t3467r1552b3538],
18	,	,	O	,	_	0	SENT_263	[p20l1487t3467r1552b3538],
19	compared	VBN	O	compare	_	0	SENT_263	[p20l1584t3465r1955b3541],
20	with	IN	O	with	prepc_compared_with	14	SENT_263	[p20l1980t3465r2143b3525],
21	5	CD	NUMBER	5	pobj	14	SENT_263	[p20l10t3560r71b3618],
22	-	:	O	-	_	0	SENT_263	[p20l10t3560r71b3618],
23	1	CD	PERCENT	1	num	24	SENT_263	[p20l90t3560r115b3617],
24	%	NN	PERCENT	%	dep	21	SENT_263	[p20l134t3557r198b3620],
25	of	IN	O	of	_	0	SENT_263	[p20l233t3557r312b3618],
26	evaluable	JJ	O	evaluable	amod	27	SENT_263	[p20l333t3557r680b3618],
27	episodes	NNS	O	episode	prep_of	24	SENT_263	[p20l712t3557r1026b3633],
28	that	IN	O	that	dep	30	SENT_263	[p20l1056t3557r1202b3618],
29	we	PRP	O	we	nsubj	30	SENT_263	[p20l1229t3577r1329b3618],
30	noted	VBD	O	note	dep	24	SENT_263	[p20l1359t3557r1593b3618],
31	.	.	O	.	_	0	SENT_263	[p20l1359t3557r1593b3618],

1	In	IN	O	in	_	0	SENT_264	[p20l92t3651r170b3710],
2	the	DT	O	the	det	5	SENT_264	[p20l247t3650r362b3711],
3	routine	JJ	O	routine	amod	5	SENT_264	[p20l440t3651r710b3711],
4	health	NN	O	health	nn	5	SENT_264	[p20l787t3650r1018b3711],
5	services	NNS	O	service	prep_in	16	SENT_264	[p20l1097t3651r1381b3711],
6	of	IN	O	of	_	0	SENT_264	[p20l1461t3650r1541b3711],
7	most	JJS	O	most	amod	9	SENT_264	[p20l1608t3664r1791b3711],
8	African	JJ	MISC	african	amod	9	SENT_264	[p20l1865t3650r2143b3711],
9	countries	NNS	O	country	prep_of	5	SENT_264	[p21l9t23r375b96],
10	,	,	O	,	_	0	SENT_264	[p21l9t23r375b96],
11	microscopic	JJ	O	microscopic	amod	12	SENT_264	[p21l419t23r871b99],
12	diagnosis	NN	O	diagnosis	nsubj	16	SENT_264	[p21l913t23r1256b99],
13	of	IN	O	of	_	0	SENT_264	[p21l1299t23r1378b83],
14	malaria	NN	O	malaria	prep_of	12	SENT_264	[p21l1408t23r1685b83],
15	is	VBZ	O	be	cop	16	SENT_264	[p21l1726t23r1779b83],
16	unusual	JJ	O	unusual	_	0	SENT_264	[p21l1820t23r2137b83],
17	.	.	O	.	_	0	SENT_264	[p21l1820t23r2137b83],

1	The	DT	O	the	det	2	SENT_265	[p21l6t115r157b176],
2	incidence	NN	O	incidence	nsubj	7	SENT_265	[p21l200t115r556b176],
3	of	IN	O	of	_	0	SENT_265	[p21l600t115r679b176],
4	aparasitaemic	JJ	O	aparasitaemic	amod	5	SENT_265	[p21l713t115r1224b191],
5	illness	NN	O	illness	prep_of	2	SENT_265	[p21l1267t115r1493b176],
6	was	VBD	O	be	cop	7	SENT_265	[p21l1535t135r1670b176],
7	high	JJ	O	high	_	0	SENT_265	[p21l1713t115r1875b191],
8	in	IN	O	in	_	0	SENT_265	[p21l1916t115r1987b175],
9	the	DT	O	the	det	12	SENT_265	[p21l2027t115r2142b176],
10	present	JJ	DATE	present	amod	12	SENT_265	[p21l6t223r281b284],
11	study	NN	O	study	nn	12	SENT_265	[p21l321t208r522b284],
12	(	NN	O	(	prep_in	7	SENT_265	[p21l566t208r861b284],
13	around	IN	O	around	_	0	SENT_265	[p21l566t208r861b284],
14	4	CD	NUMBER	4	prep_around	7	SENT_265	[p21l901t211r942b268],
15	per	IN	O	per	_	0	SENT_265	[p21l981t228r1103b284],
16	year	NN	DURATION	year	prep_per	14	SENT_265	[p21l1139t228r1296b284],
17	in	IN	O	in	prep	7	SENT_265	[p21l1333t209r1403b268],
18	both	CC	O	both	dep	17	SENT_265	[p21l1441t208r1612b269],
19	centres	NNS	O	centre	conj	17	SENT_265	[p21l1653t223r1939b281],
20	,	,	O	,	_	0	SENT_265	[p21l1653t223r1939b281],
21	with	IN	O	with	mark	24	SENT_265	[p21l1980t208r2143b269],
22	both	DT	O	both	det	23	SENT_265	[p21l6t302r177b362],
23	treatments	NNS	O	treatment	nsubj	24	SENT_265	[p21l209t302r664b377],
24	)	VBP	O	)	advcl	7	SENT_265	[p21l209t302r664b377],
25	.	.	O	.	_	0	SENT_265	[p21l209t302r664b377],

1	Many	JJ	O	many	nsubj	10	SENT_266	[p21l702t303r920b378],
2	of	IN	O	of	_	0	SENT_266	[p21l953t302r1032b362],
3	these	DT	O	these	det	5	SENT_266	[p21l1055t302r1244b362],
4	aparasitaemic	JJ	O	aparasitaemic	amod	5	SENT_266	[p21l1280t302r1792b378],
5	episodes	NNS	O	episode	prep_of	1	SENT_266	[p21l1827t302r2141b378],
6	would	MD	O	would	aux	10	SENT_266	[p21l6t394r237b455],
7	probably	RB	O	probably	advmod	10	SENT_266	[p21l265t394r598b470],
8	have	VB	O	have	aux	10	SENT_266	[p21l625t394r794b455],
9	been	VBN	O	be	cop	10	SENT_266	[p21l823t394r1001b455],
10	misdiagnosed	JJ	O	misdiagnosed	ccomp	17	SENT_266	[p21l1031t394r1542b470],
11	as	IN	O	as	_	0	SENT_266	[p21l1573t414r1642b455],
12	malaria	NN	O	malaria	prep_as	10	SENT_266	[p21l1673t394r1973b467],
13	,	,	O	,	_	0	SENT_266	[p21l1673t394r1973b467],
14	had	VBD	O	have	aux	17	SENT_266	[p21l2005t394r2143b455],
15	it	PRP	O	it	dobj	17	SENT_266	[p21l7t488r57b548],
16	not	RB	O	not	neg	17	SENT_266	[p21l102t501r226b548],
17	been	VBN	O	be	_	0	SENT_266	[p21l270t487r448b548],
18	for	IN	O	for	_	0	SENT_266	[p21l494t487r599b548],
19	the	DT	O	the	det	21	SENT_266	[p21l643t487r758b548],
20	microscopic	JJ	O	microscopic	amod	21	SENT_266	[p21l805t488r1257b563],
21	examination	NN	O	examination	prep_for	17	SENT_266	[p21l1305t488r1767b548],
22	of	IN	O	of	_	0	SENT_266	[p21l1814t487r1893b548],
23	blood	NN	O	blood	prep_of	21	SENT_266	[p21l1928t487r2142b548],
24	ﬁlms	NNS	O	ﬁlms	nsubj	17	SENT_266	[p21l7t581r186b641],
25	available	JJ	O	available	amod	24	SENT_266	[p21l237t581r560b641],
26	through	IN	O	through	_	0	SENT_266	[p21l607t581r905b657],
27	the	DT	O	the	det	28	SENT_266	[p21l951t581r1065b641],
28	study	NN	O	study	prep_through	25	SENT_266	[p21l1115t581r1335b657],
29	.	.	O	.	_	0	SENT_266	[p21l1115t581r1335b657],

1	The	DT	O	the	det	3	SENT_267	[p21l1388t581r1538b641],
2	observed	VBN	O	observe	amod	3	SENT_267	[p21l1588t581r1920b641],
3	rates	NNS	O	rate	nsubj	7	SENT_267	[p21l1967t595r2141b641],
4	might	MD	O	might	aux	7	SENT_267	[p21l7t673r224b749],
5	be	VB	O	be	cop	7	SENT_267	[p21l270t673r356b734],
6	artiﬁcially	RB	O	artiﬁcially	advmod	7	SENT_267	[p21l406t673r779b749],
7	high	JJ	O	high	_	0	SENT_267	[p21l824t673r986b749],
8	as	IN	O	as	_	0	SENT_267	[p21l1036t693r1104b734],
9	a	DT	O	a	det	10	SENT_267	[p21l1156t693r1191b734],
10	result	NN	O	result	prep_as	7	SENT_267	[p21l1239t673r1448b734],
11	of	IN	O	of	_	0	SENT_267	[p21l1496t673r1575b734],
12	the	DT	O	the	det	14	SENT_267	[p21l1612t673r1727b734],
13	privileged	JJ	O	privileged	amod	14	SENT_267	[p21l1775t673r2143b749],
14	access	NN	O	access	prep_of	10	SENT_267	[p21l9t786r235b827],
15	to	TO	O	to	aux	16	SENT_267	[p21l283t781r354b827],
16	care	VB	O	care	xcomp	7	SENT_267	[p21l404t786r554b827],
17	afforded	VBN	O	afford	dep	16	SENT_267	[p21l603t766r915b827],
18	within	IN	O	within	_	0	SENT_267	[p21l960t766r1197b827],
19	a	DT	O	a	det	21	SENT_267	[p21l1245t786r1280b827],
20	research	NN	O	research	nn	21	SENT_267	[p21l1327t766r1637b827],
21	programme	NN	O	programme	prep_within	17	SENT_267	[p21l1682t786r2137b842],
22	.	.	O	.	_	0	SENT_267	[p21l1682t786r2137b842],

1	Even	RB	O	even	advmod	2	SENT_268	[p21l7t861r194b920],
2	so	RB	O	so	advmod	6	SENT_268	[p21l224t880r323b933],
3	,	,	O	,	_	0	SENT_268	[p21l224t880r323b933],
4	it	PRP	O	it	nsubj	6	SENT_268	[p21l355t860r405b920],
5	seems	VBZ	O	seem	cop	6	SENT_268	[p21l434t879r652b920],
6	likely	JJ	O	likely	_	0	SENT_268	[p21l683t860r880b936],
7	that	IN	O	that	complm	24	SENT_268	[p21l907t860r1075b933],
8	,	,	O	,	_	0	SENT_268	[p21l907t860r1075b933],
9	in	IN	O	in	_	0	SENT_268	[p21l1107t860r1177b919],
10	the	DT	O	the	det	12	SENT_268	[p21l1205t860r1319b920],
11	real	JJ	O	real	amod	12	SENT_268	[p21l1348t860r1483b920],
12	world	NN	O	world	prep_in	24	SENT_268	[p21l1511t860r1726b920],
13	of	IN	O	of	_	0	SENT_268	[p21l1756t860r1835b920],
14	Kenyan	JJ	MISC	kenyan	amod	17	SENT_268	[p21l1854t861r2143b936],
15	or	CC	O	or	_	0	SENT_268	[p21l9t972r85b1013],
16	Malawian	JJ	MISC	malawian	conj_or	14	SENT_268	[p21l118t952r488b1013],
17	clinics	NNS	O	clinic	prep_of	12	SENT_268	[p21l525t952r780b1025],
18	,	,	O	,	_	0	SENT_268	[p21l525t952r780b1025],
19	there	EX	O	there	expl	24	SENT_268	[p21l819t952r1007b1013],
20	would	MD	O	would	aux	24	SENT_268	[p21l1042t952r1273b1013],
21	be	VB	O	be	cop	24	SENT_268	[p21l1307t952r1393b1013],
22	a	DT	O	a	det	24	SENT_268	[p21l1432t972r1466b1013],
23	higher	JJR	O	higher	amod	24	SENT_268	[p21l1502t952r1740b1028],
24	frequency	NN	O	frequency	ccomp	6	SENT_268	[p21l1773t952r2144b1028],
25	of	IN	O	of	_	0	SENT_268	[p21l9t1045r87b1106],
26	antimalarial	JJ	O	antimalarial	amod	28	SENT_268	[p21l108t1045r552b1106],
27	drug	NN	O	drug	nn	28	SENT_268	[p21l583t1045r755b1121],
28	use	NN	O	use	prep_of	24	SENT_268	[p21l782t1065r903b1106],
29	than	IN	O	than	mark	32	SENT_268	[p21l933t1045r1099b1106],
30	our	PRP$	O	we	poss	31	SENT_268	[p21l1130t1065r1256b1106],
31	trial	NN	O	trial	nsubj	32	SENT_268	[p21l1282t1045r1430b1106],
32	suggests	VBZ	O	suggest	advcl	24	SENT_268	[p21l1461t1060r1788b1121],
33	.	.	O	.	_	0	SENT_268	[p21l1461t1060r1788b1121],

1	A	DT	O	a	det	3	SENT_269	[p21l90t1140r151b1198],
2	few	JJ	O	few	amod	3	SENT_269	[p21l195t1139r323b1199],
3	patients	NNS	O	patient	nsubj	6	SENT_269	[p21l366t1139r661b1215],
4	in	IN	O	in	_	0	SENT_269	[p21l708t1139r778b1198],
5	Kenya	NNP	LOCATION	Kenya	prep_in	3	SENT_269	[p21l823t1140r1061b1215],
6	developed	VBD	O	develop	_	0	SENT_269	[p21l1108t1139r1487b1215],
7	severe	JJ	O	severe	amod	8	SENT_269	[p21l1534t1158r1759b1199],
8	anaemia	NN	O	anaemia	dobj	6	SENT_269	[p21l1808t1139r2137b1199],
9	.	.	O	.	_	0	SENT_269	[p21l1808t1139r2137b1199],

1	From	IN	O	from	_	0	SENT_270	[p21l7t1232r214b1292],
2	a	DT	O	a	det	4	SENT_270	[p21l266t1251r301b1292],
3	public-health	JJ	O	public-health	amod	4	SENT_270	[p21l351t1231r851b1307],
4	perspective	NN	O	perspective	prep_from	13	SENT_270	[p21l900t1231r1344b1307],
5	,	,	O	,	_	0	SENT_270	[p21l900t1231r1344b1307],
6	the	DT	O	the	det	7	SENT_270	[p21l1397t1231r1511b1292],
7	reason	NN	O	reason	nsubjpass	13	SENT_270	[p21l1562t1251r1806b1292],
8	for	IN	O	for	_	0	SENT_270	[p21l1856t1231r1962b1292],
9	this	DT	O	this	det	10	SENT_270	[p21l2009t1231r2141b1292],
10	ﬁnding	NN	O	ﬁnding	prep_for	7	SENT_270	[p21l7t1324r273b1400],
11	should	MD	O	should	aux	13	SENT_270	[p21l301t1324r550b1385],
12	be	VB	O	be	auxpass	13	SENT_270	[p21l577t1324r664b1385],
13	established	VBN	O	establish	ccomp	17	SENT_270	[p21l694t1324r1130b1397],
14	,	,	O	,	_	0	SENT_270	[p21l694t1324r1130b1397],
15	caution	NN	O	caution	nsubjpass	17	SENT_270	[p21l1163t1325r1440b1385],
16	is	VBZ	O	be	auxpass	17	SENT_270	[p21l1469t1325r1522b1385],
17	needed	VBN	O	need	_	0	SENT_270	[p21l1552t1324r1820b1385],
18	because	IN	O	because	_	0	SENT_270	[p21l1847t1324r2142b1385],
19	of	IN	O	of	prepc_because_of	17	SENT_270	[p21l9t1418r87b1478],
20	the	DT	O	the	det	22	SENT_270	[p21l104t1418r218b1478],
21	small	JJ	O	small	amod	22	SENT_270	[p21l247t1418r440b1478],
22	numbers	NNS	O	number	pobj	17	SENT_270	[p21l467t1418r815b1478],
23	.	.	O	.	_	0	SENT_270	[p21l467t1418r815b1478],

1	Of	IN	O	of	_	0	SENT_271	[p21l850t1418r951b1478],
2	the	DT	O	the	det	4	SENT_271	[p21l967t1418r1081b1478],
3	16	CD	NUMBER	16	num	4	SENT_271	[p21l1118t1420r1198b1478],
4	cases	NNS	O	case	prep_of	11	SENT_271	[p21l1229t1438r1415b1478],
5	in	IN	O	in	_	0	SENT_271	[p21l1443t1418r1514b1477],
6	Kenya	NNP	LOCATION	Kenya	prep_in	4	SENT_271	[p21l1540t1419r1802b1494],
7	,	,	O	,	_	0	SENT_271	[p21l1540t1419r1802b1494],
8	anaemia	NN	O	anaemia	nsubj	11	SENT_271	[p21l1834t1418r2142b1478],
9	was	VBD	O	be	cop	11	SENT_271	[p21l6t1530r141b1571],
10	more	RBR	O	more	advmod	11	SENT_271	[p21l172t1530r363b1571],
11	common	JJ	O	common	_	0	SENT_271	[p21l395t1530r724b1571],
12	in	IN	O	in	_	0	SENT_271	[p21l753t1510r823b1570],
13	the	DT	O	the	det	17	SENT_271	[p21l852t1510r966b1571],
14	chlorproguanil	NN	O	chlorproguanil	nn	17	SENT_271	[p21l999t1510r1894b1586],
15	—	NN	O	—	nn	17	SENT_271	[p21l999t1510r1894b1586],
16	dapsone	NN	O	dapsone	nn	17	SENT_271	[p21l999t1510r1894b1586],
17	group	NN	O	group	prep_in	11	SENT_271	[p21l1925t1530r2141b1586],
18	than	IN	O	than	prep	11	SENT_271	[p21l7t1603r173b1664],
19	in	IN	O	in	pcomp	18	SENT_271	[p21l214t1604r284b1663],
20	the	DT	O	the	det	22	SENT_271	[p21l324t1603r438b1664],
21	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	22	SENT_271	[p21l482t1603r1514b1679],
22	group	NN	O	group	pobj	19	SENT_271	[p21l1556t1623r1794b1679],
23	.	.	O	.	_	0	SENT_271	[p21l1556t1623r1794b1679],

1	In	IN	O	in	_	0	SENT_272	[p21l1842t1604r1920b1663],
2	most	JJS	O	most	prep_in	22	SENT_272	[p21l1961t1618r2143b1664],
3	of	IN	O	of	_	0	SENT_272	[p21l9t1697r87b1757],
4	these	DT	O	these	det	6	SENT_272	[p21l129t1697r319b1757],
5	anaemic	JJ	O	anaemic	amod	6	SENT_272	[p21l373t1697r680b1757],
6	children	NNS	O	child	prep_of	2	SENT_272	[p21l735t1697r1041b1757],
7	(	VBP	O	(	rcmod	6	SENT_272	[p21l1098t1697r1242b1772],
8	ten	CD	TIME	ten	dobj	7	SENT_272	[p21l1098t1697r1242b1772],
9	of	IN	TIME	of	_	0	SENT_272	[p21l1295t1697r1373b1757],
10	13	CD	TIME	13	num	11	SENT_272	[p21l1424t1699r1503b1757],
11	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	8	SENT_272	[p21l1560t1697r2142b1773, p21l8t1789r315b1865],
12	and	CC	O	and	_	0	SENT_272	[p21l358t1789r493b1850],
13	one	CD	TIME	one	dobj	7	SENT_272	[p21l536t1809r667b1850],
14	of	IN	TIME	of	_	0	SENT_272	[p21l710t1789r788b1850],
15	three	CD	TIME	three	num	17	SENT_272	[p21l818t1789r1007b1850],
16	sulfadoxine-pyrimethamine	JJ	O	sulfadoxine-pyrimethamine	amod	17	SENT_272	[p21l1050t1789r2139b1865],
17	)	NN	O	)	prep_of	13	SENT_272	[p21l1050t1789r2139b1865],
18	,	,	O	,	_	0	SENT_272	[p21l1050t1789r2139b1865],
19	this	DT	O	this	det	20	SENT_272	[p21l7t1882r138b1943],
20	endpoint	NN	O	endpoint	nsubjpass	22	SENT_272	[p21l193t1882r527b1958],
21	was	VBD	O	be	auxpass	22	SENT_272	[p21l576t1902r711b1943],
22	noted	VBN	O	note	_	0	SENT_272	[p21l763t1882r977b1943],
23	before	IN	O	before	mark	29	SENT_272	[p21l1027t1882r1261b1943],
24	treatment	NN	O	treatment	nsubjpass	29	SENT_272	[p21l1312t1897r1679b1943],
25	with	IN	O	with	_	0	SENT_272	[p21l1728t1882r1891b1943],
26	study	NN	O	study	nn	27	SENT_272	[p21l1943t1882r2144b1958],
27	drug	NN	O	drug	prep_with	24	SENT_272	[p21l8t1976r180b2052],
28	was	VBD	O	be	auxpass	29	SENT_272	[p21l212t1996r347b2036],
29	repeated	VBN	O	repeat	advcl	22	SENT_272	[p21l383t1976r725b2052],
30	.	.	O	.	_	0	SENT_272	[p21l383t1976r725b2052],

1	The	DT	O	the	det	5	SENT_273	[p21l764t1976r914b2036],
2	mean	JJ	O	mean	amod	5	SENT_273	[p21l950t1996r1153b2036],
3	annual	JJ	SET	annual	amod	5	SENT_273	[p21l1189t1976r1439b2036],
4	malaria	NN	O	malaria	nn	5	SENT_273	[p21l1474t1976r1750b2036],
5	incidence	NN	O	incidence	nsubj	11	SENT_273	[p21l1785t1976r2142b2036],
6	in	IN	O	in	_	0	SENT_273	[p21l7t2068r77b2128],
7	this	DT	O	this	det	9	SENT_273	[p21l104t2068r236b2129],
8	small	JJ	O	small	amod	9	SENT_273	[p21l268t2068r461b2129],
9	group	NN	O	group	prep_in	5	SENT_273	[p21l490t2088r706b2144],
10	was	VBD	O	be	cop	11	SENT_273	[p21l735t2088r870b2129],
11	6-7	CD	NUMBER	6-7	_	0	SENT_273	[p21l904t2071r1041b2141],
12	,	,	O	,	_	0	SENT_273	[p21l904t2071r1041b2141],
13	which	WDT	O	which	nsubj	14	SENT_273	[p21l1071t2068r1294b2129],
14	suggests	VBZ	O	suggest	rcmod	11	SENT_273	[p21l1324t2082r1628b2144],
15	that	IN	O	that	complm	17	SENT_273	[p21l1658t2068r1804b2129],
16	anaemia	NN	O	anaemia	nsubj	17	SENT_273	[p21l1834t2068r2142b2129],
17	resulted	VBD	O	result	ccomp	14	SENT_273	[p21l7t2161r306b2222],
18	from	IN	O	from	_	0	SENT_273	[p21l352t2161r530b2222],
19	more	JJR	O	more	amod	21	SENT_273	[p21l576t2181r767b2222],
20	frequent	JJ	O	frequent	amod	21	SENT_273	[p21l815t2161r1131b2237],
21	parasitaemia	NN	O	parasitaemia	prep_from	17	SENT_273	[p21l1176t2162r1670b2237],
22	.	.	O	.	_	0	SENT_273	[p21l1176t2162r1670b2237],

1	In	IN	O	in	_	0	SENT_274	[p21l1723t2162r1801b2221],
2	the	DT	O	the	det	5	SENT_274	[p21l1847t2161r1961b2222],
3	one	CD	NUMBER	one	num	5	SENT_274	[p21l2010t2181r2142b2222],
4	anaemic	JJ	O	anaemic	amod	5	SENT_274	[p21l9t2255r316b2315],
5	patient	NN	O	patient	prep_in	16	SENT_274	[p21l486t2255r748b2331],
6	treated	VBN	O	treat	partmod	5	SENT_274	[p21l917t2255r1179b2315],
7	with	IN	O	with	_	0	SENT_274	[p21l1348t2255r1511b2315],
8	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_with	6	SENT_274	[p21l1683t2255r2142b2315, p21l6t2347r598b2423],
9	,	,	O	,	_	0	SENT_274	[p21l1683t2255r2142b2315, p21l6t2347r598b2423],
10	resistance	NN	O	resistance	nsubj	16	SENT_274	[p21l668t2347r1034b2407],
11	to	TO	O	to	_	0	SENT_274	[p21l1101t2361r1172b2407],
12	that	DT	O	that	det	13	SENT_274	[p21l1240t2347r1386b2407],
13	drug	NN	O	drug	prep_to	10	SENT_274	[p21l1453t2347r1626b2423],
14	might	MD	O	might	aux	16	SENT_274	[p21l1690t2347r1908b2423],
15	have	VB	O	have	aux	16	SENT_274	[p21l1973t2347r2142b2408],
16	caused	VBN	O	cause	_	0	SENT_274	[p21l9t2440r261b2501],
17	anaemia	NN	O	anaemia	dobj	16	SENT_274	[p21l326t2441r655b2501],
18	.	.	O	.	_	0	SENT_274	[p21l326t2441r655b2501],

1	The	DT	O	the	det	2	SENT_275	[p21l724t2440r875b2501],
2	cause	NN	O	cause	nsubj	12	SENT_275	[p21l941t2460r1142b2501],
3	of	IN	O	of	_	0	SENT_275	[p21l1209t2440r1287b2501],
4	anaemia	NN	O	anaemia	prep_of	2	SENT_275	[p21l1343t2441r1651b2501],
5	in	IN	O	in	_	0	SENT_275	[p21l1715t2441r1785b2500],
6	the	DT	O	the	det	9	SENT_275	[p21l1848t2440r1962b2501],
7	ten	CD	NUMBER	ten	num	9	SENT_275	[p21l2026t2454r2143b2501],
8	chlorproguanil-dapsone-group	JJ	O	chlorproguanil-dapsone-group	amod	9	SENT_275	[p21l9t2534r1157b2610],
9	patients	NNS	O	patient	prep_in	4	SENT_275	[p21l1193t2534r1488b2610],
10	is	VBZ	O	be	cop	12	SENT_275	[p21l1525t2534r1577b2594],
11	less	RBR	O	less	advmod	12	SENT_275	[p21l1615t2534r1743b2594],
12	clear	JJ	O	clear	_	0	SENT_275	[p21l1783t2534r1980b2607],
13	,	,	O	,	_	0	SENT_275	[p21l1783t2534r1980b2607],
14	but	CC	O	but	_	0	SENT_275	[p21l2017t2534r2143b2594],
15	the	DT	O	the	det	17	SENT_275	[p21l7t2626r121b2686],
16	likeliest	JJS	O	likeliest	amod	17	SENT_275	[p21l160t2626r443b2686],
17	explanation	NN	O	explanation	nsubjpass	19	SENT_275	[p21l482t2626r918b2702],
18	is	VBZ	O	be	auxpass	19	SENT_275	[p21l955t2626r1009b2686],
19	repeated	VBN	O	repeat	conj_but	12	SENT_275	[p21l1048t2626r1369b2702],
20	reinfection	NN	O	reinfection	dobj	19	SENT_275	[p21l1407t2626r1811b2686],
21	because	IN	O	because	_	0	SENT_275	[p21l1847t2626r2142b2687],
22	of	IN	O	of	prepc_because_of	19	SENT_275	[p21l9t2719r87b2780],
23	rapid	JJ	O	rapid	amod	25	SENT_275	[p21l108t2719r301b2795],
24	drug	NN	O	drug	nn	25	SENT_275	[p21l333t2719r505b2795],
25	elimination	NN	O	elimination	pobj	19	SENT_275	[p21l536t2719r981b2780],
26	.	.	O	.	_	0	SENT_275	[p21l536t2719r981b2780],

1	On	IN	O	on	_	0	SENT_276	[p21l1019t2720r1132b2780],
2	the	DT	O	the	det	4	SENT_276	[p21l1162t2719r1276b2780],
3	other	JJ	O	other	amod	4	SENT_276	[p21l1310t2719r1505b2780],
4	hand	NN	O	hand	prep_on	11	SENT_276	[p21l1532t2719r1742b2792],
5	,	,	O	,	_	0	SENT_276	[p21l1532t2719r1742b2792],
6	in	IN	O	in	quantmod	7	SENT_276	[p21l1776t2720r1845b2779],
7	5	CD	TIME	5	nsubj	11	SENT_276	[p21l1879t2722r1915b2780],
8	of	IN	TIME	of	_	0	SENT_276	[p21l1952t2719r2030b2780],
9	16	CD	TIME	16	num	10	SENT_276	[p21l2060t2722r2140b2780],
10	cases	NNS	O	case	prep_of	7	SENT_276	[p21l9t2833r194b2873],
11	(	VBP	O	(	_	0	SENT_276	[p21l230t2813r297b2888],
12	3	CD	TIME	3	number	14	SENT_276	[p21l230t2813r297b2888],
13	of	IN	TIME	of	quantmod	14	SENT_276	[p21l331t2813r409b2873],
14	16	CD	TIME	16	num	18	SENT_276	[p21l436t2815r516b2873],
15	chlorproguanil	NN	O	chlorproguanil	nn	18	SENT_276	[p21l548t2813r1442b2889],
16	—	NN	O	—	nn	18	SENT_276	[p21l548t2813r1442b2889],
17	dapsone	NN	O	dapsone	nn	18	SENT_276	[p21l548t2813r1442b2889],
18	group	NN	O	group	nsubj	28	SENT_276	[p21l1471t2832r1687b2889],
19	and	CC	O	and	_	0	SENT_276	[p21l1718t2813r1854b2873],
20	2	CD	TIME	2	number	22	SENT_276	[p21l1883t2815r1922b2872],
21	of	IN	TIME	of	quantmod	22	SENT_276	[p21l1955t2813r2033b2873],
22	16	CD	TIME	16	num	27	SENT_276	[p21l2060t2815r2140b2873],
23	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	27	SENT_276	[p21l8t2905r1040b2981],
24	group	NN	O	group	nn	27	SENT_276	[p21l1145t2905r1390b2981],
25	)	CD	NUMBER	)	num	27	SENT_276	[p21l1145t2905r1390b2981],
26	severe	JJ	O	severe	amod	27	SENT_276	[p21l1502t2925r1728b2966],
27	anaemia	NN	O	anaemia	conj_and	18	SENT_276	[p21l1834t2905r2142b2965],
28	occurred	VBD	O	occur	ccomp	11	SENT_276	[p21l9t2998r338b3059],
29	soon	RB	O	soon	advmod	28	SENT_276	[p21l386t3018r560b3059],
30	after	IN	O	after	_	0	SENT_276	[p21l608t2998r777b3059],
31	drug	NN	O	drug	nn	32	SENT_276	[p21l823t2998r994b3074],
32	exposure	NN	O	exposure	prep_after	28	SENT_276	[p21l1041t3018r1395b3074],
33	.	.	O	.	_	0	SENT_276	[p21l1041t3018r1395b3074],

1	This	DT	O	this	det	2	SENT_277	[p21l1446t2998r1614b3059],
2	ﬁnding	NN	O	ﬁnding	nsubj	5	SENT_277	[p21l1663t2998r1929b3074],
3	does	VBZ	O	do	aux	5	SENT_277	[p21l1975t2998r2141b3059],
4	not	RB	O	not	neg	5	SENT_277	[p21l6t3106r130b3152],
5	prove	VB	O	prove	dep	15	SENT_277	[p21l155t3111r363b3168],
6	that	IN	O	that	complm	9	SENT_277	[p21l391t3092r537b3152],
7	anaemia	NN	O	anaemia	nsubjpass	9	SENT_277	[p21l566t3092r874b3152],
8	was	VBD	O	be	auxpass	9	SENT_277	[p21l901t3112r1036b3152],
9	caused	VBN	O	cause	ccomp	5	SENT_277	[p21l1067t3092r1319b3152],
10	by	IN	O	by	_	0	SENT_277	[p21l1346t3092r1435b3168],
11	the	DT	O	the	det	14	SENT_277	[p21l1460t3092r1575b3152],
12	drug	NN	O	drug	nn	14	SENT_277	[p21l1605t3092r2142b3168],
13	—	NN	O	—	nn	14	SENT_277	[p21l1605t3092r2142b3168],
14	malaria	NN	O	malaria	agent	9	SENT_277	[p21l1605t3092r2142b3168],
15	causes	VBZ	O	cause	_	0	SENT_277	[p21l9t3204r244b3244],
16	haemoglobin	NN	O	haemoglobin	dobj	15	SENT_277	[p21l276t3184r764b3260],
17	to	TO	O	to	aux	18	SENT_277	[p21l795t3198r865b3244],
18	drop	VB	O	drop	xcomp	15	SENT_277	[p21l900t3184r1071b3260],
19	in	IN	O	in	_	0	SENT_277	[p21l1105t3184r1174b3244],
20	the	DT	DATE	the	det	21	SENT_277	[p21l1205t3184r1319b3245],
21	week	NN	DATE	week	prep_in	18	SENT_277	[p21l1351t3184r1539b3245],
22	after	IN	O	after	mark	29	SENT_277	[p21l1570t3184r1739b3244],
23	successful	JJ	O	successful	amod	25	SENT_277	[p21l1770t3184r2142b3245],
24	treatment	NN	O	treatment	nn	25	SENT_277	[p21l7t3277r587b3338],
25	—	NN	O	—	nsubjpass	29	SENT_277	[p21l7t3277r587b3338],
26	but	CC	O	but	prep	25	SENT_277	[p21l7t3277r587b3338],
27	dapsone	NN	O	dapsone	dep	26	SENT_277	[p21l626t3277r933b3353],
28	is	VBZ	O	be	auxpass	29	SENT_277	[p21l972t3278r1025b3338],
29	known	VBN	O	know	advcl	18	SENT_277	[p21l1066t3277r1316b3338],
30	to	TO	O	to	aux	31	SENT_277	[p21l1354t3292r1424b3338],
31	cause	VB	O	cause	xcomp	29	SENT_277	[p21l1467t3297r1668b3338],
32	haemolysis	NN	O	haemolysis	nsubj	15	SENT_277	[p21l1707t3277r2139b3353],
33	,	,	O	,	_	0	SENT_277	[p21l1707t3277r2139b3353],
34	especially	RB	O	especially	appos	32	SENT_277	[p21l9t3371r367b3447],
35	in	IN	O	in	_	0	SENT_277	[p21l423t3371r493b3430],
36	people	NNS	O	people	prep_in	34	SENT_277	[p21l549t3371r796b3447],
37	deﬁcient	JJ	O	deﬁcient	amod	34	SENT_277	[p21l856t3371r1179b3431],
38	in	IN	O	in	_	0	SENT_277	[p21l1236t3371r1306b3430],
39	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	40	SENT_277	[p21l1364t3371r2142b3447],
40	dehydrogenase	NN	O	dehydrogenase	prep_in	34	SENT_277	[p21l8t3463r640b3539],
41	.	.	O	.	_	0	SENT_277	[p21l8t3463r640b3539],

1	”	NN	O	”	nsubjpass	16	SENT_278	[p21l8t3463r640b3539],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_278	[p21l688t3463r1193b3536],
3	,	,	O	,	_	0	SENT_278	[p21l688t3463r1193b3536],
4	in	IN	O	in	_	0	SENT_278	[p21l1244t3463r1314b3523],
5	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	16	SENT_278	[p21l1362t3463r1573b3536],
6	,	,	O	,	_	0	SENT_278	[p21l1362t3463r1573b3536],
7	every	DT	O	every	det	9	SENT_278	[p21l1625t3483r1820b3539],
8	malaria	NN	O	malaria	nn	9	SENT_278	[p21l1865t3463r2142b3524],
9	episode	NN	O	episode	nsubjpass	16	SENT_278	[p21l9t3556r288b3632],
10	treated	VBN	O	treat	partmod	9	SENT_278	[p21l388t3556r650b3617],
11	with	IN	O	with	_	0	SENT_278	[p21l748t3556r911b3617],
12	chlorproguanil	NN	O	chlorproguanil	nn	14	SENT_278	[p21l1012t3556r1907b3632],
13	—	NN	O	—	nn	14	SENT_278	[p21l1012t3556r1907b3632],
14	dapsone	NN	O	dapsone	prep_with	10	SENT_278	[p21l1012t3556r1907b3632],
15	was	VBD	O	be	auxpass	16	SENT_278	[p21l2006t3576r2141b3617],
16	associated	VBN	O	associate	_	0	SENT_278	[p21l9t3650r389b3710],
17	with	IN	O	with	_	0	SENT_278	[p21l465t3650r628b3710],
18	a	DT	O	a	det	20	SENT_278	[p21l707t3670r743b3710],
19	larger	JJR	O	larger	amod	20	SENT_278	[p21l821t3650r1035b3726],
20	decrease	NN	O	decrease	prep_with	16	SENT_278	[p21l1113t3650r1429b3710],
21	in	IN	O	in	_	0	SENT_278	[p21l1509t3650r1578b3709],
22	haemoglobin	NN	O	haemoglobin	prep_in	20	SENT_278	[p21l1655t3650r2143b3726],
23	between	IN	O	between	_	0	SENT_278	[p21l6t3742r317b3803],
24	days	NNS	DURATION	day	nn	25	SENT_278	[p21l357t3742r518b3818],
25	o	NN	O	o	prep_between	22	SENT_278	[p21l561t3745r600b3803],
26	and	CC	O	and	_	0	SENT_278	[p21l643t3742r779b3803],
27	7	CD	NUMBER	7	conj_and	25	SENT_278	[p21l820t3745r857b3802],
28	than	IN	O	than	mark	30	SENT_278	[p21l900t3742r1067b3803],
29	was	VBD	O	be	auxpass	30	SENT_278	[p21l1104t3762r1239b3803],
30	seen	VBN	O	see	advcl	16	SENT_278	[p21l1281t3762r1442b3803],
31	with	IN	O	with	_	0	SENT_278	[p21l1479t3742r1643b3803],
32	sulfadoxinepyrimethamine	NN	O	sulfadoxinepyrimethamine	prep_with	30	SENT_278	[p21l1683t3742r2142b3803, p22l6t16r596b92],
33	.	.	O	.	_	0	SENT_278	[p21l1683t3742r2142b3803, p22l6t16r596b92],

1	By	IN	O	by	_	0	SENT_279	[p22l665t17r763b92],
2	contrast	NN	O	contrast	agent	12	SENT_279	[p22l825t30r1127b77],
3	to	TO	O	to	_	0	SENT_279	[p22l1188t31r1259b77],
4	Kiliﬁ	NNP	PERSON	Kiliﬁ	prep_to	2	SENT_279	[p22l1324t16r1535b89],
5	,	,	O	,	_	0	SENT_279	[p22l1324t16r1535b89],
6	no	DT	O	no	det	8	SENT_279	[p22l1601t36r1692b77],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_279	[p22l1758t16r2143b92],
8	differences	NNS	O	difference	nsubjpass	12	SENT_279	[p22l8t110r411b170],
9	in	IN	O	in	_	0	SENT_279	[p22l495t110r565b169],
10	haematocrit	NN	O	haematocrit	prep_in	8	SENT_279	[p22l645t110r1095b170],
11	were	VBD	O	be	auxpass	12	SENT_279	[p22l1174t129r1348b170],
12	seen	VBN	O	see	_	0	SENT_279	[p22l1433t129r1594b170],
13	in	IN	O	in	_	0	SENT_279	[p22l1675t110r1745b169],
14	Blantyre	NNP	LOCATION	Blantyre	prep_in	12	SENT_279	[p22l1827t110r2142b186],
15	between	IN	O	between	_	0	SENT_279	[p22l6t202r317b263],
16	chlorproguanil	NN	O	chlorproguanil	nn	18	SENT_279	[p22l428t202r1323b278],
17	—	NN	O	—	nn	18	SENT_279	[p22l428t202r1323b278],
18	dapsone	NN	O	dapsone	prep_between	14	SENT_279	[p22l428t202r1323b278],
19	and	CC	O	and	_	0	SENT_279	[p22l1436t202r1571b263],
20	sulfadoxine	NN	O	sulfadoxine	nn	22	SENT_279	[p22l1682t202r2142b263],
21	—	NN	O	—	nn	22	SENT_279	[p22l1682t202r2142b263],
22	pyrimethamine	NN	O	pyrimethamine	conj_and	18	SENT_279	[p22l6t295r596b371],
23	.	.	O	.	_	0	SENT_279	[p22l6t295r596b371],

1	Chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nsubj	19	SENT_280	[p22l95t389r1015b465],
2	is	VBZ	O	be	cop	3	SENT_280	[p22l1082t389r1134b449],
3	useful	JJ	O	useful	_	0	SENT_280	[p22l1201t389r1424b449],
4	against	IN	O	against	_	0	SENT_280	[p22l1492t389r1752b465],
5	parasites	NNS	O	parasite	prep_against	3	SENT_280	[p22l1817t389r2141b465],
6	with	IN	O	with	_	0	SENT_280	[p22l6t481r168b542],
7	the	DT	O	the	det	9	SENT_280	[p22l241t481r356b542],
8	common	JJ	O	common	amod	9	SENT_280	[p22l433t501r761b542],
9	S108N	NN	O	s108n	prep_with	3	SENT_280	[p22l838t481r1122b554],
10	,	,	O	,	_	0	SENT_280	[p22l838t481r1122b554],
11	N511	NN	O	n511	prep_with	3	SENT_280	[p22l1197t482r1419b554],
12	,	,	O	,	_	0	SENT_280	[p22l1197t482r1419b554],
13	and	CC	O	and	_	0	SENT_280	[p22l1498t481r1633b542],
14	C59R	NN	O	c59r	nn	16	SENT_280	[p22l1711t481r1932b542],
15	dhfr	NN	O	dhfr	nn	16	SENT_280	[p22l2004t481r2148b557],
16	mutation	NN	O	mutation	conj_and	9	SENT_280	[p22l7t575r372b647],
17	,	,	O	,	_	0	SENT_280	[p22l7t575r372b647],
18	and	CC	O	and	_	0	SENT_280	[p22l416t574r552b635],
19	is	VBZ	O	be	conj_and	3	SENT_280	[p22l591t575r644b635],
20	under	IN	O	under	_	0	SENT_280	[p22l685t574r907b635],
21	development	NN	O	development	prep_under	19	SENT_280	[p22l946t574r1429b650],
22	as	IN	O	as	_	0	SENT_280	[p22l1470t594r1539b635],
23	an	DT	O	a	det	28	SENT_280	[p22l1582t594r1668b635],
24	inexpensive	JJ	O	inexpensive	amod	28	SENT_280	[p22l1707t575r2142b650],
25	f1xed	JJ	O	f1xed	amod	28	SENT_280	[p22l7t668r394b728],
26	—	NN	O	—	nn	28	SENT_280	[p22l7t668r394b728],
27	ratio	NN	O	ratio	nn	28	SENT_280	[p22l7t668r394b728],
28	caplet	NN	O	caplet	prep_as	21	SENT_280	[p22l484t668r727b744],
29	;	:	O	;	_	0	SENT_280	[p22l484t668r727b744],
30	we	PRP	O	we	nsubj	31	SENT_280	[p22l814t688r914b728],
31	expect	VBP	O	expect	parataxis	3	SENT_280	[p22l1003t682r1242b744],
32	that	IN	O	that	_	0	SENT_280	[p22l1327t668r1473b728],
33	chlorproguanilTHE	NN	O	chlorproguanilthe	prep_that	31	SENT_280	[p22l1560t668r2142b744, p22l78t845r140b866],

1	LANCET	NN	O	lancet	_	0	SENT_281	[p22l149t845r274b866],
2	-	:	O	-	_	0	SENT_281	[p22l284t852r291b860],
3	Vol	NN	O	vol	nn	5	SENT_281	[p22l300t845r344b866],
4	360	CD	NUMBER	360	num	5	SENT_281	[p22l354t846r400b866],
5	o	NN	O	o	dep	1	SENT_281	[p22l411t852r418b860],
6	October	NNP	DATE	October	tmod	5	SENT_281	[p22l429t845r532b866],
7	12	CD	DATE	12	num	6	SENT_281	[p22l543t846r579b870],
8	,	,	DATE	,	_	0	SENT_281	[p22l543t846r579b870],
9	2002	CD	DATE	2002	num	6	SENT_281	[p22l590t846r652b866],
10	-	:	O	-	_	0	SENT_281	[p22l662t852r670b860],
11	www.thelancet.com	NN	O	www.thelancet.com	nn	12	SENT_281	[p22l680t845r930b866],
12	l	NN	O	l	dep	5	SENT_281	[p22l1972t840r1983b866],
13	141	CD	NUMBER	141	dep	12	SENT_281	[p22l1993t840r2045b866],

1	For	IN	O	for	_	0	SENT_282	[p22l79t945r148b980],
2	personal	JJ	O	personal	amod	3	SENT_282	[p22l173t945r361b988],
3	use	NN	O	use	pobj	1	SENT_282	[p22l388t954r477b980],
4	.	.	O	.	_	0	SENT_282	[p22l388t954r477b980],

1	Only	RB	O	only	advmod	2	SENT_283	[p22l525t945r621b989],
2	reproduce	VB	O	reproduce	_	0	SENT_283	[p22l647t945r869b988],
3	with	IN	O	with	_	0	SENT_283	[p22l893t945r987b980],
4	permission	NN	O	permission	prep_with	2	SENT_283	[p22l1015t945r1256b988],
5	from	IN	O	from	_	0	SENT_283	[p22l1281t945r1379b980],
6	The	DT	O	the	det	9	SENT_283	[p22l1404t945r1484b980],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_283	[p22l1510t945r1660b980],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_283	[p22l1687t945r1919b989],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_283	[p22l1942t945r2086b988],
10	.	.	O	.	_	0	SENT_283	[p22l1942t945r2086b988],

1	ARTICLES	NNS	O	article	_	0	SENT_284	[p22l91t1064r244b1085],

1	dapsone	NN	O	dapsone	nsubjpass	4	SENT_285	[p22l12t1256r318b1332],
2	will	MD	O	will	aux	4	SENT_285	[p22l356t1256r487b1317],
3	be	VB	O	be	auxpass	4	SENT_285	[p22l524t1256r610b1317],
4	submitted	VBN	O	submit	_	0	SENT_285	[p22l651t1256r1026b1317],
5	to	TO	O	to	_	0	SENT_285	[p22l1063t1270r1134b1317],
6	the	DT	O	the	det	8	SENT_285	[p22l1174t1256r1288b1317],
7	regulatory	JJ	O	regulatory	amod	8	SENT_285	[p22l1327t1256r1708b1332],
8	authorities	NNS	O	authority	prep_to	4	SENT_285	[p22l1746t1256r2142b1317],
9	in	IN	O	in	_	0	SENT_285	[p22l11t1350r81b1409],
10	2002	CD	DATE	2002	prep_in	8	SENT_285	[p22l139t1352r345b1410],
11	.	.	O	.	_	0	SENT_285	[p22l139t1352r345b1410],

1	Unfortunately	RB	O	unfortunately	advmod	14	SENT_286	[p22l406t1349r961b1425],
2	,	,	O	,	_	0	SENT_286	[p22l406t1349r961b1425],
3	widespread	JJ	O	widespread	amod	4	SENT_286	[p22l1019t1349r1442b1425],
4	selection	NN	O	selection	nsubj	14	SENT_286	[p22l1501t1349r1827b1410],
5	of	IN	O	of	_	0	SENT_286	[p22l1885t1349r1963b1410],
6	one	CD	NUMBER	one	num	9	SENT_286	[p22l2012t1369r2142b1410],
7	additional	JJ	O	additional	amod	9	SENT_286	[p22l13t1443r388b1503],
8	dhfr	NN	O	dhfr	nn	9	SENT_286	[p22l438t1443r582b1519],
9	mutation	NN	O	mutation	prep_of	4	SENT_286	[p22l625t1443r990b1516],
10	,	,	O	,	_	0	SENT_286	[p22l625t1443r990b1516],
11	Il64L	NN	O	il64l	appos	9	SENT_286	[p22l1042t1444r1296b1516],
12	,	,	O	,	_	0	SENT_286	[p22l1042t1444r1296b1516],
13	is	VBZ	O	be	cop	14	SENT_286	[p22l1348t1443r1401b1503],
14	likely	JJ	O	likely	ccomp	42	SENT_286	[p22l1452t1443r1648b1519],
15	to	TO	O	to	aux	16	SENT_286	[p22l1695t1457r1766b1503],
16	result	VB	O	result	xcomp	14	SENT_286	[p22l1817t1443r2025b1503],
17	in	IN	O	in	_	0	SENT_286	[p22l2074t1443r2143b1502],
18	borderline	JJ	O	borderline	amod	20	SENT_286	[p22l9t1535r397b1596],
19	clinical	JJ	O	clinical	amod	20	SENT_286	[p22l488t1535r752b1596],
20	effectiveness	NN	O	effectiveness	prep_in	16	SENT_286	[p22l843t1535r1309b1596],
21	of	IN	O	of	_	0	SENT_286	[p22l1402t1535r1481b1596],
22	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	20	SENT_286	[p22l1562t1535r2143b1611, p22l12t1628r369b1704],
23	.6	CD	NUMBER	.6	num	24	SENT_286	[p22l1562t1535r2143b1611, p22l12t1628r369b1704],
24	1164M	NN	O	1164m	dobj	16	SENT_286	[p22l433t1630r693b1689],
25	was	VBD	O	be	auxpass	26	SENT_286	[p22l755t1648r890b1689],
26	reported	VBN	O	report	rcmod	24	SENT_286	[p22l956t1629r1274b1705],
27	in	IN	O	in	_	0	SENT_286	[p22l1339t1629r1409b1688],
28	isolates	NNS	O	isolate	prep_in	26	SENT_286	[p22l1473t1629r1743b1689],
29	collected	VBN	O	collect	partmod	28	SENT_286	[p22l1811t1629r2143b1689],
30	between	IN	O	between	_	0	SENT_286	[p22l9t1722r321b1782],
31	1992	CD	DATE	1992	prep_between	29	SENT_286	[p22l359t1724r535b1782],
32	and	CC	DATE	and	_	0	SENT_286	[p22l569t1722r704b1782],
33	1995	CD	DATE	1995	prep_between	29	SENT_286	[p22l742t1724r916b1782],
34	in	IN	O	in	_	0	SENT_286	[p22l950t1722r1020b1781],
35	Kenya	NNP	LOCATION	Kenya	prep_in	29	SENT_286	[p22l1049t1723r1361b1798],
36	,	,	O	,	_	0	SENT_286	[p22l1049t1723r1361b1798],
37	“	NN	O	“	nsubjpass	42	SENT_286	[p22l1049t1723r1361b1798],
38	and	CC	O	and	_	0	SENT_286	[p22l1392t1722r1527b1782],
39	I164L	NN	O	i164l	conj_and	37	SENT_286	[p22l1556t1723r1791b1782],
40	has	VBZ	O	have	aux	42	SENT_286	[p22l1816t1722r1936b1782],
41	been	VBN	O	be	auxpass	42	SENT_286	[p22l1966t1722r2143b1782],
42	detected	VBN	O	detect	_	0	SENT_286	[p22l12t1814r328b1875],
43	in	IN	O	in	_	0	SENT_286	[p22l359t1814r429b1874],
44	isolates	NNS	O	isolate	prep_in	42	SENT_286	[p22l460t1814r731b1875],
45	collected	VBN	O	collect	partmod	44	SENT_286	[p22l765t1814r1098b1875],
46	between	IN	O	between	_	0	SENT_286	[p22l1127t1814r1438b1875],
47	1998	CD	DATE	1998	prep_between	45	SENT_286	[p22l1478t1817r1653b1875],
48	and	CC	DATE	and	_	0	SENT_286	[p22l1689t1814r1824b1875],
49	1999	CD	DATE	1999	prep_between	45	SENT_286	[p22l1865t1817r2039b1875],
50	in	IN	O	in	_	0	SENT_286	[p22l2074t1814r2143b1874],
51	Tanzania	NNP	LOCATION	Tanzania	prep_in	45	SENT_286	[p22l10t1908r432b1968],
52	.	.	O	.	_	0	SENT_286	[p22l10t1908r432b1968],

1	”	NN	O	”	nsubj	10	SENT_287	[p22l10t1908r432b1968],
2	In	IN	O	in	_	0	SENT_287	[p22l485t1909r563b1967],
3	both	DT	O	both	det	4	SENT_287	[p22l613t1908r784b1968],
4	cases	NNS	O	case	prep_in	10	SENT_287	[p22l837t1927r1022b1968],
5	the	DT	O	the	det	7	SENT_287	[p22l1075t1908r1189b1968],
6	mutant	JJ	O	mutant	amod	7	SENT_287	[p22l1241t1921r1512b1968],
7	alleles	NNS	O	allele	nsubj	10	SENT_287	[p22l1565t1908r1788b1968],
8	were	VBD	O	be	cop	10	SENT_287	[p22l1840t1927r2013b1968],
9	so	RB	O	so	advmod	10	SENT_287	[p22l2067t1927r2141b1968],
10	infrequent	JJ	O	infrequent	_	0	SENT_287	[p22l11t2001r401b2077],
11	that	IN	O	that	complm	14	SENT_287	[p22l462t2001r608b2061],
12	they	PRP	O	they	nsubj	14	SENT_287	[p22l670t2001r828b2077],
13	were	VBD	O	be	cop	14	SENT_287	[p22l887t2020r1061b2061],
14	undetectable	JJ	O	undetectable	ccomp	10	SENT_287	[p22l1124t2001r1606b2061],
15	by	IN	O	by	_	0	SENT_287	[p22l1668t2001r1757b2077],
16	standard	JJ	O	standard	amod	18	SENT_287	[p22l1819t2001r2143b2061],
17	molecular	JJ	O	molecular	amod	18	SENT_287	[p22l10t2093r385b2154],
18	techniques	NNS	O	technique	prep_by	14	SENT_287	[p22l411t2093r836b2169],
19	.	.	O	.	_	0	SENT_287	[p22l411t2093r836b2169],

1	That	DT	O	that	det	2	SENT_288	[p22l870t2093r1052b2154],
2	I164L	NN	O	i164l	nsubj	6	SENT_288	[p22l1081t2094r1315b2154],
3	and	CC	O	and	_	0	SENT_288	[p22l1343t2093r1478b2154],
4	I164M	NN	O	i164m	conj_and	2	SENT_288	[p22l1507t2094r1767b2154],
5	still	RB	O	still	advmod	6	SENT_288	[p22l1797t2093r1927b2154],
6	seem	VBP	O	seem	_	0	SENT_288	[p22l1958t2113r2143b2154],
7	to	TO	O	to	aux	9	SENT_288	[p22l10t2201r81b2247],
8	be	VB	O	be	cop	9	SENT_288	[p22l148t2186r234b2247],
9	rare	JJ	O	rare	xcomp	6	SENT_288	[p22l302t2206r445b2247],
10	in	IN	O	in	mark	13	SENT_288	[p22l513t2187r583b2246],
11	Africa	NNP	LOCATION	Africa	nsubj	13	SENT_288	[p22l648t2186r874b2247],
12	could	MD	O	could	aux	13	SENT_288	[p22l943t2186r1148b2247],
13	suggest	VB	O	suggest	advcl	9	SENT_288	[p22l1217t2201r1488b2262],
14	that	IN	O	that	complm	21	SENT_288	[p22l1554t2186r1700b2247],
15	additional	JJ	O	additional	amod	19	SENT_288	[p22l1768t2186r2143b2247],
16	(	NN	O	(	nn	19	SENT_288	[p22l17t2280r528b2355],
17	unidentiﬁed	JJ	O	unidentiﬁed	amod	19	SENT_288	[p22l17t2280r528b2355],
18	)	NN	O	)	nn	19	SENT_288	[p22l17t2280r528b2355],
19	factors	NNS	O	factor	nsubjpass	21	SENT_288	[p22l574t2280r822b2340],
20	are	VBP	O	be	auxpass	21	SENT_288	[p22l866t2299r975b2340],
21	required	VBN	O	require	ccomp	13	SENT_288	[p22l1016t2280r1332b2356],
22	for	IN	O	for	_	0	SENT_288	[p22l1372t2280r1477b2340],
23	such	JJ	O	such	amod	24	SENT_288	[p22l1517t2280r1686b2340],
24	mutants	NNS	O	mutant	prep_for	21	SENT_288	[p22l1726t2294r2029b2340],
25	to	TO	O	to	aux	26	SENT_288	[p22l2070t2294r2141b2340],
26	thrive	VB	O	thrive	xcomp	21	SENT_288	[p22l10t2372r223b2433],
27	in	IN	O	in	_	0	SENT_288	[p22l271t2372r341b2432],
28	this	DT	O	this	det	29	SENT_288	[p22l388t2372r519b2433],
29	environment	NN	O	environment	prep_in	26	SENT_288	[p22l569t2372r1064b2433],
30	.	.	O	.	_	0	SENT_288	[p22l569t2372r1064b2433],

1	Thus	RB	O	thus	advmod	22	SENT_289	[p22l1115t2372r1334b2445],
2	,	,	O	,	_	0	SENT_289	[p22l1115t2372r1334b2445],
3	although	IN	O	although	mark	15	SENT_289	[p22l1385t2372r1713b2448],
4	the	DT	O	the	det	7	SENT_289	[p22l1759t2372r1873b2433],
5	useful	JJ	O	useful	amod	7	SENT_289	[p22l1920t2372r2143b2433],
6	therapeutic	JJ	O	therapeutic	amod	7	SENT_289	[p22l10t2465r433b2541],
7	lifespan	NN	O	lifespan	nsubj	15	SENT_289	[p22l465t2465r752b2541],
8	of	IN	O	of	_	0	SENT_289	[p22l784t2465r863b2526],
9	chlorproguanil	NN	O	chlorproguanil	nn	11	SENT_289	[p22l886t2465r1779b2541],
10	—	NN	O	—	nn	11	SENT_289	[p22l886t2465r1779b2541],
11	dapsone	NN	O	dapsone	prep_of	7	SENT_289	[p22l886t2465r1779b2541],
12	might	MD	O	might	aux	15	SENT_289	[p22l1811t2465r2028b2541],
13	be	VB	O	be	cop	15	SENT_289	[p22l2056t2465r2142b2526],
14	relatively	RB	O	relatively	advmod	15	SENT_289	[p22l10t2559r350b2635],
15	short	JJ	O	short	advcl	22	SENT_289	[p22l377t2559r565b2619],
16	in	IN	O	in	_	0	SENT_289	[p22l592t2559r662b2618],
17	Africa	NNP	LOCATION	Africa	prep_in	15	SENT_289	[p22l687t2559r937b2632],
18	,	,	O	,	_	0	SENT_289	[p22l687t2559r937b2632],
19	this	DT	O	this	det	20	SENT_289	[p22l967t2559r1099b2619],
20	prediction	NN	O	prediction	nsubj	22	SENT_289	[p22l1127t2559r1512b2635],
21	remains	VBZ	O	remain	cop	22	SENT_289	[p22l1539t2559r1832b2619],
22	open	JJ	O	open	_	0	SENT_289	[p22l1863t2578r2044b2635],
23	to	TO	O	to	aux	24	SENT_289	[p22l2070t2573r2141b2619],
24	doubt	VB	O	doubt	xcomp	22	SENT_289	[p22l12t2650r251b2711],
25	.	.	O	.	_	0	SENT_289	[p22l12t2650r251b2711],

1	Furthermore	RB	O	furthermore	advmod	16	SENT_290	[p22l315t2650r821b2722],
2	,	,	O	,	_	0	SENT_290	[p22l315t2650r821b2722],
3	use	NN	O	use	nsubj	16	SENT_290	[p22l882t2670r1002b2711],
4	of	IN	O	of	_	0	SENT_290	[p22l1063t2650r1142b2710],
5	the	DT	O	the	det	7	SENT_290	[p22l1189t2650r1303b2711],
6	artemisinin	NN	O	artemisinin	nn	7	SENT_290	[p22l1364t2650r1785b2711],
7	class	NN	O	class	prep_of	3	SENT_290	[p22l1844t2650r2013b2711],
8	of	IN	O	of	_	0	SENT_290	[p22l2075t2650r2153b2710],
9	antimalarial	JJ	O	antimalarial	amod	10	SENT_290	[p22l13t2743r456b2804],
10	drugs	NNS	O	drug	prep_of	7	SENT_290	[p22l574t2743r778b2819],
11	in	IN	O	in	_	0	SENT_290	[p22l896t2744r966b2803],
12	combination	NN	O	combination	prep_in	10	SENT_290	[p22l1084t2743r1555b2804],
13	with	IN	O	with	_	0	SENT_290	[p22l1669t2743r1832b2804],
14	other	JJ	O	other	amod	15	SENT_290	[p22l1950t2743r2145b2804],
15	compounds	NNS	O	compound	prep_with	12	SENT_290	[p22l12t2837r447b2913],
16	(	VBP	O	(	_	0	SENT_290	[p22l486t2837r936b2912],
17	artemisinin	NN	O	artemisinin	nn	18	SENT_290	[p22l486t2837r936b2912],
18	combination	NN	O	combination	dobj	16	SENT_290	[p22l968t2837r1440b2897],
19	therapy	NN	O	therapy	nn	20	SENT_290	[p22l1470t2837r1778b2913],
20	)	NN	O	)	nsubjpass	23	SENT_290	[p22l1470t2837r1778b2913],
21	has	VBZ	O	have	aux	23	SENT_290	[p22l1814t2837r1934b2897],
22	been	VBN	O	be	auxpass	23	SENT_290	[p22l1966t2837r2143b2897],
23	shown	VBN	O	show	rcmod	18	SENT_290	[p22l12t2929r250b2990],
24	to	TO	O	to	aux	25	SENT_290	[p22l325t2943r396b2990],
25	slow	VB	O	slow	xcomp	23	SENT_290	[p22l475t2929r639b2990],
26	the	DT	O	the	det	27	SENT_290	[p22l713t2929r827b2990],
27	rate	NN	O	rate	dobj	25	SENT_290	[p22l904t2943r1044b2990],
28	of	IN	O	of	_	0	SENT_290	[p22l1122t2929r1201b2990],
29	development	NN	O	development	prep_of	27	SENT_290	[p22l1268t2929r1751b3005],
30	of	IN	O	of	_	0	SENT_290	[p22l1827t2929r1906b2990],
31	drug	NN	O	drug	nn	32	SENT_290	[p22l1973t2929r2145b3005],
32	resistance	NN	O	resistance	prep_of	29	SENT_290	[p22l10t3022r376b3083],
33	in	IN	O	in	_	0	SENT_290	[p22l446t3023r516b3082],
34	southeast	NN	O	southeast	nn	35	SENT_290	[p22l587t3022r938b3083],
35	Asia	NNP	LOCATION	Asia	prep_in	25	SENT_290	[p22l1006t3023r1188b3095],
36	,	,	O	,	_	0	SENT_290	[p22l1006t3023r1188b3095],
37	and	CC	O	and	_	0	SENT_290	[p22l1263t3022r1398b3083],
38	adoption	NN	O	adoption	nsubj	47	SENT_290	[p22l1469t3022r1801b3098],
39	of	IN	O	of	_	0	SENT_290	[p22l1872t3022r1951b3083],
40	this	DT	O	this	det	41	SENT_290	[p22l2010t3022r2142b3083],
41	concept	NN	O	concept	prep_of	38	SENT_290	[p22l12t3130r305b3192],
42	by	IN	O	by	_	0	SENT_290	[p22l351t3116r440b3192],
43	malaria	NN	O	malaria	nn	45	SENT_290	[p22l486t3116r763b3176],
44	control	NN	O	control	nn	45	SENT_290	[p22l813t3116r1078b3176],
45	programmes	NNS	O	programme	prep_by	41	SENT_290	[p22l1126t3135r1593b3192],
46	has	VBZ	O	have	aux	47	SENT_290	[p22l1641t3116r1761b3176],
47	attracted	VBN	O	attract	conj_and	16	SENT_290	[p22l1813t3116r2143b3176],
48	much	JJ	O	much	amod	50	SENT_290	[p22l10t3208r221b3269],
49	scientiﬁc	NN	O	scientiﬁc	nn	50	SENT_290	[p22l294t3208r624b3269],
50	support	NN	O	support	dobj	47	SENT_290	[p22l698t3209r1057b3284],
51	.	.	O	.	_	0	SENT_290	[p22l698t3209r1057b3284],

1	”	NN	O	”	nn	2	SENT_291	[p22l698t3209r1057b3284],
2	A	NN	O	a	nn	4	SENT_291	[p22l1128t3209r1189b3268],
3	triple	JJ	O	triple	amod	4	SENT_291	[p22l1259t3208r1455b3284],
4	combination	NN	O	combination	nsubj	7	SENT_291	[p22l1530t3208r2001b3269],
5	of	IN	O	of	_	0	SENT_291	[p22l2075t3208r2153b3269],
6	chlorproguanil-dapsone-artesunate	NN	O	chlorproguanil-dapsone-artesunate	prep_of	4	SENT_291	[p22l12t3301r1329b3377],
7	is	VBZ	O	be	_	0	SENT_291	[p22l1423t3302r1475b3362],
8	therefore	RB	O	therefore	advmod	7	SENT_291	[p22l1570t3301r1906b3362],
9	also	RB	O	also	advmod	7	SENT_291	[p22l2001t3301r2141b3362],
10	under	IN	O	under	_	0	SENT_291	[p22l10t3395r231b3455],
11	development	NN	O	development	prep_under	7	SENT_291	[p22l260t3395r762b3471],
12	.	.	O	.	_	0	SENT_291	[p22l260t3395r762b3471],

1	Our	PRP$	O	we	poss	3	SENT_292	[p22l98t3487r246b3548],
2	main	JJ	O	main	amod	3	SENT_292	[p22l284t3487r470b3548],
3	conclusions	NNS	O	conclusion	nsubj	6	SENT_292	[p22l511t3487r946b3548],
4	are	VBP	O	be	cop	6	SENT_292	[p22l990t3507r1120b3548],
5	:	:	O	:	_	0	SENT_292	[p22l990t3507r1120b3548],
6	first	RB	ORDINAL	first	_	0	SENT_292	[p22l1165t3487r1332b3560],
7	,	,	O	,	_	0	SENT_292	[p22l1165t3487r1332b3560],
8	that	IN	O	that	dep	20	SENT_292	[p22l1375t3487r1521b3548],
9	widespread	JJ	O	widespread	amod	10	SENT_292	[p22l1559t3487r1982b3563],
10	use	NN	O	use	nsubj	20	SENT_292	[p22l2022t3507r2142b3548],
11	of	IN	O	of	_	0	SENT_292	[p22l12t3580r91b3641],
12	chlorproguanil	NN	O	chlorproguanil	nn	14	SENT_292	[p22l160t3580r1053b3656],
13	—	NN	O	—	nn	14	SENT_292	[p22l160t3580r1053b3656],
14	dapsone	NN	O	dapsone	prep_of	10	SENT_292	[p22l160t3580r1053b3656],
15	in	IN	O	in	_	0	SENT_292	[p22l1131t3581r1201b3640],
16	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	14	SENT_292	[p22l1278t3580r1466b3640],
17	or	CC	O	or	_	0	SENT_292	[p22l1545t3600r1621b3641],
18	Blantyre	NNP	LOCATION	Blantyre	prep_in	14	SENT_292	[p22l1696t3580r2011b3656],
19	is	VBZ	O	be	cop	20	SENT_292	[p22l2088t3581r2141b3641],
20	unlikely	JJ	O	unlikely	dep	6	SENT_292	[p22l10t3674r307b3750],
21	to	TO	O	to	aux	22	SENT_292	[p22l371t3688r441b3734],
22	change	VB	O	change	xcomp	20	SENT_292	[p22l511t3674r769b3750],
23	annual	JJ	SET	annual	amod	25	SENT_292	[p22l837t3674r1088b3734],
24	malaria	NN	O	malaria	nn	25	SENT_292	[p22l1154t3674r1430b3734],
25	incidence	NN	O	incidence	dobj	22	SENT_292	[p22l1496t3674r1852b3734],
26	to	TO	O	to	_	0	SENT_292	[p22l1918t3688r1988b3734],
27	an	DT	O	a	det	29	SENT_292	[p22l2058t3693r2143b3734],
28	important	JJ	O	important	amod	29	SENT_292	[p23l11t15r385b91],
29	degree	NN	O	degree	prep_to	22	SENT_292	[p23l455t15r721b91],
30	,	,	O	,	_	0	SENT_292	[p23l455t15r721b91],
31	despite	IN	O	despite	_	0	SENT_292	[p23l797t15r1058b91],
32	the	DT	O	the	det	34	SENT_292	[p23l1129t15r1243b76],
33	rapid	JJ	O	rapid	amod	34	SENT_292	[p23l1314t15r1507b91],
34	elimination	NN	O	elimination	prep_despite	20	SENT_292	[p23l1579t15r2003b76],
35	of	IN	O	of	_	0	SENT_292	[p23l2075t15r2153b76],
36	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	34	SENT_292	[p23l12t108r906b184],
37	from	IN	O	from	_	0	SENT_292	[p23l968t108r1145b169],
38	the	DT	O	the	det	39	SENT_292	[p23l1206t108r1320b169],
39	body	NN	O	body	prep_from	36	SENT_292	[p23l1381t108r1588b184],
40	;	:	O	;	_	0	SENT_292	[p23l1381t108r1588b184],
41	second	JJ	ORDINAL	second	dep	6	SENT_292	[p23l1654t108r1934b181],
42	,	,	O	,	_	0	SENT_292	[p23l1654t108r1934b181],
43	that	IN	O	that	dep	48	SENT_292	[p23l1998t108r2144b169],
44	treatment	NN	O	treatment	nn	45	SENT_292	[p23l10t216r376b262],
45	failure	NN	O	failure	nsubj	48	SENT_292	[p23l423t202r659b262],
46	is	VBZ	O	be	cop	48	SENT_292	[p23l708t202r761b262],
47	less	RBR	O	less	advmod	48	SENT_292	[p23l810t202r938b262],
48	frequent	JJ	O	frequent	dep	41	SENT_292	[p23l988t202r1304b278],
49	with	IN	O	with	_	0	SENT_292	[p23l1350t202r1512b262],
50	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_with	48	SENT_292	[p23l1562t202r2143b278, p23l12t294r318b370],
51	than	IN	O	than	prep	48	SENT_292	[p23l364t294r530b355],
52	with	IN	O	with	pcomp	51	SENT_292	[p23l573t294r736b355],
53	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	pobj	52	SENT_292	[p23l782t294r1813b370],
54	in	IN	O	in	prep	52	SENT_292	[p23l1859t294r1929b354],
55	both	CC	O	both	dep	54	SENT_292	[p23l1972t294r2144b355],
56	centres	NNS	O	centre	conj	54	SENT_292	[p23l12t400r299b458],
57	,	,	O	,	_	0	SENT_292	[p23l12t400r299b458],
58	but	CC	O	but	_	0	SENT_292	[p23l348t386r496b458],
59	,	,	O	,	_	0	SENT_292	[p23l348t386r496b458],
60	third	JJ	ORDINAL	third	advmod	66	SENT_292	[p23l547t386r751b458],
61	,	,	O	,	_	0	SENT_292	[p23l547t386r751b458],
62	that	IN	O	that	dep	66	SENT_292	[p23l802t386r948b447],
63	anaemia	NN	O	anaemia	nsubj	66	SENT_292	[p23l997t387r1305b447],
64	is	VBZ	O	be	cop	66	SENT_292	[p23l1354t387r1407b447],
65	more	RBR	O	more	advmod	66	SENT_292	[p23l1457t406r1647b447],
66	common	JJ	O	common	conj_but	48	SENT_292	[p23l1697t406r2026b447],
67	in	IN	O	in	_	0	SENT_292	[p23l2074t386r2143b446],
68	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	nn	70	SENT_292	[p23l12t480r906b556],
69	treated	JJ	O	treated	amod	70	SENT_292	[p23l934t480r1196b540],
70	patients	NNS	O	patient	prep_in	66	SENT_292	[p23l1222t480r1538b556],
71	.	.	O	.	_	0	SENT_292	[p23l1222t480r1538b556],

1	Possible	JJ	O	possible	amod	2	SENT_293	[p23l1572t480r1876b540],
2	causes	NNS	O	cause	_	0	SENT_293	[p23l1906t500r2141b540],
3	of	IN	O	of	_	0	SENT_293	[p23l12t572r91b633],
4	chlorproguanil	NN	O	chlorproguanil	nn	8	SENT_293	[p23l161t572r1472b648],
5	—	CD	NUMBER	—	num	8	SENT_293	[p23l161t572r1472b648],
6	dapsone-associated	JJ	O	dapsone-associated	amod	8	SENT_293	[p23l161t572r1472b648],
7	anaemia	NN	O	anaemia	nn	8	SENT_293	[p23l1552t572r1860b633],
8	range	NN	O	range	prep_of	2	SENT_293	[p23l1938t592r2142b648],
9	from	IN	O	from	_	0	SENT_293	[p23l10t665r188b726],
10	the	DT	O	the	det	11	SENT_293	[p23l244t665r358b726],
11	effects	NNS	O	effect	prep_from	2	SENT_293	[p23l417t665r651b726],
12	of	IN	O	of	_	0	SENT_293	[p23l711t665r789b726],
13	more	JJR	O	more	amod	15	SENT_293	[p23l835t685r1026b726],
14	frequent	JJ	O	frequent	amod	15	SENT_293	[p23l1083t665r1399b741],
15	parasitosis	NN	O	parasitosis	prep_of	11	SENT_293	[p23l1453t666r1842b741],
16	to	TO	O	to	_	0	SENT_293	[p23l1900t680r1970b726],
17	the	DT	O	the	det	18	SENT_293	[p23l2028t665r2142b726],
18	possibility	NN	O	possibility	prep_to	15	SENT_293	[p23l9t759r390b835],
19	of	IN	O	of	_	0	SENT_293	[p23l416t759r495b819],
20	adverse	JJ	O	adverse	amod	22	SENT_293	[p23l514t759r789b819],
21	drug	NN	O	drug	nn	22	SENT_293	[p23l819t759r990b835],
22	reaction	NN	O	reaction	prep_of	18	SENT_293	[p23l1016t759r1338b819],
23	.	.	O	.	_	0	SENT_293	[p23l1016t759r1338b819],

1	A	DT	O	a	det	5	SENT_294	[p23l1369t760r1430b818],
2	phase	NN	O	phase	nn	5	SENT_294	[p23l1454t759r1665b835],
3	3	CD	NUMBER	3	num	5	SENT_294	[p23l1695t761r1733b819],
4	regulatory	JJ	O	regulatory	amod	5	SENT_294	[p23l1763t759r2145b835],
5	trial	NN	O	trial	nsubjpass	11	SENT_294	[p23l10t851r159b912],
6	of	IN	O	of	_	0	SENT_294	[p23l245t851r324b912],
7	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	5	SENT_294	[p23l401t851r1294b927],
8	has	VBZ	O	have	aux	11	SENT_294	[p23l1379t851r1499b912],
9	recently	RB	DATE	recently	advmod	11	SENT_294	[p23l1586t851r1884b927],
10	been	VBN	O	be	auxpass	11	SENT_294	[p23l1965t851r2143b912],
11	completed	VBN	O	complete	_	0	SENT_294	[p23l12t944r425b1020],
12	,	,	O	,	_	0	SENT_294	[p23l12t944r425b1020],
13	and	CC	O	and	_	0	SENT_294	[p23l467t944r602b1005],
14	will	MD	O	will	aux	15	SENT_294	[p23l637t944r770b1005],
15	provide	VB	O	provide	conj_and	11	SENT_294	[p23l806t944r1087b1020],
16	further	JJ	O	further	amod	17	SENT_294	[p23l1124t944r1384b1005],
17	information	NN	O	information	dobj	15	SENT_294	[p23l1419t944r1863b1005],
18	on	IN	O	on	_	0	SENT_294	[p23l1901t964r1992b1005],
19	the	DT	O	the	det	20	SENT_294	[p23l2028t944r2142b1005],
20	safety	NN	O	safety	prep_on	15	SENT_294	[p23l12t1038r224b1114],
21	and	CC	O	and	_	0	SENT_294	[p23l280t1038r415b1098],
22	efficacy	NN	O	efficacy	prep_on	15	SENT_294	[p23l472t1038r754b1114],
23	of	IN	O	of	_	0	SENT_294	[p23l809t1038r888b1098],
24	this	DT	O	this	det	25	SENT_294	[p23l933t1038r1065b1098],
25	drug	NN	O	drug	prep_of	20	SENT_294	[p23l1123t1038r1314b1114],
26	.	.	O	.	_	0	SENT_294	[p23l1123t1038r1314b1114],

1	These	DT	O	these	det	2	SENT_295	[p23l1374t1038r1601b1098],
2	data	NNS	O	datum	nsubj	5	SENT_295	[p23l1659t1038r1815b1098],
3	will	MD	O	will	aux	5	SENT_295	[p23l1870t1038r2002b1098],
4	be	VB	O	be	cop	5	SENT_295	[p23l2057t1038r2142b1098],
5	relevant	JJ	O	relevant	_	0	SENT_295	[p23l10t1130r309b1191],
6	not	RB	O	not	neg	7	SENT_295	[p23l340t1144r464b1191],
7	only	RB	O	only	preconj	5	SENT_295	[p23l497t1130r656b1206],
8	to	TO	O	to	_	0	SENT_295	[p23l687t1144r758b1191],
9	the	DT	O	the	det	10	SENT_295	[p23l792t1130r906b1191],
10	development	NN	O	development	prep_to	5	SENT_295	[p23l941t1130r1424b1206],
11	of	IN	O	of	_	0	SENT_295	[p23l1458t1130r1537b1191],
12	chlorproguanildapsone	NN	O	chlorproguanildapsone	prep_of	10	SENT_295	[p23l1562t1130r2143b1206, p23l12t1223r342b1299],
13	,	,	O	,	_	0	SENT_295	[p23l1562t1130r2143b1206, p23l12t1223r342b1299],
14	but	CC	O	but	_	0	SENT_295	[p23l376t1223r501b1284],
15	also	RB	O	also	_	0	SENT_295	[p23l535t1223r674b1284],
16	to	TO	O	to	_	0	SENT_295	[p23l708t1238r779b1284],
17	that	DT	O	that	conj_and	10	SENT_295	[p23l812t1223r958b1284],
18	of	IN	O	of	_	0	SENT_295	[p23l991t1223r1070b1284],
19	the	DT	O	the	det	23	SENT_295	[p23l1092t1223r1206b1284],
20	triple	JJ	O	triple	amod	23	SENT_295	[p23l1238t1223r1433b1299],
21	combination	NN	O	combination	nn	23	SENT_295	[p23l1468t1223r1940b1284],
22	drug	NN	O	drug	nn	23	SENT_295	[p23l1973t1223r2145b1299],
23	chlorproguanil-dapsone-artesunate	NN	O	chlorproguanil-dapsone-artesunate	prep_of	17	SENT_295	[p23l12t1317r1351b1393],
24	.	.	O	.	_	0	SENT_295	[p23l12t1317r1351b1393],

1	Contributors	NNS	O	contributor	nsubj	4	SENT_296	[p23l13t1546r412b1599],
2	I	PRP	O	I	nsubj	3	SENT_296	[p23l7t1627r33b1684],
3	Sulo	VBP	O	sulo	rcmod	1	SENT_296	[p23l56t1627r183b1674],
4	collected	VBN	O	collect	_	0	SENT_296	[p23l208t1627r467b1674],
5	data	NNS	O	datum	dobj	4	SENT_296	[p23l491t1627r612b1674],
6	in	IN	O	in	_	0	SENT_296	[p23l635t1627r690b1673],
7	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	5	SENT_296	[p23l712t1626r875b1674],
8	.	.	O	.	_	0	SENT_296	[p23l712t1626r875b1674],

1	P	NN	O	p	nn	2	SENT_297	[p23l902t1627r941b1673],
2	Chimpeni	NNS	PERSON	chimpenus	nsubj	3	SENT_297	[p23l966t1627r1254b1686],
3	collected	VBN	O	collect	_	0	SENT_297	[p23l1278t1627r1536b1674],
4	data	NNS	O	datum	dobj	3	SENT_297	[p23l1560t1627r1682b1674],
5	in	IN	O	in	_	0	SENT_297	[p23l1705t1627r1759b1673],
6	Blantyre	NNP	LOCATION	Blantyre	prep_in	4	SENT_297	[p23l1782t1627r2043b1686],
7	.	.	O	.	_	0	SENT_297	[p23l1782t1627r2043b1686],

1	J	NNP	PERSON	J	nn	2	SENT_298	[p23l7t1703r33b1760],
2	Hatcher	NNP	PERSON	Hatcher	nsubj	10	SENT_298	[p23l54t1702r308b1759],
3	,	,	O	,	_	0	SENT_298	[p23l54t1702r308b1759],
4	W	NNP	O	W	nn	5	SENT_298	[p23l331t1703r398b1750],
5	Watkins	NNP	PERSON	Watkins	nsubj	10	SENT_298	[p23l417t1702r675b1759],
6	,	,	O	,	_	0	SENT_298	[p23l417t1702r675b1759],
7	and	CC	O	and	_	0	SENT_298	[p23l701t1702r806b1750],
8	P	NN	O	p	nn	9	SENT_298	[p23l829t1703r867b1749],
9	Winstanley	NN	PERSON	winstanley	conj_and	2	SENT_298	[p23l889t1702r1217b1761],
10	did	VBD	O	do	_	0	SENT_298	[p23l1239t1702r1331b1750],
11	statistical	JJ	O	statistical	amod	12	SENT_298	[p23l1355t1702r1625b1750],
12	analysis	NN	O	analysis	dobj	10	SENT_298	[p23l1650t1702r1889b1761],
13	.	.	O	.	_	0	SENT_298	[p23l1650t1702r1889b1761],

1	J	NNP	PERSON	J	nn	2	SENT_299	[p23l7t1778r33b1835],
2	Kublin	NNP	PERSON	Kublin	nsubj	12	SENT_299	[p23l54t1777r275b1834],
3	,	,	O	,	_	0	SENT_299	[p23l54t1777r275b1834],
4	M	NNP	O	M	nn	5	SENT_299	[p23l300t1778r364b1824],
5	Molyneux	NNP	PERSON	Molyneux	nsubj	12	SENT_299	[p23l386t1777r699b1836],
6	,	,	O	,	_	0	SENT_299	[p23l386t1777r699b1836],
7	and	CC	O	and	_	0	SENT_299	[p23l726t1777r831b1825],
8	T	NN	O	t	nn	9	SENT_299	[p23l853t1778r902b1824],
9	Taylor	NNP	PERSON	Taylor	conj_and	2	SENT_299	[p23l923t1777r1119b1836],
10	were	VBD	O	be	cop	12	SENT_299	[p23l1138t1793r1274b1825],
11	study	NN	O	study	nn	12	SENT_299	[p23l1298t1777r1455b1836],
12	co-ordinators	NNS	O	co-ordinator	_	0	SENT_299	[p23l1477t1777r1868b1825],
13	in	IN	O	in	_	0	SENT_299	[p23l1892t1777r1946b1824],
14	Blantyre	NNP	LOCATION	Blantyre	prep_in	12	SENT_299	[p23l11t1852r272b1911],
15	.	.	O	.	_	0	SENT_299	[p23l11t1852r272b1911],

1	K	NNP	O	K	nn	2	SENT_300	[p23l299t1852r352b1898],
2	Marsh	NNP	PERSON	Marsh	nsubj	8	SENT_300	[p23l372t1852r559b1899],
3	and	CC	O	and	_	0	SENT_300	[p23l583t1852r688b1899],
4	W	NNP	O	W	nn	5	SENT_300	[p23l709t1852r776b1899],
5	Watkins	NNP	PERSON	Watkins	conj_and	2	SENT_300	[p23l795t1852r1033b1899],
6	were	VBD	O	be	cop	8	SENT_300	[p23l1056t1867r1191b1899],
7	study	NN	O	study	nn	8	SENT_300	[p23l1215t1852r1372b1911],
8	co-ordinators	NNS	O	co-ordinator	_	0	SENT_300	[p23l1395t1852r1785b1899],
9	in	IN	O	in	_	0	SENT_300	[p23l1809t1852r1863b1898],
10	Kiliﬁ	NNP	LOCATION	Kiliﬁ	prep_in	8	SENT_300	[p23l1886t1851r2048b1899],
11	.	.	O	.	_	0	SENT_300	[p23l1886t1851r2048b1899],

1	P	NN	O	p	nn	2	SENT_301	[p23l11t1928r49b1974],
2	Winstanley	NN	PERSON	winstanley	nsubj	3	SENT_301	[p23l71t1927r399b1986],
3	wrote	VBD	O	write	_	0	SENT_301	[p23l419t1938r582b1975],
4	the	DT	O	the	det	5	SENT_301	[p23l605t1927r693b1975],
5	manuscript	NN	O	manuscript	dobj	3	SENT_301	[p23l717t1928r1061b1987],
6	.	.	O	.	_	0	SENT_301	[p23l717t1928r1061b1987],

1	C	NN	O	c	nn	2	SENT_302	[p23l1091t1928r1135b1975],
2	Plowe	NN	O	plowe	nsubj	16	SENT_302	[p23l1160t1927r1353b1984],
3	,	,	O	,	_	0	SENT_302	[p23l1160t1927r1353b1984],
4	M	NN	O	m	nn	5	SENT_302	[p23l1378t1928r1443b1974],
5	Molyneux	NNP	PERSON	Molyneux	nsubj	16	SENT_302	[p23l1464t1927r1778b1986],
6	,	,	O	,	_	0	SENT_302	[p23l1464t1927r1778b1986],
7	K	NNP	O	K	nn	8	SENT_302	[p23l1803t1928r1855b1974],
8	Marsh	NNP	PERSON	Marsh	nsubj	16	SENT_302	[p23l1875t1927r2080b1984],
9	,	,	O	,	_	0	SENT_302	[p23l1875t1927r2080b1984],
10	W	NNP	O	W	nn	11	SENT_302	[p23l9t2003r75b2050],
11	Watkins	NNP	PERSON	Watkins	conj_and	2	SENT_302	[p23l95t2002r352b2059],
12	,	,	O	,	_	0	SENT_302	[p23l95t2002r352b2059],
13	and	CC	O	and	_	0	SENT_302	[p23l378t2002r484b2049],
14	P	NN	O	p	nn	15	SENT_302	[p23l506t2003r545b2049],
15	Winstanley	NN	PERSON	winstanley	conj_and	2	SENT_302	[p23l566t2002r894b2061],
16	designed	VBN	O	design	_	0	SENT_302	[p23l917t2002r1171b2061],
17	the	DT	O	the	det	18	SENT_302	[p23l1194t2002r1283b2049],
18	protocol	NN	O	protocol	dobj	16	SENT_302	[p23l1305t2002r1565b2061],
19	.	.	O	.	_	0	SENT_302	[p23l1305t2002r1565b2061],

1	J	NNP	PERSON	J	nn	2	SENT_303	[p23l1588t2003r1615b2060],
2	Hatcher	NNP	PERSON	Hatcher	nsubj	22	SENT_303	[p23l1636t2002r1890b2059],
3	,	,	O	,	_	0	SENT_303	[p23l1636t2002r1890b2059],
4	J	NNP	PERSON	J	nn	5	SENT_303	[p23l7t2078r33b2135],
5	Kublin	NNP	PERSON	Kublin	conj_and	2	SENT_303	[p23l54t2077r275b2134],
6	,	,	O	,	_	0	SENT_303	[p23l54t2077r275b2134],
7	C	NNP	O	C	nn	8	SENT_303	[p23l302t2077r346b2124],
8	Plowe	NNP	O	Plowe	conj_and	2	SENT_303	[p23l372t2077r564b2134],
9	,	,	O	,	_	0	SENT_303	[p23l372t2077r564b2134],
10	M	NNP	O	M	nn	11	SENT_303	[p23l590t2078r655b2124],
11	Molyneux	NNP	PERSON	Molyneux	conj_and	2	SENT_303	[p23l676t2077r989b2136],
12	,	,	O	,	_	0	SENT_303	[p23l676t2077r989b2136],
13	K	NNP	O	K	nn	14	SENT_303	[p23l1015t2078r1067b2124],
14	Marsh	NNP	PERSON	Marsh	conj_and	2	SENT_303	[p23l1087t2077r1292b2134],
15	,	,	O	,	_	0	SENT_303	[p23l1087t2077r1292b2134],
16	T	NN	O	t	nn	17	SENT_303	[p23l1317t2078r1365b2124],
17	Taylor	NNP	PERSON	Taylor	conj_and	2	SENT_303	[p23l1387t2077r1598b2136],
18	,	,	O	,	_	0	SENT_303	[p23l1387t2077r1598b2136],
19	and	CC	O	and	_	0	SENT_303	[p23l1625t2077r1730b2124],
20	W	NNP	PERSON	W	nn	21	SENT_303	[p23l1751t2078r1818b2124],
21	Watkins	NNP	PERSON	Watkins	conj_and	2	SENT_303	[p23l1837t2077r2075b2124],
22	edited	VBD	O	edit	_	0	SENT_303	[p23l11t2152r190b2200],
23	the	DT	O	the	det	24	SENT_303	[p23l212t2152r301b2200],
24	manuscript	NN	O	manuscript	dobj	22	SENT_303	[p23l324t2153r668b2212],
25	.	.	O	.	_	0	SENT_303	[p23l324t2153r668b2212],

1	Conflict	NN	O	conflict	nsubjpass	8	SENT_304	[p23l13t2369r257b2422],
2	of	IN	O	of	_	0	SENT_304	[p23l283t2369r350b2422],
3	interest	NN	O	interest	nn	4	SENT_304	[p23l370t2370r620b2422],
4	statement	NN	O	statement	prep_of	1	SENT_304	[p23l642t2373r978b2422],
5	I	PRP	O	I	dep	4	SENT_304	[p23l7t2450r33b2507],
6	Hatcher	NNP	PERSON	Hatcher	dep	5	SENT_304	[p23l54t2450r292b2497],
7	was	VBD	O	be	auxpass	8	SENT_304	[p23l312t2465r416b2497],
8	paid	VBN	O	pay	_	0	SENT_304	[p23l440t2450r565b2509],
9	a	DT	O	a	det	10	SENT_304	[p23l589t2465r616b2497],
10	fee	NN	O	fee	iobj	8	SENT_304	[p23l639t2449r720b2497],
11	for	IN	O	for	_	0	SENT_304	[p23l743t2449r825b2497],
12	her	PRP$	O	she	poss	13	SENT_304	[p23l845t2450r939b2497],
13	help	NN	O	help	prep_for	10	SENT_304	[p23l960t2450r1082b2509],
14	in	IN	O	in	_	0	SENT_304	[p23l1106t2450r1161b2496],
15	preparation	NN	O	preparation	prep_in	13	SENT_304	[p23l1182t2450r1520b2509],
16	of	IN	O	of	_	0	SENT_304	[p23l1544t2449r1605b2497],
17	data	NNS	O	datum	prep_of	15	SENT_304	[p23l1621t2450r1743b2497],
18	for	IN	O	for	_	0	SENT_304	[p23l1765t2449r1847b2497],
19	the	DT	O	the	det	20	SENT_304	[p23l1868t2450r1957b2497],
20	dossier	NN	O	dossier	prep_for	17	SENT_304	[p23l11t2525r214b2573],
21	on	IN	O	on	_	0	SENT_304	[p23l236t2541r308b2573],
22	development	NN	O	development	prep_on	20	SENT_304	[p23l331t2525r706b2584],
23	of	IN	O	of	_	0	SENT_304	[p23l729t2525r790b2573],
24	Lapdap	NN	LOCATION	lapdap	nn	26	SENT_304	[p23l805t2525r1025b2584],
25	(	CD	NUMBER	(	num	26	SENT_304	[p23l1054t2525r1794b2584],
26	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	22	SENT_304	[p23l1054t2525r1794b2584],
27	)	CD	NUMBER	)	num	26	SENT_304	[p23l1054t2525r1794b2584],
28	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	32	SENT_304	[p23l11t2600r523b2648],
29	(	CD	NUMBER	(	num	32	SENT_304	[p23l551t2600r741b2658],
30	GSK	NNP	ORGANIZATION	GSK	nn	32	SENT_304	[p23l551t2600r741b2658],
31	)	NNP	O	)	nn	32	SENT_304	[p23l551t2600r741b2658],
32	Pharmaceuticals	NNP	O	Pharmaceuticals	dobj	8	SENT_304	[p23l768t2600r1265b2657],
33	,	,	O	,	_	0	SENT_304	[p23l768t2600r1265b2657],
34	which	WDT	O	which	nsubjpass	37	SENT_304	[p23l1289t2600r1463b2648],
35	will	MD	O	will	aux	37	SENT_304	[p23l1484t2600r1586b2648],
36	be	VB	O	be	auxpass	37	SENT_304	[p23l1608t2600r1675b2647],
37	submitted	VBN	O	submit	rcmod	32	SENT_304	[p23l1699t2600r1991b2647],
38	to	TO	O	to	_	0	SENT_304	[p23l2014t2611r2068b2647],
39	regulatory	JJ	O	regulatory	amod	40	SENT_304	[p23l10t2675r307b2734],
40	authorities	NNS	O	authority	prep_to	37	SENT_304	[p23l330t2675r654b2722],
41	.	.	O	.	_	0	SENT_304	[p23l330t2675r654b2722],

1	W	NNP	O	W	nn	2	SENT_305	[p23l679t2675r746b2722],
2	Watkins	NNP	PERSON	Watkins	nsubj	3	SENT_305	[p23l765t2675r1004b2722],
3	serves	VBZ	O	serve	dep	16	SENT_305	[p23l1028t2690r1198b2722],
4	on	IN	O	on	_	0	SENT_305	[p23l1224t2690r1294b2722],
5	the	DT	O	the	det	9	SENT_305	[p23l1317t2675r1405b2722],
6	GSK-WHO	NN	MISC	gsk-who	nn	9	SENT_305	[p23l1430t2675r1776b2722],
7	product	NN	O	product	nn	9	SENT_305	[p23l1800t2675r2030b2734],
8	development	NN	O	development	nn	9	SENT_305	[p23l11t2750r387b2809],
9	team	NN	O	team	prep_on	3	SENT_305	[p23l408t2761r551b2798],
10	for	IN	O	for	_	0	SENT_305	[p23l573t2750r655b2798],
11	Lapdapg	NN	O	lapdapg	prep_for	9	SENT_305	[p23l676t2750r915b2809],
12	this	DT	O	this	det	13	SENT_305	[p23l940t2750r1042b2798],
13	function	NN	O	function	nsubj	16	SENT_305	[p23l1066t2750r1310b2798],
14	does	VBZ	O	do	aux	16	SENT_305	[p23l1334t2750r1462b2798],
15	not	RB	O	not	neg	16	SENT_305	[p23l1485t2761r1581b2798],
16	receive	VB	O	receive	_	0	SENT_305	[p23l1603t2750r1804b2798],
17	any	DT	O	any	det	19	SENT_305	[p23l1828t2766r1928b2809],
18	consultancy	NN	O	consultancy	nn	19	SENT_305	[p23l11t2825r358b2884],
19	fees	NNS	O	fee	dobj	16	SENT_305	[p23l379t2825r487b2872],
20	or	CC	O	or	_	0	SENT_305	[p23l512t2841r571b2873],
21	honoraria	NN	O	honorarium	conj_or	19	SENT_305	[p23l591t2825r890b2872],
22	.	.	O	.	_	0	SENT_305	[p23l591t2825r890b2872],

1	His	PRP$	O	he	poss	3	SENT_306	[p23l917t2825r1014b2872],
2	research	NN	O	research	nn	3	SENT_306	[p23l1038t2825r1280b2873],
3	department	NN	O	department	nsubj	4	SENT_306	[p23l1303t2825r1639b2884],
4	receives	VBZ	O	receive	_	0	SENT_306	[p23l1661t2825r1888b2873],
5	grants	NNS	O	grant	dobj	4	SENT_306	[p23l1912t2836r2088b2884],
6	from	IN	O	from	_	0	SENT_306	[p23l10t2899r148b2947],
7	WHO	WP	O	who	prep_from	4	SENT_306	[p23l170t2900r344b2947],
8	and	CC	O	and	_	0	SENT_306	[p23l370t2900r475b2947],
9	GSK	NNP	ORGANIZATION	GSK	conj_and	4	SENT_306	[p23l499t2900r660b2947],
10	.	.	O	.	_	0	SENT_306	[p23l499t2900r660b2947],

1	P	NN	O	p	nn	2	SENT_307	[p23l687t2900r726b2946],
2	Winstanley	NN	PERSON	winstanley	nsubj	3	SENT_307	[p23l747t2900r1075b2959],
3	chairs	VBZ	O	chair	_	0	SENT_307	[p23l1097t2900r1265b2947],
4	the	DT	O	the	det	8	SENT_307	[p23l1289t2900r1378b2947],
5	GSK-WHO	NN	O	gsk-who	nn	8	SENT_307	[p23l1402t2900r1749b2947],
6	product	NN	O	product	nn	8	SENT_307	[p23l1772t2900r2003b2959],
7	development	NN	O	development	nn	8	SENT_307	[p23l11t2975r387b3035],
8	team	NN	O	team	dobj	3	SENT_307	[p23l408t2986r551b3023],
9	for	IN	O	for	_	0	SENT_307	[p23l573t2975r655b3023],
10	Lapdap	NN	LOCATION	lapdap	prep_for	8	SENT_307	[p23l676t2975r915b3035],
11	;	:	O	;	_	0	SENT_307	[p23l676t2975r915b3035],
12	this	DT	O	this	det	13	SENT_307	[p23l940t2975r1042b3023],
13	function	NN	O	function	nsubj	16	SENT_307	[p23l1066t2975r1310b3023],
14	does	VBZ	O	do	aux	16	SENT_307	[p23l1334t2975r1462b3023],
15	not	RB	O	not	neg	16	SENT_307	[p23l1485t2986r1581b3023],
16	receive	VB	O	receive	parataxis	3	SENT_307	[p23l1603t2976r1804b3023],
17	any	DT	O	any	det	19	SENT_307	[p23l1828t2991r1928b3034],
18	consultancy	NN	O	consultancy	nn	19	SENT_307	[p23l11t3050r358b3109],
19	fees	NNS	O	fee	dobj	16	SENT_307	[p23l379t3050r487b3097],
20	or	CC	O	or	_	0	SENT_307	[p23l512t3066r571b3097],
21	honoraria	NN	O	honorarium	conj_or	19	SENT_307	[p23l591t3050r890b3097],
22	.	.	O	.	_	0	SENT_307	[p23l591t3050r890b3097],

1	His	PRP$	O	he	poss	3	SENT_308	[p23l917t3050r1014b3097],
2	research	NN	O	research	nn	3	SENT_308	[p23l1038t3050r1280b3097],
3	department	NN	O	department	nsubj	4	SENT_308	[p23l1303t3050r1639b3109],
4	receives	VBZ	O	receive	_	0	SENT_308	[p23l1661t3050r1888b3098],
5	grants	NNS	O	grant	dobj	4	SENT_308	[p23l1912t3061r2088b3109],
6	from	IN	O	from	_	0	SENT_308	[p23l10t3123r148b3170],
7	WHO	WP	O	who	prep_from	4	SENT_308	[p23l170t3124r344b3170],
8	and	CC	O	and	_	0	SENT_308	[p23l370t3124r475b3170],
9	GSK	NNP	ORGANIZATION	GSK	conj_and	4	SENT_308	[p23l499t3124r660b3170],
10	.	.	O	.	_	0	SENT_308	[p23l499t3124r660b3170],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	3	SENT_309	[p24l7t92r603b158],
2	We	PRP	O	we	nsubj	3	SENT_309	[p24l9t173r105b219],
3	thank	VBP	O	thank	_	0	SENT_309	[p24l128t172r293b219],
4	C	NN	PERSON	c	nn	5	SENT_309	[p24l316t172r361b219],
5	Waruiru	NN	PERSON	waruiru	dobj	3	SENT_309	[p24l384t172r647b229],
6	,	,	O	,	_	0	SENT_309	[p24l384t172r647b229],
7	A	DT	O	a	det	8	SENT_309	[p24l670t173r718b219],
8	Sadik	NNP	PERSON	Sadik	conj_and	5	SENT_309	[p24l741t172r918b229],
9	,	,	O	,	_	0	SENT_309	[p24l741t172r918b229],
10	and	CC	O	and	_	0	SENT_309	[p24l945t172r1049b219],
11	P	NN	PERSON	p	nn	12	SENT_309	[p24l1073t173r1111b219],
12	Otieno	NN	PERSON	otieno	conj_and	5	SENT_309	[p24l1136t172r1333b219],
13	(	CD	NUMBER	(	num	15	SENT_309	[p24l1361t172r1574b230],
14	Kilifi	NNP	LOCATION	Kilifi	nn	15	SENT_309	[p24l1361t172r1574b230],
15	)	NN	O	)	dep	12	SENT_309	[p24l1361t172r1574b230],
16	,	,	O	,	_	0	SENT_309	[p24l1361t172r1574b230],
17	and	CC	O	and	_	0	SENT_309	[p24l1600t172r1705b219],
18	M	NN	O	m	conj_and	3	SENT_309	[p24l1728t173r1793b219],
19	Tembo	NN	PERSON	tembo	nn	25	SENT_309	[p24l1814t172r2025b219],
20	and	CC	O	and	_	0	SENT_309	[p24l12t247r162b304],
21	]	NN	O	]	nn	25	SENT_309	[p24l12t247r162b304],
22	Mwanechanya	NN	O	mwanechanya	nn	25	SENT_309	[p24l183t247r604b306],
23	(	CD	NUMBER	(	num	25	SENT_309	[p24l632t247r921b306],
24	Blantyre	NNP	LOCATION	Blantyre	nn	25	SENT_309	[p24l632t247r921b306],
25	)	NN	O	)	dobj	18	SENT_309	[p24l632t247r921b306],
26	for	IN	O	for	_	0	SENT_309	[p24l948t246r1030b294],
27	their	PRP$	O	they	poss	29	SENT_309	[p24l1051t247r1186b294],
28	clinical	JJ	O	clinical	amod	29	SENT_309	[p24l1208t247r1413b294],
29	help	NN	O	help	prep_for	18	SENT_309	[p24l1435t247r1575b306],
30	.	.	O	.	_	0	SENT_309	[p24l1435t247r1575b306],

1	Permission	NN	O	permission	nsubjpass	5	SENT_310	[p24l1602t247r1924b294],
2	to	TO	O	to	aux	3	SENT_310	[p24l1946t257r2001b294],
3	publish	VB	O	publish	infmod	1	SENT_310	[p24l9t322r224b381],
4	was	VBD	O	be	auxpass	5	SENT_310	[p24l245t338r350b370],
5	given	VBN	O	give	_	0	SENT_310	[p24l374t322r527b381],
6	by	IN	O	by	_	0	SENT_310	[p24l548t322r617b381],
7	the	DT	O	the	det	8	SENT_310	[p24l638t322r727b370],
8	director	NN	O	director	agent	5	SENT_310	[p24l751t322r980b370],
9	of	IN	O	of	_	0	SENT_310	[p24l1003t322r1064b370],
10	the	DT	O	the	det	14	SENT_310	[p24l1078t322r1167b370],
11	Kenya	NNP	ORGANIZATION	Kenya	nn	14	SENT_310	[p24l1191t323r1376b381],
12	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_310	[p24l1399t322r1635b370],
13	Research	NNP	ORGANIZATION	Research	nn	14	SENT_310	[p24l1659t322r1922b370],
14	Institute	NNP	ORGANIZATION	Institute	prep_of	8	SENT_310	[p24l10t397r272b444],
15	.	.	O	.	_	0	SENT_310	[p24l10t397r272b444],

1	The	DT	O	the	det	2	SENT_311	[p24l298t397r415b444],
2	study	NN	O	study	nsubj	3	SENT_311	[p24l440t397r597b456],
3	received	VBD	O	receive	_	0	SENT_311	[p24l618t397r857b444],
4	financial	JJ	O	financial	amod	5	SENT_311	[p24l879t397r1128b444],
5	support	NN	O	support	dobj	3	SENT_311	[p24l1152t408r1375b456],
6	from	IN	O	from	_	0	SENT_311	[p24l1397t397r1535b444],
7	the	DT	O	the	det	9	SENT_311	[p24l1557t397r1646b444],
8	UNDP/World	NNP	O	UNDP/World	nn	9	SENT_311	[p24l1669t397r2083b444],
9	Bank/WHO	NNP	O	Bank/WHO	prep_from	3	SENT_311	[p24l11t471r355b519],
10	Special	JJ	O	special	amod	11	SENT_311	[p24l382t472r587b531],
11	Programme	NNP	O	Programme	dep	3	SENT_311	[p24l611t472r951b531],
12	for	IN	O	for	_	0	SENT_311	[p24l974t471r1056b519],
13	Research	NNP	O	Research	prep_for	3	SENT_311	[p24l1078t472r1341b519],
14	and	CC	O	and	_	0	SENT_311	[p24l1364t472r1469b519],
15	Training	NNP	O	Training	prep_for	3	SENT_311	[p24l1491t472r1748b531],
16	in	IN	O	in	_	0	SENT_311	[p24l1769t472r1823b518],
17	Tropical	NNP	ORGANIZATION	Tropical	nn	18	SENT_311	[p24l1845t472r2095b531],
18	Medicine	NNP	ORGANIZATION	Medicine	prep_in	3	SENT_311	[p24l10t547r284b595],
19	(	CD	NUMBER	(	num	20	SENT_311	[p24l312t547r508b606],
20	TDR	NNP	ORGANIZATION	TDR	dep	18	SENT_311	[p24l312t547r508b606],
21	)	CD	NUMBER	)	num	20	SENT_311	[p24l312t547r508b606],
22	in	IN	O	in	_	0	SENT_311	[p24l535t547r589b594],
23	partnership	NN	O	partnership	prep_in	20	SENT_311	[p24l611t547r943b606],
24	with	IN	O	with	_	0	SENT_311	[p24l966t547r1093b595],
25	SmithKline	NNP	ORGANIZATION	SmithKline	nn	27	SENT_311	[p24l1117t547r1450b595],
26	Beecham	NNP	ORGANIZATION	Beecham	nn	27	SENT_311	[p24l1474t547r1741b595],
27	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_with	23	SENT_311	[p24l11t622r506b669],
28	.	.	O	.	_	0	SENT_311	[p24l11t622r506b669],

1	The	DT	O	the	det	3	SENT_312	[p24l532t622r650b669],
2	research	NN	O	research	nn	3	SENT_312	[p24l673t622r914b669],
3	facilities	NNS	O	facility	nsubjpass	11	SENT_312	[p24l936t622r1174b669],
4	(	RB	O	(	advmod	3	SENT_312	[p24l1202t622r1279b680],
5	in	IN	O	in	_	0	SENT_312	[p24l1202t622r1279b680],
6	Kenya	NNP	LOCATION	Kenya	prep_in	3	SENT_312	[p24l1301t623r1486b681],
7	and	CC	O	and	_	0	SENT_312	[p24l1511t622r1616b669],
8	Malawi	NNP	LOCATION	Malawi	prep_in	3	SENT_312	[p24l1638t622r1875b680],
9	)	CD	NUMBER	)	num	8	SENT_312	[p24l1638t622r1875b680],
10	were	VBD	O	be	auxpass	11	SENT_312	[p24l1902t637r2037b669],
11	funded	VBN	O	fund	_	0	SENT_312	[p24l9t697r215b745],
12	by	IN	O	by	_	0	SENT_312	[p24l236t697r306b756],
13	the	DT	O	the	det	15	SENT_312	[p24l327t697r416b745],
14	Wellcome	NNP	O	Wellcome	nn	15	SENT_312	[p24l438t697r731b745],
15	Trust	NNP	O	Trust	agent	11	SENT_312	[p24l754t698r933b745],
16	.	.	O	.	_	0	SENT_312	[p24l754t698r933b745],

1	K	NNP	O	K	nn	2	SENT_313	[p24l960t698r1013b744],
2	Marsh	NNP	PERSON	Marsh	nsubj	8	SENT_313	[p24l1033t697r1221b745],
3	is	VBZ	O	be	cop	8	SENT_313	[p24l1244t697r1285b745],
4	a	DT	O	a	det	8	SENT_313	[p24l1310t713r1338b745],
5	Wellcome	NNP	O	Wellcome	nn	8	SENT_313	[p24l1359t697r1652b745],
6	Trust	NNP	O	Trust	nn	8	SENT_313	[p24l1675t698r1839b745],
7	Senior	NNP	O	Senior	nn	8	SENT_313	[p24l1863t698r2051b745],
8	Fellow	NNP	O	Fellow	_	0	SENT_313	[p24l9t772r207b820],
9	in	IN	O	in	_	0	SENT_313	[p24l228t772r283b819],
10	Clinical	JJ	O	clinical	amod	11	SENT_313	[p24l308t772r533b820],
11	Science	NN	O	science	prep_in	8	SENT_313	[p24l558t772r794b820],
12	.	.	O	.	_	0	SENT_313	[p24l558t772r794b820],

1	M	NN	O	m	nn	3	SENT_314	[p24l821t773r886b819],
2	E	NN	O	e	nn	3	SENT_314	[p24l908t773r951b819],
3	Molyneux	NNP	PERSON	Molyneux	nsubj	4	SENT_314	[p24l973t772r1270b831],
4	holds	VBZ	O	hold	_	0	SENT_314	[p24l1291t772r1447b820],
5	a	DT	O	a	det	6	SENT_314	[p24l1472t788r1500b819],
6	Research	NNP	O	Research	nsubj	7	SENT_314	[p24l1524t772r1788b819],
7	Leave	VB	O	leave	ccomp	4	SENT_314	[p24l1810t773r1981b820],
8	Fellowship	NNP	O	Fellowship	dobj	7	SENT_314	[p24l9t847r326b906],
9	from	IN	O	from	_	0	SENT_314	[p24l350t846r489b894],
10	the	DT	O	the	det	12	SENT_314	[p24l512t847r601b894],
11	Wellcome	NNP	O	Wellcome	nn	12	SENT_314	[p24l622t847r916b894],
12	Trust	NNP	O	Trust	prep_from	7	SENT_314	[p24l938t847r1119b903],
13	,	,	O	,	_	0	SENT_314	[p24l938t847r1119b903],
14	and	CC	O	and	_	0	SENT_314	[p24l1146t847r1251b894],
15	W	NNP	O	W	nn	17	SENT_314	[p24l1272t847r1339b894],
16	M	NNP	O	M	nn	17	SENT_314	[p24l1360t847r1426b893],
17	Watkins	NNP	PERSON	Watkins	nsubj	23	SENT_314	[p24l1446t847r1685b894],
18	is	VBZ	O	be	cop	23	SENT_314	[p24l1709t847r1750b894],
19	a	DT	O	a	det	23	SENT_314	[p24l1775t862r1803b894],
20	Wellcome	NNP	O	Wellcome	nn	23	SENT_314	[p24l1825t847r2118b894],
21	Trust	NNP	O	Trust	nn	23	SENT_314	[p24l8t923r172b970],
22	Re-Entry	NNP	O	Re-Entry	nn	23	SENT_314	[p24l195t923r464b981],
23	Fellow	NNP	O	Fellow	conj_and	4	SENT_314	[p24l485t922r697b970],
24	.	.	O	.	_	0	SENT_314	[p24l485t922r697b970],

1	P	NN	O	p	nn	4	SENT_315	[p24l725t923r764b969],
2	A	NN	O	a	nn	4	SENT_315	[p24l785t923r833b969],
3	Winstanley	NN	O	winstanley	nn	4	SENT_315	[p24l853t922r1182b981],
4	thanks	NNS	O	thanks	_	0	SENT_315	[p24l1203t922r1393b970],
5	the	DT	O	the	det	7	SENT_315	[p24l1416t922r1506b970],
6	Wellcome	NNP	O	Wellcome	nn	7	SENT_315	[p24l1528t922r1821b970],
7	Trust	NNP	O	Trust	dep	4	SENT_315	[p24l1843t923r2007b970],
8	for	IN	O	for	_	0	SENT_315	[p24l2029t922r2111b970],
9	institutional	JJ	O	institutional	amod	10	SENT_315	[p24l9t997r362b1044],
10	support	NN	O	support	prep_for	7	SENT_315	[p24l387t1008r626b1056],
11	.	.	O	.	_	0	SENT_315	[p24l387t1008r626b1056],

1	References	NNS	O	reference	_	0	SENT_316	[p24l12t1264r373b1315],

1	1	CD	NUMBER	1	num	3	SENT_317	[p24l16t1371r36b1416],
2	Snow	NNP	O	Snow	nn	3	SENT_317	[p24l115t1369r276b1417],
3	RW	NNP	O	RW	_	0	SENT_317	[p24l298t1370r427b1426],
4	,	,	O	,	_	0	SENT_317	[p24l298t1370r427b1426],
5	Craig	NNP	PERSON	Craig	nn	6	SENT_317	[p24l455t1369r614b1428],
6	MH	NNP	PERSON	MH	appos	3	SENT_317	[p24l635t1370r775b1426],
7	,	,	O	,	_	0	SENT_317	[p24l635t1370r775b1426],
8	Deichmann	NNP	PERSON	Deichmann	nn	9	SENT_317	[p24l801t1369r1143b1417],
9	U	NNP	PERSON	U	appos	3	SENT_317	[p24l1165t1370r1236b1426],
10	,	,	O	,	_	0	SENT_317	[p24l1165t1370r1236b1426],
11	Marsh	NNP	PERSON	Marsh	nn	12	SENT_317	[p24l1261t1369r1450b1417],
12	K.	NNP	PERSON	K.	nsubj	13	SENT_317	[p24l1472t1370r1538b1417],
13	Estimating	VBG	PERSON	estimate	dep	3	SENT_317	[p24l1565t1369r1883b1428],
14	mortality	NN	O	mortality	dobj	13	SENT_317	[p24l113t1444r397b1503],
15	,	,	O	,	_	0	SENT_317	[p24l113t1444r397b1503],
16	morbidity	NN	O	morbidity	dobj	13	SENT_317	[p24l422t1444r711b1503],
17	and	CC	O	and	_	0	SENT_317	[p24l733t1444r839b1491],
18	disability	NN	O	disability	dobj	13	SENT_317	[p24l863t1444r1127b1503],
19	due	JJ	O	due	_	0	SENT_317	[p24l1150t1444r1254b1491],
20	to	TO	O	to	_	0	SENT_317	[p24l1278t1454r1333b1491],
21	malaria	NN	O	malaria	prep_due_to	13	SENT_317	[p24l1356t1444r1572b1491],
22	among	IN	O	among	_	0	SENT_317	[p24l1597t1459r1794b1503],
23	Africa	NNP	LOCATION	Africa	poss	26	SENT_317	[p24l111t1518r335b1566],
24	’s	POS	O	’s	_	0	SENT_317	[p24l111t1518r335b1566],
25	non-pregnant	JJ	O	non-pregnant	amod	26	SENT_317	[p24l358t1529r759b1578],
26	population	NN	O	population	prep_among	21	SENT_317	[p24l780t1519r1114b1578],
27	.	.	O	.	_	0	SENT_317	[p24l780t1519r1114b1578],

1	Bull	NNP	MISC	Bull	nn	4	SENT_318	[p24l1139t1519r1259b1566],
2	World	NNP	MISC	World	nn	4	SENT_318	[p24l1285t1519r1449b1566],
3	Health	NNP	MISC	Health	nn	4	SENT_318	[p24l1465t1519r1653b1566],
4	Organ	NNP	MISC	Organ	_	0	SENT_318	[p24l1679t1519r1851b1578],
5	1999	CD	DATE	1999	num	4	SENT_318	[p24l1880t1521r2037b1575],
6	;	:	O	;	_	0	SENT_318	[p24l1880t1521r2037b1575],
7	77	CD	NUMBER	77	num	9	SENT_318	[p24l116t1596r200b1640],
8	:	:	O	:	_	0	SENT_318	[p24l116t1596r200b1640],
9	624-40	CD	NUMBER	624-40	dep	4	SENT_318	[p24l229t1595r461b1640],
10	.	.	O	.	_	0	SENT_318	[p24l229t1595r461b1640],

1	2	CD	NUMBER	2	num	3	SENT_319	[p24l10t1679r41b1724],
2	Goodman	NNP	ORGANIZATION	Goodman	nn	3	SENT_319	[p24l114t1677r408b1725],
3	CA	NNP	ORGANIZATION	CA	_	0	SENT_319	[p24l433t1677r546b1734],
4	,	,	O	,	_	0	SENT_319	[p24l433t1677r546b1734],
5	Coleman	NNP	PERSON	Coleman	nn	6	SENT_319	[p24l573t1677r838b1725],
6	PG	NNP	O	PG	appos	3	SENT_319	[p24l860t1677r974b1734],
7	,	,	O	,	_	0	SENT_319	[p24l860t1677r974b1734],
8	Mills	NNP	O	Mills	nn	10	SENT_319	[p24l999t1677r1145b1725],
9	A	NNP	O	A	nn	10	SENT_319	[p24l1168t1678r1255b1735],
10	]	NN	O	]	appos	6	SENT_319	[p24l1168t1678r1255b1735],
11	.	.	O	.	_	0	SENT_319	[p24l1168t1678r1255b1735],

1	Cost	NN	O	cost	nn	3	SENT_320	[p24l1284t1677r1812b1725],
2	—	CD	NUMBER	—	num	3	SENT_320	[p24l1284t1677r1812b1725],
3	effectiveness	NN	O	effectiveness	_	0	SENT_320	[p24l1284t1677r1812b1725],
4	of	IN	O	of	_	0	SENT_320	[p24l1837t1677r1898b1725],
5	malaria	NN	O	malaria	nn	6	SENT_320	[p24l1913t1677r2129b1725],
6	control	NN	O	control	prep_of	3	SENT_320	[p24l114t1752r321b1799],
7	in	IN	O	in	_	0	SENT_320	[p24l344t1752r399b1799],
8	sub-Saharan	NNP	O	sub-Saharan	nn	9	SENT_320	[p24l422t1752r788b1799],
9	Africa	NNP	LOCATION	Africa	prep_in	3	SENT_320	[p24l809t1752r1002b1799],
10	.	.	O	.	_	0	SENT_320	[p24l809t1752r1002b1799],

1	Lancet	NNP	O	Lancet	_	0	SENT_321	[p24l1028t1753r1217b1799],
2	1999	CD	DATE	1999	num	1	SENT_321	[p24l1244t1754r1379b1799],
3	354	CD	NUMBER	354	num	5	SENT_321	[p24l1406t1753r1528b1800],
4	:	:	O	:	_	0	SENT_321	[p24l1406t1753r1528b1800],
5	378-84	CD	NUMBER	378-84	dep	1	SENT_321	[p24l1556t1754r1788b1799],
6	.	.	O	.	_	0	SENT_321	[p24l1556t1754r1788b1799],

1	3	CD	NUMBER	3	_	0	SENT_322	[p24l10t1839r40b1884],
2	Winstanley	NNP	PERSON	Winstanley	nn	3	SENT_322	[p24l111t1837r441b1896],
3	PA.	NNP	O	PA.	dep	1	SENT_322	[p24l462t1838r566b1884],
4	.	.	O	.	_	0	SENT_322	[p24l462t1838r566b1884],

1	Chemotherapy	NN	O	chemotherapy	_	0	SENT_323	[p24l596t1837r1031b1896],
2	for	IN	O	for	_	0	SENT_323	[p24l1052t1837r1134b1884],
3	falciparum	NN	O	falciparum	nn	4	SENT_323	[p24l1155t1837r1469b1896],
4	malaria	NN	O	malaria	prep_for	1	SENT_323	[p24l1491t1837r1723b1884],
5	:	:	O	:	_	0	SENT_323	[p24l1491t1837r1723b1884],
6	the	DT	O	the	det	7	SENT_323	[p24l1750t1837r1839b1884],
7	armoury	NN	O	armoury	dep	1	SENT_323	[p24l114t1927r378b1971],
8	,	,	O	,	_	0	SENT_323	[p24l114t1927r378b1971],
9	the	DT	O	the	det	10	SENT_323	[p24l403t1912r492b1959],
10	problems	NNS	O	problem	conj_and	7	SENT_323	[p24l514t1912r785b1971],
11	and	CC	O	and	_	0	SENT_323	[p24l810t1912r916b1959],
12	the	DT	O	the	det	13	SENT_323	[p24l938t1912r1027b1959],
13	prospects	NNS	O	prospects	dep	1	SENT_323	[p24l1050t1922r1343b1971],
14	.	.	O	.	_	0	SENT_323	[p24l1050t1922r1343b1971],

1	Parasitology	NNP	O	Parasitology	nn	2	SENT_324	[p24l1369t1912r1707b1971],
2	Today	NNP	DATE	Today	_	0	SENT_324	[p24l1734t1912r1904b1971],
3	2000	CD	DATE	2000	num	2	SENT_324	[p24l1927t1914r2089b1968],
4	;	:	O	;	_	0	SENT_324	[p24l1927t1914r2089b1968],
5	16	CD	NUMBER	16	num	7	SENT_324	[p24l118t1988r200b2033],
6	:	:	O	:	_	0	SENT_324	[p24l118t1988r200b2033],
7	146-53	CD	NUMBER	146-53	dep	2	SENT_324	[p24l234t1988r461b2033],
8	.	.	O	.	_	0	SENT_324	[p24l234t1988r461b2033],

1	4	CD	NUMBER	4	num	2	SENT_325	[p24l10t2072r41b2117],
2	Trape	NN	O	trape	_	0	SENT_325	[p24l112t2071r288b2129],
3	JF	NN	O	jf	dep	2	SENT_325	[p24l308t2071r393b2128],
4	.	.	O	.	_	0	SENT_325	[p24l308t2071r393b2128],

1	The	DT	O	the	det	4	SENT_326	[p24l419t2070r537b2118],
2	public	JJ	O	public	amod	4	SENT_326	[p24l559t2070r741b2129],
3	health	NN	O	health	nn	4	SENT_326	[p24l764t2070r944b2118],
4	impact	NN	O	impact	_	0	SENT_326	[p24l966t2070r1166b2129],
5	of	IN	O	of	dep	4	SENT_326	[p24l1189t2070r1251b2118],
6	chloroquine	NN	O	chloroquine	nn	7	SENT_326	[p24l1267t2070r1616b2129],
7	resistance	NN	O	resistance	pobj	5	SENT_326	[p24l1639t2070r1924b2118],
8	in	IN	O	in	dep	4	SENT_326	[p24l1948t2070r2002b2117],

1	Africa	NNP	LOCATION	Africa	_	0	SENT_327	[p24l111t2145r305b2192],
2	.	.	O	.	_	0	SENT_327	[p24l111t2145r305b2192],

1	Am	VBP	O	be	cop	2	SENT_328	[p24l327t2145r429b2192],
2	3	CD	NUMBER	3	_	0	SENT_328	[p24l445t2145r487b2204],
3	'	''	O	'	_	0	SENT_328	[p24l445t2145r487b2204],
4	Trop	NNP	O	Trop	prep	2	SENT_328	[p24l510t2146r634b2204],
5	Med	NNP	O	Med	dep	4	SENT_328	[p24l653t2145r783b2192],
6	Hyg	NNP	O	Hyg	dep	2	SENT_328	[p24l799t2146r920b2204],
7	2001	CD	DATE	2001	dep	6	SENT_328	[p24l940t2147r1102b2202],
8	;	:	O	;	_	0	SENT_328	[p24l940t2147r1102b2202],
9	64	CD	NUMBER	64	number	10	SENT_328	[p24l1128t2147r1195b2192],
10	(	CD	NUMBER	(	num	11	SENT_328	[p24l1222t2145r1401b2204],
11	suppl	NN	O	suppl	dep	7	SENT_328	[p24l1222t2145r1401b2204],
12	1-2	CD	NUMBER	1-2	num	13	SENT_328	[p24l1431t2145r1576b2203],
13	)	CD	NUMBER	)	dep	11	SENT_328	[p24l1431t2145r1576b2203],
14	:	:	O	:	_	0	SENT_328	[p24l1431t2145r1576b2203],
15	12-17	CD	DATE	12-17	dep	7	SENT_328	[p24l1610t2147r1799b2192],
16	.	.	O	.	_	0	SENT_328	[p24l1610t2147r1799b2192],

1	5	CD	NUMBER	5	num	4	SENT_329	[p24l11t2231r39b2276],
2	Watkins	NNP	ORGANIZATION	Watkins	nn	4	SENT_329	[p24l111t2229r350b2276],
3	W	NNP	ORGANIZATION	W	nn	4	SENT_329	[p24l373t2230r440b2276],
4	M	NN	ORGANIZATION	m	nsubj	22	SENT_329	[p24l461t2230r543b2286],
5	,	,	O	,	_	0	SENT_329	[p24l461t2230r543b2286],
6	Mosobo	NNP	O	Mosobo	nn	8	SENT_329	[p24l568t2229r806b2276],
7	M.	NNP	O	M.	nn	8	SENT_329	[p24l831t2230r911b2276],
8	Treatment	NN	O	treatment	appos	4	SENT_329	[p24l937t2230r1251b2276],
9	of	IN	O	of	_	0	SENT_329	[p24l1275t2229r1336b2276],
10	Plasmodium	NN	LOCATION	plasmodium	nn	12	SENT_329	[p24l1350t2229r1687b2276],
11	falciparum	NN	O	falciparum	nn	12	SENT_329	[p24l1700t2229r2003b2288],
12	malaria	NN	O	malaria	prep_of	8	SENT_329	[p24l113t2304r328b2351],
13	with	IN	O	with	_	0	SENT_329	[p24l351t2304r478b2351],
14	pyrimethamine-sulfadoxine	NN	O	pyrimethamine-sulfadoxine	prep_with	12	SENT_329	[p24l499t2303r1323b2363],
15	:	:	O	:	_	0	SENT_329	[p24l499t2303r1323b2363],
16	selective	JJ	O	selective	amod	17	SENT_329	[p24l1351t2304r1594b2351],
17	pressure	NN	O	pressure	dep	8	SENT_329	[p24l1616t2319r1859b2363],
18	for	IN	O	for	_	0	SENT_329	[p24l1883t2303r1965b2351],
19	resistance	NN	O	resistance	prep_for	17	SENT_329	[p24l113t2379r398b2427],
20	is	VBZ	O	be	cop	22	SENT_329	[p24l421t2379r463b2427],
21	a	DT	O	a	det	22	SENT_329	[p24l488t2395r516b2427],
22	function	NN	O	function	_	0	SENT_329	[p24l538t2379r784b2427],
23	of	IN	O	of	_	0	SENT_329	[p24l808t2379r869b2427],
24	long	JJ	O	long	amod	26	SENT_329	[p24l884t2379r1010b2438],
25	elimination	NN	O	elimination	nn	26	SENT_329	[p24l1033t2379r1364b2427],
26	half-life	NN	O	half-life	prep_of	22	SENT_329	[p24l1386t2379r1627b2427],
27	.	.	O	.	_	0	SENT_329	[p24l1386t2379r1627b2427],

1	Trans	NNP	O	Trans	nn	6	SENT_330	[p24l1660t2380r1814b2427],
2	R	NNP	O	R	nn	6	SENT_330	[p24l1835t2380r1881b2426],
3	Soc	NNP	O	Soc	nn	6	SENT_330	[p24l1902t2379r1998b2427],
4	Trop	NNP	O	Trop	nn	6	SENT_330	[p24l2025t2380r2149b2438],
5	Med	NNP	O	Med	nn	6	SENT_330	[p24l110t2454r241b2501],
6	Hyg	NNP	O	Hyg	_	0	SENT_330	[p24l257t2455r377b2513],
7	1993	CD	DATE	1993	num	6	SENT_330	[p24l403t2456r560b2511],
8	;	:	O	;	_	0	SENT_330	[p24l403t2456r560b2511],
9	87	CD	NUMBER	87	num	11	SENT_330	[p24l587t2456r672b2501],
10	:	:	O	:	_	0	SENT_330	[p24l587t2456r672b2501],
11	75-78	CD	DATE	75-78	dep	6	SENT_330	[p24l700t2456r895b2501],
12	.	.	O	.	_	0	SENT_330	[p24l700t2456r895b2501],

1	6	CD	NUMBER	6	num	3	SENT_331	[p24l11t2540r41b2585],
2	Watkins	NNP	ORGANIZATION	Watkins	nn	3	SENT_331	[p24l111t2538r350b2585],
3	WM	NNP	ORGANIZATION	WM	_	0	SENT_331	[p24l373t2539r524b2595],
4	,	,	O	,	_	0	SENT_331	[p24l373t2539r524b2595],
5	Mberu	NNP	O	Mberu	nn	6	SENT_331	[p24l548t2538r748b2585],
6	EK	NNP	O	EK	appos	3	SENT_331	[p24l771t2539r884b2595],
7	,	,	O	,	_	0	SENT_331	[p24l771t2539r884b2595],
8	Winstanley	NNP	ORGANIZATION	Winstanley	nn	9	SENT_331	[p24l908t2538r1237b2597],
9	PA	NN	ORGANIZATION	pa	appos	3	SENT_331	[p24l1259t2539r1364b2595],
10	,	,	O	,	_	0	SENT_331	[p24l1259t2539r1364b2595],
11	Plowe	NNP	O	Plowe	nn	14	SENT_331	[p24l1390t2538r1565b2585],
12	C.	NNP	O	C.	nn	14	SENT_331	[p24l1591t2538r1654b2585],
13	The	NNP	O	The	nn	14	SENT_331	[p24l1680t2538r1798b2585],
14	efﬁcacy	NN	O	efﬁcacy	appos	3	SENT_331	[p24l1823t2538r2042b2597],
15	of	IN	O	of	_	0	SENT_331	[p24l2064t2538r2126b2585],
16	antifolate	JJ	O	antifolate	amod	17	SENT_331	[p24l114t2612r387b2660],
17	combinations	NNS	O	combination	prep_of	14	SENT_331	[p24l411t2613r805b2660],
18	in	IN	O	in	_	0	SENT_331	[p24l829t2613r884b2659],
19	Africa	NNP	LOCATION	Africa	prep_in	3	SENT_331	[p24l905t2612r1098b2660],
20	:	:	O	:	_	0	SENT_331	[p24l905t2612r1098b2660],
21	a	DT	O	a	det	23	SENT_331	[p24l1126t2628r1154b2660],
22	predictive	JJ	O	predictive	amod	23	SENT_331	[p24l1176t2613r1464b2672],
23	model	NN	O	model	dep	3	SENT_331	[p24l1488t2613r1669b2660],
24	based	VBN	O	base	partmod	23	SENT_331	[p24l1690t2613r1857b2660],
25	on	IN	O	on	_	0	SENT_331	[p24l1881t2628r1952b2660],
26	pharmacodynamic	JJ	O	pharmacodynamic	amod	29	SENT_331	[p24l112t2688r655b2747],
27	and	CC	O	and	_	0	SENT_331	[p24l680t2688r785b2736],
28	pharmacokinetic	JJ	O	pharmacokinetic	amod	29	SENT_331	[p24l807t2688r1295b2747],
29	analyses	NNS	O	analysis	prep_on	24	SENT_331	[p24l1320t2688r1573b2747],
30	.	.	O	.	_	0	SENT_331	[p24l1320t2688r1573b2747],

1	Parasitol	NNP	O	Parasitol	nn	2	SENT_332	[p24l1599t2688r1847b2736],
2	Today	NNP	DATE	Today	_	0	SENT_332	[p24l1871t2688r2040b2747],
3	1997	CD	DATE	1997	num	2	SENT_332	[p24l120t2764r277b2818],
4	;	:	O	;	_	0	SENT_332	[p24l120t2764r277b2818],
5	13	CD	NUMBER	13	num	7	SENT_332	[p24l307t2764r390b2809],
6	:	:	O	:	_	0	SENT_332	[p24l307t2764r390b2809],
7	459-64	CD	NUMBER	459-64	dep	2	SENT_332	[p24l417t2764r650b2809],
8	.	.	O	.	_	0	SENT_332	[p24l417t2764r650b2809],

1	7	CD	NUMBER	7	num	3	SENT_333	[p24l11t2848r40b2893],
2	Nzila	NN	O	nzilum	nn	3	SENT_333	[p24l112t2846r266b2893],
3	A	NN	O	a	_	0	SENT_333	[p24l287t2847r352b2903],
4	,	,	O	,	_	0	SENT_333	[p24l287t2847r352b2903],
5	NduatiE	NN	O	nduatie	appos	3	SENT_333	[p24l376t2846r656b2903],
6	,	,	O	,	_	0	SENT_333	[p24l376t2846r656b2903],
7	Mberu	NNP	O	Mberu	nn	8	SENT_333	[p24l681t2846r880b2893],
8	E	NNP	O	E	appos	3	SENT_333	[p24l893t2847r953b2903],
9	,	,	O	,	_	0	SENT_333	[p24l893t2847r953b2903],
10	et	FW	O	et	nn	11	SENT_333	[p24l979t2857r1031b2893],
11	al.	FW	O	al.	appos	3	SENT_333	[p24l1054t2846r1116b2893],
12	.	.	O	.	_	0	SENT_333	[p24l1054t2846r1116b2893],

1	Molecular	JJ	O	molecular	amod	2	SENT_334	[p24l1143t2846r1445b2893],
2	evidence	NN	O	evidence	nsubj	10	SENT_334	[p24l1467t2846r1719b2894],
3	of	IN	O	of	_	0	SENT_334	[p24l1743t2846r1805b2893],
4	greater	JJR	O	greater	amod	6	SENT_334	[p24l1820t2857r2023b2905],
5	selective	JJ	O	selective	amod	6	SENT_334	[p24l114t2921r357b2968],
6	pressure	NN	O	pressure	prep_of	2	SENT_334	[p24l379t2936r623b2980],
7	for	IN	O	for	_	0	SENT_334	[p24l646t2920r728b2968],
8	drug	NN	O	drug	nn	9	SENT_334	[p24l750t2921r885b2980],
9	resistance	NN	O	resistance	prep_for	6	SENT_334	[p24l906t2921r1191b2968],
10	exerted	VBN	O	exert	_	0	SENT_334	[p24l1216t2921r1429b2968],
11	by	IN	O	by	_	0	SENT_334	[p24l1450t2921r1520b2980],
12	the	DT	O	the	det	16	SENT_334	[p24l1541t2921r1630b2968],
13	long	JJ	O	long	amod	16	SENT_334	[p24l1654t2921r1780b2980],
14	acting	VBG	O	act	amod	16	SENT_334	[p24l1802t2921r1978b2980],
15	antifolate	JJ	O	antifolate	amod	16	SENT_334	[p24l114t2996r387b3044],
16	pyrimethamine/sulfadoxine	NN	O	pyrimethamine/sulfadoxine	prep_by	10	SENT_334	[p24l409t2996r1210b3055],
17	compared	VBN	O	compare	_	0	SENT_334	[p24l1235t2996r1524b3055],
18	with	IN	O	with	prepc_compared_with	16	SENT_334	[p24l1546t2996r1673b3044],
19	the	DT	O	the	det	20	SENT_334	[p24l1695t2996r1784b3044],
20	shorter	JJR	O	shorter	pobj	16	SENT_334	[p24l1809t2996r2014b3044],
21	acting	VBG	O	act	partmod	20	SENT_334	[p24l114t3071r290b3130],
22	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	dobj	21	SENT_334	[p24l313t3071r1010b3130],
23	on	IN	O	on	_	0	SENT_334	[p24l1035t3087r1106b3118],
24	Kenyan	JJ	MISC	kenyan	amod	26	SENT_334	[p24l1129t3072r1354b3130],
25	Plasmodium	NN	O	plasmodium	nn	26	SENT_334	[p24l1376t3071r1713b3118],
26	falciparum	NN	O	falciparum	prep_on	21	SENT_334	[p24l1726t3071r2045b3130],
27	.	.	O	.	_	0	SENT_334	[p24l1726t3071r2045b3130],

1	3	CD	NUMBER	3	nsubj	3	SENT_335	[p24l125t3146r167b3205],
2	‘	RB	O	‘	advmod	3	SENT_335	[p24l125t3146r167b3205],
3	Infect	VB	O	infect	_	0	SENT_335	[p24l183t3146r338b3205],
4	Dis	NNP	O	Dis	dobj	3	SENT_335	[p24l357t3146r449b3193],
5	2000	CD	DATE	2000	num	4	SENT_335	[p24l472t3148r635b3202],
6	;	:	O	;	_	0	SENT_335	[p24l472t3148r635b3202],
7	181	CD	NUMBER	181	num	9	SENT_335	[p24l665t3148r782b3193],
8	:	:	O	:	_	0	SENT_335	[p24l665t3148r782b3193],
9	2023-28	CD	NUMBER	2023-28	dep	4	SENT_335	[p24l810t3148r1078b3193],
10	.	.	O	.	_	0	SENT_335	[p24l810t3148r1078b3193],

1	8	CD	NUMBER	8	num	3	SENT_336	[p24l11t3232r41b3277],
2	Snewin	NNP	ORGANIZATION	Snewin	nn	3	SENT_336	[p24l115t3230r328b3277],
3	VA	NNP	ORGANIZATION	VA	_	0	SENT_336	[p24l349t3230r461b3286],
4	,	,	O	,	_	0	SENT_336	[p24l349t3230r461b3286],
5	England	NNP	LOCATION	England	nn	6	SENT_336	[p24l486t3230r730b3289],
6	SM	NNP	O	SM	appos	3	SENT_336	[p24l755t3230r875b3286],
7	,	,	O	,	_	0	SENT_336	[p24l755t3230r875b3286],
8	Sims	NNP	PERSON	Sims	nn	9	SENT_336	[p24l903t3230r1040b3277],
9	PF	NNP	O	PF	appos	3	SENT_336	[p24l1065t3230r1166b3286],
10	,	,	O	,	_	0	SENT_336	[p24l1065t3230r1166b3286],
11	Hyde	NNP	PERSON	Hyde	nn	12	SENT_336	[p24l1192t3230r1348b3289],
12	IE	NN	O	ie	appos	3	SENT_336	[p24l1367t3230r1454b3287],
13	.	.	O	.	_	0	SENT_336	[p24l1367t3230r1454b3287],

1	Characterisation	NN	O	characterisation	_	0	SENT_337	[p24l1483t3230r1968b3277],
2	of	IN	O	of	_	0	SENT_337	[p24l1992t3229r2053b3277],
3	the	DT	O	the	det	9	SENT_337	[p24l112t3305r202b3353],
4	dihydrofolate	JJ	O	dihydrofolate	amod	9	SENT_337	[p24l226t3305r616b3364],
5	reductase	NN	O	reductase	nn	9	SENT_337	[p24l639t3305r1291b3364],
6	—	NN	O	—	nn	9	SENT_337	[p24l639t3305r1291b3364],
7	thymidylate	NN	O	thymidylate	nn	9	SENT_337	[p24l639t3305r1291b3364],
8	synthetase	NN	O	synthetase	nn	9	SENT_337	[p24l1315t3305r1616b3364],
9	gene	NN	O	gene	prep_of	1	SENT_337	[p24l1640t3321r1772b3364],
10	from	IN	O	from	_	0	SENT_337	[p24l1795t3305r1934b3353],
11	human	JJ	O	human	amod	13	SENT_337	[p24l112t3380r317b3427],
12	malaria	NN	O	malaria	nn	13	SENT_337	[p24l338t3380r554b3427],
13	parasites	NNS	O	parasite	prep_from	9	SENT_337	[p24l577t3380r830b3439],
14	highly	RB	O	highly	advmod	15	SENT_337	[p24l853t3380r1032b3439],
15	resistant	JJ	O	resistant	amod	1	SENT_337	[p24l1053t3380r1299b3427],
16	to	TO	O	to	_	0	SENT_337	[p24l1321t3391r1376b3427],
17	pyrimethamine	NN	O	pyrimethamine	prep_to	15	SENT_337	[p24l1399t3380r1859b3439],
18	.	.	O	.	_	0	SENT_337	[p24l1399t3380r1859b3439],

1	Gene	NN	O	gene	_	0	SENT_338	[p24l1891t3380r2026b3427],
2	1989	CD	DATE	1989	num	1	SENT_338	[p24l120t3455r277b3509],
3	;	:	O	;	_	0	SENT_338	[p24l120t3455r277b3509],
4	76	CD	NUMBER	76	num	6	SENT_338	[p24l304t3456r390b3500],
5	:	:	O	:	_	0	SENT_338	[p24l304t3456r390b3500],
6	41-52	CD	NUMBER	41-52	dep	1	SENT_338	[p24l417t3455r612b3500],
7	.	.	O	.	_	0	SENT_338	[p24l417t3455r612b3500],

1	9	CD	NUMBER	9	num	13	SENT_339	[p25l11t23r40b68],
2	Foote	NNP	PERSON	Foote	nn	13	SENT_339	[p25l113t21r282b68],
3	S	NNP	PERSON	S	nn	13	SENT_339	[p25l307t21r340b68],
4	J	NNP	PERSON	J	nn	13	SENT_339	[p25l361t21r403b79],
5	,	,	O	,	_	0	SENT_339	[p25l361t21r403b79],
6	Galatis	NNP	PERSON	Galatis	appos	13	SENT_339	[p25l430t21r633b68],
7	D	NNP	PERSON	D	nn	13	SENT_339	[p25l657t21r728b77],
8	,	,	O	,	_	0	SENT_339	[p25l657t21r728b77],
9	Cowman	NNP	O	Cowman	appos	13	SENT_339	[p25l756t21r1018b68],
10	A	NNP	O	A	nn	13	SENT_339	[p25l1039t21r1087b67],
11	F.	NNP	O	F.	nn	13	SENT_339	[p25l1109t21r1166b68],
12	Amino	NN	O	amino	nn	13	SENT_339	[p25l1191t21r1388b68],
13	acids	NNS	O	acid	nsubj	27	SENT_339	[p25l1414t21r1557b68],
14	in	IN	O	in	_	0	SENT_339	[p25l1581t21r1636b67],
15	the	DT	O	the	det	19	SENT_339	[p25l1658t21r1747b68],
16	dihydrofolate	JJ	O	dihydrofolate	amod	19	SENT_339	[p25l114t96r503b155],
17	reductase-thymidylate	NN	O	reductase-thymidylate	nn	19	SENT_339	[p25l526t96r1178b155],
18	synthase	NN	O	synthase	nn	19	SENT_339	[p25l1202t96r1448b155],
19	gene	NN	O	gene	prep_in	13	SENT_339	[p25l1472t112r1604b155],
20	of	IN	O	of	_	0	SENT_339	[p25l1629t96r1690b144],
21	Plasmodium	NN	LOCATION	plasmodium	nn	22	SENT_339	[p25l1704t96r2042b144],
22	falciparum	NN	O	falciparum	prep_of	19	SENT_339	[p25l103t171r406b230],
23	involved	VBN	O	involve	partmod	22	SENT_339	[p25l429t171r675b219],
24	in	IN	O	in	_	0	SENT_339	[p25l698t171r753b218],
25	cycloguanil	NN	O	cycloguanil	nn	26	SENT_339	[p25l776t171r1105b230],
26	resistance	NN	O	resistance	prep_in	23	SENT_339	[p25l1128t171r1413b219],
27	differ	VBP	O	differ	_	0	SENT_339	[p25l1438t171r1594b219],
28	from	IN	O	from	_	0	SENT_339	[p25l1614t171r1753b218],
29	those	DT	O	those	prep_from	27	SENT_339	[p25l1776t171r1929b219],
30	involved	VBN	O	involve	partmod	29	SENT_339	[p25l113t246r359b293],
31	in	IN	O	in	_	0	SENT_339	[p25l382t246r436b292],
32	pyrimethamine	NN	O	pyrimethamine	nn	33	SENT_339	[p25l458t246r901b305],
33	resistance	NN	O	resistance	prep_in	30	SENT_339	[p25l925t246r1226b293],
34	.	.	O	.	_	0	SENT_339	[p25l925t246r1226b293],

1	Proc	NNP	ORGANIZATION	Proc	nn	4	SENT_340	[p25l1252t246r1373b293],
2	Natl	NNP	ORGANIZATION	Natl	nn	4	SENT_340	[p25l1393t246r1523b293],
3	Acad	NNP	ORGANIZATION	Acad	nn	4	SENT_340	[p25l1536t246r1687b293],
4	Sci	NNP	ORGANIZATION	Sci	_	0	SENT_340	[p25l1706t246r1791b293],
5	USA	NNP	ORGANIZATION	USA	dep	4	SENT_340	[p25l1817t246r1946b293],
6	1990	CD	DATE	1990	num	5	SENT_340	[p25l1978t247r2136b302],
7	,	,	O	,	_	0	SENT_340	[p25l1978t247r2136b302],
8	87	CD	NUMBER	87	num	5	SENT_340	[p25l114t322r200b367],
9	:	:	O	:	_	0	SENT_340	[p25l114t322r200b367],
10	30	CD	NUMBER	30	dep	4	SENT_340	[p25l228t322r296b367],
11	14-1	CD	NUMBER	14-1	num	12	SENT_340	[p25l309t322r437b366],
12	7	CD	NUMBER	7	dep	10	SENT_340	[p25l450t322r479b366],
13	.	.	O	.	_	0	SENT_340	[p25l489t358r498b367],

1	10	CD	NUMBER	10	num	3	SENT_341	[p25l16t406r79b452],
2	Plowe	NNP	ORGANIZATION	Plowe	nn	3	SENT_341	[p25l113t404r289b452],
3	CV	NNP	ORGANIZATION	CV	_	0	SENT_341	[p25l314t404r427b461],
4	,	,	O	,	_	0	SENT_341	[p25l314t404r427b461],
5	Cortese	NNP	ORGANIZATION	Cortese	appos	3	SENT_341	[p25l454t404r677b452],
6	IF	IN	ORGANIZATION	if	amod	5	SENT_341	[p25l697t405r783b462],
7	,	,	O	,	_	0	SENT_341	[p25l697t405r783b462],
8	Djimde	NNP	O	Djimde	nn	9	SENT_341	[p25l809t404r1027b463],
9	A	NNP	O	A	appos	3	SENT_341	[p25l1049t405r1113b461],
10	,	,	O	,	_	0	SENT_341	[p25l1049t405r1113b461],
11	et	FW	O	et	nn	12	SENT_341	[p25l1139t415r1191b452],
12	al.	FW	O	al.	appos	3	SENT_341	[p25l1214t404r1277b452],
13	.	.	O	.	_	0	SENT_341	[p25l1214t404r1277b452],

1	Mutations	NNS	O	mutation	_	0	SENT_342	[p25l1303t404r1606b452],
2	in	IN	O	in	_	0	SENT_342	[p25l1630t404r1684b451],
3	Plasmodium	NN	LOCATION	plasmodium	nn	6	SENT_342	[p25l1706t404r2043b452],
4	falciparum	NN	O	falciparum	nn	6	SENT_342	[p25l103t479r406b538],
5	dihydrofolate	JJ	O	dihydrofolate	amod	6	SENT_342	[p25l430t479r820b538],
6	reductase	NN	O	reductase	prep_in	1	SENT_342	[p25l843t479r1120b527],
7	and	CC	O	and	_	0	SENT_342	[p25l1145t479r1251b527],
8	dihydropteroate	NN	O	dihydropteroate	nn	9	SENT_342	[p25l1275t479r1742b538],
9	synthase	NN	O	synthase	conj_and	6	SENT_342	[p25l1767t479r2013b538],
10	and	CC	O	and	_	0	SENT_342	[p25l2038t479r2143b527],
11	epidemiologic	JJ	O	epidemiologic	amod	12	SENT_342	[p25l114t554r523b613],
12	patterns	NNS	O	pattern	conj_and	6	SENT_342	[p25l545t564r782b613],
13	of	IN	O	of	_	0	SENT_342	[p25l807t553r868b601],
14	pyrimethamine-sulfadoxine	NN	O	pyrimethamine-sulfadoxine	nn	15	SENT_342	[p25l882t553r1689b613],
15	use	NN	O	use	prep_of	1	SENT_342	[p25l1712t569r1807b601],
16	and	CC	O	and	_	0	SENT_342	[p25l1832t554r1937b601],
17	resistance	NN	O	resistance	conj_and	15	SENT_342	[p25l113t629r415b677],
18	.	.	O	.	_	0	SENT_342	[p25l113t629r415b677],

1	jlnfect	NN	O	jlnfect	_	0	SENT_343	[p25l435t629r648b688],
2	Dis	NNP	O	Dis	dep	1	SENT_343	[p25l666t629r758b677],
3	1997	CD	DATE	1997	num	2	SENT_343	[p25l788t631r944b686],
4	,	,	O	,	_	0	SENT_343	[p25l788t631r944b686],
5	176	CD	NUMBER	176	num	2	SENT_343	[p25l974t631r1092b677],
6	:	:	O	:	_	0	SENT_343	[p25l974t631r1092b677],
7	1590-96	CD	NUMBER	1590-96	dep	1	SENT_343	[p25l1126t631r1390b677],
8	.	.	O	.	_	0	SENT_343	[p25l1126t631r1390b677],

1	11	CD	NUMBER	11	_	0	SENT_344	[p25l16t715r73b760],
2	Nzila	NN	O	nzilum	dep	1	SENT_344	[p25l112t713r545b761],
3	.	.	O	.	_	0	SENT_344	[p25l112t713r545b761],

1	—	NN	O	—	_	0	SENT_345	[p25l112t713r545b761],
2	.	.	O	.	_	0	SENT_345	[p25l112t713r545b761],

1	Mounda	NNP	MISC	Mounda	nn	2	SENT_346	[p25l112t713r545b761],
2	A	NNP	MISC	A	_	0	SENT_346	[p25l566t714r631b770],
3	,	,	O	,	_	0	SENT_346	[p25l566t714r631b770],
4	Mberu	NNP	O	Mberu	nn	5	SENT_346	[p25l656t713r855b761],
5	EK	NNP	O	EK	appos	2	SENT_346	[p25l877t714r992b770],
6	,	,	O	,	_	0	SENT_346	[p25l877t714r992b770],
7	Sibley	NNP	ORGANIZATION	Sibley	nn	8	SENT_346	[p25l1019t713r1195b772],
8	CH	NN	ORGANIZATION	ch	appos	2	SENT_346	[p25l1219t713r1341b770],
9	,	,	O	,	_	0	SENT_346	[p25l1219t713r1341b770],
10	Plowe	NNP	O	Plowe	nn	11	SENT_346	[p25l1366t713r1542b761],
11	CV	NNP	O	CV	appos	2	SENT_346	[p25l1567t713r1680b770],
12	,	,	O	,	_	0	SENT_346	[p25l1567t713r1680b770],
13	Winstanley	NNP	PERSON	Winstanley	appos	2	SENT_346	[p25l1703t713r2033b772],

1	PA	NN	O	pa	_	0	SENT_347	[p25l113t789r219b845],
2	,	,	O	,	_	0	SENT_347	[p25l113t789r219b845],
3	Watkins	NNP	PERSON	Watkins	nn	4	SENT_347	[p25l242t788r482b836],
4	WM.	NNP	O	WM.	appos	1	SENT_347	[p25l504t789r653b836],
5	Kenyan	JJ	MISC	kenyan	amod	9	SENT_347	[p25l680t789r906b847],
6	Plasmodium	NN	O	plasmodium	nn	9	SENT_347	[p25l927t788r1264b835],
7	falciparum	NN	O	falciparum	nn	9	SENT_347	[p25l1277t788r1580b847],
8	ﬁeld	NN	O	ﬁeld	nn	9	SENT_347	[p25l1603t788r1730b836],
9	isolates	NNS	O	isolate	dep	4	SENT_347	[p25l1752t788r1981b835],
10	:	:	O	:	_	0	SENT_347	[p25l1752t788r1981b835],
11	correlation	NN	O	correlation	dep	1	SENT_347	[p25l114t863r431b910],
12	between	IN	O	between	_	0	SENT_347	[p25l452t863r695b910],
13	pyrimethamine	NN	O	pyrimethamine	nn	16	SENT_347	[p25l717t863r1160b922],
14	and	CC	O	and	_	0	SENT_347	[p25l1185t863r1291b910],
15	chlorcycloguanil	NN	O	chlorcycloguanil	nn	16	SENT_347	[p25l1314t863r1795b922],
16	activity	NN	O	activity	prep_between	11	SENT_347	[p25l1819t863r2030b922],
17	in	FW	O	in	nn	18	SENT_347	[p25l2052t863r2102b910],
18	vitro	FW	O	vitro	dep	16	SENT_347	[p25l114t939r239b986],
19	and	CC	O	and	_	0	SENT_347	[p25l262t938r368b986],
20	point	NN	O	point	nn	21	SENT_347	[p25l389t939r543b998],
21	mutations	NNS	O	mutation	conj_and	18	SENT_347	[p25l565t938r857b986],
22	in	IN	O	in	_	0	SENT_347	[p25l882t938r936b985],
23	the	DT	O	the	det	26	SENT_347	[p25l958t938r1048b986],
24	dihydrofolate	JJ	O	dihydrofolate	amod	26	SENT_347	[p25l1072t938r1461b997],
25	reductase	NN	O	reductase	nn	26	SENT_347	[p25l1484t938r1763b986],
26	gene	NN	O	gene	prep_in	21	SENT_347	[p25l1786t954r1935b998],
27	.	.	O	.	_	0	SENT_347	[p25l1786t954r1935b998],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_348	[p25l108t1013r417b1060],
2	Agents	NNPS	O	Agents	nn	3	SENT_348	[p25l435t1013r622b1072],
3	Chemother	NNP	O	Chemother	_	0	SENT_348	[p25l646t1013r942b1060],
4	1998	CD	DATE	1998	dep	3	SENT_348	[p25l968t1015r1125b1070],
5	;	:	O	;	_	0	SENT_348	[p25l968t1015r1125b1070],
6	42	CD	NUMBER	42	num	8	SENT_348	[p25l1151t1015r1236b1061],
7	:	:	O	:	_	0	SENT_348	[p25l1151t1015r1236b1061],
8	164-69	CD	NUMBER	164-69	dep	3	SENT_348	[p25l1270t1015r1497b1061],
9	.	.	O	.	_	0	SENT_348	[p25l1270t1015r1497b1061],

1	12	CD	NUMBER	12	num	3	SENT_349	[p25l16t1099r79b1144],
2	Brooks	NNP	ORGANIZATION	Brooks	nn	3	SENT_349	[p25l113t1097r316b1144],
3	DR	NN	ORGANIZATION	dr	_	0	SENT_349	[p25l340t1098r460b1154],
4	,	,	O	,	_	0	SENT_349	[p25l340t1098r460b1154],
5	Wang	NNP	PERSON	Wang	nn	6	SENT_349	[p25l483t1098r655b1156],
6	P	NN	O	p	appos	3	SENT_349	[p25l677t1098r734b1154],
7	,	,	O	,	_	0	SENT_349	[p25l677t1098r734b1154],
8	Read	NNP	O	Read	nn	9	SENT_349	[p25l759t1097r907b1145],
9	M	NNP	O	M	appos	6	SENT_349	[p25l930t1098r1012b1154],
10	,	,	O	,	_	0	SENT_349	[p25l930t1098r1012b1154],
11	Watkins	NNP	ORGANIZATION	Watkins	nn	12	SENT_349	[p25l1036t1097r1275b1145],
12	WM	NNP	ORGANIZATION	WM	appos	6	SENT_349	[p25l1297t1098r1448b1154],
13	,	,	O	,	_	0	SENT_349	[p25l1297t1098r1448b1154],
14	Sims	NNP	PERSON	Sims	nn	15	SENT_349	[p25l1475t1097r1613b1145],
15	PF	NNP	O	PF	appos	6	SENT_349	[p25l1637t1098r1739b1154],
16	,	,	O	,	_	0	SENT_349	[p25l1637t1098r1739b1154],
17	Hyde	NNP	PERSON	Hyde	nn	18	SENT_349	[p25l1764t1097r1920b1156],
18	JE	NNP	O	JE	appos	6	SENT_349	[p25l1940t1098r2026b1155],
19	.	.	O	.	_	0	SENT_349	[p25l1940t1098r2026b1155],

1	Sequence	NN	O	sequence	nn	2	SENT_350	[p25l115t1172r393b1231],
2	Variation	NN	O	variation	_	0	SENT_350	[p25l414t1172r673b1219],
3	of	IN	O	of	_	0	SENT_350	[p25l697t1171r758b1219],
4	the	DT	O	the	det	9	SENT_350	[p25l773t1172r862b1219],
5	hydroxymethyldihydropterin	NN	O	hydroxymethyldihydropterin	nn	9	SENT_350	[p25l884t1172r1729b1231],
6	pyrophosphokinase	NN	O	pyrophosphokinase	nn	9	SENT_350	[p25l112t1247r679b1307],
7	dihydropteroate	NN	O	dihydropteroate	nn	9	SENT_350	[p25l703t1247r1171b1307],
8	synthetase	NN	O	synthetase	nn	9	SENT_350	[p25l1195t1247r1496b1307],
9	gene	NN	O	gene	prep_of	2	SENT_350	[p25l1520t1263r1652b1307],
10	in	IN	O	in	_	0	SENT_350	[p25l1676t1248r1730b1294],
11	lines	NNS	O	line	prep_in	9	SENT_350	[p25l1753t1247r1883b1295],
12	of	IN	O	of	_	0	SENT_350	[p25l1909t1247r1970b1295],
13	the	DT	O	the	det	18	SENT_350	[p25l1985t1247r2074b1295],
14	human	JJ	O	human	amod	18	SENT_350	[p25l112t1322r317b1369],
15	malaria	NN	O	malaria	nn	18	SENT_350	[p25l338t1322r554b1369],
16	parasite	NN	O	parasite	nn	18	SENT_350	[p25l577t1322r803b1381],
17	Plasmodium	NN	O	plasmodium	nn	18	SENT_350	[p25l826t1322r1163b1369],
18	falciparum	NN	O	falciparum	prep_of	11	SENT_350	[p25l1176t1322r1497b1381],
19	,	,	O	,	_	0	SENT_350	[p25l1176t1322r1497b1381],
20	with	IN	O	with	_	0	SENT_350	[p25l1521t1322r1648b1370],
21	differing	VBG	O	differ	amod	22	SENT_350	[p25l1672t1322r1918b1381],
22	resistance	NN	O	resistance	prep_with	9	SENT_350	[p25l113t1397r398b1444],
23	to	TO	O	to	_	0	SENT_350	[p25l421t1407r476b1444],
24	sulfadoxine	NN	O	sulfadoxine	prep_to	22	SENT_350	[p25l502t1396r851b1444],
25	.	.	O	.	_	0	SENT_350	[p25l502t1396r851b1444],

1	Eur	NNP	O	Eur	nn	3	SENT_351	[p25l877t1397r1036b1456],
2	}	NNP	O	}	nn	3	SENT_351	[p25l877t1397r1036b1456],
3	Biochem	NNP	ORGANIZATION	Biochem	_	0	SENT_351	[p25l1052t1397r1304b1453],
4	,	,	O	,	_	0	SENT_351	[p25l1052t1397r1304b1453],
5	1994	CD	DATE	1994	appos	3	SENT_351	[p25l1336t1399r1493b1453],
6	;	:	O	;	_	0	SENT_351	[p25l1336t1399r1493b1453],
7	224	CD	NUMBER	224	num	9	SENT_351	[p25l1519t1399r1641b1444],
8	:	:	O	:	_	0	SENT_351	[p25l1519t1399r1641b1444],
9	397-405	CD	NUMBER	397-405	dep	3	SENT_351	[p25l1669t1398r1939b1444],
10	.	.	O	.	_	0	SENT_351	[p25l1669t1398r1939b1444],

1	13	CD	NUMBER	13	num	3	SENT_352	[p25l16t1483r78b1528],
2	Hastings	NNP	ORGANIZATION	Hastings	nn	3	SENT_352	[p25l113t1481r367b1540],
3	MD	NNP	ORGANIZATION	MD	_	0	SENT_352	[p25l391t1481r530b1537],
4	,	,	O	,	_	0	SENT_352	[p25l391t1481r530b1537],
5	Bates	NNP	PERSON	Bates	nn	7	SENT_352	[p25l556t1481r712b1528],
6	S	NNP	O	S	nn	7	SENT_352	[p25l738t1481r815b1539],
7	]	NN	O	]	appos	3	SENT_352	[p25l738t1481r815b1539],
8	,	,	O	,	_	0	SENT_352	[p25l738t1481r815b1539],
9	Blackstone	VBP	ORGANIZATION	blackstone	dep	10	SENT_352	[p25l840t1481r1158b1528],
10	EA	NN	ORGANIZATION	ea	appos	7	SENT_352	[p25l1181t1481r1290b1537],
11	,	,	O	,	_	0	SENT_352	[p25l1181t1481r1290b1537],
12	Monks	NNPS	O	Monks	nn	13	SENT_352	[p25l1315t1481r1515b1528],
13	SM	NNP	O	SM	appos	10	SENT_352	[p25l1542t1481r1662b1537],
14	,	,	O	,	_	0	SENT_352	[p25l1542t1481r1662b1537],

1	Mutabingwa	NNP	PERSON	Mutabingwa	nn	2	SENT_353	[p25l113t1556r483b1616],
2	TK	NN	O	tk	_	0	SENT_353	[p25l505t1557r626b1613],
3	,	,	O	,	_	0	SENT_353	[p25l505t1557r626b1613],
4	Sibley	NNP	PERSON	Sibley	nn	5	SENT_353	[p25l653t1556r829b1615],
5	CH	NN	O	ch	appos	2	SENT_353	[p25l853t1556r973b1604],
6	.	.	O	.	_	0	SENT_353	[p25l853t1556r973b1604],

1	Highly	RB	O	highly	_	0	SENT_354	[p25l1000t1556r1198b1616],
2	pyrimethamine	NN	O	pyrimethamine	npadvmod	4	SENT_354	[p25l1218t1556r1936b1616],
3	—	CD	NUMBER	—	num	2	SENT_354	[p25l1218t1556r1936b1616],
4	resistant	JJ	O	resistant	amod	5	SENT_354	[p25l1218t1556r1936b1616],
5	alleles	NNS	O	allele	pobj	1	SENT_354	[p25l1960t1556r2134b1604],
6	of	IN	O	of	_	0	SENT_354	[p25l114t1631r175b1678],
7	dihydrofolate	JJ	O	dihydrofolate	amod	8	SENT_354	[p25l192t1631r580b1690],
8	reductase	NN	O	reductase	prep_of	5	SENT_354	[p25l604t1631r882b1679],
9	in	IN	O	in	_	0	SENT_354	[p25l906t1631r960b1678],
10	isolates	NNS	O	isolate	prep_in	1	SENT_354	[p25l983t1631r1194b1679],
11	of	IN	O	of	_	0	SENT_354	[p25l1219t1631r1280b1678],
12	Plasmodium	NN	LOCATION	plasmodium	nn	13	SENT_354	[p25l1295t1631r1631b1678],
13	falciparum	NN	O	falciparum	prep_of	10	SENT_354	[p25l1644t1631r1948b1690],
14	from	IN	O	from	_	0	SENT_354	[p25l1970t1631r2110b1678],
15	Tanzania	NNP	LOCATION	Tanzania	prep_from	1	SENT_354	[p25l112t1706r401b1753],
16	.	.	O	.	_	0	SENT_354	[p25l112t1706r401b1753],

1	Trans	NNP	O	Trans	nn	4	SENT_355	[p25l434t1706r588b1753],
2	R	NNP	O	R	nn	4	SENT_355	[p25l609t1706r655b1752],
3	Soc	NNP	O	Soc	nn	4	SENT_355	[p25l677t1706r772b1753],
4	Trop	NNP	O	Trop	nsubj	5	SENT_355	[p25l800t1706r923b1765],
5	Med	VBD	O	med	_	0	SENT_355	[p25l942t1706r1073b1753],
6	Hyg	NN	O	hyg	nn	7	SENT_355	[p25l1089t1706r1209b1765],
7	(	NN	O	(	dobj	5	SENT_355	[p25l1233t1706r1309b1764],
8	in	IN	O	in	_	0	SENT_355	[p25l1233t1706r1309b1764],
9	press	NN	O	press	nn	10	SENT_355	[p25l1330t1706r1520b1765],
10	)	NN	O	)	prep_in	5	SENT_355	[p25l1330t1706r1520b1765],
11	.	.	O	.	_	0	SENT_355	[p25l1330t1706r1520b1765],

1	14	CD	NUMBER	14	num	3	SENT_356	[p25l16t1791r79b1836],
2	Winstanley	NNP	ORGANIZATION	Winstanley	nn	3	SENT_356	[p25l111t1790r441b1849],
3	PA	NN	ORGANIZATION	pa	_	0	SENT_356	[p25l463t1790r568b1846],
4	,	,	O	,	_	0	SENT_356	[p25l463t1790r568b1846],
5	Watkins	NNP	ORGANIZATION	Watkins	nn	6	SENT_356	[p25l591t1790r831b1837],
6	WM	NNP	ORGANIZATION	WM	appos	3	SENT_356	[p25l853t1790r1004b1846],
7	,	,	O	,	_	0	SENT_356	[p25l853t1790r1004b1846],
8	Muhia	NNP	ORGANIZATION	Muhia	nn	9	SENT_356	[p25l1029t1790r1221b1837],
9	D	NNP	ORGANIZATION	D	appos	3	SENT_356	[p25l1245t1790r1316b1846],
10	,	,	O	,	_	0	SENT_356	[p25l1245t1790r1316b1846],
11	Szwandt	NNP	O	Szwandt	nn	12	SENT_356	[p25l1343t1790r1590b1837],
12	S	NNP	O	S	appos	3	SENT_356	[p25l1615t1790r1667b1846],
13	,	,	O	,	_	0	SENT_356	[p25l1615t1790r1667b1846],
14	Amukoye	NNP	O	Amukoye	nn	15	SENT_356	[p25l1691t1790r1970b1849],
15	E	NNP	O	E	appos	3	SENT_356	[p25l1993t1790r2053b1846],
16	,	,	O	,	_	0	SENT_356	[p25l1993t1790r2053b1846],
17	Marsh	NNP	PERSON	Marsh	nn	21	SENT_356	[p25l113t1865r301b1913],
18	K.	NNP	PERSON	K.	nn	21	SENT_356	[p25l324t1866r390b1913],
19	Chlorproguanil	NNP	PERSON	Chlorproguanil	nn	21	SENT_356	[p25l420t1865r1137b1925],
20	—	NN	O	—	nn	21	SENT_356	[p25l420t1865r1137b1925],
21	dapsone	NN	O	dapsone	appos	3	SENT_356	[p25l420t1865r1137b1925],
22	for	IN	O	for	_	0	SENT_356	[p25l1160t1865r1242b1913],
23	uncomplicated	JJ	O	uncomplicated	amod	25	SENT_356	[p25l1263t1865r1699b1925],
24	falciparum	NN	O	falciparum	nn	25	SENT_356	[p25l1721t1865r2035b1925],
25	malaria	NN	O	malaria	prep_for	21	SENT_356	[p25l113t1940r329b1987],
26	in	IN	O	in	_	0	SENT_356	[p25l352t1940r406b1987],
27	young	JJ	O	young	amod	28	SENT_356	[p25l427t1956r608b1999],
28	children	NNS	O	child	prep_in	3	SENT_356	[p25l630t1940r885b1988],
29	:	:	O	:	_	0	SENT_356	[p25l630t1940r885b1988],
30	pharmacokinetics	NNS	O	pharmacokinetic	dep	3	SENT_356	[p25l911t1940r1426b1999],
31	and	CC	O	and	_	0	SENT_356	[p25l1452t1940r1557b1988],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_356	[p25l1580t1940r1909b1999],
33	range	NN	O	range	dep	3	SENT_356	[p25l1933t1956r2109b1999],
34	.	.	O	.	_	0	SENT_356	[p25l1933t1956r2109b1999],

1	Trans	NNP	O	Trans	nn	6	SENT_357	[p25l119t2015r273b2062],
2	R	NNP	O	R	nn	6	SENT_357	[p25l294t2015r340b2061],
3	Soc	NNP	O	Soc	nn	6	SENT_357	[p25l362t2015r457b2062],
4	Trop	NNP	O	Trop	nn	6	SENT_357	[p25l485t2015r609b2074],
5	Med	NNP	O	Med	nn	6	SENT_357	[p25l628t2015r757b2062],
6	Hyg	NNP	O	Hyg	_	0	SENT_357	[p25l774t2015r895b2074],
7	1997	CD	DATE	1997	num	6	SENT_357	[p25l920t2016r1077b2071],
8	;	:	O	;	_	0	SENT_357	[p25l920t2016r1077b2071],
9	91	CD	NUMBER	91	num	11	SENT_357	[p25l1103t2017r1190b2062],
10	:	:	O	:	_	0	SENT_357	[p25l1103t2017r1190b2062],
11	322-27	CD	NUMBER	322-27	dep	6	SENT_357	[p25l1218t2016r1450b2062],
12	.	.	O	.	_	0	SENT_357	[p25l1218t2016r1450b2062],

1	15	CD	NUMBER	15	num	3	SENT_358	[p25l16t2100r77b2146],
2	Amukoye	NN	O	amukoye	nn	3	SENT_358	[p25l111t2099r391b2158],
3	E	NN	O	e	_	0	SENT_358	[p25l414t2099r474b2155],
4	,	,	O	,	_	0	SENT_358	[p25l414t2099r474b2155],
5	Winstanley	NNP	ORGANIZATION	Winstanley	nn	6	SENT_358	[p25l497t2099r827b2158],
6	PA	NN	ORGANIZATION	pa	appos	3	SENT_358	[p25l849t2099r954b2155],
7	,	,	O	,	_	0	SENT_358	[p25l849t2099r954b2155],
8	Watkins	NNP	ORGANIZATION	Watkins	nn	9	SENT_358	[p25l977t2099r1217b2146],
9	WM	NNP	ORGANIZATION	WM	appos	3	SENT_358	[p25l1239t2099r1390b2155],
10	,	,	O	,	_	0	SENT_358	[p25l1239t2099r1390b2155],
11	et	FW	O	et	nn	12	SENT_358	[p25l1416t2109r1467b2146],
12	al.	FW	O	al.	appos	3	SENT_358	[p25l1490t2099r1553b2146],
13	.	.	O	.	_	0	SENT_358	[p25l1490t2099r1553b2146],

1	Chlorproguanildapsone	NNP	O	Chlorproguanildapsone	_	0	SENT_359	[p25l1582t2099r2056b2158, p25l114t2174r370b2234],
2	:	:	O	:	_	0	SENT_359	[p25l1582t2099r2056b2158, p25l114t2174r370b2234],

1	an	DT	O	a	det	3	SENT_360	[p25l398t2190r465b2222],
2	effective	JJ	O	effective	amod	3	SENT_360	[p25l489t2174r729b2222],
3	treatment	NN	O	treatment	_	0	SENT_360	[p25l751t2185r1037b2222],
4	for	IN	O	for	_	0	SENT_360	[p25l1059t2174r1141b2222],
5	uncomplicated	JJ	O	uncomplicated	amod	7	SENT_360	[p25l1162t2174r1598b2234],
6	falciparum	NN	O	falciparum	nn	7	SENT_360	[p25l1620t2174r1934b2234],
7	malaria	NN	O	malaria	prep_for	3	SENT_360	[p25l113t2249r345b2296],
8	.	.	O	.	_	0	SENT_360	[p25l113t2249r345b2296],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_361	[p25l367t2249r676b2296],
2	Agents	NNPS	O	Agents	nn	3	SENT_361	[p25l693t2249r881b2308],
3	Chemother	NNP	O	Chemother	_	0	SENT_361	[p25l904t2249r1201b2296],
4	1997	CD	DATE	1997	dep	3	SENT_361	[p25l1227t2251r1384b2306],
5	;	:	O	;	_	0	SENT_361	[p25l1227t2251r1384b2306],
6	41	CD	NUMBER	41	num	8	SENT_361	[p25l1409t2251r1496b2297],
7	:	:	O	:	_	0	SENT_361	[p25l1409t2251r1496b2297],
8	2261-64	CD	NUMBER	2261-64	dep	3	SENT_361	[p25l1524t2251r1793b2297],
9	.	.	O	.	_	0	SENT_361	[p25l1524t2251r1793b2297],

1	16	CD	NUMBER	16	num	3	SENT_362	[p25l16t2335r79b2381],
2	Winstanley	NNP	ORGANIZATION	Winstanley	nn	3	SENT_362	[p25l111t2333r441b2392],
3	PA	NN	ORGANIZATION	pa	_	0	SENT_362	[p25l463t2334r568b2390],
4	,	,	O	,	_	0	SENT_362	[p25l463t2334r568b2390],
5	Mberu	NNP	O	Mberu	nn	6	SENT_362	[p25l593t2333r792b2380],
6	EK	NNP	O	EK	appos	3	SENT_362	[p25l815t2334r929b2390],
7	,	,	O	,	_	0	SENT_362	[p25l815t2334r929b2390],
8	Szwandt	NNP	ORGANIZATION	Szwandt	nn	9	SENT_362	[p25l956t2333r1203b2381],
9	ISF	NNP	ORGANIZATION	ISF	appos	3	SENT_362	[p25l1226t2333r1350b2390],
10	,	,	O	,	_	0	SENT_362	[p25l1226t2333r1350b2390],
11	Breckenridge	NNP	ORGANIZATION	Breckenridge	nn	12	SENT_362	[p25l1376t2333r1762b2392],
12	AM	NNP	ORGANIZATION	AM	appos	9	SENT_362	[p25l1784t2334r1916b2390],
13	,	,	O	,	_	0	SENT_362	[p25l1784t2334r1916b2390],

1	Watkins	NNP	PERSON	Watkins	nn	3	SENT_363	[p25l111t2408r350b2455],
2	WM.	NNP	O	WM.	nn	3	SENT_363	[p25l373t2408r522b2455],
3	The	NNP	O	The	nsubj	4	SENT_363	[p25l548t2408r666b2455],
4	in-vitro	FW	O	in-vitro	_	0	SENT_363	[p25l690t2408r895b2455],
5	activity	NN	O	activity	dobj	4	SENT_363	[p25l918t2408r1128b2467],
6	of	IN	O	of	_	0	SENT_363	[p25l1151t2407r1212b2455],
7	novel	JJ	O	novel	amod	10	SENT_363	[p25l1227t2408r1383b2455],
8	antifolate	JJ	O	antifolate	amod	10	SENT_363	[p25l1407t2407r1680b2455],
9	drug	NN	O	drug	nn	10	SENT_363	[p25l1704t2408r1838b2467],
10	combinations	NNS	O	combination	prep_of	5	SENT_363	[p25l114t2483r508b2531],
11	against	IN	O	against	_	0	SENT_363	[p25l533t2484r737b2543],
12	Plasmodium	NN	O	plasmodium	nn	13	SENT_363	[p25l757t2484r1094b2531],
13	falciparum	NN	O	falciparum	prep_against	4	SENT_363	[p25l1107t2484r1410b2543],
14	and	CC	O	and	_	0	SENT_363	[p25l1435t2483r1540b2531],
15	human	JJ	O	human	amod	19	SENT_363	[p25l1562t2483r1766b2531],
16	granulocyte	NN	O	granulocyte	nn	19	SENT_363	[p25l113t2558r454b2617],
17	colony	NN	O	colony	nn	19	SENT_363	[p25l479t2558r1117b2617],
18	—	NN	O	—	nn	19	SENT_363	[p25l479t2558r1117b2617],
19	forming-units	NNS	O	forming-unit	conj_and	13	SENT_363	[p25l479t2558r1117b2617],
20	.	.	O	.	_	0	SENT_363	[p25l479t2558r1117b2617],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_364	[p25l1138t2558r1447b2605],
2	Agents	NNPS	O	Agents	nn	3	SENT_364	[p25l1465t2558r1653b2617],
3	Chemother	NNP	O	Chemother	_	0	SENT_364	[p25l1676t2558r1973b2605],
4	1995	CD	DATE	1995	dep	3	SENT_364	[p25l120t2633r277b2687],
5	;	:	O	;	_	0	SENT_364	[p25l120t2633r277b2687],
6	39	CD	NUMBER	39	num	8	SENT_364	[p25l303t2634r390b2678],
7	:	:	O	:	_	0	SENT_364	[p25l303t2634r390b2678],
8	948-52	CD	NUMBER	948-52	dep	3	SENT_364	[p25l418t2633r650b2678],
9	.	.	O	.	_	0	SENT_364	[p25l418t2633r650b2678],

1	17	CD	NUMBER	17	num	3	SENT_365	[p25l16t2718r78b2762],
2	Mutabingwa	NN	ORGANIZATION	mutabingwa	nn	3	SENT_365	[p25l113t2716r483b2775],
3	T	NN	ORGANIZATION	t	_	0	SENT_365	[p25l505t2716r571b2772],
4	,	,	O	,	_	0	SENT_365	[p25l505t2716r571b2772],
5	Nzila	NNP	LOCATION	Nzila	nn	6	SENT_365	[p25l596t2716r750b2763],
6	A	NNP	O	A	appos	3	SENT_365	[p25l771t2716r836b2772],
7	,	,	O	,	_	0	SENT_365	[p25l771t2716r836b2772],
8	Mberu	NNP	O	Mberu	nn	9	SENT_365	[p25l860t2716r1060b2763],
9	E	NNP	O	E	appos	3	SENT_365	[p25l1083t2716r1143b2772],
10	,	,	O	,	_	0	SENT_365	[p25l1083t2716r1143b2772],
11	et	FW	O	et	nn	12	SENT_365	[p25l1169t2726r1220b2763],
12	al.	FW	O	al.	appos	3	SENT_365	[p25l1243t2716r1306b2763],
13	.	.	O	.	_	0	SENT_365	[p25l1243t2716r1306b2763],

1	Chlorproguanil	NNP	O	Chlorproguanil	nn	3	SENT_366	[p25l1336t2716r2052b2775],
2	—	NN	O	—	nn	3	SENT_366	[p25l1336t2716r2052b2775],
3	dapsone	NN	O	dapsone	_	0	SENT_366	[p25l1336t2716r2052b2775],
4	for	IN	O	for	_	0	SENT_366	[p25l113t2791r195b2839],
5	treatment	NN	O	treatment	prep_for	3	SENT_366	[p25l216t2802r502b2839],
6	of	IN	O	of	_	0	SENT_366	[p25l525t2791r586b2839],
7	drug	NN	O	drug	npadvmod	9	SENT_366	[p25l602t2791r1009b2851],
8	—	CD	NUMBER	—	num	7	SENT_366	[p25l602t2791r1009b2851],
9	resistant	JJ	O	resistant	amod	11	SENT_366	[p25l602t2791r1009b2851],
10	falciparum	NN	O	falciparum	nn	11	SENT_366	[p25l1031t2791r1345b2851],
11	malaria	NN	O	malaria	prep_of	3	SENT_366	[p25l1367t2791r1583b2839],
12	in	IN	O	in	_	0	SENT_366	[p25l1606t2791r1661b2838],
13	Tanzania	NNP	LOCATION	Tanzania	prep_in	3	SENT_366	[p25l1682t2792r1971b2839],
14	.	.	O	.	_	0	SENT_366	[p25l1682t2792r1971b2839],

1	Lancet	NNP	O	Lancet	_	0	SENT_367	[p25l112t2867r301b2914],
2	2001	CD	DATE	2001	num	1	SENT_367	[p25l322t2868r484b2923],
3	;	:	O	;	_	0	SENT_367	[p25l322t2868r484b2923],
4	358	CD	NUMBER	358	num	6	SENT_367	[p25l511t2867r632b2914],
5	:	:	O	:	_	0	SENT_367	[p25l511t2867r632b2914],
6	1218-23	CD	NUMBER	1218-23	dep	1	SENT_367	[p25l665t2868r930b2914],
7	.	.	O	.	_	0	SENT_367	[p25l665t2868r930b2914],

1	18	CD	NUMBER	18	num	3	SENT_368	[p25l16t2953r78b2999],
2	Kublin	NNP	ORGANIZATION	Kublin	nn	3	SENT_368	[p25l113t2951r317b2998],
3	JG	NNP	ORGANIZATION	JG	_	0	SENT_368	[p25l336t2951r435b3009],
4	,	,	O	,	_	0	SENT_368	[p25l336t2951r435b3009],
5	Dzinjalamala	NNP	PERSON	Dzinjalamala	nn	6	SENT_368	[p25l460t2951r845b3010],
6	F	NN	PERSON	f	appos	3	SENT_368	[p25l868t2952r926b3008],
7	,	,	O	,	_	0	SENT_368	[p25l868t2952r926b3008],
8	Kamwendo	NN	PERSON	kamwendo	nn	9	SENT_368	[p25l952t2951r1287b2999],
9	D	NN	O	d	appos	3	SENT_368	[p25l1311t2952r1382b3008],
10	,	,	O	,	_	0	SENT_368	[p25l1311t2952r1382b3008],
11	et	FW	O	et	nn	12	SENT_368	[p25l1408t2962r1460b2998],
12	al.	FW	O	al.	appos	3	SENT_368	[p25l1483t2951r1546b2998],
13	.	.	O	.	_	0	SENT_368	[p25l1483t2951r1546b2998],

1	Molecular	JJ	O	molecular	amod	2	SENT_369	[p25l1572t2951r1874b2998],
2	markers	NNS	O	marker	_	0	SENT_369	[p25l1895t2951r2126b2998],
3	for	IN	O	for	_	0	SENT_369	[p25l113t3026r195b3073],
4	failure	NN	O	failure	prep_for	2	SENT_369	[p25l216t3026r401b3073],
5	of	IN	O	of	_	0	SENT_369	[p25l425t3026r487b3073],
6	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	nn	9	SENT_369	[p25l503t3026r1307b3085],
7	and	CC	O	and	_	0	SENT_369	[p25l1332t3026r1438b3073],
8	chlorproguanildapsone	NN	O	chlorproguanildapsone	nn	9	SENT_369	[p25l1462t3026r1915b3085, p25l114t3101r353b3161],
9	treatment	NN	O	treatment	prep_of	2	SENT_369	[p25l376t3112r662b3149],
10	of	IN	O	of	_	0	SENT_369	[p25l685t3101r746b3149],
11	Plasmodium	NN	O	plasmodium	nn	13	SENT_369	[p25l760t3102r1097b3149],
12	falciparum	NN	O	falciparum	nn	13	SENT_369	[p25l1110t3102r1413b3161],
13	malaria	NN	O	malaria	prep_of	2	SENT_369	[p25l1437t3101r1669b3149],
14	.	.	O	.	_	0	SENT_369	[p25l1437t3101r1669b3149],

1	3	CD	NUMBER	3	nsubj	3	SENT_370	[p25l1689t3102r1730b3160],
2	’	RB	O	’	advmod	3	SENT_370	[p25l1689t3102r1730b3160],
3	Infect	VB	O	infect	_	0	SENT_370	[p25l1746t3102r1902b3160],
4	Dis	NNP	O	Dis	dobj	3	SENT_370	[p25l1920t3102r2012b3149],
5	2001	CD	DATE	2001	num	4	SENT_370	[p25l115t3178r277b3233],
6	;	:	O	;	_	0	SENT_370	[p25l115t3178r277b3233],
7	185	CD	NUMBER	185	num	9	SENT_370	[p25l307t3177r425b3224],
8	:	:	O	:	_	0	SENT_370	[p25l307t3177r425b3224],
9	380-88	CD	NUMBER	380-88	dep	4	SENT_370	[p25l453t3178r682b3224],
10	.	.	O	.	_	0	SENT_370	[p25l453t3178r682b3224],

1	19	CD	NUMBER	19	num	3	SENT_371	[p25l16t3263r78b3309],
2	Nevill	NNP	ORGANIZATION	Nevill	nn	3	SENT_371	[p25l112t3261r287b3309],
3	CG	NNP	ORGANIZATION	CG	_	0	SENT_371	[p25l313t3261r433b3318],
4	,	,	O	,	_	0	SENT_371	[p25l313t3261r433b3318],
5	Some	DT	O	some	det	6	SENT_371	[p25l461t3261r621b3309],
6	ES	NN	O	e	appos	3	SENT_371	[p25l645t3261r745b3318],
7	,	,	O	,	_	0	SENT_371	[p25l645t3261r745b3318],
8	Mung	NNP	O	Mung	nn	11	SENT_371	[p25l770t3261r1050b3320],
9	’	NNP	O	’	nn	11	SENT_371	[p25l770t3261r1050b3320],
10	ala	NN	O	alum	nn	11	SENT_371	[p25l770t3261r1050b3320],
11	VO	NNP	O	VO	appos	3	SENT_371	[p25l1072t3261r1190b3318],
12	,	,	O	,	_	0	SENT_371	[p25l1072t3261r1190b3318],
13	et	FW	O	et	nn	14	SENT_371	[p25l1217t3272r1268b3308],
14	al.	FW	O	al.	appos	3	SENT_371	[p25l1291t3261r1354b3308],
15	.	.	O	.	_	0	SENT_371	[p25l1291t3261r1354b3308],

1	Insecticide-treated	JJ	O	insecticide-treated	amod	2	SENT_372	[p25l1381t3261r1929b3309],
2	bednets	NNS	O	bednet	nsubj	3	SENT_372	[p25l112t3336r338b3383],
3	reduce	VB	O	reduce	_	0	SENT_372	[p25l362t3336r557b3383],
4	mortality	NN	O	mortality	nn	7	SENT_372	[p25l580t3336r848b3395],
5	and	CC	O	and	_	0	SENT_372	[p25l871t3336r976b3383],
6	severe	JJ	O	severe	conj_and	4	SENT_372	[p25l1000t3351r1176b3383],
7	morbidity	NN	O	morbidity	dobj	3	SENT_372	[p25l1200t3336r1488b3395],
8	from	IN	O	from	_	0	SENT_372	[p25l1509t3336r1649b3383],
9	malaria	NN	O	malaria	prep_from	7	SENT_372	[p25l1671t3336r1887b3383],
10	among	IN	O	among	_	0	SENT_372	[p25l1911t3351r2108b3395],
11	children	NNS	O	child	prep_among	3	SENT_372	[p25l114t3411r353b3459],
12	on	IN	O	on	_	0	SENT_372	[p25l377t3427r448b3459],
13	the	DT	O	the	det	15	SENT_372	[p25l470t3411r559b3459],
14	Kenyan	JJ	MISC	kenyan	amod	15	SENT_372	[p25l583t3412r808b3471],
15	coast	NN	O	coast	prep_on	11	SENT_372	[p25l832t3422r995b3459],
16	.	.	O	.	_	0	SENT_372	[p25l832t3422r995b3459],

1	Trop	NNP	O	Trop	nn	3	SENT_373	[p25l1028t3412r1152b3471],
2	Med	NNP	O	Med	nn	3	SENT_373	[p25l1171t3412r1301b3459],
3	Int	NNP	O	Int	_	0	SENT_373	[p25l1318t3412r1401b3459],
4	Health	NNP	O	Health	dep	3	SENT_373	[p25l1419t3412r1606b3459],
5	1996	CD	DATE	1996	num	4	SENT_373	[p25l1635t3413r1792b3468],
6	,	,	O	,	_	0	SENT_373	[p25l1635t3413r1792b3468],
7	1	CD	NUMBER	1	num	4	SENT_373	[p25l1822t3413r1869b3459],
8	:	:	O	:	_	0	SENT_373	[p25l1822t3413r1869b3459],
9	139-46	CD	NUMBER	139-46	dep	3	SENT_373	[p25l1903t3413r2130b3459],
10	.	.	O	.	_	0	SENT_373	[p25l1903t3413r2130b3459],

1	1	CD	NUMBER	1	num	2	SENT_374	[p25l80t3567r91b3593],
2	l42	NN	O	l42	_	0	SENT_374	[p25l101t3567r156b3593],
3	THE	DT	O	the	det	4	SENT_374	[p25l1196t3572r1257b3593],
4	LANCET	NN	O	lancet	dep	2	SENT_374	[p25l1267t3572r1391b3593],
5	-	:	O	-	_	0	SENT_374	[p25l1401t3579r1409b3587],
6	Vol	NN	O	vol	dep	2	SENT_374	[p25l1418t3572r1462b3593],
7	360	CD	NUMBER	360	num	6	SENT_374	[p25l1472t3573r1518b3593],
8	-	:	O	-	_	0	SENT_374	[p25l1529t3579r1536b3587],
9	October	NNP	DATE	October	dep	6	SENT_374	[p25l1547t3572r1650b3593],
10	12	CD	DATE	12	num	9	SENT_374	[p25l1661t3573r1697b3597],
11	,	,	DATE	,	_	0	SENT_374	[p25l1661t3573r1697b3597],
12	2002	CD	DATE	2002	num	9	SENT_374	[p25l1708t3573r1769b3593],
13	-	:	O	-	_	0	SENT_374	[p25l1780t3579r1788b3587],
14	www.thelancet.com	NN	O	www.thelancet.com	dep	9	SENT_374	[p25l1797t3572r2048b3593],

1	For	IN	O	for	_	0	SENT_375	[p25l81t3672r149b3707],
2	personal	JJ	O	personal	amod	3	SENT_375	[p25l174t3672r362b3715],
3	use	NN	O	use	pobj	1	SENT_375	[p25l390t3681r479b3707],
4	.	.	O	.	_	0	SENT_375	[p25l390t3681r479b3707],

1	Only	RB	O	only	advmod	2	SENT_376	[p25l527t3672r623b3716],
2	reproduce	VB	O	reproduce	_	0	SENT_376	[p25l648t3672r871b3715],
3	with	IN	O	with	_	0	SENT_376	[p25l895t3672r989b3707],
4	permission	NN	O	permission	prep_with	2	SENT_376	[p25l1017t3672r1258b3715],
5	from	IN	O	from	_	0	SENT_376	[p25l1283t3672r1381b3707],
6	The	DT	O	the	det	9	SENT_376	[p25l1406t3672r1486b3707],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_376	[p25l1512t3672r1662b3707],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_376	[p25l1688t3672r1921b3716],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_376	[p25l1944t3672r2088b3715],
10	.	.	O	.	_	0	SENT_376	[p25l1944t3672r2088b3715],

1	ARTICLES	NNS	O	article	_	0	SENT_377	[p25l1913t3791r2067b3812],

1	20	CD	NUMBER	20	_	0	SENT_378	[p26l7t175r70b218],
2	World	NNP	O	World	nn	4	SENT_378	[p26l100t173r273b218],
3	Health	NNP	O	Health	nn	4	SENT_378	[p26l294t173r478b218],
4	Organisation	NNP	O	Organisation	dep	1	SENT_378	[p26l500t174r864b229],
5	.	.	O	.	_	0	SENT_378	[p26l500t174r864b229],

1	Severe	JJ	O	severe	amod	2	SENT_379	[p26l891t174r1065b218],
2	falciparum	NN	O	falciparum	_	0	SENT_379	[p26l1087t173r1378b229],
3	malaria	NN	O	malaria	dep	2	SENT_379	[p26l1398t173r1614b218],
4	.	.	O	.	_	0	SENT_379	[p26l1398t173r1614b218],

1	Trans	NNP	O	Trans	nn	3	SENT_380	[p26l1644t174r1787b217],
2	R	NNP	O	R	nn	3	SENT_380	[p26l1807t174r1849b217],
3	Soc	NNP	O	Soc	_	0	SENT_380	[p26l1869t174r1957b218],

1	Trop	NNP	O	Trop	nn	3	SENT_381	[p26l108t244r223b299],
2	Med	NNP	O	Med	nn	3	SENT_381	[p26l240t244r361b287],
3	Hyg	NNP	O	Hyg	_	0	SENT_381	[p26l376t244r500b299],
4	,	,	O	,	_	0	SENT_381	[p26l376t244r500b299],
5	2000	CD	DATE	2000	appos	3	SENT_381	[p26l525t245r676b296],
6	;	:	O	;	_	0	SENT_381	[p26l525t245r676b296],
7	94	CD	NUMBER	94	number	8	SENT_381	[p26l701t245r764b288],
8	(	CD	NUMBER	(	num	9	SENT_381	[p26l791t243r957b299],
9	Suppl	NN	O	suppl	dep	3	SENT_381	[p26l791t243r957b299],
10	1	CD	NUMBER	1	num	11	SENT_381	[p26l984t244r1048b298],
11	)	NN	O	)	dep	9	SENT_381	[p26l984t244r1048b298],
12	.	.	O	.	_	0	SENT_381	[p26l984t244r1048b298],

1	21	CD	NUMBER	21	_	0	SENT_382	[p26l7t322r65b364],
2	World	NNP	ORGANIZATION	World	nn	4	SENT_382	[p26l100t320r272b364],
3	Health	NNP	ORGANIZATION	Health	nn	4	SENT_382	[p26l294t320r478b364],
4	Organisation	NNP	ORGANIZATION	Organisation	dep	1	SENT_382	[p26l500t320r864b375],
5	.	.	O	.	_	0	SENT_382	[p26l500t320r864b375],

1	Assessment	NNP	O	Assessment	_	0	SENT_383	[p26l887t321r1202b364],
2	of	IN	O	of	_	0	SENT_383	[p26l1223t320r1281b364],
3	therapeutic	JJ	O	therapeutic	amod	4	SENT_383	[p26l1294t320r1600b375],
4	efﬁcacy	NN	O	efﬁcacy	prep_of	1	SENT_383	[p26l1623t320r1826b375],
5	of	IN	O	of	_	0	SENT_383	[p26l1847t320r1904b364],
6	antimalarial	JJ	O	antimalarial	amod	7	SENT_383	[p26l103t390r424b434],
7	drugs	NNS	O	drug	prep_of	4	SENT_383	[p26l446t390r610b445],
8	:	:	O	:	_	0	SENT_383	[p26l446t390r610b445],
9	WHO/MAL/96	NN	O	who/mal/96	dep	1	SENT_383	[p26l633t390r1225b435],
10	.1077	CD	NUMBER	.1077	dep	9	SENT_383	[p26l633t390r1225b435],
11	.	.	O	.	_	0	SENT_383	[p26l633t390r1225b435],

1	Geneva	NNP	LOCATION	Geneva	_	0	SENT_384	[p26l1252t390r1469b435],
2	:	:	O	:	_	0	SENT_384	[p26l1252t390r1469b435],
3	WHO	WP	O	who	dep	1	SENT_384	[p26l1493t390r1674b443],
4	,	,	O	,	_	0	SENT_384	[p26l1493t390r1674b443],
5	1996	CD	DATE	1996	appos	3	SENT_384	[p26l1704t392r1847b435],
6	.	.	O	.	_	0	SENT_384	[p26l1704t392r1847b435],

1	22	CD	NUMBER	22	num	3	SENT_385	[p26l7t469r70b510],
2	Nosten	NNP	O	Nosten	nn	3	SENT_385	[p26l101t467r298b511],
3	F	NN	O	f	_	0	SENT_385	[p26l319t467r373b519],
4	,	,	O	,	_	0	SENT_385	[p26l319t467r373b519],
5	ter	NN	O	ter	nn	7	SENT_385	[p26l396t477r469b511],
6	Kuile	NNP	O	Kuile	nn	7	SENT_385	[p26l489t467r636b511],
7	FO	NNP	O	FO	appos	3	SENT_385	[p26l658t467r762b519],
8	,	,	O	,	_	0	SENT_385	[p26l658t467r762b519],
9	Luxemburger	NNP	O	Luxemburger	nn	10	SENT_385	[p26l785t467r1157b522],
10	C	NNP	O	C	appos	3	SENT_385	[p26l1179t467r1239b519],
11	,	,	O	,	_	0	SENT_385	[p26l1179t467r1239b519],
12	et	FW	O	et	nn	13	SENT_385	[p26l1263t477r1311b511],
13	al.	FW	O	al.	appos	3	SENT_385	[p26l1332t467r1391b511],
14	.	.	O	.	_	0	SENT_385	[p26l1332t467r1391b511],

1	Cardiac	JJ	MISC	cardiac	amod	2	SENT_386	[p26l1418t467r1628b511],
2	effects	NNS	O	effect	_	0	SENT_386	[p26l1650t466r1820b511],
3	of	IN	O	of	_	0	SENT_386	[p26l103t537r160b581],
4	antimalarial	JJ	O	antimalarial	amod	5	SENT_386	[p26l175t537r496b581],
5	treatment	NN	O	treatment	prep_of	2	SENT_386	[p26l517t547r782b581],
6	with	IN	O	with	_	0	SENT_386	[p26l801t537r919b581],
7	halofantrine	NN	O	halofantrine	prep_with	2	SENT_386	[p26l939t537r1283b581],
8	.	.	O	.	_	0	SENT_386	[p26l939t537r1283b581],

1	Lancet	NNP	O	Lancet	_	0	SENT_387	[p26l1307t538r1482b581],
2	1993	CD	DATE	1993	num	1	SENT_387	[p26l1506t539r1652b590],
3	;	:	O	;	_	0	SENT_387	[p26l1506t539r1652b590],
4	341	CD	NUMBER	341	num	6	SENT_387	[p26l1676t539r1788b581],
5	:	:	O	:	_	0	SENT_387	[p26l1676t539r1788b581],
6	1054-56	CD	NUMBER	1054-56	dep	1	SENT_387	[p26l109t608r353b650],
7	.	.	O	.	_	0	SENT_387	[p26l109t608r353b650],

1	23	CD	NUMBER	23	num	3	SENT_388	[p26l7t685r69b728],
2	Byrd	NNP	O	Byrd	nn	3	SENT_388	[p26l102t683r232b739],
3	SR	NN	O	sr	_	0	SENT_388	[p26l255t684r349b736],
4	,	,	O	,	_	0	SENT_388	[p26l255t684r349b736],
5	Gelber	NNP	PERSON	Gelber	nn	6	SENT_388	[p26l373t683r558b728],
6	RH	NNP	O	RH	appos	3	SENT_388	[p26l578t684r687b727],
7	.	.	O	.	_	0	SENT_388	[p26l578t684r687b727],

1	Effect	NN	O	effect	_	0	SENT_389	[p26l712t683r872b728],
2	of	IN	O	of	_	0	SENT_389	[p26l894t683r951b728],
3	dapsone	NN	O	dapsone	prep_of	1	SENT_389	[p26l966t683r1187b739],
4	on	IN	O	on	_	0	SENT_389	[p26l1210t698r1276b728],
5	haemoglobin	NN	O	haemoglobin	nn	6	SENT_389	[p26l1296t683r1649b739],
6	concentration	NN	O	concentration	prep_on	1	SENT_389	[p26l103t753r478b797],
7	in	IN	O	in	_	0	SENT_389	[p26l499t753r550b796],
8	patients	NNS	O	patient	prep_in	1	SENT_389	[p26l569t753r782b808],
9	with	IN	O	with	_	0	SENT_389	[p26l803t753r921b797],
10	leprosy	NNP	O	leprosy	prep_with	8	SENT_389	[p26l942t753r1149b808],
11	.	.	O	.	_	0	SENT_389	[p26l942t753r1149b808],

1	Lepr	NNP	O	Lepr	nn	2	SENT_390	[p26l1174t753r1293b808],
2	Rev	NN	O	rev	_	0	SENT_390	[p26l1309t753r1408b797],
3	1991	CD	DATE	1991	num	2	SENT_390	[p26l1435t754r1580b805],
4	;	:	O	;	_	0	SENT_390	[p26l1435t754r1580b805],
5	62	CD	NUMBER	62	num	7	SENT_390	[p26l1604t755r1684b797],
6	:	:	O	:	_	0	SENT_390	[p26l1604t755r1684b797],
7	171-78	CD	NUMBER	171-78	dep	2	SENT_390	[p26l1715t754r1925b797],
8	.	.	O	.	_	0	SENT_390	[p26l1715t754r1925b797],

1	Clinical	JJ	O	clinical	amod	2	SENT_391	[p26l13t1016r467b1115],
2	picture	NN	O	picture	_	0	SENT_391	[p26l524t1016r953b1138],

1	Necrobiosis	NN	O	necrobiosis	_	0	SENT_392	[p26l16t1199r683b1291],
2	lipoidica	NN	O	lipoidica	nn	3	SENT_392	[p26l732t1199r1208b1312],
3	diabeticorum	NN	O	diabeticorum	dep	1	SENT_392	[p26l1255t1199r2006b1291],

1	Mark	NNP	PERSON	Mark	nn	3	SENT_393	[p26l12t1440r222b1506],
2	A	NNP	PERSON	A	nn	3	SENT_393	[p26l246t1440r298b1505],
3	Marinella	NNP	PERSON	Marinella	_	0	SENT_393	[p26l336t1440r714b1506],

1	A	DT	O	a	det	3	SENT_394	[p26l7t1655r77b1722],
2	38-year-old	JJ	DURATION	38-year-old	amod	3	SENT_394	[p26l115t1654r599b1740],
3	woman	NN	O	woman	nsubjpass	16	SENT_394	[p26l634t1676r943b1723],
4	with	IN	O	with	_	0	SENT_394	[p26l978t1654r1161b1723],
5	poorly	RB	O	poorly	advmod	6	SENT_394	[p26l1197t1654r1467b1741],
6	controlled	VBN	O	control	amod	7	SENT_394	[p26l1504t1654r1928b1723],
7	type	NN	O	type	prep_with	3	SENT_394	[p26l1966t1669r2141b1741],
8	1	CD	NUMBER	1	num	10	SENT_394	[p26l20t1764r48b1829],
9	diabetes	NN	O	diabetes	nn	10	SENT_394	[p26l154t1761r493b1830],
10	mellitus	NN	O	mellitus	nsubj	11	SENT_394	[p26l588t1761r919b1830],
11	complicated	VBN	O	complicate	parataxis	16	SENT_394	[p26l1016t1761r1528b1848],
12	by	IN	O	by	_	0	SENT_394	[p26l1619t1761r1720b1848],
13	diabetic	JJ	O	diabetic	amod	14	SENT_394	[p26l1813t1761r2141b1830],
14	nephropathy	NN	O	nephropathy	prep_by	11	SENT_394	[p26l8t1866r543b1953],
15	was	VBD	O	be	auxpass	16	SENT_394	[p26l685t1889r838b1936],
16	admitted	VBN	O	admit	_	0	SENT_394	[p26l989t1866r1363b1936],
17	for	IN	O	for	_	0	SENT_394	[p26l1509t1866r1628b1936],
18	coronary	JJ	O	coronary	amod	19	SENT_394	[p26l1774t1889r2144b1953],
19	angiography	NN	O	angiography	prep_for	16	SENT_394	[p26l11t1973r526b2060],
20	following	VBG	O	follow	_	0	SENT_394	[p26l619t1973r1008b2060],
21	an	DT	O	a	det	24	SENT_394	[p26l1104t1996r1202b2043],
22	abnormal	JJ	O	abnormal	amod	24	SENT_394	[p26l1299t1973r1696b2043],
23	thallium	NN	O	thallium	nn	24	SENT_394	[p26l1792t1973r2142b2043],
24	study	NN	O	study	prep_following	19	SENT_394	[p26l11t2082r257b2169],
25	.	.	O	.	_	0	SENT_394	[p26l11t2082r257b2169],

1	On	IN	O	on	_	0	SENT_395	[p26l333t2082r462b2151],
2	physical	JJ	O	physical	amod	3	SENT_395	[p26l527t2082r864b2169],
3	examination	NN	O	examination	prep_on	6	SENT_395	[p26l934t2082r1451b2151],
4	she	PRP	O	she	nsubj	6	SENT_395	[p26l1520t2082r1651b2151],
5	had	VBD	O	have	aux	6	SENT_395	[p26l1719t2082r1874b2151],
6	welldemarcated	VBN	O	welldemarcate	ccomp	17	SENT_395	[p26l1939t2082r2141b2151, p26l11t2187r526b2270],
7	,	,	O	,	_	0	SENT_395	[p26l1939t2082r2141b2151, p26l11t2187r526b2270],
8	waxy	NN	O	waxy	nn	10	SENT_395	[p26l611t2210r825b2274],
9	erythematous	JJ	O	erythematous	amod	10	SENT_395	[p26l908t2187r1473b2274],
10	plaques	NNS	O	plaque	nsubj	17	SENT_395	[p26l1557t2187r1875b2274],
11	with	IN	O	with	_	0	SENT_395	[p26l1959t2187r2143b2257],
12	prominent	JJ	O	prominent	amod	13	SENT_395	[p26l7t2295r450b2381],
13	telangiectasias	NNS	O	telangiectasia	prep_with	10	SENT_395	[p26l578t2294r1176b2381],
14	over	IN	O	over	_	0	SENT_395	[p26l1308t2317r1486b2364],
15	both	DT	O	both	det	16	SENT_395	[p26l1611t2294r1804b2364],
16	shins	NNS	O	shin	prep_over	13	SENT_395	[p26l1933t2294r2140b2364],
17	(	VBP	O	(	_	0	SENT_395	[p26l16t2403r346b2490],
18	ﬁgure	NN	O	ﬁgure	nn	19	SENT_395	[p26l16t2403r346b2490],
19	)	NN	O	)	dobj	17	SENT_395	[p26l16t2403r346b2490],
20	.	.	O	.	_	0	SENT_395	[p26l16t2403r346b2490],

1	These	DT	O	these	det	2	SENT_396	[p26l450t2403r705b2472],
2	lesions	NNS	O	lesion	nsubj	4	SENT_396	[p26l805t2403r1083b2472],
3	are	VBP	O	be	cop	4	SENT_396	[p26l1186t2425r1308b2472],
4	characteristic	JJ	O	characteristic	_	0	SENT_396	[p26l1409t2403r1963b2472],
5	of	IN	O	of	_	0	SENT_396	[p26l2064t2403r2153b2472],
6	necrobiosis	NN	O	necrobiosis	nn	8	SENT_396	[p26l8t2508r478b2578],
7	lipoidica	NN	O	lipoidica	nn	8	SENT_396	[p26l513t2508r870b2595],
8	diabeticorum	NN	O	diabeticorum	prep_of	4	SENT_396	[p26l905t2508r1489b2591],
9	,	,	O	,	_	0	SENT_396	[p26l905t2508r1489b2591],
10	an	DT	O	a	det	14	SENT_396	[p26l1528t2531r1625b2578],
11	uncommon	JJ	O	uncommon	amod	12	SENT_396	[p26l1658t2531r2143b2578],
12	granulomatous	JJ	O	granulomatous	amod	14	SENT_396	[p26l9t2615r637b2702],
13	inﬂammatory	JJ	O	inﬂammatory	amod	14	SENT_396	[p26l700t2615r1267b2702],
14	dermopathy	NN	O	dermopathy	appos	8	SENT_396	[p26l1327t2615r1835b2702],
15	which	WDT	O	which	nsubj	16	SENT_396	[p26l1892t2615r2143b2685],
16	affects	VBZ	O	affect	rcmod	14	SENT_396	[p26l11t2724r273b2793],
17	less	JJR	O	less	mwe	18	SENT_396	[p26l342t2724r485b2793],
18	than	IN	O	than	quantmod	19	SENT_396	[p26l553t2724r740b2793],
19	1	CD	PERCENT	1	num	20	SENT_396	[p26l817t2724r939b2795],
20	%	NN	PERCENT	%	dobj	16	SENT_396	[p26l817t2724r939b2795],
21	of	IN	O	of	_	0	SENT_396	[p26l1013t2724r1102b2793],
22	patients	NNS	O	patient	prep_of	20	SENT_396	[p26l1156t2724r1484b2811],
23	with	IN	O	with	_	0	SENT_396	[p26l1551t2724r1733b2793],
24	diabetes	NN	O	diabetes	nn	25	SENT_396	[p26l1801t2724r2140b2793],
25	mellitus	NN	O	mellitus	prep_with	22	SENT_396	[p26l8t2830r363b2900],
26	.	.	O	.	_	0	SENT_396	[p26l8t2830r363b2900],

1	24	CD	NUMBER	24	num	3	SENT_397	[p26l57t3068r125b3112],
2	Mookherjee	NN	ORGANIZATION	mookherjee	nn	3	SENT_397	[p26l157t3066r501b3124],
3	S	NN	ORGANIZATION	s	_	0	SENT_397	[p26l525t3067r577b3122],
4	,	,	O	,	_	0	SENT_397	[p26l525t3067r577b3122],
5	Howard	NNP	PERSON	Howard	nn	6	SENT_397	[p26l602t3066r834b3113],
6	V	NNP	PERSON	V	appos	3	SENT_397	[p26l854t3067r917b3122],
7	,	,	O	,	_	0	SENT_397	[p26l854t3067r917b3122],
8	Nzila	NNP	LOCATION	Nzila	appos	6	SENT_397	[p26l941t3066r1397b3113],
9	.	.	O	.	_	0	SENT_397	[p26l941t3066r1397b3113],

1	—	NN	O	—	_	0	SENT_398	[p26l941t3066r1397b3113],
2	.	.	O	.	_	0	SENT_398	[p26l941t3066r1397b3113],

1	Mouanda	NNP	MISC	Mouanda	nn	2	SENT_399	[p26l941t3066r1397b3113],
2	A	NNP	MISC	A	_	0	SENT_399	[p26l1418t3067r1481b3122],
3	,	,	O	,	_	0	SENT_399	[p26l1418t3067r1481b3122],
4	Watkins	NNP	PERSON	Watkins	nn	5	SENT_399	[p26l1504t3066r1738b3113],
5	W	NNP	O	W	appos	2	SENT_399	[p26l1760t3067r1842b3122],
6	,	,	O	,	_	0	SENT_399	[p26l1760t3067r1842b3122],

1	Sibley	NNP	PERSON	Sibley	_	0	SENT_400	[p26l160t3142r333b3200],
2	CH	NN	O	ch	dep	1	SENT_400	[p26l356t3142r474b3188],
3	.	.	O	.	_	0	SENT_400	[p26l356t3142r474b3188],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_401	[p26l500t3141r888b3188],
2	and	CC	O	and	_	0	SENT_401	[p26l912t3142r1015b3188],
3	analysis	NN	O	analysis	conj_and	1	SENT_401	[p26l1039t3142r1257b3200],
4	of	IN	O	of	_	0	SENT_401	[p26l1281t3141r1341b3188],
5	dihydrofolate	JJ	O	dihydrofolate	amod	7	SENT_401	[p26l1357t3141r1738b3200],
6	reductase	NN	O	reductase	nn	7	SENT_401	[p26l1761t3142r2033b3188],
7	alleles	NNS	O	allele	prep_of	1	SENT_401	[p26l159t3218r330b3264],
8	from	IN	O	from	_	0	SENT_401	[p26l353t3218r489b3264],
9	Plasmodium	NN	LOCATION	plasmodium	nn	10	SENT_401	[p26l511t3218r841b3264],
10	falciparum	NN	O	falciparum	prep_from	7	SENT_401	[p26l853t3218r1150b3276],
11	present	JJ	DATE	present	amod	1	SENT_401	[p26l1172t3228r1383b3276],
12	at	IN	O	at	_	0	SENT_401	[p26l1406t3228r1456b3264],
13	low	JJ	O	low	amod	14	SENT_401	[p26l1478t3218r1578b3264],
14	frequency	NN	O	frequency	prep_at	11	SENT_401	[p26l1599t3218r1883b3276],
15	in	IN	O	in	_	0	SENT_401	[p26l1904t3218r1957b3264],
16	polyclonal	JJ	O	polyclonal	amod	18	SENT_401	[p26l157t3294r452b3352],
17	patient	NN	O	patient	nn	18	SENT_401	[p26l474t3294r674b3352],
18	samples	NNS	O	sample	prep_in	14	SENT_401	[p26l697t3294r937b3352],
19	.	.	O	.	_	0	SENT_401	[p26l697t3294r937b3352],

1	Am	VBP	O	be	dep	3	SENT_402	[p26l959t3294r1059b3340],
2	3	CD	NUMBER	3	num	3	SENT_402	[p26l1074t3294r1116b3352],
3	‘	CD	NUMBER	‘	_	0	SENT_402	[p26l1074t3294r1116b3352],
4	Trop	NNP	O	Trop	nn	6	SENT_402	[p26l1139t3295r1259b3352],
5	Med	NNP	O	Med	nn	6	SENT_402	[p26l1278t3294r1406b3341],
6	Hyg	NNP	O	Hyg	dep	3	SENT_402	[p26l1422t3295r1540b3352],
7	1999	CD	DATE	1999	dep	6	SENT_402	[p26l1565t3296r1719b3350],
8	;	:	O	;	_	0	SENT_402	[p26l1565t3296r1719b3350],
9	61	CD	NUMBER	61	dep	7	SENT_402	[p26l1744t3296r1829b3341],
10	:	:	O	:	_	0	SENT_402	[p26l1744t3296r1829b3341],
11	13	CD	NUMBER	13	num	12	SENT_402	[p26l165t3372r225b3416],
12	1-40	CD	NUMBER	1-40	dep	9	SENT_402	[p26l238t3372r387b3416],
13	.	.	O	.	_	0	SENT_402	[p26l238t3372r387b3416],

1	25	CD	NUMBER	25	num	3	SENT_403	[p26l57t3453r123b3497],
2	Brockman	NNP	ORGANIZATION	Brockman	nn	3	SENT_403	[p26l158t3451r454b3497],
3	A	NNP	ORGANIZATION	A	_	0	SENT_403	[p26l474t3452r538b3507],
4	,	,	O	,	_	0	SENT_403	[p26l474t3452r538b3507],
5	Price	NNP	O	Price	nn	6	SENT_403	[p26l563t3451r706b3497],
6	RN	NNP	O	RN	appos	3	SENT_403	[p26l730t3452r847b3507],
7	,	,	O	,	_	0	SENT_403	[p26l730t3452r847b3507],
8	van	NNP	O	van	nn	10	SENT_403	[p26l870t3466r970b3497],
9	Vugt	NNP	O	Vugt	nn	10	SENT_403	[p26l990t3452r1130b3509],
10	M	NN	O	m	appos	3	SENT_403	[p26l1151t3452r1232b3507],
11	,	,	O	,	_	0	SENT_403	[p26l1151t3452r1232b3507],
12	et	FW	O	et	nn	13	SENT_403	[p26l1258t3461r1308b3497],
13	al.	FW	O	al.	appos	3	SENT_403	[p26l1330t3451r1392b3497],
14	.	.	O	.	_	0	SENT_403	[p26l1330t3451r1392b3497],

1	Plasmodium	NN	O	plasmodium	nn	2	SENT_404	[p26l1418t3451r1748b3497],
2	falciparum	NN	O	falciparum	_	0	SENT_404	[p26l1760t3451r2058b3509],
3	antimalarial	JJ	O	antimalarial	amod	5	SENT_404	[p26l159t3527r499b3574],
4	drug	NN	O	drug	nn	5	SENT_404	[p26l522t3527r654b3585],
5	susceptibility	NN	O	susceptibility	dep	2	SENT_404	[p26l676t3527r1052b3585],
6	on	IN	O	on	_	0	SENT_404	[p26l1074t3542r1144b3574],
7	the	DT	O	the	det	11	SENT_404	[p26l1165t3527r1253b3574],
8	north	NN	O	north	nn	11	SENT_404	[p26l1275t3527r1680b3574],
9	—	CD	NUMBER	—	num	11	SENT_404	[p26l1275t3527r1680b3574],
10	western	JJ	O	western	amod	11	SENT_404	[p26l1275t3527r1680b3574],
11	border	NN	O	border	prep_on	5	SENT_404	[p26l1700t3527r1893b3574],
12	of	IN	O	of	_	0	SENT_404	[p26l1915t3527r1975b3574],
13	Thailand	NNP	LOCATION	Thailand	prep_of	11	SENT_404	[p26l157t3603r419b3650],
14	during	IN	O	during	_	0	SENT_404	[p26l442t3603r630b3662],
15	ﬁve	CD	NUMBER	ﬁve	num	16	SENT_404	[p26l651t3603r750b3650],
16	years	NNS	NUMBER	year	prep_during	13	SENT_404	[p26l771t3618r916b3661],
17	of	IN	O	of	_	0	SENT_404	[p26l940t3603r1000b3650],
18	extensive	JJ	O	extensive	amod	19	SENT_404	[p26l1016t3604r1276b3650],
19	use	NN	O	use	prep_of	16	SENT_404	[p26l1298t3618r1390b3650],
20	of	IN	O	of	_	0	SENT_404	[p26l1415t3603r1475b3650],
21	artesunate	NN	O	artesunate	nn	23	SENT_404	[p26l1491t3603r2153b3662],
22	—	NN	O	—	nn	23	SENT_404	[p26l1491t3603r2153b3662],
23	meﬂoquine	NN	O	meﬂoquine	prep_of	19	SENT_404	[p26l1491t3603r2153b3662],
24	.	.	O	.	_	0	SENT_404	[p26l1491t3603r2153b3662],

1	Trans	NNP	O	Trans	nn	6	SENT_405	[p26l164t3679r315b3725],
2	R	NNP	O	R	nn	6	SENT_405	[p26l336t3679r381b3725],
3	Soc	NNP	O	Soc	nn	6	SENT_405	[p26l402t3679r494b3725],
4	Trop	NNP	O	Trop	nn	6	SENT_405	[p26l522t3679r643b3737],
5	Med	NNP	O	Med	nn	6	SENT_405	[p26l662t3679r789b3725],
6	Hyg	NNP	O	Hyg	_	0	SENT_405	[p26l805t3679r923b3737],
7	2000	CD	DATE	2000	num	6	SENT_405	[p26l943t3681r1102b3734],
8	;	:	O	;	_	0	SENT_405	[p26l943t3681r1102b3734],
9	94	CD	NUMBER	94	num	11	SENT_405	[p26l1128t3681r1212b3725],
10	:	:	O	:	_	0	SENT_405	[p26l1128t3681r1212b3725],
11	537-44	CD	NUMBER	537-44	dep	6	SENT_405	[p26l1241t3680r1467b3725],
12	.	.	O	.	_	0	SENT_405	[p26l1241t3680r1467b3725],

1	Wright	NNP	ORGANIZATION	Wright	nn	4	SENT_406	[p27l76t1623r168b1651],
2	State	NNP	ORGANIZATION	State	nn	4	SENT_406	[p27l178t1623r254b1646],
3	University	NNP	ORGANIZATION	University	nn	4	SENT_406	[p27l265t1623r402b1651],
4	School	NNP	ORGANIZATION	School	dep	18	SENT_406	[p27l412t1623r505b1646],
5	of	IN	ORGANIZATION	of	_	0	SENT_406	[p27l516t1623r543b1646],
6	Medicine	NNP	ORGANIZATION	Medicine	nn	10	SENT_406	[p27l553t1623r687b1650],
7	,	,	O	,	_	0	SENT_406	[p27l553t1623r687b1650],
8	Dayton	NNP	LOCATION	Dayton	appos	10	SENT_406	[p27l700t1623r804b1651],
9	,	,	O	,	_	0	SENT_406	[p27l700t1623r804b1651],
10	Ohio	NNP	LOCATION	Ohio	prep_of	4	SENT_406	[p27l816t1623r877b1646],
11	45429	CD	NUMBER	45429	num	10	SENT_406	[p27l887t1623r988b1650],
12	,	,	O	,	_	0	SENT_406	[p27l887t1623r988b1650],
13	USA	NNP	LOCATION	USA	appos	10	SENT_406	[p27l1001t1623r1058b1646],
14	(	CD	NUMBER	(	num	15	SENT_406	[p27l1069t1623r1101b1651],
15	M	NN	O	m	dep	18	SENT_406	[p27l1069t1623r1101b1651],
16	A	NN	O	a	nn	18	SENT_406	[p27l1112t1623r1129b1645],
17	Marinella	NN	O	marinellum	nn	18	SENT_406	[p27l1141t1623r1263b1646],
18	MD	NN	O	md	_	0	SENT_406	[p27l1275t1623r1316b1651],
19	)	CD	NUMBER	)	dep	18	SENT_406	[p27l1275t1623r1316b1651],

1	THE	DT	O	the	det	2	SENT_407	[p27l78t2879r140b2900],
2	LANCET	NN	O	lancet	poss	4	SENT_407	[p27l149t2878r274b2900],
3	'	POS	O	'	_	0	SENT_407	[p27l283t2886r291b2894],
4	Vol	NN	O	vol	_	0	SENT_407	[p27l300t2879r344b2900],
5	360	CD	NUMBER	360	dep	4	SENT_407	[p27l354t2880r400b2900],
6	-	:	O	-	_	0	SENT_407	[p27l411t2886r418b2894],
7	October	NNP	DATE	October	dep	4	SENT_407	[p27l429t2879r532b2900],
8	12	CD	DATE	12	num	7	SENT_407	[p27l543t2879r579b2904],
9	,	,	DATE	,	_	0	SENT_407	[p27l543t2879r579b2904],
10	2002	CD	DATE	2002	num	7	SENT_407	[p27l590t2880r652b2900],
11	-	:	O	-	_	0	SENT_407	[p27l662t2886r670b2894],
12	www.thelancet.com	NN	O	www.thelancet.com	dep	7	SENT_407	[p27l679t2879r930b2900],
13	1	CD	NUMBER	1	number	14	SENT_407	[p27l1972t2874r1983b2900],
14	143	CD	NUMBER	143	dep	12	SENT_407	[p27l1993t2874r2048b2900],
15	For	IN	O	for	_	0	SENT_407	[p27l79t2979r148b3014],
16	personal	JJ	O	personal	amod	17	SENT_407	[p27l173t2979r361b3023],
17	use	NN	O	use	prep_for	14	SENT_407	[p27l388t2988r477b3014],
18	.	.	O	.	_	0	SENT_407	[p27l388t2988r477b3014],

1	Only	RB	O	only	advmod	2	SENT_408	[p27l525t2979r622b3023],
2	reproduce	VB	O	reproduce	_	0	SENT_408	[p27l647t2979r869b3023],
3	with	IN	O	with	_	0	SENT_408	[p27l893t2979r988b3014],
4	permission	NN	O	permission	prep_with	2	SENT_408	[p27l1015t2979r1256b3023],
5	from	IN	O	from	_	0	SENT_408	[p27l1281t2979r1379b3014],
6	The	DT	O	the	det	9	SENT_408	[p27l1404t2979r1484b3014],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_408	[p27l1510t2979r1660b3014],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_408	[p27l1686t2979r1919b3023],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_408	[p27l1942t2979r2086b3023],
10	.	.	O	.	_	0	SENT_408	[p27l1942t2979r2086b3023],

